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“Scientists are a friendly, atheistic, hard-working, beer-drinking lot 
whose minds are preoccupied with sex, chess and baseball when 
they are not preoccupied with science.” 
 
Yann Martel, Life of Pi 
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Chapter 1 
Asymmetric Synthesis of Chiral 
Heterocycles 
A selection of enantioselective synthetic approaches to chiral heterocycles is 
presented. The focus lies on catalytic asymmetric transformations with transition 
metal catalysts. Chiral phosphoramidite ligands serve as the vantage point as they 
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1. Chiral Heterocycles 
Many naturally occuring compounds with biological activity posess chiral 
heterocycles as structural elements. Some illustrative examples are displayed in 
Figure 1. Laurenditerpenol (1), containing a bicyclic tetrahydrofuran moiety, was 
found to be a small molecule suppressor of tumor growth in human breast tumor 
cells.
1,2
 The substituted chiral piperidine alkaloid
3
 coniin (2) is a potent neurotoxin 
which acts by blocking the nicotinic receptor in the post-synaptic membrane.
4
 
Complex opoid alkaloid morphine (3) is used as a potent painkiller.
4
 It posesses 
both a nitrogen- and an oxygen-containing heterocycle. Artemisinin (4) bears a rare 
example of a naturally occuring peroxide, which is key to its anti-malarial activity, 
even though the exact mode of action is still subject of discussion.
5-9
 Finally, 
synthetic chiral piperidine paroxetine (5) is a selective serotonine reuptake inhibitor 




Figure 1 Some biologically active compounds bearing chiral heterocycles 
The broad range of biological activites of chiral heterocyclic compounds makes 
them valuable and interesting targets for organic synthesis, both from the industrial 
as well as academic perspective. On the one hand, large-scale and cost-effective 
synthesis is of major interest, whereas on the other hand, method-development or 
structural confirmation might be the main focus of researchers. This holds true not 
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only for naturally occuring products, but also for synthetic analogues thereof or de 
novo designed biologically active compounds. 
 
2. Synthetic approaches to chiral heterocycles 
When the synthesis of a chiral molecule, for example a chiral heterocyclic 
structure, is envisaged, a variety of approaches can be followed to introduce the 
stereogenic centers.
12-14
 The most common include racemic synthesis followed by 
separation of enantiomers, synthesis based on the chiral pool or enantioselective 
synthesis.
15-18
 Each of these approaches has its advantages and there is no 
general gold-standard. Rather, the strategic use and combination of these 
methods, before the background of cost-effectiveness and synthetic difficulty, 
seems to be the ideal approach to a particular target.
19-21
 In the following, the focus 
shall be on of the major approaches to enantioselective synthesis, namely 
asymmetric catalysis. 
 
3. Asymmetric transition metal-catalyzed reactions  
The field of asymmetric transition metal-catalysis is wide,
15
 and has been 
recognized by the 2001 chemistry Nobel prize,
22-24
 which awarded the development 
of “chirally catalyzed” reactions.
25
 The notion of introducing stereogenic centers 
using metal-catalysts bearing chiral ligands has some advantages: Ideally, a very 
small amount of chiral catalyst is sufficient for the synthesis of a large quantitiy of a 
chiral product. In the case where both enantiomers of the chiral catalyst of interest 
are available, both enantiomers of the desired product can be synthesized 
selectively. Catalyst optimization by ligand screening opens up the possibility to 
quickly select, optimize and improve the asymmetric transformation. 
Over the years, some so-called “privileged ligands” have emerged, which can be 
successfully applied to many different asymmetric transformations.
26
 In the 
following section, asymmetric catalysis with chiral phosphoramidite ligands will be 
discussed. On the one hand, this showcases the versatility of this class of ligands, 
which can partly be attributed to their modular setup and the resulting facile 
diversification. On the other hand, as these types of ligands have been applied to a 
wide variety of reactions,
27-32
 they serve as a good example and overview for the 
wide applicability and synthetic usefulness of asymmetric transition metal catalysis 
in general. In the following section, some applications of phosphoramidites in the 






4. Synthesis of chiral heterocycles with phosphoramidite ligands  
In this section, a selection of catalytic asymmetric transformations is presented, 
which are based on phosphoramidite-transition metal complexes as chiral catalysts 
for the synthesis of chiral heterocycles. This section is subdivided by reaction 
mechanisms; starting off with the Cu-catalyzed conjugate addition reaction (see 
section 4.1). This transformation employs organometallic reagents as carbon 
nucleophiles, therefore it mostly makes use of heterocyclic -unsaturated 
carbonyl compounds as substrates, when chiral heterocycles are envisaged. A 
different approach can be taken when the allylic substitution reaction is chosen 
(see section 4.2): especially the Ir-catalyzed allylic substitution, which accepts a 
wide variety of heteroatom-based nucleophiles is ideally suited for the construction 
of chiral heterocycles. Other than the transition metal-catalyzed conjugate addition, 
which is mainly restricted to the use of carbon nucleophiles, the heteroatom can be 
introduced directly through this methodology and has led to many examples of 
syntheses of chiral heterocylces (vide infra). Finally, a selection of asymmetric 
catalytic approaches based on other mechanisms is discussed (section 4.3). 
 
4.1 Cu-catalyzed conjugate addition reactions 
The asymmetric conjugate addition reaction ranks among the most studied 
synthetic transformation in the last decades.
33-37
 Especially the development of an 
effective enantioselective copper-catalyzed conjugate addition of organometallic 
reagents has for a long time been a major challenge in synthetic chemistry.
27,38-43
 
In this transformation, the nucleophile is transferred to the β-position of an -
unsaturated system 6 (e.g. an enone) to yield a stabilized carbanion 7 (Scheme 1). 
This intermediate can subsequently be protonated, yielding β-chiral product 8 or it 
can be quenched by addition of another electrophile to provide chiral compounds 9 
with vicinal stereocenters. 
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Scheme 1 Conjugate addition 
A well-known problem that had to be overcome was the high affinity of 
organometallic reagents towards the 1,2-addition directly to the electron 
withdrawing group. This catalytic asymmetric conjugate addition methodology has 
successfully been developed for a wide variety of substrates (e.g. enones, -
unsaturated esters, nitroalkenes, etc.) and organometallic nucleophiles (Grignard 
reagents, organozinc, and -aluminium compounds) and furthermore has been 
applied to numerous natural product syntheses.
33-40,44
 Two representative 
examples are discussed in the following section. 
 
Asymmetric synthesis of chiral heterocycles bearing quaternary centers 
The copper-catalyzed conjugate addition of diethylzinc to enones was applied to 
derivatives of Meldrum's acid, yielding derivatives of β-substituted carboxylic 
acids.
45
 This transformation was extended to arylalkylidene derivatives of 
Meldrum's acid 10, carrying two substituents at the olefin moiety (Scheme 2).
46
 
With phosphoramidite ligand L1 the addition products 11 were obtained in 
excellent yields and ee values up to 95%. This reaction furnishes an attractive 
route for the synthesis of chiral quaternary carbon atoms
47-53
 and has recently been 
applied to the asymmetric synthesis of chiral succinimides 12 and chiral γ-








Scheme 2 Conjugate addition to derivatives of Meldrum's acid 
 
Asymmetric synthesis of myrtine 
The copper-catalyzed asymmetric conjugate addition reaction with trialkylaluminum 
reagents to enones
28,55-62
 has been applied in the first catalytic asymmetric 
synthesis of the alkaloid myrtine (17),
63
 which has been isolated from heather 
plants
64
 (Scheme 3). For the key step, introducing the first stereogenic center, a 
copper-catalyzed addition of trimethylaluminum to 15 with phosphoramidite ligand 
L2 was employed to achieve high yields and stereoselectivites. The conjugate 
addition product 16 was formed with excellent enantioselectivity. 
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Scheme 3 Catalytic enantioselective synthesis of myrtine 
 
4.2 Asymmetric allylic substitution reactions 
The allylic substitution, especially the methodology based upon palladium catalysis, 
is a reaction of major significance for the generation of chiral, multifunctional 
building blocks and ranks among the key transformations for organic synthesis.
65-71
 
One of the typical features of the palladium-catalyzed reaction is that 'soft' 
nucleophiles such as malonates are transferred directly to the allyl-complex 19, 
whereas 'hard' nucleophiles like organozinc or Grignard reagents are proposed as 
being transmetalated to palladium to give allyl-palladium complex 20 prior to C-C 
bond formation (Scheme 4).
70,71
 Thus a different outcome for the products 21/22 of 
the substitution reaction occurs for the different types of nucleophiles. Contrary to 
the conjugate addition reactions (vide supra), the phosphoramidite to metal ratio 
required for the best results in terms of enantioselectivity is 1:1, not depending on 
which metal is employed as catalyst (Cu, Ir or Pd). It should be noted that the 
leaving group in the allylic substitutions is different for the various catalytic 
systems. Whereas the Cu/phosphoramidite catalysts perform best with allylic 
halides (Cl or Br),
37,72
 the related Cu/ferrocenyl-based bisphosphine catalysts
35
 
strictly require bromides as leaving groups for best performance. Asymmetric allylic 
substitutions with chiral Cu/NHC complexes employ allylic phosphonates as 
leaving groups
73
; Pd-catalyzed allylic substitutions generally use allylic acetates, 
carbonates or benzoates
65,66,68-71
 and the Ir/phosphoramidite catalysts give the best 
results with allylic carbonates.
74
 This sensitivity with regard to the leaving group in 
allylic substitution reactions could stem from the different structural requirements of 






Scheme 4 Allylic substitution 
 
Pd-catalyzed allylic substitutions 
The Tsuji-Trost palladium-catalyzed allylic substitution is a well-established 
transformation to yield important, multifunctional chiral building blocks for organic 
synthesis and has been the key step in numerous total syntheses.
65,66,68-71
 In recent 
years, phosphoramidite ligands have been applied to these palladium-catalyzed 
reactions.  
 
Asymmetric total synthesis of γ-lycorane 
The highest enantioselectivities so far with the Pd/phosphoramidite catalytic 
system in allylic substitutions were obtained in the desymmetrization reactions of 
dibenzoylcyclohexene 23 (Scheme 5).
75
 In order to synthesize the naturally 
occuring alkaloid γ-lycorane 26, malonate derivative 24 was employed as carbon 
nucleophile. With phosphoramidite ligand L3, excellent ee values up to 99% for 
cyclohexene 25, a key precursor to 26, were reached. Unfortunately, the 
stereogenic center of the malonate moiety could not be installed with high 
diasteroselectivity due to epimerization. 
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Scheme 5 Desymmetrization based on Pd-catalyzed allylic substitution 
 
Pd-catalyzed [3+2] trimethylenemethane cycloadditons 
The closely related palladium-catalyzed [3+2] cycloaddition of a 
trimethylenemethane unit is a marvellous and extremely useful transformation to 
provide 5-membered cyclic compounds and the development of an asymmetric 
variant has long been a highly warranted goal.
76
  
Recently, an asymmetric Pd-catalyzed [3+2] trimethylenemethane cycloaddition of 
3-acetoxy-2-trimethylsilyl-methylpropene 27 to various Michael acceptors 28 in the 
presence of phosphoramidite ligands was disclosed.
77
 The application of 
phosphoramidites to this particular transformation marks a major breakthrough, as 
catalysts based on these chiral ligands achieve for the first time high 
enantioselectivities. The reaction mechanism is noteworthy, as it combines 
transition-metal chemistry, through metal-allyl species, with the 1,3-dipolar 
cycloaddtions. The mechanism can be exemplified with the transformation depicted 
in Scheme 6. Substituted allyl acetate 27 can form a Pd-allyl complex through 
oxidative addition, the leaving group (in this case the acetate) is reacting further, 
and attacks the TMS group. The Si-C bond is then cleaved, leaving zwitterionic 
complex 29 behind. This carbanion, together with the positively charged Pd-allyl 
moiety, now forms the 1,3-dipolar partner for the subsequent cycloaddition with an 
olefin (28) or another unsaturated substrate. This reaction gave important multi-





enantioselectivities (up to 84%, 84% ee). However, further research is needed to 
improve the enantioselectivities for these transformations. L4 proved to be the 
preferred ligand for this transformation (Scheme 6). The choice of ligand proved to 
be crucial in order to create the steric constraints at the palladium catalyst required 
for high selectivities (compare also Chapter 2) in the outer-sphere addition
76
 distal 
from the coordinating ligand of the intermediate 29 to the olefin. Equally good 
results were obtained for the reaction with aryl- and alkylidene tetralones as 




Scheme 6 Pd-catalyzed [3+2] trimethylenemethane cycloaddition 
This method was successfully extended to accomplish the synthesis of important 
intermediates including spirocyclic oxindole cyclopentanes 33 and 34.
79
 Oxindoles 
31 were reacted with allylic acetate 32 to yield the spirocyclic compounds 33 and 
34 in excellent yields and stereoselectivities (up to 99% ee) (Scheme 7). Just as in 
the aforementioned example, the choice of the phosphoramidite ligand proved to 
be critical. With 1-naphthyl-pyrrolidine-derived L6, compound 33 was the favoured 
product (reaching diastereoselectivities 33/34: >20:1), whereas with the 2-naphthyl-
derived ligand L5 diastereoisomer 34 (33/34: 1:6) was obtained. The authors claim 
that the origin of this selectivity lies in the different steric demands of the two 
ligands that results in a different approach of 31 to the intermediate palladium-
complex either from the re or the si face. 
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Scheme 7 Pd-catalyzed [3+2] cycloaddition with oxindole substrates 
 
Ir-catalyzed allylic substitutions 
Iridium-catalyzed substitution reactions have gained much attention over the last 
years.
74,80-83
 In fact, next to the copper-catalyzed conjugate addition, the iridium-
catalyzed allylic substitution has been one of the most prominent reactions in 
general for which phosphoramidite ligands were applied. The first appearance of 
this reaction employing phosphoramidites as chiral ligands was as early as 1999, 
when the iridium-catalyzed allylic alkylation of allylic acetates 35 (LG = OAc) with 
sodium malonates to form 36 was reported (Scheme 8).
84
 Although, with some 
exceptions, low enantioselectivities were observed at that time, the transformation 
set the stage for numerous important iridium-based methods developed in recent 
years. One important feature of the iridium-catalyzed allylic substitution is that it 
allows for the application of carbon-, oxygen-, sulfur- as well as nitrogen-based 









Scheme 8 Ir-catalyzed allylic substitution 
 
Mechanistic studies and identification of the active Ir catalyst 
Elaborate studies of this transformation were carried out, focussing on the origin of 
regio- and stereoselectivity as well as on the influence of different phosphoramidite 
ligands.
92,93
 However, the reaction mechanism and the active species involved 
remained largely unclear, and the desired optically active products were only 
obtained when LiCl was employed as an additive. The presence of halide ions 
ensured fast σ-π isomerization of the intermediate Ir-allyl complex,
94,95
 and thus 
higher control of the stereoselectivity by the chiral phosphoramidite ligand. It was 
not until 2003 that the non-innocence of the amine moiety of the phosphoramidite 
ligand L1 was discovered when studying the related allylic amination and 
etherification reaction,
96,97
 thus paving the way for more sophisticated catalyst 
design.
98
 These investigations showed that, under basic conditions, 
phosphoramidite ligand (S,S,S)-L1 forms iridacycle 39 from the iridium(I) precursor 
via a C-H activation of a methyl group in the amine moiety of the phosphoramidite 
(Scheme 9). Remarkable is the fact that only the (S,S,S)-L1 diastereoisomer 
undergoes this activation and can subsequently serve as a good catalyst for the 
iridium-catalyzed allylic substitution reaction. This is in contrast to the conjugate 
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Scheme 9 Cyclometalation of L1 
Since the allylic substitution furnishes a stereogenic center with a heteroatom and 
a neighbouring terminal double bond, ideal starting points for further synthesis, the 
transformation with O- or N-nucleophiles is perfectly suited to be applied in the 
synthesis of chiral heterocycles. This has been demonstrated by a variety of total 
syntheses which rely on the Ir-catalyzed allylic substitution methodology as key 
steps.
99-105
 Some target molecules are depicted in Figure 2, two representative 
syntheses are discussed in more detail below (see Scheme 10 and Scheme 11). 
 








Asymmetric synthesis of nicotine 
A total synthesis of nicotine (47) was reported based on the allylic amination as the 
key step to introduce the desired chiral amine (Scheme 10).
106
 In this synthetic 
route, allylic carbonate 44 was reacted with allylamine 45 in the presence of an 
iridium/phosphoramidite catalytic system to give the corresponding chiral 
diallylamine 46. With ligand L7
107
 allylic amine 46 was formed in moderate yield but 
with excellent regio- and stereoselectivity. This secondary amine served as the key 
chiral building block and was transformed into nicotine 47 in a few steps. 
 
Scheme 10 Total synthesis of (-)-(S)-nicotine 
An iridium/phosphoramidite-catalyzed etherification was used as one of the key 
steps in a total synthesis of centrolobine (51) (Scheme 11).
99
 For the total 
synthesis, the Cu-alkoxide of cyclopentenol 48 was reacted with allyl carbonate 49 
in the presence of a Ir/L8
108
 complex to yield the corresponding branched allylic 
ether 50 with excellent ee. The use of the copper alkoxide had been found to be 
crucial with regards to the branched/linear selectivity and the enantioselectivity for 
the reaction of secondary alkoxides.
109
 Compound 50 could be transformed into 
centrolobine 51 in a few steps. 
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Scheme 11 Asymmetric synthesis of centrolobine 
 
4.3 Miscellaneous reactions 
In this section, some reactions leading to chiral heterocycles will be discussed, that 
do not employ the abovementioned conjugate addition or allylic substitution 
mechanisms, but nevertheless serve as good examples for the effective 
construction of chiral heterocycles. 
 
Rh-catalyzed [2+2+2] cycloaddition reactions 
A new intermolecular rhodium-catalyzed [2+2+2] cycloaddition of a variety of aryl 
acetylenes 53 and alkenyl isocyanates 53 was discovered (Scheme 12).
110,111
 
Using TADDOL-derived phosphoramidite ligand L9, the nitrogen-bridged bicyclic 
enones 54 and 55 were obtained with ee's up to 94%. The predominant product 54 
was obtained exlusively when donor-substituted arylacetylenes 52 were used. 
Heterocycle 54 could be used as the key chiral building block for the synthesis of 
lasubine II (56), a natural alkaloid found in the tree Lagerstroemia subcostata.
112
 
The Rh-catalyzed asymmetric [2+2+2] cycloaddition has recently been extended to 
gem-disubstituted olefins, rendering this method suitable for the preparation of 
quaternary stereogenic centers.
113














Scheme 12 Rh-catalyzed [2+2+2] cycloaddition 
 
Ag-catalyzed 1,3-dipolar cycloaddition reactions 
The first successful catalytic application of a phosphoramidite-silver complex was 
also recently reported.
118
 A silver-catalyzed 1,3-dipolar cycloaddition of aryl-
substituted iminoglycinates 57 and activated olefins such as tert-butyl acrylate 
58
119
 furnished proline derivatives 59. With phosphoramidite L1 (compare Scheme 
2) a variety of pyrrolidines 59 with multiple stereogenic centers were obtained, with 
generally good yields and excellent stereoselectivities (Scheme 13). 
 




Synthesis of Chiral Heterocycles 
 
5. Aim and outline of this thesis 
As chiral heterocyclic compounds are of major importance through their biological 
activities, selective synthetic routes towards these targets are highly warranted, 
especially if a possible natural source cannot be exploited in large quantities. 
Furthermore, many non-natural pharmaceuticals bear chiral heterocycles as key 
structural elements. Therefore, the development of new synthetic routes towards 
these structures is of major importance for organic synthesis.  
The aim of this thesis was to develop new catalytic asymmetric transformations for 
the synthesis of chiral heterocycles. Ideally, the corresponding chiral heteroatom-
containing building blocks should become available in high yields and 
stereoselectivities. Furthermore, since our approach is based on chiral metal-
complexes, both enantiomers of the desired products should become available. 
Our approach was based on catalytic asymmetric methodology developed in our 
laboratories as well as chiral catalysts known in the literature. Starting from the 
established methods, also new catalytic asymmetric transformations were 
developed. In chapter 2, the asymmetric synthesis of 2,5-arylpyrrolidines 
employing Ir-catalyzed allylic amination with ammonia is described. The extension 
of this work can be found in chapter 3, where the development of the first 
asymmetric Ir-catalyzed intramolecular allylic amidation is described. Chiral 
tetrahydroisoquinolines, important chiral building blocks as well as 5- to 7-
membered saturated N-heterocycles could be obtained via this new approach. The 
attempted extension of this to the asymmetric synthesis of chiral β-carboline 
compounds is described in chapter 4. Related chiral saturated N-heterocycles with 
various ring sizes could be obtained via a complementary route employing a 
combination of Cu-catalyzed asymmetric allylic alkylation and ring-closing 
metathesis. This project is described in chapter 5. During the course of this 
research, also an approach to chiral oxygen-containing heterocycles was 
developed: the access to chiral coumarin dervatives using Cu-catalyzed conjugate 
additions of Grignard reagents employing a Cu/bisphosphine catalyst is discussed 
in chapter 6. The reaction intermediates of these reactions were found to be good 
starting points for a variety of reactions to give, among others, formal conjugate 
addition products of -unsaturated amides. Finally, the application of 
phosphoramidite ligands synthesized from chiral pyrrolidines (compare chapter 2) 
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Chapter 2 
Catalytic Asymmetric Synthesis of 
2,5-Naphthylpyrrolidine 
A novel, straightforward fully catalytic asymmetric synthesis of chiral 2,5-
naphthylpyrrolidine based upon an iridium-catalyzed double allylic amination with 
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Chiral 2,5-disubstituted pyrrolidines 1 (Figure 1) are versatile chiral compounds that 
have been used for a large variety of asymmetric transformations. For example, 
they have been employed as chiral C2-symmetric auxiliaries
1
 for the asymmetric 





 Furthermore, derivatives of 2,5-chiral 
pyrrolidines have been shown to act as stereodirecting auxiliaries in asymmetric 
Wittig rearrangements.
4
 In catalytic asymmetric transformations, these compounds 
have been used as chiral ligands for the asymmetric addition of diethylzinc to 
aldehydes
5




Figure 1 Chiral 2,5-disubstituted pyrrolidines 
More recently, chiral 2,5-disubstituted pyrrolidines have been shown to be efficient 
organocatalysts for a variety of asymmetric transformations such as Michael 
additions
8
 and α-halogenation of aldehydes and ketones.
9-11
 As an example, the α-
chlorination of aldehydes is depicted in Scheme 1.
10
 When aldehydes 2 were 
reacted with NCS (3) as the chlorine source in the presence of catalytic amounts of  
2,5-phenylpyrrolidine 4, the corresponding α-chlorinated aldehydes 5 were isolated 
in up to excellent yields and enantioselectivities. 
 
Scheme 1 Organocatalytic asymmetric α-chlorination of aldehydes 
Phosphoramidite ligands
12,13
 prepared from chiral 2,5-disubstituted pyrrolidines 
were reported to give high enantioselectivities in asymmetric palladium-catalyzed 
[3+2] trimethylenemethane cycloadditions (see also Chapter 1).
14-17
 This 
methodology represents an elegant route towards cyclic compounds, including 
heterocycles.
16,17
 When allyl acetate 6 was reacted with Boc-protected imines 7 in 
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the presence of a Pd/L1 complex, the corresponding chiral pyrrolidines 8 were 
accessible in high yields and enantioselectivities (Scheme 2). It was shown that the 
phosphoramidites derived from chiral 2,5-arylpyrrolidines such as L1 were key to 
achieve high enantioselectivities for this transformation. Replacement of the 
naphthyl substitutents on the pyrrolidine with phenyl groups led to a dramatic drop 
in enantioselectivity (to 35% ee for 5 (Ar = Ph)). Ligand L1 thus creates a unique 




Scheme 2 Pd-catalyzed asymmetric [3+2] trimethylenemethane addition with imines 
Although a few synthetic routes towards chiral 2,5-arylpyrrolidines are known,
18-22
 
they do not include the preparation of sterically demanding aryl-substituted 
pyrrolidines 1, such as naphthyl-subsituted ones. A report employing asymmetric 
borane reduction of 1,4-diketones specifically highlights the elusiveness of these 
substrates in undergoing reduction.
21
  
Approaches based upon the enantioselective deprotonation/arylation of Boc-
protected pyrrolidines utilizing organolithium reagents and naturally occurring (-)-
sparteine have been disclosed.
22-24
 One example of a sparteine-mediated 
asymmetric lithiation of N-Boc-pyrrolidine 9 followed by a Negishi coupling in a 
one-pot protocol has been reported (Scheme 3).
22
 When 9 was lithiated in the 
presence of (-)-sparteine (10), then transmetalated to zinc and a subsequent 
Negishi coupling with phenylbromide was carried out, chiral 2-phenyl-pyrrolidine 11 
was isolated in very good yields and enantioselectivity. The same reaction could be 
carried out on 11 once more to give the corresponding 2,5-diphenyl pyrrolidine 12. 
These transformations have been reported to work well with a variety of aromatics, 
however, the possibility to construct naphthyl-substituents (precursors for L1) was 
not disclosed. The use of an enantiomerically pure stoichiometric reagent such as 
10 renders this method not attractive in terms of atom economy. Moreover, since 





products 11 and 12 is accessible through this approach; a drawback when chiral 
ligands such as L1 derived from chiral pyrrolidines are employed in the synthesis of 
complex target molecules where a particular stereoisomer is desirable. 
 
Scheme 3 Asymmetric lithiation/Negishi coupling 
A catalytic enantioselective synthesis of chiral 2,5-naphthylpyrrolidines based on 





 could be selectively reduced to the chiral 1,4-diol 15 in the 
presence of a chiral Co-salen complex 14, employing NaBH4 as the reducing agent 
(Scheme 4). For this reaction to proceed with high yields and enantioselectivities, it 
is important that tetrahydrofuryl alcohol (THFA) and NaBH4 are premixed, since 
this will form a NaBHx(THFA) adduct, which ensures high selectivities and 
reactivities.
27
 With diol 15 in hand, it could be transformed to the corresponding N-
allylpyrrolidine 16 in good yields, followed by a deprotection of the allyl moiety with 
Wilkinsons’s catalyst to give the desired chiral 2,5-dinaphthylpyrrolidine 17 in good 
yields and excellent enantioselectivity.  
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Scheme 4 Reported synthesis of 2,5-dinaphthylpyrrolidine 
Unfortunately, in our hands, these results were not reproducible or not practicable 
for the synthesis of naphthyl-substituted pyrrolidine 17 for a variety of reasons. 
First, the synthesis of the chiral salen ligand of 14 could not be achieved, as the 
literature procedures
28
 turned out to be not reproducible in our hands. The optically 
active cobalt complex 14 is commercially available, so we could still attempt the 
asymmetric synthesis of 17 (Scheme 5). The Co-catalyzed asymmetric reduction of 
13 could be rendered feasible only if higher temperatures than reported were 
employed. In our hands, carrying out the synthesis at -40 °C, as reported, led to no 
conversion of 13. When we raised the temperature to -20 °C, we could isolate 
chiral diol 14 in low yields but with enantioselectivities close to the ones previously 
reported. The following transformation to the N-protected pyrrolidine 16 turned out 
to be not reproducible either: under the reported conditions, no reaction to 16 was 
observed, in our hands, the best results were found when solvents, reactions times 
and temperatures were changed to more drastic conditions. However, even then 
chiral pyrrolidine 16 was only isolated in trace amounts. The following deprotection 
of the allylamine moiety of 16 to give pyrrolidine 17 did not occur at all under the 
published conditions and could furthermore not be rendered feasible with a variety 
of other deprotection conditions. With these disappointing results in hand, we 
decided to abandon this synthetic route, as it was not a useful one to obtain chiral 






Scheme 5 Attempted synthesis of 17 
 
2. Goal 
We were interested in the application of sterically very demanding phosphoramidite 
ligands L1 for the use in Ni-catalyzed reductive coupling reactions (see Chapter 7), 
as we expected them to improve the enantioselectivity in those transformations. 
Therefore, we were interested in a synthetic pathway towards C2-symmetric chiral 
pyrrolidines. As the only literature procedure was not reproducible in our hands 
(see Scheme 4 and Scheme 5), we sought to develop a new synthetic route 
towards chiral 2,5-diarylpyrrolidines that would provide the products in high optical 
purity. Ideally this new approach would furnish both enantiomers of the envisaged 
products. With foresight to possible applications as parts of chiral ligands or as 
organocatalysts, both enantiomers of the chiral diarylpyrrolidines should be 
available.  
A study regarding the direct allylic amination with ammonia was disclosed,
29
 in 
which the authors found not the anticipated monoamination of cinnamyl carbonate 
18 to chiral allylamine 20 in the presence of catalytic amounts of iridacycle 19, but 
reaction towards the secondary diallylamine 21 (Scheme 6). This observation 
stems most probably from the fact that primary amine 20 is a much better 
nucleophile with regard to Ir-catalyzed allylic amination than ammonia itself. Hence, 
no traces of the reaction intermediate 20 were observed in the reaction mixture. 
Nevertheless, the disubstituted product 21 was isolated in excellent yield and 
stereoselectivities.  
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Scheme 6 Ir-catalyzed double allylic amination with ammonia 
We decided to make use of this – originally unwanted – diallylation reaction of 
allylic carbonates 22 with ammonia and use diallylamines 23 as possible starting 
points for the synthesis of chiral 2,5-diarylpyrrolidines. With chiral compounds 23 in 
hand, ring-closing metathesis would lead to the corresponding diarylpyrrolines 24, 
subsequent reduction of the double bond would furnish the desired 
diarylpyrrolidines 25 (Scheme 7). Since the two stereogenic centers are 
constructed early in the synthesis, it is a prerequisite that the subsequent reactions 
do not compromize the stereochemistry generated at the α-position of the nitrogen 
atom. This is especially important for the hydrogenation step to give 25, since 





Scheme 7 Anticipated synthetic route 
Since both enantiomers of the phosphoramidite ligand L2 are readily available, 
also both enantiomers of 25 should be accessible, which is a major advantage over 






3. Results and Discussion 
When we started off to probe the viability of the anticipated synthetic route to 
diarylpyrrolidines, we chose to use the 2-naphthyl-substituted pyrrolidines 26 and 
27 as targets to develop and optimize the synthesis (Figure 2). The corresponding 
phosphoramidite ligand had shown remarkable effects in the asymmetric Pd-
catalyzed [3+2] trimethylenemethane addition reaction (vide supra).
15,17
 
Furthermore, ortho-methoxyphenyl-derived pyrrolidine 27 should be an interesting 
chiral building block for phosphoramidite ligands, as ortho-methoxy substituents 
often show remarkable effects in comparison with the corresponding phenyl 





Figure 2 Envisaged target structures 
 
3.1 Synthesis of starting materials 
Allylic carbonates 32, starting materials for the double allylic amination with 
ammonia, with a 2-naphthyl and a ortho-methoxyphenyl moiety were synthesized 
in a straightforward manner (Scheme 8). Allylic alcohol 29a was prepared from the 
corresponding -unsaturated aldehyde 28 by reduction with DIBAL-H. For 
naphthyl-substituted substrate 32b, we started with naphthaldehyde 30, which was 
converted to the corresponding -unsaturated ester 31 by Horner-Wadsworth-
Emmons reaction
41
 in good yield (75%). Subsequent reduction of the ester to the 
allylic alcohol 29b proceeded in moderate yield.  Both allylic alcohols 29 could 
smoothly be transformed to the corresponding allylic carbonates 32. 
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Scheme 8 Synthesis of allylic carbonates 
At a later stage of this project, a shorter route to 32b was developed; commercially 
available 2-vinylnaphthalene 33 could be transformed to the corresponding allylic 





dicarbonate 34 in very good yield (Scheme 9). The dicarbonate 34 ensured full 
conversion to 32b, since cross metathesis of 33 with the corresponding allyl methyl 
carbonate under similar reaction conditions led to low conversion to 32b and 




Scheme 9 Alternative synthesis of allylic carbonate 32b 
 
3.2 Ir-catalyzed double allylic amination 
When the allylic amination of allylic carbonates was studied with (S,S,S)-19 as 
catalyst, we were delighted to find that 32a and 32b were converted smoothly to 
the corresponding amines 35 (Scheme 10). 35b was isolated with excellent 
stereoselectivities and yields after 16 hours, whereas diallylamine 35a was formed 






Scheme 10 Ir-catalyzed allylic amination 
A few factors have been found to be influential on the outcome of this 
transformation, which has been optimized with the transformation of substrate 32b: 
Catalyst loading 
It was found that with 2.0 mol% of (S,S,S)-19 the reaction proceeded with the same 
outcome with regards to stereoselectivity, but with considerably lower conversion of 
32b (~40% conversion, as judged by 
1
H NMR). Adding the catalyst in four batches 
of 0.5 mol% over a period of 4 hours did not improve the conversion, indicating that 
the catalyst stays active in the reaction mixture.  
Temperature 
The reaction was also run at elevated temperature (50 °C), and did show faster 
conversion to the desired product 35b with equally good enantioselectivities, 
however, still 6.0 mol% of (S,S,S)-19 were necessary to ensure full consumption of 
allylic carbonate 32b. For practical reasons, the reactions were run at ambient 
temperature in the following. 
Concentration 
The amounts of solvents proved to be influential on the conversion of 32 as well. In 
a typical experiment, a NH3 solution in EtOH was added to the allylic carbonate to 
give a ~0.7 molar suspension. Carbonates 32 do not dissolve well in the ammonia 
solution, so THF was added until all carbonate was dissolved (typically at a ratio 
EtOH/THF 2:1) and the reaction mixture stirred overnight, which ensured full 
conversion of 32. If more THF was added (exceeding ratios EtOH/THF 1:1), the 
reaction would still take place with the same stereoselectivities, however, with 
considerably lower conversion. From this observation, it can be concluded that a 
too low concentration of the nucleophile (NH3) is detrimental in terms of 
conversion. It is improbable that the catalyst loses its activity because of the higher 
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It should be noted that the enantioselectivity of 35 was determined by comparison 
of both enantiomers of 35 by chiral HPLC, since a direct racemic allylic amination 
was not available. (i.e. no non-chiral phosphoramidite-based iridacycle has been 
synthesized) At the same time, this served as an example that both enantiomers of 
35 are available through this allylic amination protocol. The absolute configuration 
of 35b was later assigned by comparison of the NMR data and optical rotation of 
phosphoramidite L1, synthesized from chiral pyrrolidine 26 (vide infra) with 
literature.
17
 The absolute configuration of 35a was then assigned in analogy to 35b. 
  
3.3 Ring-closing metathesis to give chiral pyrrolines 
With chiral diallylamines 35 in hand, we went on to investigate the following ring-
closing metathesis towards the corresponding chiral pyrrolines 37. Ring-closing 
metathesis of 35b was initially examined with Mo-based catalysts, since they were 
reported to exert catalytic activity with unprotected secondary amines (Scheme 
11).
44
 In our case however, employing catalytic amounts of the Schrock-Hoveyda 
catalyst 36, no turnover of 35b was observed, which we attribute to the steric 
constraints of 35b.  
 
Scheme 11 Attempted ring-closing metathesis with Mo-based catalyst 
Ring-closing metathesis of 35 based upon ruthenium catalysts is hampered by the 
potential donor abilities of the nitrogen in 35, so we decided to convert 35b to the 
corresponding HBr salt to conceal this functionality. This approach had been 
employed successfully in the literature.
45-47





metathesis of 35b•HBr with Hoveyda-Grubbs 2
nd
 generation catalyst, which had 
been reported to be the catalyst of choice for the formation of pyrrolines.
42,45,47,48
 
Employing elevated temperatures (1,2-dichloroethane at reflux) and 4.0 mol% 
Hoveyda-Grubbs 2
nd
 generation catalyst, chiral pyrroline 37 was obtained in 79% 
yield (Scheme 12). Importantly, 37 was formed without loss of ee. Noteworthy is 
the fact that the corresponding HCl salt of 35b led to decomposition of the starting 
material under reaction conditions. This particular behaviour had been observed in 
previous studies,
45





 generation) catalysts 37 was obtained in lower yields. 
Several factors are influencing the positive outcome of this reaction: The HBr salt 
of 35b has to be thoroughly dried, so that no traces of acetic acid are present (HBr 
was employed as a solution in acetic acid). Secondly, the catalyst has to be added 
in two batches of 2.0 mol% each, since rapid catalyst deactivation was observed. 
Furthermore, to achieve high isolated yields, a two step procedure has to be 
followed: After cooling down, the first batch of the product can just be filtered off 
and washed with acetone. Like this, analytically pure HBr salt of 37 is obtained 
(~60%). However, it turned out that not all 37•HBr was precipitated as after workup 
of the reaction mixture, a second part of the product was obtained after 
deprotection of the salt and purification by column chromatography. It is important 
that the column is run not too slow, since decomposition of 37 during 
chromatography is observed. The combined batches after filtration and column 
chromatography amount for the reported 79% yield. As will be seen in the following 
section, the reduction of the double bond is carried out with an excess of base, so 
that deprotection of the HBr salt of 37 poses no problems. 
 
Scheme 12 Ring-closing metathesis with Ru-based catalyst 
 
3.4 Reduction of the double bond 
The subsequent reduction of the olefin in pyrroline 37 was first attempted by 
homogenous Rh-catalysed hydrogenation
49
 (Scheme 13), but here also, the 
unprotected amine suppressed any conversion. The hydrogenation of the 
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corresponding HBr salt of 37 under the same conditions turned out to be unfruitful 
as well.  
 
Scheme 13 Attempted hydrogentation of 37 
Since heterogeneous hydrogenation with palladium on solid supports is known to 
racemize allylic amines,
30-40
 we refrained from applying this methodology into our 
synthesis. Instead, we were investigating the use of diimide (39) as reducing 
agent
50
 for the double bond of pyrroline 37. Diimide (or diazene) itself is unstable, 
as it readily disproportionates to hydrazine 38 and dinitrogen (Scheme 14). 
However, when formed in situ, it can be used as a reducing agent for non-polarized 
double bonds, diimid itself being oxidized to dinitrogen, leaving the reduced 
product 41 behind.
50
 The most important feature of this reduction protocol is the 
fact that it is assumed to proceed via a concerted mechanism with a six-membered 
transition state 40. This fact makes the use of this methodology inobjectionable for 
the reduction of double bonds bearing α-stereogenic centers.  
 
Scheme 14 Reduction with diimide / disproportionation of diimide 
It had been reported in the literature that diimide can be generated in situ under 





 and directly used as mild reducing agents for olefins. We 
tried both conditions on chiral pyrroline 37, but neither of the reactions led to 
conversion of 37 (Scheme 15), as in both cases, the starting material was isolated 
unreacted. This is possibly due to the short lifetime of diimide under the given 
reaction conditions. Effectively, the concentration of diimide 39 has to be higher to 






Scheme 15 Attempted reduction of 37 with diimide 
In our institute, a metal-free reduction of olefins based on catalytic formation of 
diimide 39 from cheap and readily available hydrazine with riboflavin-derived 
catalyst 44 and molecular oxygen has been developed.
55
 In this reaction, 44 
oxidizes hydrazine to the actual reducing agent, diimide 39, and then gets 
reoxidized by molecular oxygen (Scheme 16). The actual role of the organocatalyst 
44 on the double bond reduction is therefore of indirect nature.  
 
Scheme 16 Organocatalytic reduction of double bonds 
Catalyst 44 can be synthesized in a one-step procedure from riboflavine. When we 
applied the standard reaction conditions
55
 to the reduction of 37 (Table 1), no 
conversion to 26 was observed, most probably due to the insolubility of 37 in 
ethanol (Table 1, entry 1). When the same reaction was carried out in a mixture of 
dichloromethane and ethanol to ensure solubility of 37, we observed that the 
corresponding pyrrolidine 26 was formed, albeit in very low yields (Table 1, entry 
2). Raising the catalyst loading to 50.0 mol% led to a significant increase in 
conversion of 37 (Table 1, entry 3). It is important to note that even with 
comparatively high catalyst loading of 44 we can still speak of an efficient catalyst, 
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since 44 is only catalytically converting hydrazine 38 to diimide 39, which in turn 
facilitates the double bond reduction. Riboflavine 44 has thus no direct effect on 
the transformation of 37. We found that when the catalyst and hydrazine were 
added slowly (over a period of 10 hours via syringe pump) to the reaction mixture, 
a remarkable increase in conversion was observed (Table 1, entry 4). Finally, full 
conversion to 26 was obtained with 1.0 eq. of riboflavine 44 with respect to 
pyrroline 37 (Table 1, entry 5). As expected, the corresponding pyrrolidine 26 was 
formed without loss of ee. Furthermore, as this transformation is carried out in 
basic conditions, also the HBr salt of 37, which was obtained from the previous 
reaction, could be employed directly. 
Table 1 Reduction of 37 with riboflavine organocatalyst 44 
 
Entry Solvent Amount of 44 Conversion
a
 
1 EtOH 10 n.d. 
2 CH2Cl2/EtOH 1:1 10 traces 
3 CH2Cl2/EtOH 1:1 50
b
 50% 
4 CH2Cl2/EtOH 1:1 50
c
 80% 








H NMR.  
b
44 and hydrazine hydrate added in 5 min. 
c
44 and hydrazine hydrate added 
slowly over a period of 10 h. 
d
81% isolated yield. 
The success of the slow-addition protocol for this demanding substrate with 
regards to reduction of the double bond can be explained by the fact that the 
catalyst 44 as well as diimide (39) have a limited lifetime under the given reaction 
conditions. The active concentration of the reducing agent is effectively lowered 
during the reaction by diimide disproportionation to dinitrogen and hydrazine (see 
Scheme 14).
56,57
 By adding the organocatalyst 44 and hydrazine 38 slowly to the 
mixture, the active concentration of diimide (39) stays constant during the reaction, 
allowing for higher turnover of the reduction of sterically demanding substrates. 











3.5 Synthesis of the corresponding phosphoramidite ligands 
With chiral 2,5-naphthylpyrrolidine in hand, we went on to synthesize the 
corresponding phosphoramidite ligand L1. When 26 was reacted in the presence 
of phosphochloridite 45,
59
 the corresponding phosphoramidite ligand L1 was 
obtained in 60% yield (Scheme 17). It is important to note that the triethylamine 
used has to be freshly distilled over CaH2 for this transformation to proceed 
smoothly. Failure to do this resulted in rapid hydrolysis of phosphochloridite 45 and 
therefore no conversion of pyrrolidine 26. The analytical data of L1 served as basis 
for the determination of the absolute configuration of 26 and thus also its 
precursors by comparison with literature data.
17
 It can be said that the Ir-catalyzed 
double allylic amination with ammonia employing (S,S,S)-19 as catalyst gives the 
corresponding (S,S)-products 35, such as displayed in the previous schemes. It is 
important to note that the attempted synthesis of the (R,S,S)-diastereomer of L1 
gave only traces of product via this synthetic route, indicating that the (S,S,S)-
diastereomer of L1 is sterically favoured.  
 
Scheme 17 Synthesis of phosphoramidites L1 (only the S-diastereomer of BINOL is displayed) 
The synthetic intermediate pyrroline 37 could also be transformed to a 
phosphoramidite ligand. For this reaction to occur, a different synthetic procedure 
was chosen. First, pyrroline 37 was transformed to the corresponding Li-amide, 
and then reacted with phosphochloridite 45 to give the phosphoramidite L3 in 
moderate yields (Scheme 18). It should be noted that the purification of 
phosphoramidites L1 and L3 is difficult due to their instability on silicagel, which 
leads to decomposition to the corresponding starting materials, pyrroline 37 or 
pyrrolidine 26, respectively, during purification. Therefore, column chromatography 
has to be carried out quickly with high polarity of the eluent. 
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Scheme 18 Synthesis of phosphoramidite L3 
 
4. Conclusions  
In summary, we have developed a new, concise catalytic asymmetric synthetic 
route towards chiral 2,5-diarylpyrrolidines. The key step of this synthetic route is a 
double asymmetric allylic amination with ammonia catalyzed by an 
iridium/phosphoramidite complex. This is a powerful reaction which creates two 
stereogenic centers in one transformation in high stereoselectivities, at the same 
time, it is atom-economic in terms of the nitrogen nucleophile used, namely 
ammonia. All steps of the pyrrolidine synthesis are high yielding and both 
enantiomers of the products are available through this novel pathway. The latter is 
a clear advantage over the existing sparteine-mediated processes. Furthermore, 
with the exception of salt formation of 35, the synthesis is protecting group free. 
We successfully employed this new synthetic route to prepare the corresponding 
pyrrolidine- and pyrroline-based phosphoramidite ligands L1 and L3.  
Along the way, we have optimized the protocol for the organocatalytic reduction of 
double bonds employing a riboflavine catalyst. With the new reaction protocol for 
the riboflavine-catalyzed reduction of double bonds, also sterically demanding and 
compounds prone to racemization under hydrogenative conditions can be reduced 
smoothly without endangering any stereogenic center. 
 
5. Experimental section 
General  
Starting materials were purchased from Acros, Sigma–Aldrich or Strem and were 





necessary, dried and distilled prior to use. Toluene was distilled over Na, THF and 
diethylether were distilled over Na/benzophenone. Column chromatography was 
performed on silica gel (Silicycle SiliaFlash P60, 230–400 mesh). TLC was 
performed on silica gel 60/Kieselguhr F254. 
1
H NMR and 
13
C NMR spectra were 





C) or a Varian AMX400 (399.93 MHz for 
1
H, 100.59 MHz for 
13
C) 
spectrometer. Chemical shifts are reported in  values (ppm) relative to literature 
values of solvents and reference compounds.
60
 The following abbreviations are 
used to indicate multiplicity: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), br (broad). Mass spectra (HRMS) were performed on a Orbitrap system 
from Thermo Scientific. HPLC analysis was performed on a Shimadzu HPLC 
system equipped with two LC-10AD vp solvent delivery systems, a DGU-14 A 
degasser, a SIL-10AD vp auto injector, an SPD-M10 A vp diode array detector, a 
CTO-10 A vp column oven and an SCL-10A vp system controller by using the 
columns indicated for each compound separately. All glassware was flame-dried 







 were synthesized according to literature procedures.  
 
(E)-3-(2-Methoxyphenyl)prop-2-en-1-ol 29a 
(E)-3-(2-methoxyphenyl)acrylaldehyde 28 (1.0 eq., 2.00 g, 12.33 mmol) was 
dissolved in CH2Cl2 (50 ml) and cooled to -78 °C, then 1.50 
eq. diisobutylaluminum hydride (18.50 ml, 18.50 mmol) 
solution (c = 1.0 M in CH2Cl2) was added dropwise. The 
mixture was allowed to warm to ambient temperature and 
stirred for 16 h. After completion of the reaction, as judged 
by TLC, 50 mL of a saturated solution of Rochelle’s salt 
(potassium sodium tartrate) was added and the resulting slurry stirred at rt for 2 h. 
The mixture was then extracted with Et2O (3x 20 mL) and washed with water (2x 
30 mL). The combined organic phases were dried over MgSO4  and all volatiles 
were removed in vacuo to give (E)-3-(2-methoxyphenyl)prop-2-en-1-ol 29a (2.025 
g, 12.33 mmol, quant.) as a colourless oil. The product was used directly in the 
next reaction without further purification. 
 
(E)-Ethyl 3-(naphthalen-2-yl)acrylate 31 
According to a literature procedure,
41
 1.0 eq. triethyl phosphonoacetate (3.97 ml, 
20.0 mmol) was dissolved in 75 mL dry THF at rt. 
Then, 1.0 eq methylmagnesium bromide (6.67 ml, 
20.0 mmol) solution (c = 3.0 M) was added dropwise 
via syringe. The solution was stirred at r.t. for 15 min. 
Then, a solution of 1.1 eq. naphthaldehyde 30 (3.44 
g, 22.0 mmol) in 25 mL dry THF was added slowly 
through a syringe. The resulting yellow mixture was 
heated at reflux for 16 h. After cooling to rt, the reaction was quenched by addition 
of sat. aq. NH4Cl solution (50 ml). The mixture was extracted with diethyl ether (3x 
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25 mL), dried over MgSO4, and subsequently, all volatiles were removed in vacuo 
to yield a yellow solid. The crude product was purified by column chromatography 
(SiO2, pentane/EtOAc 800:15, Rf = 0.2 in pentane/EtOAc 100:1) to yield 3.39 g 
(15.0 mmol, 75%) of the desired product 31 as a white powder. 
1
H NMR (400 MHz, 
CDCl3) δ 7.94 (s, 1H), 7.90 – 7.80 (m, 4H), 7.67 (dd, J = 8.6, 1.7 Hz, 1H), 7.56 – 
7.47 (m, 2H), 6.55 (d, J = 16.0 Hz, 1H), 4.29 (q, J = 7.1 Hz, 2H), 1.39 – 1.33 (t, J = 








(E)-Ethyl 3-(naphthalen-2-yl)acrylate 31 (1.0 eq., 9.866 g, 43.6 mmol) was 
dissolved in CH2Cl2 (50 ml) and cooled to -78 °C. To 
this solution, 2.4 eq. diisobutylaluminum hydride (105 
ml, 105 mmol) solution (c = 1.0 in CH2Cl2) was added 
dropwise. The reaction mixture was stirred for 1 h at 
the same temperature. When TLC analysis showed 
complete dissappearence of the starting material, the 
reaction mixture was warmed to rt and a 100 mL sat. solution of Rochelle’s salt 
was added carefully to quench the reaction. This mixture was stirred vigorously at 
rt for 3 h. This mixture was extracted with CH2Cl2 (3x 50 mL). The combined 
organic phases were dried over MgSO4 and all volatiles were removed in vacuo to 
yield (E)-3-(naphthalen-2-yl)prop-2-en-1-ol 29b (5.46 g, 29.6 mmol, 68 %) as a 
white powder. This was used without further purification. (Rf = 0.25 in Pentane / 
EtOAc 40:1) 
1
H NMR (400 MHz, CDCl3) δ 7.82 (ddd, J = 13.5, 8.2, 3.7 Hz, 3H), 
7.74 (s, 1H), 7.61 (dd, J = 8.6, 1.6 Hz, 1H), 7.52 – 7.41 (m, 2H), 6.79 (d, J = 15.9 
Hz, 1H), 6.50 (dt, J = 15.9, 5.7 Hz, 1H), 4.39 (td, J = 5.8, 1.4 Hz, 2H), 1.49 (t, J = 




-H2O] calcd for C13H11: 167.0855; found: 
167.0852. 
 
(Z)-But-2-ene-1,4-diyl dimethyl dicarbonate 34
62
  
(Z)-But-2-ene-1,4-diol (1.0 eq., 5.0 ml, 60.7 mmol), 2.0 eq. pyridine (9.82 ml, 121 
mmol) were dissolved in CH2Cl2 (50 ml) at 0 °C, 
then 2.2 eq. chloro methylformiate (10.32 ml, 134 
mmol) were added dropwise and the mixture was 
allowed to warm to room temperature. After TLC 
showed full conversion (~1 h), the mixture was 
extracted 3x with aq. HCl (2N) and the resulting 
organic phases were dried over Na2SO4. After removal of all volatiles in vacuo, (Z)-
but-2-ene-1,4-diyl dimethyl dicarbonate 34 (11.91 g, 58.3 mmol, 96 %) was isolated 
as a white solid. 
1
H NMR (400 MHz, CDCl3) δ 5.75 – 5.67 (m, 2H), 4.69 – 4.63 (m, 
4H), 3.70 – 3.65 (m, 6H). 
13





] calcd for C18H12O6Na: 227.0526; found: 227.0535. 
 





To a solution of allyl alcohol 29 (1.0 eq.) and pyridine (2.2 eq.) in CH2Cl2 (20 
mL/mmol) methyl chloroformate (2.0 eq.) was added dropwise at 0 °C. After 5 min. 
the solution was warmed to room temperature and was stirred for 1 h. Then, it was 
washed with aq. HCl (2N) (3x 5 mL/mmol) and dried over Na2SO4. The 
corresponding products 32 were obtained as a white solid after evaporation of the 
solvent. 
 
(E)-3-(2-Methoxyphenyl)allyl methyl carbonate 32a 
According to the general procedure, 1.00 eq. (E)-3-(2-methoxyphenyl)prop-2-en-1-
ol 29a (2.025 g, 12.33 mmol) was transformed to (E)-
3-(2-methoxyphenyl)allyl methyl carbonate 32a (2.20 
g, 9.90 mmol, 80 %) as a white powder. 
1
H NMR (201 
MHz, CDCl3) δ 7.43 (dd, J = 7.6, 1.6 Hz, 1H), 7.32 – 
7.15 (m, 1H), 6.97 (d, J = 4.2 Hz, 1H), 6.88 (t, J = 7.4 
Hz, 2H), 6.49 – 6.18 (m, 1H), 4.89 – 4.71 (m, 2H), 
3.84 (s, 3H), 3.80 (s, 3H). HRMS-ESI
+
: m/z [M-OCO2Me] calcd for C11H10O: 
147.0810; found: 147.0804. 
 
(E)-Methyl 3-(naphthalen-2-yl)allyl carbonate 32b
63
  
2-Vinylnaphthalene 33 (1.00 eq., 0.154 g, 1.00 mmol) was dissolved in 10 mL 
CH2Cl2 at room temperature and 
butenedimethylcarbonate 34 (2.00 eq., 0.409 g, 
2.00 mmol) were added. Then, a solution of 5 
mol% Hoveyda-Grubbs 2
nd
 generation catalyst 
(0.031 g, 0.05 mmol) in 0.5 mL CH2Cl2 was 
added and the reaction mixture was heated at 
reflux for 16 h. After cooling, all volatiles were removed in vacuo to give a brown-
green solid. This was purified by column chromatography (SiO2, pentane/EtOAc 
20:1, Rf = 0.8 in pentane/EtOAc 10:1) to give 32b as a white powder (0.218 g, 0.9 
mmol, 90%). 
1
H NMR (200 MHz, CDCl3): δ = 7.90 – 7.72 (m, 4H), 7.60 (m, 1H), 
7.48 (m, 2H), 6.86 (d, J = 15.9 Hz, 1H), 6.43 (dt, J = 15.8, 6.4 Hz, 1H), 4.86 (dd, J 
= 6.4, 1.2 Hz, 2H), 3.85 – 3.82 (s, 2H). 
13
C NMR (50 MHz, CDCl3): δ = 155.66, 
134.85, 133.44, 133.42, 133.20, 128.28, 128.05, 127.64, 127.01, 126.33, 126.15, 




 calcd for C13H11: 
167.0861; found: 167.0853. 
 
(S)-Bis((S)-1-(2-methoxyphenyl)allyl)amine 35a 
(E)-3-(2-Methoxyphenyl)allyl methyl carbonate 32a (1.0 eq., 0.027 g, 0.121 mmol) 
and 0.06 eq. (S,S,S)-19 (0.010 g, 7.25 µmol) were 
mixed in a dried Schlenk tube and 1 mL ammonia in 
EtOH (c = 2.0 M) was added. THF was added until all 
starting materials were dissolved (~0.7 mL). The 
reaction was stirred for 16 h at rt. The conversion was 
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checked by TLC analysis. After full conversion was reached, all volatiles were 
removed in vacuo to yield the crude product, which was further purified by column 
chromatography (SiO2, Pet-ether 40-60/EtOAc 20:1 + 1% NEt3, Rf = 0.45 in Pet-
ether 40-60/ EtOAc 10:1) to yield (S)-bis((S)-1-(2-methoxyphenyl)allyl)amine 35a 
as a white solid (0.033 g, 0.106 mmol, 88 %, 99% ee). 
1
H NMR (201 MHz, CDCl3) 
δ 7.33 (d, J = 7.4 Hz, 2H), 7.29 – 7.14 (m, 2H), 7.06 – 6.78 (m, 4H), 6.23 – 5.81 (m, 
2H), 5.26 – 4.94 (m, 4H), 4.53 (t, J = 6.9 Hz, 2H), 3.77 (s, 3H), 3.75 (s, 3H), 2.14 (s 
(br), 1H). 
13
C NMR (50 MHz, CDCl3) δ 157.16, 140.33, 128.39, 127.82, 120.71, 




] calcd for 
C20H24NO2: 310.1802; found: 310.1800. HPLC analysis: The ee was determined by 
HPLC analysis, Chiralpak AD (n-heptane/i-PrOH 99:1, 200 nm, flow rate 0.5 
mL/min), retention times (min.) S,S-enantiomer: 4.49, R,R-enantiomer: 5.03. The 
enantiomeric excess was obtained by comparison of both the pure enantiomers as 
well as a mixture of both enantiomers of 35a. 
 
(S)-Bis((S)-1-(naphthalen-2-yl)allyl)amine 35b 
In a glovebox, (E)-methyl (3-(naphthalen-2-yl)allyl) carbonate 32b (1.00 eq., 0.242 
g, 1.00 mmol) and 6.00 mol% 19 (0.083 g, 
0.060 mmol) were introduced into a flame-
dried Schlenk tube. After sealing, the tube 
was taken out of the glovebox, flushed with 
nitrogen and 1.5 mL of a 2.0 M solution of 
ammonia in ethanol was added. Then, dry 
THF was added dropwise until all of the 
starting material was dissolved (~0.8 mL). 
The yellow mixture was stirred at room temperature for 16 h. After full conversion 
was reached, as checked by TLC, all volatiles were removed in vacuo and the 
resulting yellow oil was purified by flash chromatography (SiO2, pentane/EtOAc 
40:1 + 1% NEt3, Rf = 0.85 in pentane/EtOAc 10:1) to yield (S)-bis((S)-1-
(naphthalen-2-yl)allyl)amine 35b (0.166 g, 0.475 mmol, 95 % yield) as a colourless 
oil. [α]D
20
 = -104.6 (c = 1.02, CHCl3) 
1
H NMR (200 MHz, CDCl3): δ = 7.97 – 7.81 (m, 
6H), 7.77 (s, 2H), 7.62 – 7.40 (m, 6H), 6.26 – 5.90 (m, 2H), 5.33 (t, J = 1.4 Hz, 1H), 
5.28 – 5.21 (m, 2H), 5.20 – 5.15 (m, 1H), 4.41 (d, J = 6.6 Hz, 2H), 3.86 (s (br), 1H). 
13
C NMR (50 MHz, CDCl3): δ = 140.80, 140.01, 133.45, 132.85, 128.29, 127.81, 





calcd for C26H24N: 350.1909; found: 350.1901. HPLC analysis: ee was determined 
by HPLC analysis, Chiralpak AD (n-heptane/i-PrOH 95:5, 215 nm, flow rate 0.5 
mL/min), retention times (min.) S,S-enantiomer: 4.05, R,R-enantiomer: 4.67. The 
enantiomeric excess was obtained by comparison of both the pure enantiomers as 











(S)-Bis((S)-1-(naphthalen-2-yl)allyl)amine 35b (1.00 eq., 0.330 g, 0.944 mmol) was 
dissolved in 10 mL EtOAc at r.t. and 5 mL 
hydrogen bromide solution (32% in AcOH) 
was added. After stirring for 5 min, all 
volatiles were removed in vacuo and the 
yellow oil was dried under vacuum for 16 h 
to yield a pale yellow solid. This was 
dissolved in degassed DCE (5.00 mL) and subsequently 2.0 mol% Hoveyda-
Grubbs 2
nd
 generation catalyst (0.024 g, 0.038 mmol) in 1 mL of DCE (5.00 mL) 
were added. This mixture was heated to reflux for 6 h. Then, 2.0 mol% of catalyst 
were added and the reaction mixture was heated at reflux for 16 hours. The 
conversion of the reaction was checked by 
1
H NMR (Samples were washed with 
2N aq. KOH and extracted with CH2Cl2). After cooling, the mixture was filtered and 
the resulting brown solid was washed several times with acetone to yield the HBr 
salt of the desired product 37 as an off-white solid after drying. The resulting 
organic phase was washed with 2N aq. KOH solution (3x 10 mL). After re-
extraction of the aqueous layers with 10 mL CH2Cl2, the combined organic phases 
were dried over Na2SO4 and all volatiles were removed in vacuo to yield a dark 
green solid. This was purified by column chromatography (SiO2, Pentane/EtOAc 
20:1 + 1% NEt3, Rf = 0.5 in Pentane/EtOAc 10:1) to yield (2S,5S)-2,5-
di(naphthalen-2-yl)-2,5-dihydro-1H-pyrrole 37 (0.240 g, 0.746 mmol, 79 % yield) as 
a white powder. (Combined yield from column chromatography and filtration). [α]D
20
 
= -521.25 (c = 1.01, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ = 7.90 – 7.80 (m, 8H), 
7.54 (m, 2H), 7.52 – 7.42 (m, 4H), 6.11 (m, 2H), 5.56 (m, 2H), 2.44 (s (br), 1H). 
13
C 
NMR (50 MHz, CDCl3): δ = 141.72, 133.49, 132.91, 132.49, 128.55, 128.36, 





 calcd for C24H20N: 322.1596; found: 322.1591. HPLC analysis: ee was 
determined by HPLC analysis, Chiralcel OD-H (n-heptane/i-PrOH 95.5:0.5, 210 
nm, flow rate 0.5 mL/min), retention times (min.) S,S-enantiomer: 9.47, R,R-
enantiomer: 10.29. The enantiomeric excess was obtained by comparison of both 





(2S,5S)-2,5-Di(naphthalen-2-yl)-2,5-dihydro-1H-pyrrole 37 (1.00 eq., 0.142 g, 0.442 
mmol) (or the corresponding HBr salt) was 
dissolved in 10 mL CH2Cl2 at r.t., an oxygen 
atmosphere was applied (1 atm) and the 
reaction mixture was stirred extremely 
vigourously. Then, via syringe pump, a 
solution of riboflavin catalyst 44 (0.180 g) in 
10 mL ethanol and an excess hydrazine 
hydrate (4.30 ml, 88.00 mmol) were added over a period of 10 h. The reaction 
mixture was stirred at rt for 16 h and the progress of the reaction was checked by 
1
H NMR. (Samples were washed with H2O and extracted with CH2Cl2.) The mixture 
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was washed with water (3x 10 mL), the aqueous layers were reextracted with 
CH2Cl2 (10 mL) and the organic layers combined. After drying over Na2SO4, all 
volatiles were removed in vacuo to yield a pale yellow solid. This was purified by 
column chromatography (SiO2, pentane/EtOAc 20:1 + 1% NEt3, Rf = 0.3 in 
pentane/EtOAc 10:1) to yield (2S,5S)-2,5-di(naphthalen-2-yl)pyrrolidine 26 (0.116 
g, 0.358 mmol, 81 % yield) as a white powder. [α]D
20
 = -127.9 (c = 0.91, CHCl3). 
1
H 
NMR (400 MHz, CDCl3): δ = 7.94 – 7.82 (m, 8H), 7.61 (dd, J = 8.5, 1.7 Hz, 2H), 
7.55 – 7.42 (m, 4H), 4.82 (t, J = 6.8 Hz, 2H), 2.66 – 2.46 (m, 2H), 2.39 (s (br), 1H), 
2.07 (m, 2H). 
13
C NMR (50 MHz, CDCl3): δ = 143.16, 133.41, 132.63, 128.29, 





 calcd for C24H22N: 324.1752; found: 324.1745. HPLC analysis: ee was 
determined by HPLC analysis, Chiralpak AD (n-heptane/i-PrOH 95:5, 225 nm, flow 
rate 0.5 mL/min), retention times (min.) R,R-enantiomer: 12.33, S,S-enantiomer: 
15.03. The enantiomeric excess was obtained by comparison of both the pure 





(2S,5S)-2,5-di(naphthalen-2-yl)pyrrolidine 26 (1.00 eq., 0.085 g, 0.263 mmol), 
triethylamine (5.00 eq., 0.183 ml, 1.314 mmol) and 
DMAP (0.01 eq., 3.2 mg, 0.027 mmol) were dissolved 
in 5 mL toluene and cooled to 0 °C. To this, a 0.5 
molar solution of (S)-phosphochloridite 45 (1.20 eq., 
0.631 ml, 0.315 mmol) was added dropwise. The 
reaction was allowed to warm up to room temperature 
and stirred for 16 h. Then, all volatiles were removed 
in vacuo and the residual off-white solid was purified 
by column chromatography. (SiO2, Pentate / EtOAc 
10:1 + 1% NEt3, Rf = 0.9 in pentane / EtOAc 10:1) to 
yield phosphoramidite L1 (0.100 g, 0.157 mmol, 60% 
yield) as a white powder. [α]D
20
 = -6.2 (c = 0.86, 
CHCl3). 
1
H NMR (400 MHz, CDCl3): δ = 7.98 – 7.79 
(m, 10H), 7.56 (m, 5H), 7.44 (d, J = 8.5 Hz, 2H), 7.35 
– 7.29 (m, 3H), 7.25 – 7.15 (m, 2H), 7.11 (m, 2H), 
6.60 (d, J = 8.0 Hz, 1H), 5.87 (d, J = 8.0 Hz, 1H), 5.39 (d, J = 6.6 Hz, 2H), 2.54 (m, 
2H), 1.81 (m, 2H). 
13
C NMR (50 MHz, CDCl3): δ = 149.48, 149.04, 143.39, 143.29, 
133.43, 132.75, 131.25, 130.19, 129.89, 128.26, 127.99, 127.70, 127.06, 126.94, 
126.24, 125.70, 125.41, 125.22, 124.58, 123.98, 121.91, 120.84, 62.86, 33.23. 
31
P-




 calcd for 










(S,S,S)-Phosphoramidite ligand L3 
(2S,5S)-2,5-Di(naphthalen-2-yl)-2,5-dihydro-1H-pyrrole 37 (1.0 eq. 0.065 g, 0.202 
mmol) was dissolved in toluene (2 ml) and cooled to -
78 °C. Then, 1.0 eq. nBuLi (0.126 ml, 0.202 mmol) 
solution (c = 1.6 M) was added slowly. The reaction 
mixture was stirred at –78 ° for 2 h, then the lithium 
amide solution was added to a solution of (S)-
phosphorchloridite 45 (0.485 ml, 0.243 mmol) in 
toluene (10 mL), which was cooled to 0 °C. The 
mixture was stirred overnight and was allowed to 
warm up to rt. Subsequently, the reaction mixture was 
filtered through celite and all volatiles were removed in 
vacuo to yield the crude product as a yellow solid. This 
was purified by column chromatography (SiO2, 
pentane / EtOAc 20:1 + 1% NEt3, Rf = 0.9 in pentane / 
EtOAc 10:1) to yield L3  (0.050 g, 0.079 mmol, 39%) 
as a white solid. 
1
H NMR (400 MHz, CDCl3) δ 7.87 (d, 
J = 8.1 Hz, 2H), 7.78 (dd, J = 8.7, 5.5 Hz, 4H), 7.61 – 7.42 (m, 12H), 7.32 – 7.17 
(m, 6H), 6.21 (d, J = 8.8 Hz, 1H), 6.04 (s, 2H), 5.99 (d, J = 8.7 Hz, 1H), 5.86 (s, 
2H). 
13
C NMR (101 MHz, CDCl3) δ 140.29, 133.52, 133.09, 132.00, 131.24, 
131.05, 130.08, 128.69, 128.46, 128.12, 127.93, 127.66, 127.62, 127.14, 126.63, 
126.49, 126.21, 126.10, 125.76, 125.70, 125.56, 125.14, 124.56, 123.68, 123.14, 
121.87, 120.98, 69.98. 
31
P NMR (162 MHz, CDCl3) δ 145.22. [α]D
20
 = -12.4 (c = 
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Chapter 3  
Iridium-catalyzed Allylic Amidation 
- Asymmetric Synthesis of  
Tetrahydroisoquinolines and 
Saturated N-Heterocycles 
The first intramolecular asymmetric Ir-catalyzed allylic amidation has been 
developed. Using this transformation, the asymmetric synthesis of chiral nitrogen-
containing heterocycles, especially tetrahydroisoquinolines is achieved in excellent 
yields and enantioselectivities. The products are important chiral building blocks for 















Parts of this chapter have been published: Teichert, J.F.; Fañanás-Mastral, M.; 
Feringa, B.L. Angew. Chem. Int. Ed. 2011, 123, 714 - 717. 
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Naturally occuring or synthetic compounds based on the bicyclic 
tetrahydroisoquinoline core are a large class of compounds which often show 
interesting biological activities.
1,2
  As examples, Reticuline (1) and Tubocurarine (2) 
are depicted (Figure 1). Reticuline is an alkaloid found in the latex of opium poppy; 
it has recently been suggested that it is one of the intermediates for the in vivo 
biosynthesis of morphine, indicating that it is an important compound related to 
intercellular signalling.
3,4
 Tubocurarine (2) is found in the plant extracts of the 
climbing plant Chondrodendron tomentosum which has been used by South 
American natives as arrow poison.
1
 It has been used since the 1970s as 
anaesthetic and 2 and derivatives thereof are in use today as highly active
5
 




Figure 1 Examples of biologically active chiral tetrahydroisoquinolines 
In living organisms, the tetrahydroisoquinoline core is constructed via two closely 
related pathways, employing a Mannich-type or Pictet-Spengler-type reaction 
(Scheme 1):
1
 Phenylethylamine precursors 3, derived from tyrosine, are 
transformed to tetrahydroisoquinolines 5 either by direct condensation with an 
aldehyde to form 5 directly, or via the second pathway employing α-ketoacids, that 
runs via amino acid intermediates 4 followed by decarboxylation to yield 5. Both 
pathways have been found in nature, and generally more sophisticated 
substitutents (R’) like aryl groups are introduced as the corresponding aldehydes, 
whereas simpler substituents like H or Me are usually incorporated to the target 
structures 5 via the ketoacids. 
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Scheme 1 Biosynthesis of tetrahydroisoquinolines 
 
1.2 Synthetic approaches to chiral tetrahydroisoquinolines 
Tetrahydroisoquinoline compounds represent important targets for synthesis, and 
therefore much effort has been directed towards the development of efficient 
enantioselective routes to prepare these important chiral structures.
8-13
 Generally, 
the approaches taken from the phenylethylamine 6 follow two distinct routes, 
mimicking nature’s approach to the same compounds.
8
 The first is via Bischler-
Napieralsky cyclization of amides 7 followed by hydrogenation/reduction of the 
resulting iminium ion 8 to 9 and the second is by Pictet-Spengler condensation 
reactions of 6 with aldehydes to give 9 (Scheme 2). It should be noted that the 
Pictet-Spengler reaction gives better results when electron-rich aromatic 
compounds are employed. The Bischler-Napieralksy reaction, on the other hand, 
has a broader scope in this regard. Although a variety of enantioselective methods 
using the former approach are known, a general asymmetric Pictet-Spengler 
reaction to generate tetrahydroisoquinolines with high yields and 









Scheme 2 General synthetic approaches to tetrahydroisoquinolines 
Some of the reported strategies will be discussed briefly. One approach to chiral 
tetrahydroisoquinolines is based on an asymmetric Ru-catalyzed transfer 
hydrogenation of cyclic iminium ions – products of the Bischler-Napieralsky 
reaction - giving tetrahydroisoquinolines 12 bearing unfunctionalized 5- or 6-
membered rings.
14,15
 In this case, iminium ion 11 can be converted to the 
corresponding chiral isoquinoline 12 (n = 1, Crispine A – vide infra) in very good 
yields and enantioselectivities (Scheme 3). For the asymmetric transfer 
hydrogenation, a Ru catalyst based on a chiral diamine was employed. 
 
Scheme 3 Asymmetric transfer hydrogenation 
An acyl-Mannich reaction to construct the related chiral dihydroisoquinolines 16 
has recently been described.
16
 With chiral thiourea 15 in 10 mol% loading, the 
conversion of quinolines 13 with silyl enolether 14 to the desired chiral products 16 
proceeds with generally very good yields and enantioselectivities. It has to be 
noted, though, that the temperature plays a critical role in this transformation and 
has to be carefully controlled to achieve the reported results, certainly a downside 
in terms of applicability. To reach the envisaged tetrahydroisoquinolines, one 
further reduction/hydrogenation step has to be carried out. 
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Scheme 4 Asymmetric acyl-Mannich reaction 
A Lewis acid-catalyzed aromatic cyclization of allylamines 17 was reported.
17
 This 
transformation gives rise to the corresponding N-protected tetrahydroisoquinolines 
18 with a terminal double bond as substituent in up to excellent yields. These 
compounds are valuable building blocks with a variety of possibilities for further 
functionalization. The substituent R’ in the α-position to the nitrogen atom was 
found to have little influence on the diastereoselectivity. It is important to note that 
for this transformation, only electron-rich aromatic compounds 17 are converted to 
the desired products 18. If R = Me, no turnover was found under a number of 
cyclization conditions. This marks an important downside of this method and the 
related Pictet-Spengler reaction
8
 which requires activated aromatic compounds for 
the ring-closing to occur. 
 
Scheme 5 Lewis-acid catalyzed aromatic cyclizations 
 
2 Goal 
The aim of this research was to develop a transition-metal based catalytic 
asymmetric approach to chiral tetrahydroisoquinolines. It should be general in 
terms of substrate scope and thus independent of the electronic parameters of the 
aromatic system. In this manner, problems associated with the widely-used Pictet-
Spengler reaction should be overcome. Ideally, this approach to chiral nitrogen-
containing heterocycles should be general and not be limited to 
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tetrahydroisoquinolines alone or 6-membered N-heterocycles. Needless to say, the 
formation of both enantiomers should be feasible with high selectivity. We 
envisaged that an allylic substitution protocol should be able to fulfill all of the 
above prerequisites. Furthermore, it would furnish a stereogenic center bearing a 
terminal double bond, which is an ideal starting point for further synthesis. As the 
last requirement, if an N-protecting group had to be employed, it should be easily 
removable. 
 
3 Results and Discussion 
From related studies on β-carboline compounds (see Chapter 4), it was clear that 
the direct allylic amination approach was not viable, i.e. making use of an 
unprotected ethylamine moiety and employing it as nucleophile for the 
intramolecular allylic amination. We instead chose to employ a nitrogen-based 
functional group that could act both as the nucleophile for the allylic substitution as 
well as acting as a protecting group during the preparation of the desired starting 
material. As a third requirement, the protecting group should be easily removed 
after installation of the tetrahydroisoquinoline structure. We therefore chose the 
(trifluoro)acetamide as a nucleophile/protecting group for our approach.  





chiral ligands represents powerful synthetic methodology which has found 
application in many natural product syntheses.
18,24
 One major advantage of the 
asymmetric iridium-catalyzed allylic substitution is its tolerance towards a large 
variety of nucleophiles, including ammonia.
29-33
 Amides as nucleophiles for these 
transformations have only been reported in the case of potassium 
trifluoroacetamide as ammonia surrogate
29
 or in allylic amidation reactions via 
decarboxylative pathways.
34,35
 Apart from the aforementioned literature 
precedents, a general, highly selective allylic amidation had not been developed, 
therefore we chose to investigate the Ir-catalyzed allylic amidation for the synthesis 
of tetrahydroisoquinolines. Employing iridium catalysts would enable us to work at 
ambient temperatures with a well-understood, but still tunable catalyst system. 
 
3.1 Synthetic approach  
To synthesize the envisaged starting materials 20 for the allylic amidation, i.e. 
phenylethylamines bearing an ortho-allylic carbonate substituent, the approach 
taken was to make use of a Pd-catalyzed cross-coupling reaction to install the 
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allylic alcohol moiety (Scheme 6). For this, 2-iodo or 2-bromo phenylethylamine 
derivatives 21 had to be prepared, which could subsequently be cross-coupled to 
an appropriate organometallic compound. It turned out that the preparation of the 
2-halophenylethylamines 21 represented the bottleneck of the synthesis, since 
selective ortho-halogenation with both electron-rich and –deficient aromatics 
cannot be achieved via a single methodology. Thus, one of the limitations of the 
scope for the preparation of tetrahydroisoquinolines via Ir-catalyzed allylic 
amidation as described in this chapter turned out to be the preparation of the 
corresponding halogenated starting materials (vide infra). 
 
Scheme 6 Retrosynthetic approach 
As mentioned before, the usefulness of the trifluoroacetamide group in the selected 
synthetic approach is twofold. First it serves as protecting group during the 
synthesis of the allylic carbonates 20, whose key step relies on a Pd-catalyzed 
cross-coupling reaction to introduce the allylic moiety (Scheme 6). Here, 
unprotected amines are generally not accepted. Second, amide 20 serves as the 
actual nucleophile of the Ir-catalyzed allylic substitution, which furnishes the 
tetrahydroisoquinoline core 19. An important property of the trifluoroacetamide 
group is that the secondary amine moiety could easily be deprotected without 
jeopardizing the adjacent sensitive allylic-benzylic stereocentre. This is a major 
advantage over N-protecting groups which have to be removed by hydrogenolysis, 
36,37





3.2 Synthesis of starting materials  
Synthesis of the 2-halophenylethylamine derivatives 
First, the commercially unavailable ortho-halophenylethylamine derivatives had to 
be synthesized. The protection of the primary amines 22 to the corresponding 








Scheme 7 Preparation of (trifluoro)acetamides 23 
The choice of the appropriate iodination method was crucial with for a high yielding 
and regioselective transformation. With electron-rich (trifluoro)acetamides 24 , 
simple iodination with the electrophilic reagent ICl could be achieved according to 
literature procedures
49
 yielding the desired ortho-iodophenylethylamides 26 with 
high yields and complete regioselectivity (Scheme 8). The preparation of 27 was 
carried out according to a literature procedure,
50
 starting from the commercially 
available nitrile 25, which was converted to 27 through a 
iodination/reduction/protection protocol in good yield. 
 
Scheme 8 Iodination of electron-rich phenylethylamines
49,50
 
However, iodination of para-tolylphenylethyltrifluoroacetamide 28a could not be 
carried out in a selective fashion according to the same approach due to lack of 
regioselectivity of the aromatic substitution, which can be attributed to the lower 
electron density of the aromatic ring. The same holds true for the para-chloro 
derivative 28b. For the selective ortho-iodination of those two compounds, an 





 The corresponding iodides 29 were obtained with 
excellent yields and regioselectivities. Finally, for the unsubstituted 
  
  57 
Ir-catalyzed allylic amidation 
phenylethylamine derivative 30f (see Scheme 10), the trifluoroacetamide-derivative 
of the commercially available bromide was used for the subsequent cross-coupling 
reaction. 
 
Scheme 9 Selective Iodination with IPy2 





 with 5.0 mol% Pd catalyst was carried out at 70 °C 
(Scheme 10). This coupling method was found to be the highest yielding and most 
reliable coupling protocol, as established in preliminary studies (see also chapter 
4). Iodides 30 were smoothly converted to the allylic alcohols 31 in high yields, an 
exception being the electron poor para-chloro compound 31e, with 51% isolated 
yield. In the case of the bromo-phenylethyltrifluoroacetamide with no further 
substituents on the aromatic ring, a slightly elevated temperature of 90 °C had to 
be used to achieve full conversion to the desired product. Already at this stage the 
detrimental performance of the acetamide protection group in comparison to the 
trifluoroacetamide group was visible, since the acetamide-protected allylic alcohol 
31f was isolated in substantially lower yield, due to the (unexpected) considerably 
higher polarity and subsequent difficult purification. This general trend is visible 
through the following transformations, further supporting the choice of 
trifluoroacetamide as the protecting group. Conversion of the allylic alcohols 31 to 
the corresponding carbonates 32 with methyl chloroformate proceeded in high 
yields. 
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Synthesis of the linear allylic carbonates 
The synthesis of the linear allylic carbonates for the allylic amidation to give 
saturated N-heterocycles is straightforward (Scheme 11). Trifluoroacetamide (33) 
was alkylated with bromoalkenes of varying chain lengths to give the 
corresponding terminal alkenes 34 in excellent yields. Alkenes 34 were 
subsequently transformed to the allylic carbonates 35 by cross-metathesis with Z-
butenediyl methyl carbonate in good yields,
31
 employing Hoveyda-Grubbs 2
nd
 
generation catalyst (Scheme 11).
55
 It is important to note that for the latter reaction 
to occur in high yields, elevated temperatures of 70 °C were necessary. Reactions 
in refluxing CH2Cl2 gave low conversions to the corresponding carbonates 35. 
 
 
Scheme 11 Preparation of linear allylic carbonates 
 
3.3 Catalyst optimization 
Base screening 
One of the most influential components of the Ir-catalyzed allylic amidation turned 
out to be the base. Not only were substantial changes in the conversion of the 
benchmark substrate 32a observed, but the base proved to be highly influential in 
terms of enantioselectivity. Compound 32a was chosen as the starting point of the 
investigation since the 4,5-dimethoxy substitution of 37a is very common in 
naturally occuring tetrahydroisoquinoline alkaloids, but also it served as a point of 
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comparison to the related Pd-based catalytic systems.
13,49
 We set off to investigate 
the influence of various bases on the catalytic system, which was comprised of 
preformed iridacycle 36 in THF at 50 °C (Table 1).
20
 In 36, two phosphoramidite 
ligands are bound to the Ir, one in a κ
1
 fashion via the P atom and one in a κ
2
 
fashion, where both a P and a C atom coordinate to Ir to form a five-membered 
iridacycle. DBU gave 70% conversion and 81% ee (Table 1, entry 1). With catalytic 
amounts of DBU the same enantioselectivity was found, however the reactions did 
not achieve full conversion to 37a. Other related organic bases such as TBD and 
DABCO (see Table 1), which had been reported earlier in combination with Ir 
catalysts for allylic substitutions
56,57
 led to significantly lower or no conversion and  
low enantioselectivities (Table 1, entries 2,5). In the case of TBD, the starting 
material was recovered (Table 1, entry 2). Inorganic bases such as K3PO4 and 
Cs2CO3 (Table 1, entries 3,4) performed similarly disappointing with regard to 
conversion and enantioselectivities. 
  










 70% 81% 
2 TBD
e
 n.d. n.d. 
3 K3PO4 10% 19% 
4 Cs2CO3 15% 22% 
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 10% 31% 
a
 Reaction conditions: 1.0 eq. 32a (16.9 mg, 0.05 mmol), 5.0 mol% 36 (3.45 mg, 0.0025 mmol) and 1.0 
eq. base (0.05 mmol) were dissolved in 1 mL THF and stirred under a N2 atmosphere at 50 °C for 20 h. 
b
Determined by HPLC. 
c









From these results it became clear that the base plays a crucial role for the 
performance of the catalyst with regard to both turnover as well as 
stereodiscrimination. This seems to be in contrast with some of the previously 
reported allylic amination protocols which work well without a base (apart from the 
catalytic amounts of base necessary for the activation of the catalyst).
20,23,57
 In 
those cases, the alkoxide leaving group acts as an additional base to neutralize the 
protons of the nucleophile. One could speculate that the positively charged 
counterion that is formed by protonation of the base could have an influence on the 
allylic substitution, possibly due to a coordinating and thus activating effect of the 
leaving group or the nucleophile. Additional studies are clearly needed to elucidate 
the role of the base in allylic substitutions with iridacycles as catalysts. 
 
Catalyst optimization 
Further investigations to improve the catalytic allylic amidation were carried out. 
With preformed iridacycle 36 at elevated temperatures (50 °C) the reaction did not 
reach full conversion overnight, and the desired tetrahydroisoquinoline 37a could 
be isolated in only 33% yield (Table 2, entry 1). However, we were delighted to find 
that an in situ formed iridacycle, prepared from catalytic amounts of 
phosphoramidite ligand L1 and [Ir(COD)Cl]2, showed a higher activity and led to full 
conversion (73% yield) under the same conditions (Table 2, entry 2) with similar 
enantioselectivities (83% ee). This effect could be explained by the fact that in 
preformed catalyst 36, the κ
1
-phosphoramidite has to decoordinate to liberate a 
coordination site for the intermediate Ir-allyl species
22,58,59
 to form. In the case of 
the in situ prepared iridacycle, only one equivalent of phosphoramidite ligand L1 
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with respect to the iridium is present, so that the last coordination site of the 
catalyst is most probably occupied by a solvent molecule, in our case THF. This is 
expected to dissociate more quickly, giving rise to a much more active catalyst. 
One would hypothesize that the enantioselectivity should remain the same for both 
catalysts, since the ligand staying on the Ir atom stays the same, which is in 
accordance to our observations (Table 2, entries 1,2). It has been established 
earlier that it is the stereogenic center of the iridacycle that governs the 
stereodiscrimination of the transformation.
60
 Lowering the temperature (RT) did not 
affect the enantioselectivity but again resulted in incomplete conversion (Table 2, 
entry 3). Turning to the related, methoxy-substituted phosphoramidite L2,
61
 we 
found the product of the intramolecular asymmetric allylic amidation in excellent 
enantioselectivities (95% ee), with an even higher yield observed at room 
temperature (Table 2, entries 4,5). The ortho-methoxy substitution of L2 clearly has 
a remarkable effect on the transformation. However, it is not established whether 
this effect has its origin in a possible additional coordination, changes in the 
electronic properties or steric effects of ligand L2. Particularly noteworthy is the fact 
that when the corresponding acetamide was subjected to the optimized reaction 
conditions, no allylic amidation occurred even at elevated temperatures (Table 2, 
entry 6), indicating that trifluoroacetamides possess ideal electronic and/or acidic 
requirements for the asymmetric transformation envisaged. 
Table 2 Catalyst optimization
a 
 





1 CF3 (32a) 36 50 °C 33%
e
 81% 
2 CF3 (32a) Ir/L1
d
 50 °C 73% 83% 
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4 CF3 (32a) Ir/L2
d
 50 °C 82% 94% 
5 CF3 (32a) Ir/L2
d
 RT 90% 95% 
6 CH3 (32f) Ir/L2
d
 50 °C n.d. n.d. 
a
Reaction conditions: 1.0 eq. 32a or 32f (0.05 mmol), 5.0 mol% Ir catalyst (0.0025 mmol) and 1.0 eq. 
DBU (8 μL, 0.05 mmol) were dissolved in 1 mL THF and stirred under a N2 atmosphere at the indicated 




Determined by HPLC, see experimental 
section. 
d
See Experimental section. 
e
Reaction did not reach full conversion.  
 
3.4 Substrate scope 
Tetrahydroisoquinolines 
To probe the substrate scope of the catalytic system, a collection of chiral 
tetrahydroisoquinolines were prepared, posessing the most common substitution 
patterns of natural products (Table 3).
1,2
 Tetrahydroisoquinolines with donor 
substituents, such as methoxy-, dioxo- as well as methyl groups 37a-c (Table 3, 
entries 1-3) were all obtained in very good yields and with excellent enantiomeric 
excesses ranging from 91 - 95%. Furthermore, the unsubstituted 
tetrahydroisoquinoline 37d (Table 3, entry 4) could be isolated with similarly good 
results (78%, 94% ee). The reactions could be scaled up to 1 mmol scale with the 
same results in terms of yields and enantioselectivities. The absolute configuration 
of the products was established by comparison of the sign of the optical rotation of 
37a to earlier studies.
13
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37a rt 97% 95% 
2 
 
37b rt 89% 94% 
3 
 
37c rt 92% 91% 
4 
 
37d rt 78% 94% 
a
 See experimental section. 
b
 Isolated yields. 
c
 Determined by HPLC, see experimental section.  
With chloro-substituted substrate 32e, unexpected results were obtained when the 
Ir-catalyzed allylic amidation was attempted (Table 4). Under optimized reaction 
conditions (Table 4, entry 1), full conversion was observed overnight, but as the 
sole product the isomerized enamide 39 was isolated as a mixture of E and Z 
double bond isomers. The same outcome was found with a catalyst prepared from 
the related phosphoramidite ligand L1 (Table 4, entry 2), albeit with slightly lower 
conversion, reflecting the same trends in terms of activity as found earlier. To 
probe whether the base had an influence on the double-bond isomerization, the 
reaction was carried out at ambient temperature with only catalytic amounts of 
DBU, which had led to lower conversion in the previously studied cases. In the 
case of substrate 32e, however, full conversion to the unwanted enamide 39 was 
observed (Table 4, entry 3). Preformed iridacycle 36 led to no conversion of the 
allylic carbonate 32e, independent of the presence of base (Table 4, entries 4,5). In 
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previous studies of Ir-catalyzed asymmetric allylic etherifications, a similar effect of 
double bond isomerization had been observed.
62
 In that case, the addition of 
catalytic amounts of phenylpropyne to the catalyst had been shown to prevent the 
unwanted isomerization from occuring. When we carried out the allylic amidation in 
the presence of catalytic amounts of phenylpropyne (Table 4, entry 6), still the 
same complete isomerization to enamide 39 was observed. It can be speculated 
that the electronic parameters of the substrate enabled the unwanted isomerization 
to take place, this would then represent a limitation of this catalytic transformation. 
Table 4 Ir-catalyzed allylic amidation of 32e 
 
Entry Conditions 38/39 Conversion ee 
1 
2.5 mol% [Ir(COD)Cl]2 
5.0 mol% L2, 2.0 eq. DBU, 50 °C 
0/100 Full (63% yield) n.d. 
2 
2.5 mol% [Ir(COD)Cl]2 
5.0 mol% L1, 2.0 eq. DBU, 50 °C 
0/100 80% (32% yield) n.d. 
3 
2.5 mol% [Ir(COD)Cl]2 
5.0 mol% L2, 10 mol% DBU, rt 
0/100 full n.d. 
4 5.0 mol% 36 (preformed), 50 °C - none n.d. 
5 
5.0 mol% 36 (preformed) 
2.0 eq. DBU, 50 °C 
- none n.d. 
6 
2.5 mol% [Ir(COD)Cl]2 
5.0 mol% L2 
20 mol% phenylpropyne 
2.0 eq. DBU, 50 °C 
0/100 Full n.d. 
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Saturated N-heterocycles 
The methodology of the asymmetric intramolecular allylic amidation could be 
extended to the synthesis of other chiral nitrogen-containing heterocycles. This 
shows the generality of this transformation, which is not limited to substrates 
bearing aromatic rings in the backbone. Along these lines, 5-, 6- and 7-membered 
chiral heterocycles 40a-c could be synthesized (Table 5, entries 1 – 3). For these 
reactions to proceed smoothly, elevated temperatures of 50 °C were required to 
ensure full conversion. At room temperature, the reactions proceeded with the 
same outcome in terms of enantioselectivity, but with about 50% conversion. The 
reason that in the earlier case of the tetrahydroisoquinolines a lower temperature 
was sufficient for full conversion could be explained by the ortho-substitution of 
both the nucleophile as well as the allyl carbonate on the phenyl ring. In this case, 
the two reaction partners are spatially already closer to each other and less energy 
is necessary for the molecule to adopt a conformation that is beneficial for the 
allylic amidation to take place. This phenomenon is known in literature under the 
name “steric compression”.
63
  In all cases of the saturated heterocycles, however, 
very good to excellent enantioselectivities (up to 96% ee) were found, 
demonstrating the versatility of our new catalytic transformation. The actual yields 
of the products 40a and 40b are low due to their volatilty, however, full conversion 
to the desired heterocycles 40 could be established by 
1
H NMR analysis of the 
crude reaction mixture.  

















































A side reaction was observed, see Scheme 12. 
Noteworthy is the fact that when the synthesis of chiral azepane 40c was 
investigated (Table 5, entry 3), an unexpected side reaction occurred. When allylic 
carbonate 35c was reacted under allylic amidation conditions at 50 °C, chiral 
azepane 40c was found along with linear diene 42 as the major product (Scheme 
12). The product distribution seemed to be independent of temperature (i.e. the 
same outcome was observed at room temperature) and amount of DBU employed. 
This side reaction was only observed for 40c and not in the synthesis of piperidine 
40b or pyrrolidine 40a, indicating that the mechanism of the formation of the 7-
membered ring requires special spatial constraints. Therefore, the formation of the 
azepane is slower and the intermediate Ir-allyl species can react further in via other 
pathways. In the absence of the Ir-catalyst, no reaction was observed, indicating 
that the Ir catalyst is essential for this transformation to take place.  
 
Scheme 12 Observed side reaction / formation of azepane 
There are two possible mechanisms for the formation of the linear diene 42. Since 
it was observed that the formation of 42 only takes place in the presence of the Ir 
catalyst, it can be assumed that the first step involves the formation of the Ir-allyl 
complex. This had previously been isolated and postulated as one of the key steps 
of Ir-catalyzed allylic substitution.
22,58,59
 After formation of the allyl-Ir-complex from 
allylic carbonate 35c, the oxygen atom of the trifluoroacetate could act as a 
nucleophile for the allylic substitution (Scheme 13, path A); a reaction related to 
recent observations made in the Ir-catalyzed asymmetric allylic substitution with 
thiocarbamates,
64
 resulting in a 9-membered heterocycle 44, which can 
subsequently undergo elimination to form the linear diene 42. Alternatively, Ir-
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complex 43 could undergo β-hydride elimination to form 42 directly (Scheme 13, 
path B). This decomposition reaction would hint towards a relatively long-lived 
intermediate 43, which could be explained by the sterically unfavoured formation of 
the envisaged product 44 containing a seven-membered ring. This would also 
explain why similar side-reactions were not observed in the synthesis of pyrrolidine 
40a and piperidine 40b. 
 
Scheme 13 Proposed mechanisms for the formation of diene 42 
 
3.5 Deprotection of the trifluoroacetamide 
The ease of deprotection of the products of the intramolecular asymmetric allylic 
amidation, i.e. chiral secondary trifluoroacetamides, was demonstrated with the 
conversion of 37a (Scheme 14). The product was simply stirred at ambient 
temperature in the presence of an excess of K2CO3 in MeOH/H2O to yield the 
corresponding chiral homoallylic amine 45 in excellent yield, without loss of ee. 
Bearing both a terminal olefin and a secondary amine, 45 is a highly versatile chiral 
building block for the synthesis of chiral tetrahydroisoquinoline-derived structures. 
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3.6 Application of chiral tetrahydroisoquinolines in synthesis 
To demonstrate the synthetic utility of the chiral allylic amidation products 37 they 
were explored in synthetic studies towards natural products and biologically active 
compounds. In both cases, the following synthetic steps were building upon the 
highly functional building blocks such as 45, making use of the secondary amine 
and the terminal double bond.   
 
Attempted Synthesis of Crispine A 
Crispine A (12) is an isoquinoline alkaloid isolated from the thistle Carduus crispus, 
from which extracts have been used in traditional Chinese medicine for the 
treatment of rheumatism.
65
 The attempted synthesis was based on chiral 
tetrahydroisoquinoline 45, which was N-allylated to give 46 in good yields (Scheme 
15). The subsequent synthetic route comprised a ring-closing metathesis reaction 
with Ru-based catalysts,
55
  to give the tricyclic precursor to Crispine A 47. To finish 
the synthesis, a metal-free reduction of the double bond was intended,
66,67
 
however, the ring-closed product was oxidized during the metathesis reaction to 
give pyrroline 48. The tendency to quickly oxidize had been observed with related 
compounds earlier,
17
 and in our hands could not be prevented by changing the 
reaction conditions to lower temperatures and/or variation of the metathesis 
catalyst. The use of Mo-based metathesis catalysts
68
 did not show conversion in 
this case. 
 
Scheme 15 Attempted Synthesis of Crispine A 
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Attempted Synthesis of Almorexant 
Almorexant (51)
69
 is a potent inhibitor of the orexin neuropeptide hormones in 
humans, which have an influence on awakeness (Scheme 16).
70
 Therefore, orexin 
inhibitors are used for the treatment of insomnia. It carries a chiral 
tetrahydroisoquinoline core next to an α-chiral amide. We chose this molecule as a 
potential synthetic target to demonstrate the usefulness of the Ir-catalyzed allylic 
amidation. From the N-deprotected compound 45, a functionalization of the 
terminal double bond via Pd-catalyzed cross-coupling followed by a Ugi-type 
reaction
71
 should lead to 50. It needed to be investigated in how far the stereogenic 
center of 49 could induce steroselectivity for the formation of the second 
stereocenter in 50.  Finally, reduction of the double bond
66,67
  would give rise to 
Almorexant (51). 
 
Scheme 16 Anticipated total synthesis of almorexant (51) 
Preliminary synthetic studies revealed the general feasiblity of the envisaged 
synthesis, however, as in the previous case with Crispine A, partial oxidation of the 
nitrogen-containing ring of the tetrahydroisoquinoline core presented some 
synthetic challenge. 
We started off by investigating the possibility of directly installing the para-
trifluorostyrene moiety by cross-metathesis with the N-protected 
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tetrahydroisoquinoline 37a, however, all attempts with Ru-based metathesis 
catalysts did not lead to conversion of 37a to 53 (Scheme 17). The fact that mainly 
the homodimer of 52 was found in the reaction mixture is indicative that the 
reactivity of the terminal olefin of 37a is relatively low. The same low reactivity was 
also found in preliminary attempts to carry out a hydroboration on 37a which led to 
no conversion either.  
 
Scheme 17 Attempted cross metathesis 
The functionalization of the terminal double bond of 37a to yield styrene 55 was 
achieved by employing the Heck reaction. The desired product 55 could be 
obtained from the reaction of tetrahydroisoquinoline 37a with iodobenzene 54 in 
good yield (Scheme 18). However, it should be mentioned that as a side product, 
the isomerized enamide 56 was found. This preliminary result indicates that some 
optimization of the Heck reaction conditions is still necessary. The mixture of 55 
with 56 was subjected to a reduction of the internal double bond employing a 
metal-free flavin-catalyzed recuction protocol
66,67
 furnishing 58 in moderate yield. 
Again, 56 was still present in the reaction mixture. The following deprotection of the 
trifluoroacetamide group went smoothly, however it was accompanied by complete 
oxidation to the corresponding ketimine 59. It is expected that side-product 56 also 
gives 59 after deprotection and isomerization (see also Scheme 19). Even under 
reductive deprotection conditions employing DIBAL-H, 59 was the only product 
isolated, indicating a very fast oxidation of the anticipated secondary amine to 59 
upon contact with air. 
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Scheme 18 Attempted synthesis of Almorexant 
To avoid oxidation of the products, the synthetic steps of reduction and 
deprotection were reversed (Scheme 19). When the impure mixture of the Heck 
reaction, namely trifluoroacetamide 55  and enamide 56, was deprotected before 
the internal olefin was reduced, the desired product 60 could be found as the major 
product. In this case we find it as a mixture with the isomerized product 59, which 
we attributed as the product of the deprotection and isomerization of 56. This result 
and the outcome of the previous attempt (Scheme 17) show that, in principle, the 
deprotection of the trifluoroacetamide moiety is possible, however, the presence of 
the olefin is necessary to prevent oxidation or isomerization to unwanted side 









Scheme 19 Deprotection of 55 
The aforementioned results lead to the conclusion that a revised synthetic route 
should be followed to prevent any isomerization or oxidation (Scheme 20): Starting 
off from the deprotected tetrahydroisoquinoline 45, which has been known to be 
stable towards oxidation, first the Ugi-type reaction
71
 to yield the amide should be 
carried out. The next step would be functionalization of the terminal olefin to 
introduce the trifluorotolyl group with subsequent reduction of the double bond.  
This can be carried out by the Heck reaction, which is to be optimized to prevent 
the formation of side-products. This route would lead to the target molecule, 
almorexant (51) avoiding oxidation-labile intermediates. As an alternative, the 
hydroboration of 61 and subsequent Suzuki coupling of 63 would circumvent the 
need for later reduction of the internal double bond.  
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3.7 Intermolecular allylic amidation 
It was anticipated that the newly developed catalyst system for the Ir-catalyzed 
allylic amidation could be extended to an intermolecular variant. This would bear 
some advantages: It would open up the possibility to introduce amines bearing a 
short (i.e. methyl or ethyl) alkyl group, which are difficult to employ in the allylic 
amination due to the fact that they are gaseous. Secondly, since the amines would 
be introduced to the new molecule bearing a trifluoroacetamide group, they would 
be introduced in a protected fashion. If a longer synthesis is envisaged or the allylic 
amidation is carried out early in the synthetic route, this could be advantageous. 
The reaction of N-methyl trifluoroacetamide 65 with cinnamyl methyl carbonate 64 
was used as the benchmark reaction to investigate this catalytic transformation 
(Table 6). With the Ir/L1 catalyst, full conversion of the starting material was 
achieved, however, the only product isolated was the isomerized enamide 67 
(Table 6, entry 1). The same results were found at ambient temperature and with 
only catalytic amounts of base (Table 6, entries 2,3). Also the addition of catalytic 
amounts of phenylpropyne, as mentioned earlier, did not prevent the isomerization 
from taking place (Table 6, entry 4). Again, as in the case of the para-chloro 
tetrahydroisoquinoline 32 (vide supra), it seems that the electronic properties of the 
substrate govern the product distribution of this transformation. For example, the 
phenyl substituent could lead to the isomerization, as the double bond in 67 is 
stabilized through conjugation. 
Table 6 Intermolecular allylic amidation 
 
Entry Conditions Conversion 66 / 67 
1 2.0 eq. DBU, 50 °C full 0/100 
2 2.0 eq. DBU, rt ~80% 0/100 
3 10.0 mol% DBU, 50 °C full 0/100 
4 
2.0 eq. DBU, 50 °C 
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4 Conclusions and Future prospects 
In conclusion, we have developed a new asymmetric synthesis of chiral nitrogen-
containing heterocycles, especially tetrahydroisoquinolines, which are important 
building blocks for the synthesis of biologically active products. Our approach is 
based on the first intramolecular asymmetric Ir-catalyzed allylic amidation, and the 
desired products are accessible in excellent yields and enantioselectivities. The 
trifluoroacetamide group serves two purposes in this approach; initially it is used as 
a protecting group during the synthesis stage of the starting materials, but further 
on its enhanced nucleophilicity is exploited for the key asymmetric allylic amidation 
step. We have also demonstrated that deprotection to the corresponding amine 
can be readily executed without loss of ee.  
The applicability of the corresponding products has been demonstrated by two 
attempted synthesis of a naturally occuring and a biologically active product. Both 
syntheses did reveal the tendency of certain tetrahydroisoquinolines to oxidize. 
However, for the synthesis of Almorexant, preliminary studies have led to the 
proposal of a revised synthetic route which should not be hampered by possible 
oxidation of intermediates. 
In the case of the attempted intermolecular allylic amidation and the attempted 
synthesis of para-chlorotetrahydroisoquinoline, where only the isomerized 
enamides were isolated, albeit in good yield, more work has to be done to 
overcome the deterioration of the desired products. The above mentioned 
discovery that the addition of internal alkynes could prevent a similar isomerization 
for an allylic etherification with Ir catalysts has recently led to the identification of a 
highly active Ir-ethene complex 70, which is also capable of selective direct 
asymmetric amination with ammonia (Scheme 21).
30,72
  This more selective 
catalyst should be employed to reinvestigate the reactions which so far have led to 
the isomerized enamides. 
 
Scheme 21 Direct asymmetric allylic amination with ammonia 
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One disadvantage of the present catalytic asymmetric synthesis of 
tetrahydroisoquinolines is that the substrate scope is effectively limited by the 
problematic introduction of the halogens for the Stille cross-coupling, which installs 
the allylic alcohol moiety. Ideally, the allylic alcohol could be introduced without 
prior halogenation of the aromatic ring. A directed C-H activation with transition 
metals
73,74
 could be envisaged (Scheme 22). Again, the trifluoracetamide group 
could be employed: it could direct the C-H activation to the ortho position of 71, 
leading to the desired substitution pattern of the aromatic ring 72. In this manner, 
the synthetic route towards tetrahydroisoquinolines would be shortened 
significantly. 
 
Scheme 22 Proposed C-H activation methodology 
 
5 Experimental Section 
 
General 
Chromatography: Merck silica gel type 9385 230-400 mesh, TLC: Merck silica gel 
60,0.25 mm. Components were visualized by UV and cerium/molybdenum staining. 
Progress and conversion of the reaction were determined by GC-MS (GC, 
HP6890: MS HP5973) with an HP1 or HP5 column (Agilent Technologies, Palo 
Alto, CA). Mass spectra were recorded on a AEI-MS-902 mass spectrometer (EI+) 






C-NMR were recorded on a Varian 
AMX400 (400 and 100.59 MHz, respectively) using TMS or CFCl3 as reference, a 
Varian VXR300 (300 and 75 MHz, respectively) or a Varian Gemini 200, using 
CDCl3 as solvent. Chemical shift values are reported in ppm with the solvent 
resonance as the internal standard (CHCl3: δ 7.26 for 
1
H, δ 77.0 for 
13
C). Data are 
reported as follows: chemical shifts, multiplicity (s = singlet, d = doublet, t = triplet, 
q = quartet, br = broad, m = multiplet), coupling constants (Hz), and integration. 
Optical rotations were measured on a Schmidt + Haensch polarimeter (Polartronic 
MH8) with a 10 cm cell (c given in g/100 mL). Enantiomeric excesses (ee values) 
were determined by HPLC analysis using a Shimadzu LC-10ADVP HPLC 
equipped with a Shimadzu SPD-M10AVP diode array detector and chiral columns 
as indicated. Ees were determined by comparison with the corresponding chiral 
compounds or the mixtures of both R and S enantiomers. All reactions were carried 
out under a nitrogen atmosphere using oven dried glassware and using standard 
Schlenk techniques. CH2Cl2 was dried and distilled over calcium hydride, THF and 
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Et2O were dried and distilled over Na/benzophenone. Toluene was dried and 
distilled over Na. [Ir(COD)Cl]2 was purchased from Strem Chemicals, Inc.. 
Complex 36 was prepared according to literature.
20,29
 Ligand L1 was prepared 
according to literature.
75




General trifluroacetylation/acetylation protocol: 
To a solution of the corresponding amine (1.0 eq.) and NEt3 (2.0 eq.) in CH2Cl2 (2 
mL/mmol) was added dropwise trifluoroacetic anhydride (1.2 eq.) (or acetic 
anhydride in the case of 30f) at 0 °C. The mixture was stirred at this temperature 
for 1 h. The reaction was quenched with water (10 ml) and the mixture extracted 
with CH2Cl2 (3 x 5mL). The combined organic layers were washed with brine, dried 
over Na2SO4 and concentrated under vacuum to afford the corresponding N-
trifluoroacetyl or N-acetyl compound. The products were used without further 
purification. 
 
Preparation of halides 30a-e 
Substrate 30a (X = I) was synthesized following literature procedures.
49
 Substrate 
30b (X = I) was prepared following the general trifluoroacetylation protocol (see 
above) from 2-(2-iodo-3,4-methyldioxyphenyl)ethylamine which was made 
following literature procedures.
50
 30c (X = I) was synthesized from 30a using 
IPy2BF4 (which was recrystallized from CH2Cl2/Et2O before use) as iodinating agent 
following a literature procedure.
52
 Substrate 30d (X = Br) was prepared following 
the general trifluoroacetylation protocol (see above) from commercial 2-
bromophenethylamine. 30f was synthesized following the same procedure as for 
30a,
49




In analogy to a literature procedure,
52
 1.00 eq. N-(4-chlorophenethyl)-2,2,2-
trifluoroacetamide 29b (0.126 g, 0.5 mmol) was 
dissolved in a mixture of CH2Cl2 (100 ml) and 
trifluoracetic acid (10 ml). 4.40 eq. of 
tetrafluorboric acid in Et2O (0.295 ml, 2.0 mmol) 
was added, followed by slow addition of freshly 
recrystallized 2.20 eq. bispyridineiodonium 
tetrafluoroborate (0.371 g, 2.0 mmol). The 
reaction mixture was stirred at room temperature until full conversion was reached 
as judged by GC/MS (~1h). Then, the reaction was quenched by addition of cold 
water (50 mL), the mixture was washed with saturated aq. Na2S2O3 solution (2x 50 
mL). After drying over Na2SO4 and removal of all volatiles N-(4-chloro-2-
iodophenethyl)-2,2,2-trifluoroacetamide 30e (0.175 g, 0.464 mmol, 93 %) was 
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NMR (201 MHz, CDCl3) δ 7.81 (d, J = 2.1 Hz, 1H), 7.32 – 7.20 (m, 1H), 7.10 (d, J = 
8.2 Hz, 1H), 6.92 (s (br), 1H), 3.57 (dd, J = 13.4, 6.8 Hz, 2H), 2.99 (t, J = 7.2 Hz, 
2H). 
13
C NMR (50 MHz, CDCl3) δ 157.53 (q, J = 36.0 Hz), 138.94, 138.89, 133.33, 
130.34, 128.74, 115.69 (q, J = 293.2 Hz),100.02, 39.67, 38.66. 
19
F NMR (189 MHz, 
CDCl3) δ -75.90. HRMS: (ESI
+





General procedure for the synthesis of substrates 31 (Stille coupling): 
To a mixture of halides 30 (1.0 eq.), E-β-tributylstannylpropenol
54
 (1.2 eq.) and LiCl 
(3.0 eq.) in dry DMF (6 mL/mmol), bis(triphenylphosphine)palladium dichloride (5.0 
mol%) was added under nitrogen atmosphere. The resulting solution was stirred at 
70 °C for 16 h. After cooling to room temperature, the mixture was diluted with 
ethyl acetate (15 mL/mmol) and washed with water (4 x 10 mL/mmol). The organic 
layer was dried over Na2SO4 and concentrated under vacuum. Purification by 




Following the general procedure, 274 mg of 31a (0.83 mmol, 83%) were isolated 
from the reaction of iodide 30a (403 mg, 1 mmol) 
after purification by column chromatography 
using ethyl acetate/pentane 3:1 as eluent. 
1
H 
NMR (400 MHz, CDCl3) δ 6.96 (s, 1H), 6.93 (br s, 
1H), 6.80 (dt, J = 15.6, 1.4 Hz, 1H), 6.60 (s, 1H), 
6.17 (dt, J = 15.6, 5.4 Hz, 1H), 4.31 (dd, J = 5.4, 
1.6 Hz, 2H), 3.86 (s, 3H), 3.84 (s, 3H), 3.48 (q, J 
= 6.7, 2H), 2.89 (t, J = 6.7, 2H), 2.52 (br s, 1H). 
13
C NMR (101 MHz, CDCl3) δ 157.4 (q, J = 37.0 Hz), 148.8, 148.1, 129.5, 128.4, 




Following the general procedure, 297 mg 31b (0.94 mmol, 78%) were isolated from 
the reaction of iodide 30b (464 mg, 1.2 mmol) 
after purification by column chromatography 
using ethyl acetate/pentane 2:1 as eluent. 
1
H 
NMR (400 MHz, CDCl3) δ 6.96 (s, 1H), 6.82 (dt, 
J = 15.6, 1.5 Hz, 1H), 6.61 (s, 1H), 6.46 (br s, 
1H), 6.16 (dt, J = 15.6, 5.3 Hz, 1H), 5.95 (s, 
2H), 4.33 (t, J = 5.3 Hz, 2H), 3.49 (q, J = 7.1 
Hz, 2H), 2.89 (t, J = 7.1 Hz, 2H), 1.91 (t (br), J = 
5.4 Hz, 1H). 
13
C NMR (101 MHz, CDCl3) δ 
157.5 (q, J = 37.0 Hz), 147.4, 147.2, 130.1, 130.0, 129.8, 128.7, 127.10, 109.6, 
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106.4, 101.1, 63.4, 40.9, 32.4. 
19
F NMR: (376 MHz, CDCl3) δ = -75.98. HRMS 
(ESI+, m/z): calculated for C14H14F3NO4Na [M+Na
+




Following the general procedure, 104 mg 31c (0.36 mmol, 72%) were isolated from 
the reaction of iodide 30c (178 mg, 0.5 mmol) after 
purification by column chromatography using ethyl 
acetate/pentane 2:1 as eluent. 
1
H NMR (400 MHz, 
CDCl3) δ 7.27 (d, J = 9.2 Hz, 1H), 7.07 – 6.99 (m, 2H), 
6.88 (dt, J = 15.7, 1.2 Hz, 1H), 6.75 (s (br), 1H), 6.26 
(dt, J = 15.7, 5.2 Hz, 1H), 4.34 (dd, J = 5.2, 1.2 Hz, 
2H), 3.50 (q, J = 7.3 Hz, 2H), 2.92 (t, J = 7.3 Hz, 2H), 
2.33 (s, 3H), 1.87 (s (br), 1H). 
13
C NMR (101 MHz, 
CDCl3) δ 157.5 (q, J = 36.9 Hz), 137.0, 136.1, 131.9, 131.4, 129.8, 128.7, 127.4, 
127.3, 63.4, 40.8, 32.2, 21.0. The CF3 peaks could not be detected. 
19
F NMR: (376 
MHz, CDCl3) δ = -75.99. 
 
(E)-2,2,2-trifluoro-N-(2-(3-hydroxyprop-1-enyl)phenethyl)acetamide 31d 
Following the general procedure, heating the reaction mixture at 90 °C in this case, 
108 mg 31d (0.4 mmol, 79%) were isolated from the 
reaction of bromide 30d (148 mg, 0.5 mmol) after 
purification by column chromatography using ethyl 
acetate/pentane 2:1 as eluent. 
1
H NMR (400 MHz, 
CDCl3) δ 7.46 (dd, J = 7.1, 2.3 Hz, 1H), 7.24 – 7.21 (m, 
2H), 7.13 (dd, J = 6.7, 2.2 Hz, 1H), 6.92 (dt, J = 15.7, 1.6 
Hz, 1H), 6.90 (s (br), 1H), 6.26 (dt, J = 15.7, 5.2 Hz, 1H), 
4.34 (dd, J = 5.2, 1.6 Hz, 2H), 3.51 (q, J = 7.3 Hz, 2H), 
2.96 (t, J = 7.3 Hz, 2H), 2.61 (s (br), 1H). 
13
C NMR (101 MHz, CDCl3) δ 157.5 (q, J 
= 37.1 Hz), 136.3, 134.9, 131.6, 129.9, 127.9, 127.5, 127.3, 126.7, 115.8, (q, J = 
287.4 Hz), 63.3, 40.6, 32.6. HRMS (ESI+, m/z): calculated for C13H14F3NO2Na 
[M+Na
+




Following the general procedure, (E)-N-(4-chloro-2(3-hydroxyprop-1-en-1-
yl)phenethyl)-2,2,2-trifluoroacetamide 31e (0.074 
g, 0.240 mmol, 52%) was isolated from the 
reaction of iodide 30e (175 mg, 0.46 mmol) after 
purification by column chromatography (SiO2, 
pentane/EtOAc 1:1, Rf = 0.60 in pentane/EtOAc 
1:1). 
1
H NMR (201 MHz, CDCl3) δ 7.41 (d, J = 2.0 
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Hz, 1H), 7.33 – 7.10 (m, 2H), 7.04 (d, J = 8.2 Hz, 1H), 6.85 (d, J = 15.8 Hz, 1H), 
6.35 – 6.14 (m, 1H), 4.33 (dd, J = 4.8, 1.4 Hz, 2H), 3.45 (dd, J = 14.8, 6.6 Hz, 2H), 
3.02 – 2.85 (m, 2H). 
13
C NMR (50 MHz, CDCl3) δ 137.98, 133.34, 133.09, 132.78, 
131.15, 127.63, 126.44, 125.81, 62.89, 40.45, 32.06. COCF3 signals were not 
observed. 
19
F NMR (189 MHz, CDCl3) δ -75.97. HRMS: (ESI
+
) calculated for 
C13H13ClF3NO2Na [M+Na
+
]: 330.0479, found: 330.0472. 
 
(E)-N-(2-(3-hydroxyprop-1-enyl)-4,5-dimethoxyphenethyl)acetamide 31f 
Following the general procedure, heating the reaction mixture at 80 °C in this case, 
42 mg 31f (0.15 mmol, 30%) were isolated from the 
reaction of iodide 30f (139 mg, 0.4 mmol) after 
purification by column chromatography using ethyl 
acetate/methanol 10:1 as eluent. 
1
H NMR (400 MHz, 
CDCl3) δ 6.97 (s, 1H), 6.88 (dt, J = 15.7, 1.4 Hz, 
1H), 6.62 (s, 1H), 6.17 (dt, J = 15.7, 5.4 Hz, 1H), 
5.71 (s (br), 1H), 4.33 (dd, J = 5.3, 1.4 Hz, 2H), 3.88 
(s, 3H), 3.86 (s, 3H), 3.38 (q, J = 7.4 Hz, 2H), 2.83 (t, 
J = 7.4 Hz, 2H), 2.65 (s (br), 1H), 1.94 (s, 3H). 
13
C NMR (101 MHz, CDCl3) δ 170.4, 
148.6, 147.8, 129.3, 128.8, 128.6, 127.7, 112.8, 109.1, 63.5, 56.0, 55.9, 40.7, 33.0, 
23.3. 
 
General procedure for the synthesis of allylic carbonates 32: 
To a solution of allyl alcohol 31 (1 equiv.) and pyridine (3 equiv.) in CH2Cl2 (20 
mL/mmol) methyl chloroformate (1.5 equiv.) was added dropwise at 0 °C. After 5 
min. the solution was warmed to room temperature and was stirred for 1 h. Then, it 
was washed with aq. HCl (2N) (3 x 5 mL/mmol) and dried over Na2SO4. The 





Following the general procedure, 280 mg of 32a (0.72 mmol, 90%) were isolated 
as a white solid from the reaction of allyl 
alcohol 31a (267 mg, 0.8 mmol). 
1
H NMR (400 
MHz, CDCl3) δ 6.97 (s, 1H), 6.89 (dt, J = 15.6, 
1.0 Hz, 1H), 6.62 (s, 1H), 6.47 (s (br), 1H), 6.11 
(dt, J = 15.6, 6.6 Hz, 1H), 4.80 (dd, J = 6.6, 1.0 
Hz, 2H), 3.89 (s, 3H), 3.86 (s, 3H), 3.80 (s, 
3H), 3.51 (q, J = 6.8 Hz, 2H), 2.92 (t, J = 7.1 
Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 157.2 
(q, J = 36.7 Hz), 155.7, 149.3, 148.1, 131.9, 










Following the general procedure, 258 mg of 32b (0.70 mmol, 92%) were isolated 
from the reaction of allyl alcohol 31b (240 mg, 0.76 
mmol). 
1
H NMR (400 MHz, CDCl3) δ 6.94 (s, 1H), 
6.87 (dt, J = 15.6, 1.2 Hz, 1H), 6.62 (s, 1H), 6.59 (s 
(br), 1H), 6.05 (dt, J = 15.5, 6.5 Hz, 1H), 5.94 (s, 
2H), 4.77 (dd, J = 6.5, 1.2 Hz, 2H), 3.79 (s, 3H), 
3.47 (q, J = 7.1 Hz, 2H), 2.88 (t, J = 7.1 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 157.2 (q, J = 36.9 
Hz), 155.7, 148.0, 147.1, 132.0, 129.6, 128.9, 
123.5, 115.8 (q, J = 287.7 Hz), 109.7, 106.4, 101.3, 
68.5, 54.8, 40.8, 32.2. 
19
F NMR: (376 MHz, CDCl3) δ = -76.01. HRMS (ESI,
+
, m/z): 
calculated for C16H16F3NO6Na [M+Na
+





Following the general procedure, 114 mg of 32c (0.33 mmol, 95%) were isolated 
from the reaction of allyl alcohol 31c (101 mg, 0.35 
mmol). 
1
H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 9.3 
Hz, 1H), 7.12 – 6.98 (m, 2H), 6.93 (dt, J = 15.7, 1.3 
Hz, 1H), 6.44 (s (br), 1H), 6.18 (dt, J = 15.6, 6.4 Hz, 
1H), 4.80 (dd, J = 6.4, 1.3 Hz, 2H), 3.80 (s, 3H), 3.50 
(q, J = 7.0 Hz, 2H), 2.93 (t, J = 7.0 Hz, 2H), 2.33 (s, 
3H). 
13
C NMR (101 MHz, CDCl3) δ 157.7 (q, J = 36.9 
Hz), 155.3, 137.0, 135.1, 132.4, 132.2, 129.9, 129.3, 
127.4, 125.0, 115.8 (q, J = 287.8 Hz), 68.5, 54.8, 
40.7, 31.9, 21.0. 
19
F NMR: (376 MHz, CDCl3) δ = -76.02. HRMS (ESI
+
, m/z): 
calculated for C16H18F3NO4Na [M+Na
+







(E)-methyl 3-(2-(2-(2,2,2-trifluoroacetamido)ethyl)phenyl)allyl carbonate 32d 
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Following the general procedure, 126 mg of 32d (0.38 mmol, 95%) were isolated 
from the reaction of allyl alcohol 31d (108 mg, 0.4 
mmol). 
1
H NMR (400 MHz, CDCl3) δ 7.46 (dd, J = 5.7, 
3.7 Hz, 1H), 7.31 – 7.18 (m, 2H), 7.14 (dd, J = 5.6, 3.6 
Hz, 1H), 6.97 (dt, J = 15.7, 1.2 Hz, 1H), 6.73 (s (br), 
1H), 6.18 (dt, J = 15.6, 6.4 Hz, 1H), 4.80 (dd, J = 6.4, 
1.2 Hz, 2H), 3.78 (s, 3H), 3.51 (q, J = 7.3 Hz, 2H), 2.96 
(t, J = 7.3 Hz, 2H). 
13
C NMR (101 MHz, CDCl3) δ 
157.3, (q, J = 37.0 Hz), 155.7, 135.4, 135.4, 132.1, 
129.9, 128.5, 127.5, 126.8, 125.3, 115.8 (q, J = 287.7 Hz), 68.4, 54.8, 40.6, 32.4. 
HRMS (ESI
+
, m/z): calculated for C15H16F3NO4Na [M+Na
+





Following the general procedure, (E)-3-(5-chloro-(2-(2,2,2-
trifluoroacetamido)ethyl)phenyl)allyl methyl 
carbonate 32e (0.084 g, 0.230 mmol, 96 %) were 
isolated as a white solid from the reaction of allyl 
alcohol 31e (74 mg, 0.24 mmol). 
1
H NMR (201 MHz, 
CDCl3) δ 7.42 (d, J = 2.1 Hz, 1H), 7.20 (dd, J = 8.2, 
2.2 Hz, 1H), 7.05 (dd, J = 9.6, 5.6 Hz, 1H), 6.89 (d, J 
= 15.7 Hz, 1H), 6.79 (s (br), 1H), 6.17 (dt, J = 15.6, 
6.2 Hz, 1H), 4.77 (dt, J = 10.5, 5.3 Hz, 2H), 3.86 – 3.73 (m, 3H), 3.47 (dd, J = 14.1, 
6.9 Hz, 2H), 2.92 (t, J = 7.3 Hz, 2H). 
13
C NMR (50 MHz, CDCl3) δ 157.30 (q, J = 
36.2 Hz), 155.65, 137.06, 133.81, 133.16, 131.23, 130.62, 128.29, 126.61, 126.56, 
115.71 (q, J = 291.0 Hz), 68.00, 54.86, 40.37, 31.79. 
19
F NMR (189 MHz, CDCl3) δ 
-76.00. HRMS: (ESI
+
) calculated for C13H15ClF3NO4Na [M+Na
+
]: 388.0534, found: 
388.0533. 
 
(E)-3-(2-(2-acetamidoethyl)-4,5-dimethoxyphenyl)allyl methyl carbonate 32f 
Following the general procedure, 29 mg of 32f (0.08 mmol, 86%) were isolated 
from the reaction of allyl alcohol 31f (28 mg, 0.1 mmol). 
1
H NMR (400 MHz, CDCl3) 
δ 6.96 (s, 1H), 6.90 (d, J = 15.6 Hz, 1H), 6.64 (s, 
1H), 6.10 (dt, J = 15.5, 6.6 Hz, 1H), 5.61 (s (br), 
1H), 4.79 (d, J = 6.6 Hz, 2H), 3.88 (s, 3H), 3.86 (s, 
3H), 3.79 (s, 3H), 3.40 (q, J = 6.9 Hz, 2H), 2.84 (t, J 
= 6.9 Hz, 2H), 1.93 (s, 3H). 
13
C NMR (101 MHz, 
CDCl3) δ 170.2, 155.7, 149.3, 147.9, 132.3, 129.6, 
127.3, 122.4, 112.8, 109.0, 68.7, 55.97, 55.9, 54.8, 
40.7, 32.5, 23.3. 
 
General Procedure for the alkylation of 2,2,2-trifluoroacetamide to give 34 
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2,2,2-trifluoroacetamide (33) (1.0 eq.) was dissolved in DMF (Volume: 50 ml per 10 
mmol) and added to a suspension of 1.05 eq. sodium hydride in DMF (Volume: 20 
ml per 10 mmol) at 0 °C. After all gas evolution ceased, 1.05 eq. of the appropriate 
bromide was added and the reaction mixture was heated to 50 °C for 3 h. After the 
reaction showed full conversion (by TLC), 50 mL EtOAc was added and the 
reaction mixture was washed with water (80 mL per 10 mmol) and 2x with brine (2x 
80 mL per 10 mmol). After drying over MgSO4, all volatiles were removed under 
reduced pressure to give the desired alkyltrifluoroacetamides 34. These products 





Following the general procedure for the alkylation of 2,2,2-trifluoroacetamide, 1.442 
g of 34a (7.96 mmol, 99%) were isolated as a pale 
yellow oil from the reaction of 2,2,2-trifluoroacetamide 
33 (0.909 g, 8.04 mmol) with 5-bromopent-1-ene (1.00 
ml, 8.44 mmol). 
1
H NMR: (400 MHz, CDCl3) δ = 7.23 (s 
(br), 1H), 5.75 (ddt, J = 17.0, 10.2, 6.7 Hz, 1H), 5.14 – 
4.84 (m, 2H), 3.39 – 3.22 (m, 2H), 2.19 – 1.95 (m, 2H), 1.78 – 1.58 (m, 3H). 
13
C 
NMR: (100 MHz, CDCl3) δ = 157.4 (q, J = 36.7 Hz), 137.0, 115.8 (q, J = 287.2 Hz), 
115.5, 39.4, 30.7, 27.7. 
19
F NMR: (376 MHz, CDCl3) δ = -76.21. HRMS (ESI
+
): 
calculated for C7H11F3NO [M+H
+
]: 182.0787, found: 182.0784. 
 
2,2,2-trifluoro-N-(hex-5-en-1-yl)acetamide 34b 
Following the general procedure for the alkylation of 2,2,2-trifluoroacetamide, 1.352 
g 34b (6,93 mmol, 98%) were isolated as a pale 
yellow oil from the reaction of 2,2,2-
trifluoroacetamide 33 (0.799 g, 7.07 mmol) with 6-
bromo-1-hexene (1.00 ml, 7.42 mmol). 
1
H NMR: (400 
MHz, CDCl3) δ = 7.30 (s (br) 1H), 5.83 – 5.59 (m, 
1H), 5.11 – 4.70 (m, 2H), 3.34 – 3.22 (m, 2H), 2.09 – 
2.00 (m, 2H), 1.63 – 1.48 (m, 2H), 1.47 – 1.31 (m, 2H). 
13
C NMR: (101 MHz, 
CDCl3) δ =  157.3 (q, J = 36.8 Hz), 137.9, 115.9 (q, J = 287.8 Hz), 114.8, 39.7, 
33.0, 28.1, 25.8. 
19





]: 196.0944, found: 196.1103. 
 
2,2,2-trifluoro-N-(hept-6-en-1-yl)acetamide 34c 
Following the general procedure for the alkylation of 2,2,2-trifluoroacetamide, 1.294 
g 34c (6.19 mmol, 99%) were isolated as a pale 
yellow oil from the reaction of 2,2,2-
trifluoroacetamide 33 (0.706 g, 6.25 mmol) with 7-
bromohept-1-ene (1.00 ml, 6.56 mmol). 
1
H NMR: 
(400 MHz, CDCl3) δ = 6.68 (s (br), 1H), 5.92 – 
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5.61 (m, 1H), 5.08 – 4.84 (m, 2H), 3.40 – 3.27 (m, 2H), 2.12 – 1.97 (m, 2H), 1.67 – 
1.51 (m, 2H), 1.48 – 1.29 (m, 4H). 
13
C NMR: (101 MHz, CDCl3) δ = 157.3 (q, J = 
36.8 Hz), 138.4, 115.9 (q, J = 288.3 Hz), 114.6, 39.9, 33.4, 28.7, 28.3, 26.0. 
19
F 
NMR: (376 MHz, CDCl3) δ = -76.07. HRMS (ESI
+
): calculated for C9H15F3NO 
[M+H
+
]: 210.1100, found: 210.2215. 
 
General Procedure for the cross-metathesis of 34 with butendiyl 
dimethylcarbonate
77
 to give allylic carbonates 35 
Trifluoroacetamides 34a-c (1.0 eq.) were dissolved under a N2 atmosphere in 
degassed toluene (10 ml per 2 mmol), then 2.00 eq. of (Z)-but-2-ene-1,4-diyl 
dimethyl dicarbonate were added and finally 5.0 mol% Hoveyda-Grubbs 2
nd
 
generation was added. The mixture was heated to 70 °C and stirred until TLC 
showed full conversion (2-6 h). After cooling to ambient temperature, all volatiles 
were removed under reduced pressure and crude product was purified by column 
chromatography (SiO2, Pentane/EtOAc) to give the pure compounds 35. 
 
(E)-Methyl (6-(2,2,2-trifluoroacetamido)hex-2-en-1-yl) carbonate 35a 
Following the general procedure for the cross-metathesis with butendiyl 
dimethylcarbonate, 1.00 g 34a (5.52 
mmol) was reacted with 2.254 g butendiyl 
dimethylcarbonate (11.04 mmol) to give 
1.233 g 35a (4.58 mmol, 83%) after 
column chromatography (SiO2, 
pentane/EtOAc 10:1, Rf = 0.20 in Pentane/EtOAc 10:1). 
1
H NMR: (400 MHz, 
CDCl3) δ = 6.75 (s (br), 1H), 5.76 (dd, J = 14.4, 7.6 Hz, 1H), 5.67 – 5.54 (m, 1H), 
4.54 (d, J = 6.3 Hz, 2H), 3.75 (s, 3H), 3.34 (dd, J = 13.4, 6.7 Hz, 2H), 2.11 (dd, J = 
14.2, 7.1 Hz, 2H), 1.77 – 1.57 (m, 2H). 
13
C NMR: (101 MHz, CDCl3) δ = 157.2 (q, J 
= 36.7 Hz), 155.6, 135.0, 124.6, 115.8 (q, J = 289.6 Hz), 68.1, 54.7, 39.3, 29.3, 
27.8. 
19
F NMR: (376 MHz, CDCl3) δ = -76.02. HRMS (ESI
+
): calculated for 
C10H14F3NO4Na [M+Na
+
]: 292.0767, found: 292.0762. 
 
(E)-Methyl (7-(2,2,2-trifluoroacetamido)hept-2-en-1-yl) carbonate 35b 
Following the general procedure for the cross-metathesis with butendiyl 
dimethylcarbonate, 0.500 g 34b (2.56 
mmol) were reacted with 1.046 g 
butendiyl dimethylcarbonate (5.12 
mmol) to give 0.573 g 35b (2.20 mmol, 
79%) after column chromatography 
(SiO2, pentane/EtOAc 10:1, Rf = 0.18 in Pentane/EtOAc 10:1). 
1
H NMR: (201 MHz, 
CDCl3) δ = 7.22 (s (br), 1H), 5.87 – 5.35 (m, 2H), 4.47 (d, J = 6.2 Hz, 2H), 3.77 – 
3.57 (m, 3H), 3.25 (dd, J = 13.0, 6.6 Hz, 3H), 2.15 – 1.91 (m, 2H), 1.76 – 1.24 (m, 
4H). 
13
C NMR: (50 MHz, CDCl3) δ = 157.2 (q, J = 37.1 Hz), 155.4, 136.0, 123.7, 
115.8 (q, J = 290.2 Hz), 68.2, 54.4, 39.5, 31.4, 28.0, 25.5. 
19
F NMR: (189 MHz, 
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CDCl3) δ = -76.15. HRMS (ESI
+
): calculated for C11H13F3NO4Na [M+Na
+
]: 
306.0924, found: 306.0908. 
 
(E)-methyl (8-(2,2,2-trifluoroacetamido)oct-2-en-1-yl) carbonate 35c 
Following the general procedure for the cross-metathesis with butendiyl 
dimethylcarbonate, 1.00 g 34c (4.78 
mmol) was reacted with 1.952 g 
butendiyl dimethylcarbonate (9.56 
mmol) to give 1.023 g 35c (3.44 
mmol, 72%) after column 
chromatography (SiO2, pentane/EtOAc 10:1, Rf = 0.22 in Pentane/EtOAc 10:1). 
1
H 
NMR: (201 MHz, CDCl3) δ = 6.73 (s (br), 1H), 5.93 – 5.36 (m, 2H), 4.53 (d, J = 6.3 
Hz, 2H), 3.74 (s, 3H), 3.31 (dd, J = 13.4, 6.7 Hz, 2H), 2.16 – 1.91 (m, 2H), 1.68 – 
1.46 (m, 2H), 1.46 – 1.17 (m, 4H). 
13
C NMR: (50 MHz, CDCl3) δ = 157.2 (q, J = 
36.4 Hz), 155.6, 136.6, 123.5, 115.9 (q, J = 288.5 Hz), 68.5, 54.6, 39.8, 31.9, 28.6, 
28.1, 26.0. 
19
F NMR: (189 MHz, CDCl3) δ = -76.04. HRMS (ESI
+
): calculated for 
C12H18F3NO4Na [M+Na
+
]: 320.1080, found: 320.1077.  
 
General Procedure for the Iridium-catalyzed asymmetric allylic amidation 
 [Ir(COD)Cl]2 (2.5 mol%) and 5.0 mol% L2 were dissolved in dry THF (1.0 mL per 
0.2 mmol) under a N2 atmosphere. Then, 1.00 eq. DBU was added and the 
reaction mixture was heated at 50 °C for 30 min. Then, the solution was brought to 
the appropriate temperature and 1.0 eq. allylic carbonate 32 or 35 was added. The 
reaction mixture was stirred until TLC showed full conversion. All volatiles were 
removed under reduced pressure to yield the crude product as an orange oil. This 





The title compound was prepared from 32a (117 mg, 0.30 mmol) following the 
general procedure for the Ir-catalyzed asymmetric 
allylic amidation at room temperature. Purification by 
column chromatography (SiO2, Pentane/EtOAc 3:1) 
afforded 37a (92 mg, 0.29 mmol, 95% ee, 97%) as a 
colourless oil as a mixture of two conformers in 3.6:1 
ratio (determined by 
1
H NMR at 20 °C). 
1
H NMR (400 
MHz, CDCl3) δ 6.62 (s, 1H, minor), 6.60 (s, 1H, major), 6.58 (s, 1H, major), 6.55 (s, 
1H, minor), 6.00 – 5.91 (m, 2H major + 1H minor), 5.44 (d, J = 4.0 Hz, 1H minor), 
5.30 (dd, J = 9.9, 0.8 Hz, 1H major), 5.29 (d, J = 10.0 Hz, 1H minor), 5.12 (dd, J = 
15.5, 0.8 Hz, 1H major), 5.03 (d, J = 17.1 Hz, 1H minor), 4.51 – 4.46 (m, 1H minor), 
4.03 – 3.98 (m, 1H major), 3.85 (s, 3H, minor), 3.84 (s, 3H, major), 3.84 (s, 3H, 
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minor), 3.83 (s, 3H, major), 3.53 (ddd, J = 13.8, 12.1, 3.9 Hz, 1H major), 3.24 (td, J 
= 12.2, 4.2 Hz, 1H minor), 3.00 – 2.90 (m, 1H major + 1H minor), 2.76 – 2.68 (m, 
1H major + 1H minor). 
13
C NMR (101 MHz, CDCl3) δ 155.6 (q, J = 35.8 Hz) 
(major), 148.6 (minor), 148.3 (major), 147.8 (major), 147.7 (minor), 136.5 (minor), 
135.6 (major), 126.0 (minor), 125.3 (major), 124.7 (major), 124.4 (minor), 118.6 
(major), 118.5 (minor), 116.8 (q, J = 287.9 Hz), 111.4 (minor), 111.1 (major), 110.6 
(major), 110.3 (minor), 57.9 (minor), 56.0 (minor), 56.0 (major), 55.9 (major), 55.5 
(major), 40.0 (major), 37.7 (minor), 28.7 (major), 27.2 (minor). 
19
F NMR: (376 MHz, 
CDCl3) δ = -68.7 (minor), -69.4 (major). HRMS (APCI+, m/z): calculated for 
C15H17F3NO3 [M+H
+
]: 316.1155, found: 316.1140. [α] D
20
 = + 168.3 (c = 0.85 in 
CHCl3) ee determination by chiral HPLC (Chiralpak OJ-H: n-heptane/2-propanol 
90:10, 40 °C isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 19.7 min 





The title compound was prepared from 32b (75 mg, 
0.20 mmol) following the general procedure at room 
temperature. Purification by column chromatography 
(SiO2, Pentane/Et2O 10:1) afforded 37b (54 mg, 0.18 
mmol, 94% ee, 89%) as a colourless oil as a mixture 
of two conformers in 3.5:1 ratio (determined by 
1
H 
NMR at 20 °C). 
1
H NMR (400 MHz, CDCl3) δ 6.61 (s, 1H, minor), 6.58 (s, 2H, 
major), 6.56 (s, 1H, minor), 6.02 – 5.88 (m, 4H major + 3H minor), 5.40 (d, J = 4.2 
Hz, 1H minor), 5.30 (dd, J = 9.9, 1.0 Hz, 1H major), 5.29 (d, J = 10.1 Hz, 1H 
minor), 5.12 (dd, J = 15.5, 1.0 Hz, 1H major), 5.05 (d, J = 17.2 Hz, 1H minor), 4.46 
– 4.39 (m, 1H minor), 4.02 – 3.94 (m, 1H major), 3.54 (ddd, J = 14.0, 11.6, 3.9 Hz, 
1H major), 3.24 (td, J = 11.5, 4.7 Hz, 1H minor), 2.97 – 2.87 (m, 1H major + 1H 
minor), 2.75 – 2.68 (m, 1H major + 1H minor). 
13
C NMR (101 MHz, CDCl3) δ 155.8 
(q, J = 35.8 Hz) (major), 147.3 (minor), 147.0 (major), 146.5 (major), 146.4 (minor), 
136.4 (minor), 135.5 (major), 127.3 (minor), 126.5 (major), 125.8 (major), 125.6 
(minor), 118.5 (major), 118.4 (minor), 116.5 (q, J = 288.0 Hz) (major), 108.6 
(minor), 108.3 (major), 107.8 (major), 107.4 (minor), 101.2 (minor), 101.1 (major), 
58.1 (minor), 55.9 (major), 40.0 (major), 37.9 (minor), 29.1 (major), 27.6 (minor). 
19
F NMR: (376 MHz, CDCl3) δ = -68.7 (minor), -69.4 (major). HRMS (APCI+, m/z): 
calculated for C14H13F3NO3 [M+H
+
]: 300.0842, found: 300.0839. [α] D
20
 = + 153.2 (c 
= 1.0 in CHCl3) ee determination by chiral HPLC (Chiralpak AD-H: n-heptane/2-
propanol 98:2, 40 °C isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 23.4 











The title compound was prepared from 32c (34 mg, 0.15 mmol) following the 
general procedure at room temperature. Purification by 
column chromatography (SiO2, Pentane/Et2O 20:1) 
afforded 37c (25 mg, 0.14 mmol, 91% ee, 92%) as a 
colourless oil as a mixture of two conformers in 3.1:1 
ratio (determined by 
1
H NMR at 20 °C). 
1
H NMR (400 
MHz, CDCl3) δ 7.05 (d, J = 8.2 Hz, 1H major +1H 
minor), 7.04 (s, 1H, major + 1H minor), 6.95 (d, J = 8.2 Hz, 1H major +1H minor), 
6.06 – 5.93 (m, 2H major + 1H minor), 5.50 (d, J = 4.0 Hz, 1H minor), 5.32 – 5.28 
(m, 1H major +1H minor), 5.12 (dd, J = 16.3, 0.7 Hz, 1H major), 5.04 (d, J = 17.0 
Hz, 1H minor), 4.49 – 4.44 (m, 1H minor), 4.05 – 4.00 (m, 1H major), 3.58 (ddd, J = 
14.0, 11.8, 4.0 Hz, 1H major), 3.24 (td, J = 12.4, 4.7 Hz, 1H minor), 3.03 – 2.93 (m, 
1H major + 1H minor), 2.84 – 2.76 (m, 1H major + 1H minor), 2.33 (s, 3H minor), 
2.33 (s, 3H major). 
13
C NMR (101 MHz, CDCl3) δ 155.6 (q, J = 36.0 Hz) (major), 
136.6 (minor), 136.3 (major), 136.1 (minor), 135.6 (major), 132.8 (major), 132.6 
(minor), 130.1 (major), 130.0 (minor), 128.9 (minor), 128.6 (major), 128.5 (major), 
128.2 (major), 128.1 (minor), 118.2 (major), 118.1 (minor), 116.5 (q, J = 287.7 Hz) 
(major), 58.3 (minor), 56.0 (major), 40.3 (major), 38.22 (minor), 28.7 (major), 27.2 
(minor), 21.0 (major), 20.99 (minor). 
19
F NMR: (376 MHz, CDCl3) δ = -68.7 (minor), 
-69.4 (major). HRMS (ESI+, m/z): calculated for C14H15F3NO [M+H
+
]: 270.1100, 
found: 270.1088. [α] D
20
 = + 152.4 (c = 1.0 in CHCl3) ee determination by chiral 
HPLC (Chiralpak OJ-H: n-heptane/2-propanol 99:1, 40 °C isotherm, 210 nm, flow 
rate 0.5 mL/min), retention times: 13.3 min (minor), 15.2 min (major).  
 
(S)-2,2,2-Trifluoro-1-(1-vinyl-3,4-dihydroisoquinolin-2(1H)-yl)ethanone 37d 
The title compound was prepared from 32d (33 mg, 0.10 mmol) following the 
general procedure at room temperature. Purification by 
column chromatography (SiO2, Pentane/Et2O 15:1) 
afforded 37d (20 mg, 0.08 mmol, 94% ee, 78%) as a 
colourless oil as a mixture of two conformers in 3.4:1 ratio 
(determined by 
1
H NMR at 20 °C). 
1
H NMR (400 MHz, 
CDCl3) δ 7.25 – 7.11 (m, 4H major + 4H minor), 6.05 – 
5.93 (m, 2H major + 1H minor), 5.55 (d, J = 3.8 Hz, 1H minor), 5.31 (dd, J = 9.8, 
1.1 Hz, 1H major), 5.30 (d, J = 10.2 Hz, 1H minor), 5.12 (dd, J = 16.5, 1.1 Hz, 1H 
major), 5.05 (d, J = 17.1 Hz, 1H minor), 4.51 – 4.45 (m, 1H minor), 4.08 – 4.00 (m, 
1H major), 3.60 (td, J = 12.0, 4.0 Hz, 1H major), 3.33 (td, J = 12.0, 4.5 Hz, 1H 
minor), 3.08 – 2.98 (m, 1H major + 1H minor), 2.88 – 2.80 (m, 1H major + 1H 
minor). 
13
C NMR (101 MHz, CDCl3) δ 155.6 (q, J = 36.0 Hz) (major), 136.6 (minor), 
135.6 (major), 133.9 (minor), 133.6 (minor), 133.2 (major), 133.0 (major), 129.1 
(minor), 128.8 (major), 128.2 (major), 127.7 (minor), 127.7 (minor), 127.3 (major), 
126.6 (major), 126.5 (minor), 118.3 (major), 118.3 (minor), 116.5 (q, J = 287.9 Hz) 
(major), 58.2 (minor), 55.9 (major), 40.1 (major), 38.0 (minor), 29.1 (major), 27.6 
(minor). 
19
F NMR: (376 MHz, CDCl3) δ = -68.7 (minor), -69.4 (major). HRMS (ESI+, 
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m/z): calculated for C13H13F3NO [M+H
+
]: 256.0944, found: 256.0941. [α] D
20
 = + 
186.8 (c = 1.0 in CHCl3) ee determination by chiral HPLC (Chiralpak OJ-H: n-
heptane/2-propanol 98:2, 40 °C isotherm, 220 nm, flow rate 0.5 mL/min), retention 




The title compound was prepared from 32e (0.020 g, 0.055 mmol) following the 
general procedure for the Ir-catalyzed asymmetric 
allylic amidation at 50 °C. Purification by column 
chromatography (SiO2, Pentane/EtOAc 20:1, Rf = 0.95 
in Pentane/EtOAc 10:1) afforded  1-(7-chloro-1-
ethylidene-3,4-dihydroisoquinolin-2(1H)-yl)-2,2,2-
trifluoroethanone 39 (0.010 g, 0.035 mmol, 63% ) as a 
colourless oil. 39 was isolated as a mixture of 2 isomers 
(ratio 1:1.3). 
1
H NMR (400 MHz, CDCl3) δ 7.53 (d, J = 
2.1 Hz, 1H, major), 7.40 (d, J = 2.1 Hz, 1H, minor), 7.25 – 7.14 (m, 1H), 7.04 (d, J = 
8.2 Hz, 1H), 6.32 (q, J = 7.1 Hz, 1H, major), 6.16 (q, J = 7.2 Hz, 1H, minor), 5.03 – 
4.77 (m, 1H), 3.33 – 3.10 (m, 2H), 2.88 – 2.71 (m, 1H), 1.85 (d, J = 7.1 Hz, 3H, 
minor), 1.70 (d, J = 7.1 Hz, 3H, major). 
13
C NMR (101 MHz, CDCl3) δ 130.43, 
130.31, 130.12, 128.18, 127.86, 123.81, 123.39, 121.80, 45.10, 29.62, 27.43. Only 
major peaks are given. 
19
F NMR (376 MHz, CDCl3) δ -69.21 (major), -70.20 
(minor). HRMS: (ESI
+
) calculated for C13H12ClF3NO [M+H
+




The title compound was prepared from 35a (0.100 g, 0.371 mmol) following the 
general procedure for the Ir-catalyzed asymmetric allylic 
amidation at 50 °C. Purification by column chromatography 
(SiO2, Pentane/EtOAc 10:1, Rf = 0.75 in pentane/EtOAc 10:1) 
afforded 40a (0.040 g, 0.207 mmol, 96% ee, 56%) as a 
colourless oil. 40a was isolated as a mixture of 2 conformers. 
(ratio 1 : 2.5) 
1
H NMR: (201 MHz, CDCl3) δ = 5.92 – 5.53 (m, 
1H), 5.28 – 4.97 (m, 2H), 4.67 (d, J = 4.9 Hz, 1H), 3.78 – 3.46 
(m, 2H), 2.16 – 1.70 (m, 4H). 
13
C NMR: (101 MHz, CDCl3) δ = 155.4 (q, J = 37.1 
Hz), 136.8 (minor), 135.3 (major), 116.3 (q, J = 287.9 Hz, major), 116.2 (q, J = 
286.6 Hz, minor), 115.4 (major), 115.1 (minor), 60.4 (major), 59.8 (minor), 47.3 
(minor), 46.6 (major), 32.3 (minor), 29.8 (major), 23.8 (major), 20.1 (minor). 
19
F 
NMR: (189 MHz, CDCl3) δ = -70.94 (minor), -72.71 (major). HRMS (ESI
+
): 
calculated for C8H11F3NO [M+H
+
]: 194.0787, found: 194.0790. [α]D
20
 = 44.6 (c = 1.0 
in CHCl3). ee determination by chiral HPLC (Chiralpak AD-H: n-heptane/2-propanol 
98:2, 40 °C isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 10.5 min 








The title compound was prepared from 35b (0.060 g, 0.212 mmol) following the 
general procedure for the Ir-catalyzed asymmetric allylic 
amidation at 50 °C. Purification by column chromatography 
(SiO2, Pentane/EtOAc 20:1, Rf = 0.90 in pentane/EtOAc 10:1) 
afforded 40b (0.030 g, 0.144 mmol, 88% ee, 68%) as a 
colourless oil. 40b was isolated as a mixture of 2 conformers 
(ratio 1:1.7). 
1
H NMR: (400 MHz, CDCl3) δ = 5.95 – 5.65 (m, 
1H), 5.31 (t, J = 11.5 Hz, 1H), 5.26 (s (br), 1H major), 5.15 (t, J 
= 16.4 Hz, 1H), 4.68 (s, 1H, minor), 4.39 (d, J = 12.7 Hz, 1H, 
minor), 3.80 (d, J = 13.3 Hz, 1H, major), 3.24 (t, J = 13.3 Hz, 1H, major), 2.91 (t, J 
= 13.0 Hz, 1H, minor), 1.90 (d, J = 13.2 Hz, 1H), 1.81 – 1.60 (m, 4H), 1.58 – 1.41 
(m, 1H). 
13
C NMR: (50 MHz, CDCl3) δ = 156.8 (q, J = 36.6 Hz), 135.2 (minor), 
134.6 (major), 117.8 (minor), 117.5 (major), 116.7 (q, J = 186.9 Hz), 54.8 (minor), 
51.9 (major), 42.0 (minor), 39.2 (major), 29.6 (minor), 28.3 (major), 26.0 (major), 
25.3 (minor), 19.3. 
19
F NMR: (376 MHz, CDCl3) δ = -68.75 (minor), -68.79 (major). 
HRMS (ESI
+
): calculated for C9H12F3NONa [M+Na
+
]: 230.0763, found: 230.0752. 
[α]D
20
 = 55.6 (c = 1.2 in CHCl3). ee determination by chiral HPLC (Chiralpak OB-H: 
n-heptane/2-propanol 99.9:0.1, 40 °C isotherm, 230 nm, flow rate 0.5 mL/min), 
retention times: 13.5 min (minor enantiomer), 15.2 min (major enantiomer).  
 
(R)-2,2,2-Trifluoro-1-(2-vinylazepan-1-yl)ethanone 40c 
The title compound was prepared from 35c (0.100 g, 0.336 mmol) following the 
general procedure for the Ir-catalyzed asymmetric allylic 
amidation at 50 °C. Purification by column chromatography 
(SiO2, Pentane/EtOAc 10:1, Rf = 0.90 in pentane/EtOAc 10:1) 
afforded 40c (0.019 g, 0.086 mmol, 92% ee, 25%) as a 
colourless oil. 40c was isolated as a mixture of 2 conformers. 
(ratio 2:3) 
1
H NMR: (400 MHz, CDCl3) δ = 5.87 – 5.64 (m, 1H), 
5.13 (dd, J = 19.5, 10.6 Hz, 1H), 5.05 (d, J = 17.3 Hz, 1H), 4.92 
– 4.81 (m, 1H, minor), 4.45 (s (br), 1H, major), 4.06 (d, J = 13.6 
Hz, 1H, major), 3.81 (d, J = 15.0 Hz, 1H, minor), 3.19 – 3.04 (m, 1H, minor), 2.82 
(t, J = 12.7 Hz, 1H, major), 2.20 (ddd, J = 23.2, 15.0, 7.2 Hz, 1H), 1.98 – 1.79 (m, 
2H), 1.69 - 1.46 (m, 3H), 1.30 (tt, J = 17.3, 8.7 Hz, 2H). 
13
C NMR: (101 MHz, 
CDCl3) δ = 136.7 (major), 135.6 (minor), 114.8 (major), 114.6 (minor), 58.3 (minor), 
57.9 (major), 43.1 (minor), 42.9 (major), 33.7 (major), 32.3 (minor), 30.7 (minor), 
29.6 (major), 28.9 (minor), 26.6 (major), 24.8 (minor), 23.9 (major). The COCF3 
peaks could not be detected. 
19
F NMR: (376 MHz, CDCl3) δ = -68.31 (major), -
68.72 (minor). HRMS (ESI
+
): calculated for C10H15F3NO [M+H
+
]: 222.1100, found: 
222.1103. [α]D
20
 = 76.8 (c = 1.0 in CHCl3). ee determination by chiral HPLC 
(Chiralpak AS-H: n-heptane/2-propanol 99:1, 40 °C isotherm, 220 nm, flow rate 0.5 
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2,2,2-Trifluoro-N-(octa-5,7-dienyl)acetamide 42 
The title compound was prepared from 35c (0.100 g, 0.336 mmol) following the 
general procedure for the Ir-catalyzed 
asymmetric allylic amidation at 50 °C. 
Purification by column chromatography (SiO2, 
pentane/EtOAc 10:1, Rf = 0.70 in 
Pentane/EtOAc 10:1) afforded 42 (0.019 g, 
0.086 mmol, 92% ee, 25%) as a colourless oil. 
42 was isolated as a mixture of 2 isomers. (ratio 3:2) 
1
H NMR: (400 MHz, CDCl3) δ 
= 6.60 (dt, J = 16.9, 10.6 Hz, 1H, major), 6.41 (s (br), 1H), 6.36 – 6.23 (m, 1H, 
minor), 6.13 – 5.97 (m, 1H), 5.78 – 5.59 (m, 1H, minor), 5.50 – 5.34 (m, 1H, major), 
5.20 (d, J = 16.9 Hz, 1H, major), 5.16 – 5.04 (m, 1H), 4.98 (d, J = 10.1 Hz, 1H, 
minor), 3.36 (dd, J = 13.4, 6.7 Hz, 2H), 2.23 (q, J = 7.3 Hz, 2H, major), 2.12 (dd, J 
= 14.3, 7.1 Hz, 2H, minor), 1.69 – 1.53 (m, 2H), 1.51 – 1.38 (m, 2H). 
13
C NMR: 
(101 MHz, CDCl3) δ = 157.2 (q, J = 39.0 Hz), 137.0, 134.0, 131.9, 131.7, 131.4, 
123.0, 117.5, 115.8 (q, J = 288.0 Hz), 115.3, 39.8, 31.9, 29.7, 28.41, 27.0, 26.5, 
26.1. 
19
F NMR: (376 MHz, CDCl3) δ = -76.00. HRMS (ESI
+
): calculated for 
C10H15F3NO [M+H
+
]: 222.1103, found: 222.1100. 
 
(S)-6,7-Dimethoxy-1-vinyl-1,2,3,4-tetrahydroisoquinoline 45 
Trifluoroacetamide 37a (46 mg, 0.15 mmol) was dissolved in a mixture of 
MeOH/water (7 mL/1 mL) at room temperature. K2CO3 
was added to the solution and the resulting mixture was 
stirred during 16 h. Then, MeOH was removed under 
vacuum, water was added (10 mL) and the aqueous 
solution was extracted with EtOAc (3 x 5 mL). The 
combined organic layer was dried over Na2SO4 and the 
solvent was removed to afford amine 45 as a white solid 
(32 mg, 96%, 97% ee). 
1
H NMR (300 MHz, CDCl3) δ 6.58 (s, 1H), 6.57 (s, 1H), 
5.93 (ddd, J = 17.4 Hz, 10.0, 7.8 Hz, 1H), 5.24 (d, J = 17.4 Hz, 1H), 5.23 (d, J = 
10.0 Hz, 1H), 4.40 (d, J = 7.8 Hz, 1H), 3.84 (s, 3H), 3.81 (s, 3H), 3.27 – 3.19 (m, 
1H), 3.06 – 2.97 (m, 1H), 2.86 – 2.77 (m, 1H), 2.67 (dt, J = 16.1, 4.8 Hz, 1H), 2.13 
(s (br), 1H). 
13
C NMR (75 MHz, CDCl3) δ 147.9, 147.3, 140.8, 128.7, 127.1, 117.5, 
111.8, 110.5, 60.2, 56.2, 55.9, 41.9, 29.3. HRMS (ESI+, m/z): calculated for 
C13H18NO2 [M+H
+
]: 220.1332, found: 220.1325. [α] D
20
 = + 76.0 (c = 0.5, CHCl3). ee 
determination by chiral HPLC (Chiralpak OJ-H: n-heptane/2-propanol 98:2, 40 °C 
isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 30.4 min (major), 38.7 












(S)-6,7-dimethoxy-1-vinyl-1,2,3,4-tetrahydroisoquinoline 45a (1.00 eq., 0.020 g, 
0.091 mmol) was dissolved in THF (Volume: 10 ml) 
and cooled to -78 °C. Then 1.00 eq. BuLi solution in 
hexanes (c = 1.6 M) (0.057 ml, 0.091 mmol) was 
added dropwise and the reaction was stirred at -78 
°C for 1 h. Then, 2.00 eq. allyl bromide (0.016 ml, 
0.182 mmol) were added and the mixture was 
allowed to warm to r.t. and stirred for 16 h. The 
reaction was quenched by addition of sat. aq. NH4Cl solution (10 mL). Extraction 
with Et2O (2x 30 mL) and subsequent drying of the organic phases over MgSO4, 
filtration and removal of all volatiles under reduced pressure yielded the crude 
product. This was purified by column chromatography (SiO2, pentane/EtOAc 10:1, 
Rf = 0.80 in pentane/EtOAc 8:2) to yield (S)-2-allyl-6,7-dimethoxy-1-vinyl-1,2,3,4-
tetrahydroisoquinoline 46 (0.020 g, 0.077 mmol, 85 %) as a colourless oil. 
1
H NMR 
(201 MHz, CDCl3) δ 6.50 (s, 2H), 6.00 – 5.44 (m, 2H), 5.36 – 5.02 (m, 4H), 3.91 (d, 
J = 8.5 Hz, 1H), 3.76 (s, 3H), 3.72 (s, 3H), 3.52 – 3.30 (m, 1H), 3.17 – 2.88 (m, 
2H), 2.86 – 2.62 (m, 2H), 2.47 (ddd, J = 12.2, 7.7, 4.8 Hz, 1H). 
13
C NMR (50 MHz, 
CDCl3) δ 147.45, 146.87, 139.33, 135.32, 127.74, 126.53, 118.04, 117.58, 111.07, 
110.90, 66.09, 57.39, 55.72, 55.66, 46.15, 28.11. HRMS: (ESI
+
) calculated for 
C16H22NO2 [M+H
+
]: 260.1645, found: 260.1640. [α]D
20
 = 55.2 (c = 1.1 in CHCl3).  
 
2,2,2-Trifluoro-N-methyl-N-(1-phenylprop-1-enyl)acetamide 67 
67 was prepared in the reaction of 1.0 eq. cinnamyl methyl carbonate 64 (0.020 g, 
0.104 mmol) and 2.0 eq. 2,2,2-trifluoro-N-methylacetamide 65 
(0.026 g, 0.208 mmol) following the general procedure for the 
Ir-catalyzed asymmetric allylic amidation at 50 °C, employing 
L1 as ligand. Purification by column chromatography (SiO2, 
Pentane/EtOAc 20:1, Rf = 0.60 in Pentane/EtOAc 10:1) 
afforded 2,2,2-trifluoro-N-methyl-N-(1-phenylprop-1-en-1-
yl)acetamide 67 (0.016 g, 0.066 mmol, 63%) as a colourless 
oil. 67 was isolated as two double bond isomers (ratio: 1:5.5) 
1
H NMR (201 MHz, 
CDCl3) δ 7.60 – 7.20 (m, 5H), 6.38 (q, J = 7.1 Hz, 1H, major), 6.20 (dd, J = 14.0, 
7.0 Hz, 1H, minor), 3.23 (s, 3H, minor), 3.18 (s, 3H, major), 1.82 (d, J = 7.1 Hz, 3H, 
major), 1.75 (d, J = 7.0 Hz, 3H, minor). 
13
C NMR (50 MHz, CDCl3) δ 128.86, 
128.81, 128.36, 128.31, 124.72, 124.29, 37.10, 13.85. Only major peaks are given, 
the COCF3 peaks were not observed. 
19
F NMR (189 MHz, CDCl3) δ -69.86 (minor), 
-69.97 (major). HRMS: (ESI
+
) calculated for C12H13F3NO [M+H
+
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Chapter 4 
Synthetic Approaches towards β-
Carbolines 
The catalytic asymmetric synthesis of multifunctional chiral β-carboline compounds 
was attempted through two Ir-catalyzed allylic substitution protocols. The 
asymmetric allylic amination as well as the allylic amidation were investigated. 
Synthetic routes towards the required allylic carbonates were developed, however, 
those compounds could not be transformed to the desired β-carbolines through Ir-

























β-Carboline- or tryptoline-derived alkaloids
1-3
 are a large class of naturally occuring 
compounds which show a wide variety of biological and therapeutic activities 
(Figure 1).
4-6
 As examples of this family
7
 of molecules, the two antihypertensives 
reserpine (3) and ajmalicine (4) are displayed.
8-10
 Both 3 and 4 can be isolated 
from evergreen trees of the Rauwolfia species. Reserpine (3) acts through the 
inhibition of accumulation of biologically active amines, e.g. serotonin and 
catecholamines, in the brain and other body organs.
9
 Structurally related ajmalicine 
(4), however, is an inhibitor of α1-andrenergic receptors
11
 displaying just a small 
variety of the biological activities associated with this class of compounds. Many 
synthetic strategies have been developed to make substituted indoles and 
tryptamines,
12-14
  Pictet-Spengler and Mannich-type condensation reactions being 




Figure 1 Examples of β-carboline compounds 
Some of the synthetic approaches to chiral β-carbolines are discussed in the 
following sections.  
An organocatalytic cascade reaction to give the related quinolizidine compounds 8 
in straightforward manner was recently reported (Scheme 1).
18
 With catalytic 
amounts of prolinol 7 the desired products 8 were accessible in a one-pot 
procedure from -unsaturated aldehydes 5 and tryptamine 6. Compounds 8 were 
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isolated in up to good yields reaching excellent enantioselectivities. Even though 
the aryl-substituted tetracyclic compounds are not commonly found in nature, this 
marks an impressive transformation, generating three stereocenters in one 
reaction. 
 
Scheme 1 Organocatalytic cascade reaction 
The direct asymmetric Pictet-Spengler reaction with tryptamines and aldehydes to 
chiral β-carbolines represents a major challenge since after imine formation from 
the aldehyde and the primary amine fast isomerization to the corresponding 
enamines and subsequent aldol condensations take place.
19
 This problem was 
overcome in related yet different ways recently (Scheme 2).
19-21
 The asymmetric 
Pictet-Spengler reactions were carried out with catalytic amounts of chiral 
phosphoric acids
22,23
 10 and 13. In the first case (Scheme 2a) the aldol 
condensation reaction could be suppressed by geminal substitution with esters 9. 
Via this pathway, the corresponding β-carbolines 11 were isolated in up to very 
good yields and with good enantioselectivities. In the second case (Scheme 2b), 
the primary nitrogen was protected as the sulfenylamine 12 preventing the 
unwanted aldol-condensation from taking place. The sulfenylamine protecting 
group could be removed in situ. Like this, chiral β-carbolines 14 bearing no 
substituents on the piperidine ring were obtained with up to good selectivities. 
These two reports mark important breakthroughs for the asymmetric Pictet-
Spengler reactions, however, it should be noted that the aldehydes and the 
corresponding R groups in products 11 and 14 are mostly unfunctionalized and 
hence prevent easy further application in synthesis, such as annulation to 
tetracyclic compounds. One notable exception to this is the use of an aldehyde 









Scheme 2 Catalytic asymmetric Pictet-Spengler reactions 
Next to the abovementioned examples of organocatalytic approaches to β-
carbolines also some transition metal-catalyzed reactions are known. In Scheme 3, 
an asymmetric Pd-catalyzed intramolecular allylic substitution is depicted.
25
 When 
tryptamines 15 bearing an allylic carbonate moiety were subjected to allylic 
substitution conditions with catalytic amounts of a Pd/L1 complex, the 
corresponding chiral β-carbolines 16 were isolated in up to excellent yields and 
with very good enantioselectivities. It should be noted, however, that if 16 was 
employed as a chiral building block in further synthesis, deprotection of the N-
benzyl group under hydrogenolytic conditions would jeopardize the terminal double 
bond as well and thus would limit the possible further functionalizations at that 
position. 
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Scheme 3 Pd-catalyzed asymmetric synthesis of β-carbolines 
 
2. Goal  
The aim of this project was to develop a catalytic asymmetric synthesis of chiral β-
carboline building blocks, in analogy to the asymmetric Ir-catalyzed allylic 
amidation for the synthesis of chiral tetrahydroisoquinolines (see Chapter 3). β-
Carbolines and tetrahydroisoquinolines are related structures, the only difference 
being the “backbone” of the molecule containing an indole or a phenyl moiety, 
respectively. We therefore sought to expand the allylic substitution methodology to 
these structures. In analogy to the previously described catalytic asymmetric 
methodology, chiral building blocks with a multitude of starting points for further 
functionalization should be obtained via the envisaged route, furnishing valuable 
synthetic intermediates for further synthesis. 
 
3. Results and discussion 
Two synthetic approaches were taken in this project, the first was to employ a 
direct allylic amination with a primary amine to construct the chiral piperidine of the 
β-carboline cores 18 with an unprotected primary nitrogen (path A in Scheme 4). 
This approach proved to be problematic due to the choice of protecting groups 
necessary for synthesis as well as incompatibility of the synthetic approach to 18 
with the required leaving group for the allylic subsititution, the methyl carbonate. 
The second approach was to attempt the allylic amidation as outlined in Chapter 3, 
making use of a TFA N-protecting group in 20 that can still act as a nucleophile in 
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the Ir-catalyzed allylic substitution (path B in Scheme 4). This approach was 
synthetically more viable, and the desired starting materials 20 for the construction 
of the chiral β-carbolines 19 were accessible in this way. 
 
Scheme 4 Retrosynthetic approach to chiral β-carbolines 
 
3.1 The direct allylic amination approach 
The synthetic approach to primary amine 18 was based upon literature precedents 
for the preparation of synthetic intermediates 22 to 25,
26,27
 employing a phthalimide 
protecting group for the primary amine of tryptamine (Scheme 5). We anticipated 
that the late-stage deprotection of the phthalimide to the primary amine should be 
compatible with the allylic carbonate moiety. After protection of both nitrogen atoms 
of 21 with a Boc and a phthalimide group, respectively, tryptamine 24 was 
converted to bromide 25 with pyridinium tribromide in excellent yields. Compound 
25 served as precursor for the first key step in the synthesis of β-carbolines, since 
the allyl alcohol moiety would be installed via Pd-catalyzed cross coupling 
methodology.  
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Scheme 5 Synthesis of bromide 25 
 
Suzuki cross coupling 
Among the first attempts to install the allyl alcohol moiety in the 2-position of the 
indoles was the investigation of a Suzuki coupling
28-32
 of bromide 25 with boronate 
28,
26
 which had been prepared from catecholborane (26) and TBS-protected 
propargylic alcohol 27 (Scheme 6).  
 
Scheme 6 Preparation of catecholboronate 28 
The results of the Suzuki coupling are summarized in Table 1. First, literature 
conditions
26
 were applied for the transformation of 25 (Table 1, entry 1), however, it 
was observed that only low coversion to the desired coupling product 29 was 
achieved. Milder conditions (Table 1, entry 2) did not lead to any conversion either. 
However, when a catalyst comprising of palladium(II) acetate and 
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triphenylphosphine in the presence of aqueous sodium carbonate solution was 
investigated under different reaction conditions (Table 1, entries 3,4), it was found 
that both in propanol/water and THF/water mixtures the corresponding protected 
allylic alcohols 29 could be obtained with good yields after short reaction times. 
However, it turned out that these reactions were not reproducible, as the 
conversion was very low in most of the cases. Unfortunately, even after tedious 
purification of both 25 and 28, the Suzuki coupling could not be rendered 
reproducible, so that it was necessary to investigate other cross coupling reactions. 
Table 1 Suzuki coupling of bromide 25  
 






5.0 mol% Pd(PPh3)4 
toluene, 100 °C 
2N NaOH, 
5.0 mol% LiCl 
Low conversion n.d. 
2 
5.0 mol% Pd(PPh3)4 
2.0 eq. Na2CO3 
THF/H2O 5:1, rt 
- No conversion - 
3 
5.0 mol% Pd(OAc)2 
10 mol% PPh3 
2.0 eq. Na2CO3 
n-propanol/H2O 5:1, reflux 
- 
Full conversion in 




5.0 mol% Pd(OAc)2 
10 mol% PPh3 
2.0 eq. Na2CO3 
THF/H2O 5:1, reflux 
5 drops 
ethylene glycol 
Full conversion in 
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Heck cross coupling 
The Heck reaction
31,33,34
 of bromide 25 with allyl alcohol or derivatives thereof (30) 
was attempted next. With acetal-protected acrolein (Table 2, entry 1) no turnover 
was found with the standard catalyst comprising palladium(II) acetate and 
triphenylphosphine. Under the same conditions, TBS-protected allylic alcohol as 
well as allylic alcohol itself (Table 2, entries 2,3) were giving full conversion in short 
reaction times (~1 h), however the desired product 31 was isolated as a mixture 
with all other double bond isomers (E/Z, terminal/vicinal substitution), which could 
not be separated, rendering this coupling not useful for the further synthesis. The 
same result was found when Pd-BIAN
35
 complex 32, which had been successfully 
used in the related oxidative Heck reaction,
36
 was employed for the Heck reaction 
with allyl alcohol. 







5.0 mol% Pd(OAc)2 
10.0 mol% PPh3  
No conversion  
2 
5.0 mol% Pd(OAc)2 
10.0 mol% PPh3 
 
Full conversion, mixture 




5.0 mol% Pd(OAc)2 
10.0 mol% PPh3 
 
Full conversion, mixture 
of double bond isomers 
4 5.0 mol% 32  
Full conversion, mixture 
of double bond isomers 
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Kumada cross coupling 
The Kumada cross coupling
37
 of 25 with vinylmagnesium bromide was also 
investigated. The corresponding terminal olefin 34 was anticipated to be further 
transformed to the desired allyl carbonate by cross metathesis (compare Chapters 
2 and 3). However, it was found that under the reaction conditions, the phthalimide 
protecting group was not tolerated, as a fast and selective attack on the imide to 
give 35, was observed. 
 
Scheme 7 Attempted Kumada coupling 
 
Stille cross coupling 
As the last option, we attempted the Stille reaction to install the allylic alcohol 
moiety in the 2-position of the indole. Since it is known that the Stille reaction works 
best with unsaturated iodides as coupling partners,
38-40
 we set out to synthesize the 
corresponding iodide, starting off from fully protected tryptamine 36. As illustrated 
in Table 3, a variety of conditions were investigated. Most of the entries – with the 
exception of entry 3 – do give conversion to the desired iodide 37, however, the 
products are accompanied by side-products or not-separable impurities. Similar 
results were found with lithiation and subsequent trapping with iodine or 1,2-
diiodoethane
41
 (Table 3, entries 1,2). With the strongly electrophilic iodonium 
monochloride, deprotection of the Boc group was observed (Table 3, entry 3), most 
probably due to a Lewis acid-promoted elimination of the tert-butoxy moiety. Using 
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desired product 37 was observed in the reaction mixture, but could not be obtained 
pure. To our delight, a mercury-mediated iodination
43
 gave excellent results in 
terms of yields and selectivities, and 37 could be obtained in up to 2 g scale via this 
method (Table 3, entry 5). 
Table 3 Iodination of tryptamine 36  
 
Entry Conditions Conversion Comment 
1 
2.4 eq. tBuLi, 2.6 eq. I2 
THF, -78 °C to rt 
Mixture of products  
2 1.1 eq. tBuLi, 1.0 eq. 38
41
 Mixture of products  
3 1.1 eq. ICl, CH2Cl2, rt 
Full conversion, 






1.1 eq. IPy2, 2.2 eq. HBF4, 
CH2Cl2, rt 





1.3 eq. Hg(OTFA)2, CH2Cl2, rt 
1.5 eq. I2 
Selective reaction, 
quantitative yield 
can be scaled to 2g 
 
With iodide 37 in hand, we investigated the Stille coupling reaction (Table 4) with 
stannane 39, which was obtained in one step from propargyl alcohol.
44
 We started 
off optimizing the reaction conditions, employing Pd(PPh3)4 as catalyst and LiCl as 
additive.
38
 However, with various solvents tested, little or no conversion to the 
coupling product 40 was observed (Table 4, entries 1-3). Addition of CsF and 
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catalytic amounts of CuI, which had led to improved results in earlier studies,
45
 
showed no effect on the envisaged reaction (Table 4, entry 4). However, at 
elevated temperatures and with a Pd(II) precatalyst, the desired product was 
obtained in acceptable yield (Table 4, entry 5). Furthermore, this reaction proved to 
be scalable without compromizing the yields. From the optimization, it is not clear 
yet whether the temperature or the additive in combination with the Pd precursor 
was the decisive change for the positive outcome of the reaction. 
Table 4 Optimization Stille coupling 
 
Entry Conditions Additives Comment 
1 5.0 mol% Pd(PPh3)4, DMF, 50 °C 3.0 eq. LiCl Low conversion 
2 5.0 mol% Pd(PPh3)4, THF, 50 °C 3.0 eq. LiCl Low conversion 
3 5.0 mol% Pd(PPh3)4, toluene, 50 °C 3.0 eq. LiCl Low conversion 
4
45
 5.0 mol% Pd(PPh3)4, DMF, 50 °C 
2.0 eq. CsF 
10 mol% CuI 
Low conversion 
5 5.0 mol% PdCl2(PPh3)2, DMF, 75 °C 3.0 eq. LiCl 65% yield 
 
Allylic alcohol 40 could be smoothly transformed to the corresponding methyl 
carbonate 41 (Scheme 8), which bears the necessary leaving group for the 
anticipated Ir-catalyzed allylic substitution. 
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Scheme 8 Synthesis of allylic carbonate 41 
With allylic carbonate 41 in hand, we set off to investigate the deprotection of the 
phthalimide protection group. This was expected to be a difficult transformation, 
since phthalimides are generally cleaved with nucleophilic reagents. However, the 
allylic carbonate which is also present in 41 should also be susceptible to 
nucleophilic attack. The same holds true if a reductive pathway should be chosen. 
Therefore, judicious choice of deprotection conditions was expected to be 
necessary. As a third requirement, the Boc protection of the indole moiety in 41 
should remain intact, since indoles are known to be N-nucleophiles in the Ir-
catalyzed allylic amination.
46
 Protection of this position ensured supression of a 
competing intermolecular allylic substitution.  
We started off by investigating the deprotection of the phthalimide group with 
hydrazine hydrate (Table 5).
47
 Under standard conditions in ethanol at ambient 
temperature, it was observed that 41 did not dissolve and with one equivalent of 
hydrazine, no reaction took place (Table 5, entry 1). When more equivalents of 
hydrazine were added, little conversion to the desired deprotected primary amine 
was observed (Table 5, entry 2). However, when the reaction mixture was allowed 
to stir overnight, full conversion of the primary amine 42 to the ring-closed β-
carboline 43 was observed, most probably due to the basicity of hydrazine (Table 
5, entry 3). Reactions which employed hydrazine stock solutions in either EtOH or 
THF led to no conversion (Table 5, entries 4-6), with the exception of the reaction 
using an excess of hydrazine in THF, which led to equal amounts of the desired 42, 
next to the ring-closed 43 and aminoalcohol 44 (Table 5, entry 7). It is known in 
literature that phthalimides can also be deprotected with primary amines,
47-49
 so we 
investigated this possibility next. Indeed, this manner of deprotection proved to be 
more fruitful, since we observed full conversion of phthalimide 41 with an excess of 
methylamine in water (Table 5, entry 8), albeit with complete conversion to β-
carboline 43. When the solvent was changed to ethanol, full conversion to the 
desired primary amine 42 was achieved, however in this case, diamide 45 and 
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semi-deprotected diamide 46 being inseparable impurities (Table 5, entries 9,10). It 
was compound 42 from these reactions that was used for further studies. Finally, 
the deprotection with butylamine was attempted to achieve an easier purification of 
42, but these reaction either led to low conversion to 42 overnight, or to complete 
deprotection to amino alcohol 44 (Table 5, entries 11,12). 
Table 5 Deprotection of phthalimide 41 
 
Entry Conditions Comment 42/43
a
  
1 1.0 eq. H2NNH2•H2O, EtOH, rt After 1h, no conv. - 
41 does not 
dissolve 
2 3.0 eq. H2NNH2•H2O, EtOH, rt 





3 3.0 eq. H2NNH2•H2O, EtOH, rt 





4 1.0 eq. H2NNH2•H2O
b
, EtOH, rt No conv. after 16h - - 
5 5.0 eq. H2NNH2•H2O
b
, EtOH, rt No conv. after 16h - - 
6 1.0 eq. H2NNH2•H2O
c
, EtOH, rt No conv. after 16h - - 
7 4.0 eq. H2NNH2•H2O
c




5.0 eq. MeNH2 (40% in H2O), 
EtOH, rt, 16h 
Full conv. 0/100 50% 43 
9 
5.0 eq. MeNH2 (33% in EtOH), 
EtOH, rt, 16h 
50% conv. 100/0 
Major 
impurities 
45 + 46 
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10.0 eq. MeNH2 (33% in EtOH), 
EtOH, rt, 16h 
Full conv. 100/0 
Major 
impurities 
45 + 46 
11 10.0 eq. BuNH2 , EtOH, rt, 16h 20% conv. 100/0  








Hydrazine hydrate stock solution in EtOH (1M). 
c
H2NNH2 
solution in THF (1M). 
 
From the attempts to deprotect phthalimide 41 selectively, it can be concluded that 
one the one hand, employing hydrazine the desired selective deprotection could 
not be achieved due to overreaction to 43. On the other hand, with methylamine 
the reaction does work and can be summarized as follows: The first nucleophilic 
attack on the phthalimide to give diamide 46 is very fast (1 h), the second attack on 
46 itself is then much slower, which is accompanied by unwanted side reactions to 
amino alcohol 44. 
With impure 42 in hand, we attempted the Ir-catalyzed allylic amination with 
iridacycle 48 (Table 6). Generally, this reaction does not require a base,
50
 but 
under these conditions, no conversion of 42 was found (Table 6, entry 1). With 
more drastic conditions employing Cs2CO3 as a base and elevated temperatures, 
which had been employed earlier for the allylic substitution with indoles,
51
 also no 
conversion to 47 was found either (Table 6, entry 2). 
  
110 
   
Chapter 4 
 
Table 6 Attempted Ir-catalyzed allylic amination 
 
Entry Conditions Comment 
1 rt, 16h No conversion 
2 2.0 eq. Cs2CO3, 50 °C, 16h No conversion 
 
From these results is was not clear as to why the anticipated reaction did not work 
as envisaged. It could be that the impurities of 42 played a role, although a 
possible coordination of the Boc-group to the Ir-catalyst and subsequent 
deactivation of the catalyst could not be excluded. It is also interesting to note that 
under basic conditions during the deprotection of the phthalimide with hydrazine 
(see Table 5) the corresponding β-carboline 43 was observed, but not in the case 
of the reaction with Cs2CO3 with elevated temperatures. Thus, another possibility of 
deactivation of the catalyst could be the strong interaction of the allylic carbonate 
42 with the catalyst that would lead to deactivation by formation of a catalytically 
inactive Ir complex.  
With the results of the unsuccessful allylic amination to give β-carbolines and the 
problems associated with the deprotection of the phthalimide protecting group in 
hand, we decided to adapt our synthetic approach. Having established the key 
synthetic steps to construct the allylic carbonate via Stille coupling of a 2-iodoindole 
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(vide supra), we decided to change the protecting group strategy, but keep the 
same synthetic approach. We envisioned to investigate the use of an N-
substitutent that would serve on the one hand as a protecting group during the Pd-
catalyzed cross coupling, and on the other hand act as the nucleophile for an allylic 
substitution (see also Chapter 3). Furthermore, the protecting group of the indole-
nitrogen was varied, so that possible influences of the Boc-group of the previous 
approach could be investigated. 
 
3.2 The allylic amidation approach 
Our synthetic approach started from commercially available tryptamines 21 
(Scheme 9). After protection of the indole nitrogen and trifluoroacetylation of the 
primary amine we obtained the protected tryptamines 48a-c in very good yields. 
Furthermore, trifluoroacetamide 47d without a substituent on the indole nitrogen 
could be synthesized. 
 
Scheme 9 Synthesis of trifluoroacetamide-protected indoles 
We then went on to investigate the possible iodination of 48 in the 2-position of the 
indole system. The reported Hg-mediated iodination
43
, that had been used earlier 
on Boc-protected indoles 36 (vide supra) worked also fine for the trifluoroacetamide 
48d with a Boc protecting group (Scheme 10). However, in the case of indoles 48a-
c with a different substitution than Boc on the indole-nitrogen, this transformation 
proved to be difficult when scaling up the reactions.  This outcome was 
unexpected, and could be explained by solubility problems of either the indoles 
48a-c or the mercury salt, as very high dilutions have been shown to be necessary 
for the reaction to proceed smoothly. About a further coordination or a stabilizing 








Scheme 10 Hg-mediated iodination of 48 
We turned to the use of iodine monochloride as an electrophilic iodination agent for 
48, which we had successfully applied on electron-rich phenylethylamine 
derivatives (see Chapter 3).
52,53
 In the case of tryptamines 48a and 47d this 
showed to be no feasable synthetic pathway, as the corresponding chlorides 50 
were isolated (Scheme 11), resulting from a reaction of the indole moiety of 
47d/48a in the 2-position with ICl. The following Stille reaction (see also Scheme 
12) with stannane 52 showed no turnover with the chlorides 50.   
 
Scheme 11 Attempted Stille reaction with chlorotryptamines 
For the synthesis of the desired iodoindoles 49, suitable reagents for the envisaged 
Pd-catalyzed carbon-carbon coupling reaction later on in the synthetic route, we 
refrained to a lithiation-iodination protocol. After metalation of 48 with butyllithium, 
iodine as electrophile furnishes the desired iodine-substituted indoles 49 in 
moderate yields. (For the trapping of the lithiated species with another electrophile, 
see Scheme 16) For the following cross-coupling, the role of the trifluoroacetamide 
group as a protecting group was exploited. Since Pd-catalyzed couplings only 
rarely proceed in the presence of primary amines, this feature comes in to our 
advantage. Subsequently, the allylic alcohol moiety was introduced via Stille 
coupling with stannane 52.
44
 In the case of the iodides 49, the coupling proceeded 
smoothly to the desired allylic alcohols 51 (68 - 71%). These could be transformed 
to the corresponding methyl carbonates 53 in a straightforward manner (Scheme 
12). 
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Scheme 12 Synthesis of protected allylic carbonates 
With allylic carbonates 53 in hand, we set off to investigate whether they would 
serve as precursors to a selection of transition metal-catalyzed allylic amidation 
reactions, based on Ir or Pd catalysts. Both methodologies had been proven viable 
for the related phenylethylamine derivatives
53,54
 to give tetrahydroisoquinolines, 
and, in the case of the Ir-catalyzed allylic amidation, also chiral saturated N-
heterocycles (see Chapter 3). 
The results of the attempted Ir-catalyzed allylic amidation are summarized in Table 
7. First, the influence of different substitutions on the indole moiety were 
investigated with a catalyst comprising 2.5 mol% of [Ir(COD)Cl]2, 5.0 mol% 
phosphoramidite L2 and two equivalents of DBU (Table 7, entries 2-6). Under 
these conditions, neither of the allylic carbonates 53 gave any conversion to 54, 
supporting the notion that the influence of the Boc-group which was believed to 
prevent the Ir-catalyzed allylic amination from occuring earlier (Table 6) does not 
have a major influence on the catalyst. Also, L3 was employed in one case (Table 
7, entry 4) but no improvement was observed. When the temperature was raised to 
90 °C, a small amount of the desired product 53 was observed (Table 7, entries 7-
10), however, it could be shown that this was the product of a blank reaction 
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independent of the presence of Ir-catalyst and 54 was thus formed in a racemic 
fashion (Table 7, entry 8). Finally, the influence of a variety of bases was 
investigated with benzyl-protected indole 53 (Table 7, entries 11-17). Again, it was 
found that the influence of the base on the envisaged reaction is remarkable, with 
TBD leading to decomposition of the starting material (Table 7, entry 11) and 
K3PO4 leading to no conversion at all (Table 7, entry 13). However, it could be 
established that the blank reaction without Ir catalyst proceeded cleanly to the 
desired products at elevated temperatures in dioxane with Cs2CO3 as a base 
(Table 7, entry 17). The employment of the much stronger base NaH led to 
decomposition of allylic carbonate 53 to the corresponding allylic alcohol 51 (Table 
7, entries 18,19).  
Table 7 Attempted Ir-catalyzed allylic amidation 
 
Entry R R’ Catalyst Conditions Comment 
1 H Boc - 2.0 eq. DBU, THF, 50 °C, 16h no conversion 
2 H Boc [Ir(COD)Cl]2/L2 2.0 eq. DBU, THF, 50 °C, 16h no conversion 
3 H Me [Ir(COD)Cl]2/L2 2.0 eq. DBU, THF, 50 °C, 16h no conversion 
4 H Me [Ir(COD)Cl]2/L3 2.0 eq. DBU, THF, 50 °C, 16h no conversion 
5 H Bn [Ir(COD)Cl]2/L2 2.0 eq. DBU, THF, 50 °C, 16h no conversion 
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Entry R R’ Catalyst Conditions Comment 
6 OMe Bn [Ir(COD)Cl]2/L2 2.0 eq. DBU, THF, 50 °C, 16h no conversion 
7
a
 H Me 48 
2.0 eq. DBU, THF, 50 °C to 90 
°C, 16h 
no conversion 
8 H Me - 






9 H Me 48 






10 H Me [Ir(COD)Cl]2/L3 






11 H Bn 48 




12 H Bn 48 






13 H Bn 48 
2.0 eq. K3PO4, dioxane, 100 °C, 
16h 
no conversion 
14 H Bn 48 






15 H Bn 48 






16 H Bn 48 








17 H Bn - 
2.0 eq. Cs2CO3, dioxane, 100 
°C, 16h 
full conversion 
18 H Bn - 1.0 eq. NaH, THF, rt 
full conversion 
to 51 










53 was isolated as a racemic 
mixture. 
d
Microwave heating (300W, 2h). 
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From these results it was concluded that the Ir-catalyzed intermolecular allylic 
amidation to form β-carbolines was not successful. It could be speculated as to 
why this reaction did not take place, keeping in mind that the related 
tetrahydroisoquinolines were easily accessible through this synthetic pathway (see 
Chapter 3). In the case of 54, the six-membered heterocycles formed is part of a 
ring system that is annulated to a five membered ring, namely the indole. This is in 
contrast to the tetrahydroisoquinolines, where a phenyl ring was attached to the 
piperidine to be formed. This structural change could have lead to steric constraints 
which prevented the Ir-catalyst to attack, or prevent an intermediate Ir-allyl complex 
from reacting further to the desired products. Furthermore, it could be speculated 
that the electronic changes brought about by the indole moiety change the 
electronic nature of the allylic carbonate in such a way that an allylic substitution is 
prevented from taking place. A last possibility would be the formation of a 
catalytically inactive Ir-indole complex which would lower the concentration of 
active catalyst in the reaction mixture. To probe some of these issues, a variety of 
test reactions were carried out.  
 
Competition Experiments 
To probe as to why the Ir-catalyzed allylic amidation of 53 would not take place, we 
conducted a competition experiment (Scheme 13). Carbonate 53 was subjected to 
the standard asymmetric allylic amidation conditions for 1 h, after which 53 was 
found to be completely unreacted in the mixture. Then, linear allylic carbonate 55 
was added and stirred under the same conditions for 5 more hours. After this time, 
carbonate 55 had been fully converted to chiral piperidine 56 as previously 
reported (see Chapter 3), whereas tryptamine-derived carbonate 53 was left 
unreacted in the mixture. From this experiment it can be concluded that no stable Ir 
complex with tryptamine 53 is formed, since no deactivation of the catalyst was 
observed when a second substrate was added. The formation of a catalytically 
active species of the Ir complex with 53 seemed to be prevented due to the steric 
and/or electronic parameters of 53. The competition experiment was also carried 
out in deuterated THF and followed by 
31
P NMR spectroscopy, but no catalytically 
active species was observed, so no clear conclusions could be drawn from this 
experiment. The observation of an active catalytic species in Ir-catalyzed allylic 
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Scheme 13 Competition experiment 
 
Intermolecular allylic amination 
To test whether or not an Ir-allyl complex, which is generally accepted to be the key 
catalytic intermediate in Ir-catalyzed allylic substitutions
56,58,59
 was formed, an 
intermolecular allylic amination was carried out under previously published reaction 
conditions (Scheme 14).
55
 When allylic carbonate 53 was reacted with an excess of 
benzylamine in the presence of iridacycle 48 as catalyst, no conversion of the 
starting material was observed.
60
 From this observation it can be concluded that 
most probably there is no Ir-allyl species formed, which is a prerequisite for the 
allylic substitution to occur. Therefore, it seems that attack of the Ir catalyst on 
allylic carbonate 53 is prevented either by steric or electronic factors. 
 
Scheme 14 Attempted intermolecular allylic amination 
  
Pd-catalyzed allylic amidation 
Finally, an effort was made to examine the allylic amidation with a Pd-
phosphoramidite complex as catalyst. This had been published earlier as an 
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efficient catalyst to prepare a chiral tetrahydroisoquinoline from the corresponding 
allylic carbonates and trifluoroacetamides.
54
 However, under these conditions 
(Scheme 15), no conversion of 53 was observed. This hints at a problem with the 
reactivity of the starting material, since two transition metal-based catalysts, 
previously successful for the synthesis of tetrahydroisoquinolines, did not achieve 
any conversion to the desired product 54. 
 
Scheme 15 Attempted Pd-catalyzed allylic amidation 
To make the allylic carbonate more accessible for a potential transition metal-
based catalyst, we attempted to synthesize an allylic carbonate with a “reversed” 
allyl moiety, meaning that the corresponding secondary allylic alcohol would be 
synthesized. These kind of substrates had been shown to undergo allylic amination 
with Ir-phosphoramidite catalysts as well.
61
 When iodoindole 48b was lithiated as 
shown previously and then quenched with acrolein as electrophile, secondary 
allylic alcohol 58 could be obtained. It was then attempted to transform 58 to the 
desired carbonate 59, however the standard conditions for the transformation of an 
alcohol to a carbonate failed to give any conversion (Scheme 16). When the same 
experiment was carried out with the stronger base BuLi, the rearranged linear 
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Scheme 16 Attempted synthesis of an indole carrying a secondary allyl carbonate 
In the end, racemic β-carbolines were synthesized via the route that had been 
discovered during the catalyst screening process (compare Table 7). When allylic 
carbonates 53a-c were reacted with Cs2CO3 as a base at elevated temperatures, 
the corresponding β-carbolines 60a-c were obtained in good yield (Scheme 17). 
 
Scheme 17 Racemic synthesis of β-carbolines 
It is interesting to note that the products 60a-c were isolated as mixtures of 
isomers/rotamers. Whereas 60a shows two distinct signals in 
19
F NMR, which we 
attribute to the E/Z isomers of the trifluoroacetamide, 60b and 60c show two 
additional resonances, giving a set of four signals in 
19
F NMR. We assigned these 
extra signals to two rotamers resulting from the hindered rotation of the benzyl 
protecting group. To probe this hypothesis, we have conducted variable 
temperature 
19
F NMR measurements of 60b in DMSO-d6 (Figure 2). From the 
NMR spectra can be seen that 2 signals (1 and 3 in Figure 2) coalesce at 80 °C, as 
can be expected from rotamers. The fourth resonance (4 in Figure 2) gradually 
disappears at higher temperatures, a phenomenon that can be attributed to E/Z 
isomers of the trifluoroacetamide moiety, since at higher temperature the 
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thermodynamically more stable species (signal 2 in Figure 2) should be prevalent 





F NMR of 60b in DMSO-d6, t from 25 °C (= 1) to 95 °C (= 15) in increments of 5 °C 
 
4. Conclusions 
It was attempted to develop an Ir-catalyzed intramolecular allylic substitution with 
nitrogen nucleophiles for the synthesis of chiral β-carboline building blocks. The 
synthesis of the precursors of the final asymmetric metal-catalyzed step was 
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achieved and is based upon a key Pd-catalyzed cross coupling to introduce the 
allyl alcohol moiety in the 2-position of the indole. A direct allylic amination was 
attempted but this could not be realized through difficulties with the selective 
synthesis of a primary amine in the presence of the allylic carbonate required for 
the Ir-catalyzed step. A second approach to develop an allylic amidation 
circumvented this problem, but suffered from the fact that the Ir-based catalysis did 
not take place. From a number of test experiments it can be concluded that the 
formation of the key intermediate for the catalysis, the Ir-allyl species, does not 
form with the indole precursors due to steric and/or electronic reasons. However, 
the racemic synthesis of the desired products could finally be achieved. It should 
be noted that also for this transformation to run smoothly, judicious choice of base 
is necessary (with Cs2CO3 being the base of choice in this case).  
It is not clear with the present results whether the envisaged intramolecular allylic 
amination or amidation can be rendered feasible with transition metal-based 
catalysts. However, many methods for catalytic asymmetric allylic substitution are 
known and it could be investigated in how far they are applicable for the synthesis 
of β-carboline compounds. 
 
5. Experimental section 
General 
For general remarks, see chapter 3. Stannane 52 was prepared according to 
literature.
44








 (1.0 eq., 
4.00 g, 10.25 mmol) was dissolved in 200 mL CH2Cl2 at 
21 °C. Then 1.3 eq. bis(2,2,2-trifluoroacetoxy)mercury 
(5.68 g, 13.32 mmol) was added and the mixture was 
stirred for 20 min. Then it was washed with 2M aq. KI 
solution (2x 100 mL), dried over Na2SO4 and filtered. To 
the filtrate was added 1.5 eq. iodine (3.90 g, 15.37 mmol) 
and the mixture was stirred for another 3 h at 21 °C. The 
red precipitate was filtered and the filtrate was washed 
with saturated solution of Na2S2O3 (2x 100 mL), dried over 
Na2SO4 and all volatiles were removed under reduced 
pressure  to give tert-butyl 3-(2-(1,3-dioxoisoindolin-2-
yl)ethyl)-2-iodo-1H-indole-1-carboxylate 37 (3.86 g, 7.48 
mmol, 73%) as an off-white solid. 
1
H NMR (201 MHz, CDCl3) δ 8.17 – 7.98 (m, 
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1H), 7.97 – 7.74 (m, 2H), 7.74 – 7.55 (m, 3H), 7.39 – 7.07 (m, 2H), 4.12 – 3.75 (m, 
2H), 3.32 – 2.97 (m, 2H), 1.70 (s, 9H). 
13
C NMR (50 MHz, CDCl3) δ 168.04, 
149.20, 137.97, 133.80, 132.05, 129.46, 125.99, 124.36, 123.10, 122.76, 118.02, 
115.53, 85.01, 79.15, 36.62, 28.24, 27.34, 27.04. HRMS: (ESI
+
) calculated for 
C23H21lN2O4 [M+H
+
]: 516.0541, found: 516.0507. 
 
General procedure for the N-protection of tryptamines (Synthesis of 47) 
1.0 eq. of the appropriate tryptamine was dissolved in DMF (Volume: 50 ml / 20 
mmol) at 21 °C and added to a solution of 1.1 eq. sodium 
hydride in DMF (Volume: 50 ml / 20 mmol) and the 
solution was stirred for 30 min. Then, it was cooled to 0 °C 
and 1.1 eq. methyl iodide was added dropwise. After 
stirring at 21 °C for 1 h, the reaction was quenched with 
water and the mixture extracted with EtOAc. After drying 
over MgSO4 and removal of all volatiles under reduced 
pressure, 47 were isolated as brown solids. These 
products were used without further purification.  
 
N-(2-(1H-Indol-3-yl)ethyl)-2,2,2-trifluoroacetamide (47d) 
Tryptamine 21 (1.0 eq., 1.00 g, 6.24 mmol) was dissolved in CH2Cl2 (Volume: 50 
ml) and cooled to 0 °C. Then, 4.0 eq. pyridine (0.530 
ml, 6.55 mmol) were added and subsequently, 5.0 eq. 
trifluoroacetic anhydride (0.926 ml, 6.55 mmol) were 
added dropwise. The mixture was allowed to warm to 
room temperature and stirred for 16 h. After completion 
(as judged by TLC), the mixture was washed with 2N 
aq. HCl (3x 20 mL) and dried over MgSO4. After 
filtration and removal of all volatiles under reduced 
pressure, N-(2-(1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 47d (1.567 g, 6.12 
mmol, 98%) was obtained as a brown solid. This was used without further 
purification. 
1
H NMR: (201 MHz, CDCl3) δ 8.46 (s (br), 1H), 7.71 (d, J = 7.6 Hz, 
1H), 7.51 – 7.20 (m, 3H), 7.17 – 6.97 (m, 2H), 3.70 (q, J = 6.6 Hz, 2H), 3.10 (t, J = 
6.9 Hz, 2H). 
13
C NMR: (50 MHz, CDCl3) δ 157.40 (q, J = 36.9 Hz), 136.31, 126.85, 
122.28, 122.02, 119.31, 118.19, 115.84 (q, J = 286.8 Hz), 111.36, 111.29, 40.17, 
24.31. 
19
F NMR: (189 MHz, CDCl3) δ -75.89. HRMS: (ESI
+
, m/z) calculated for 
C12H12F3N2O1 [M+H
+
]: 257.0896, found: 257.0877. 
 
General procedure for the preparation of trifluoroacetamides 48  
1.0 eq. 47 was dissolved in CH2Cl2 (Volume: 50 ml / 20 mmol) and the solution was 
cooled to 0 °C. Then, 1.05 eq. pyridine was added and subsequently 1.05 eq. 
2,2,2-trifluoroacetic anhydride was added dropwise. The mixture was allowed to 
warm to room temperature and stirred for 16 h. After completion, the mixture was 
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washed with 2N aq. HCl (3x 50 mL / 20 mmol) and dried over MgSO4. After 
filtration and removal of all volatiles under reduced pressure, compounds 48 were 
obtained as brown solids. These products were used without further purification. 
 
2,2,2-Trifluoro-N-(2-(1-methyl-1H-indol-3-yl)ethyl)acetamide (48a) 
Following the general procedure, the reaction of 1.0 eq. 2-(1-methyl-1H-indol-3-
yl)ethanamine 47a (3.48 g, 20 mmol) gave to 2,2,2-
trifluoro-N-(2-(1-methyl-1H-indol-3-yl)ethyl)acetamide 
48a (4.70 g, 17.40 mmol, 87%). 
1
H NMR: (201 MHz, 
CDCl3) δ 7.59 (d, J = 7.8 Hz, 1H), 7.42 – 7.09 (m, 3H), 
6.91 (s, 1H), 6.70 – 6.30 (s (br), 1H), 3.76 (s, 3H), 3.68 
(dd, J = 12.9, 6.5 Hz, 2H), 3.15 – 2.97 (m, 2H). 
13
C 
NMR: (50 MHz, CDCl3) δ 137.18, 127.37, 126.91, 
121.98, 119.16, 118.50, 110.14, 109.44, 40.28, 32.61, 
24.56. COCF3 peaks not observed. 
19
F NMR: (189 
MHz, CDCl3) δ -76.00. HRMS: (ESI
+
, m/z) calculated for C13H14F3N2O1 [M+H
+
]: 
271.1053, found: 271.1035. 
 
N-(2-(1-Benzyl-1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide (48b) 
Following the general procedure, the reaction of 1.0 eq. 2-(1-benzyl-1H-indol-3-
yl)ethanamine 47b (5.01 g, 20 mmol) gave N-(2-(1-
benzyl-1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 
48b (6.44 g, 18.60 mmol, 93%). 
1
H NMR: (201 MHz, 
CDCl3) δ 7.81 – 7.59 (m, 1H), 7.51 – 7.11 (m, 8H), 
7.09 – 6.90 (m, 2H), 5.31 (s, 2H), 3.73 (dd, J = 13.1, 
6.7 Hz, 2H), 3.12 (t, J = 7.0 Hz, 2H). 
13
C NMR: (50 
MHz, CDCl3) δ 137.24, 136.68, 128.77, 128.60, 
127.58, 127.51, 126.66, 126.13, 122.00, 119.26, 
118.59, 110.84, 109.80, 49.68, 40.04, 24.41. COCF3 peaks not observed. 
19
F 
NMR: (189 MHz, CDCl3) δ -75.74. HRMS: (APCI, m/z) calculated for C19H18F3N2O1 
[M+H
+
]: 347.1366, found: 347.1361. 
 
N-(2-(1-Benzyl-5-methoxy-1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide (48c) 
Following the general procedure, the reaction of 1.0 eq. 2-(1-benzyl-5-methoxy-1H-
indol-3-yl)ethanamine 47c (1.475 g, 5.26 mmol) 
gave N-(2-(1 benzyl-5-methoxy-1H-indol-3-
yl)ethyl)-2,2,2-trifluoroacetamide 48c (1.657 g, 
4.40 mmol, 84%). 
1
H NMR: (400 MHz, CDCl3) δ 
7.35 – 7.22 (m, 2H), 7.18 (d, J = 8.9 Hz, 1H), 
7.10 (d, J = 6.5 Hz, 2H), 7.02 (s, 1H), 6.95 (s, 
1H), 6.91 – 6.83 (m, 1H), 6.41 (s (br), 1H), 5.25 
(s, 2H), 3.86 (s, 3H), 3.68 (dd, J = 12.7, 6.4 Hz, 
2H), 3.02 (t, J = 6.6 Hz, 2H). 
13
C NMR: (101 MHz, CDCl3) δ 154.13, 137.31, 
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132.10, 128.77, 127.89, 127.69, 126.85, 126.73, 112.47, 110.83, 110.23, 100.32, 
55.85, 50.14, 40.00, 24.64. COCF3 peaks not observed. 
19
F NMR: (376 MHz, 
CDCl3) δ -75.97. HRMS: (ESI
+
, m/z) calculated for C20H19F3N2O2Na [M+Na
+
]: 
399.1291, found: 399.1277. 
 
General procedure for the iodination of tryptamines 48 (Synthesis of 49) 
Trifluoroacetamide 48 (1.0 eq.) was dissolved in Et2O (Volume: 10 ml / 2 mmol) 
and the solution cooled to 0 °C. Then, 2.5 eq. BuLi were added dropwise and the 
reaction was allowed to warm to room temperature. After 2 hours, the reaction 
mixture was cooled to 0 °C again, and 1.5 eq. iodine was added. After warming to 
room temperature, the reaction was quenched by addition of a saturated Na2S2O3 
solution (10 ml / 2 mmol), the mixture was washed with water (3x 10 mL / 2 mmol) 
and extracted with Et2O (2x 20 mL / 2 mmol). After drying over MgSO4, all volatiles 
were removed under reduced pressure. Purification of the crude mixture by column 
chromatography gave 49. 
 
2,2,2-Trifluoro-N-(2-(2-iodo-1-methyl-1H-indol-3-yl)ethyl)acetamide (49a)  
Following the general procedure, the reaction of 1.0 eq. 2,2,2-trifluoro-N-(2-(1-
methyl-1H-indol-3-yl)ethyl)acetamide 48a (0.500 g, 
1.850 mmol) gave 2,2,2-trifluoro-N-(2-(2-iodo-1-methyl-
1H-indol-3-yl)ethyl)acetamide 49a (0.403 g, 1.018 
mmol, 55%) as a white solid after purification by column 
chromatography (Rf = 0.80 in pentane/EtOAc 8:2, SiO2, 
pentane/EtOAc 8:2). 
1
H NMR: (201 MHz, CDCl3) δ 7.60 
(d, J = 7.6 Hz, 1H), 7.32 (t, J = 8.3 Hz, 1H), 7.18 (dd, J 
= 15.9, 7.9 Hz, 2H), 7.07 (s (br), 1H), 3.75 (s, 3H), 3.65 
(q, J = 6.7 Hz, 2H), 3.09 (t, J = 6.9 Hz, 2H). 
13
C NMR: (50 MHz, CDCl3) δ 159.29 
(q, J = 36.8 Hz), 138.40, 127.36, 122.03, 119.50, 117.49, 116.63, 115.76 (q, J = 
288.6 Hz), 109.69, 87.84, 39.92, 33.99, 26.61. 
19
F NMR: (189 MHz, CDCl3) δ -
75.67. HRMS: (APCI, m/z) calculated for C13H13F3N2O1 [M+H
+




Following the general procedure, the reaction of 1.0 eq. N-(2-(1-benzyl-1H-indol-3-
yl)ethyl)-2,2,2-trifluoroacetamide 48b (2.00 g, 5.77 
mmol) gave N-(2-(1-benzyl-2-iodo-1H-indol-3-yl)ethyl)-
2,2,2-trifluoroacetamide 49b (1.309 g, 2.77 mmol, 
48%) as a white solid after purification by column 
chromatography (Rf = 0.66 in pentane/EtOAc 10:1, 
SiO2, pentane/EtOAc 10:1). 
1
H NMR: (201 MHz, 
CDCl3) δ 7.64 – 7.51 (m, 1H), 7.37 – 7.21 (m, 4H), 
7.20 – 7.09 (m, 2H), 7.07 – 6.97 (m, 2H), 6.35 (s (br), 
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1H), 5.44 (s, 2H), 3.69 (q, J = 6.4 Hz, 2H), 3.11 (t, J = 6.6 Hz, 2H). 
13
C NMR: (101 
MHz, CDCl3) δ 157.21 (q, J = 36.4 Hz), 138.37, 136.87, 128.65, 127.78, 127.44, 
126.24, 122.48, 119.99, 117.74, 117.44, 115.75 (q, J = 286.8 Hz), 110.34, 87.87, 
50.60, 39.87, 26.83. 
19
F NMR: (376 MHz, CDCl3) δ -75.77. HRMS: (APCI, m/z) 
calculated for C19H17F3N2O1 [M+H
+




Following the general procedure, the reaction of 1.0 eq. N-(2-(1-benzyl-5-methoxy-
1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 48c 
(1.657 g, 4.40 mmol) gave N-(2-(1-benzyl-2-
iodo-5-methoxy-1H-indol-3-yl)ethyl)-2,2,2-
trifluoroacetamide 49c (1.150 g, 2.289 mmol, 
52%) as a white solid after purification by column 
chromatography (Rf = 0.55 in pentane/EtOAc 
10:1, SiO2, pentane/EtOAc 10:1). 
1
H NMR: (201 
MHz, CDCl3) δ 7.43 – 7.21 (m, 4H), 7.15 (d, J = 
8.9 Hz, 1H), 7.01 (dd, J = 9.3, 2.5 Hz, 2H), 6.78 (dd, J = 8.9, 2.4 Hz, 1H), 6.37 (s 
(br), 1H), 5.39 (s, 2H), 3.84 (s, 3H), 3.68 (dd, J = 12.7, 6.4 Hz, 2H), 3.07 (t, J = 6.6 
Hz, 2H). 
13
C NMR: (50 MHz, CDCl3) δ 154.41, 137.00, 133.78, 128.76, 128.56, 
127.55, 126.98, 126.27, 116.70, 112.81, 111.30, 99.36, 55.79, 50.92, 39.88, 26.88. 
COCF3 peaks not observed. 
19
F NMR: (189 MHz, CDCl3) δ -75.88. HRMS: (ESI
+
, 
m/z) calculated for C20H18F3IN2O2Na [M+Na
+




tert-Butyl 3-(2-(2,2,2-trifluoroacetamido)ethyl)-1H-indole-1-carboxylate (1.0 eq., 
0.278 g, 0.780 mmol) 48
64
 was dissolved in CH2Cl2 
(50 ml) at 21 °C. Then 1.3 eq. bis(2,2,2-
trifluoroacetoxy)mercury (0.433 g, 1.015 mmol) was 
added and the mixture was stirred for 20 minutes. 
Then it was washed with 2M aq. KI solution (2x 30 
mL), dried over Na2SO4 and filtered. To the filtrate 
was added 1.5 eq. diiodine (0.297 g, 1.171 mmol) and 
the mixture was stirred for another 3h at 21 °C. The 
red precipitate was filtered and the filtrate was washed with saturated aq. solution 
of Na2S2O3 (2x 30 ml), dried over Na2SO4 and all volatiles were removed under 
reduced pressure  to give the crude product. This was purified by column 
chromatography (Rf = 0.85 in pentane / EtOAc 8:2, SiO2, pentane/EtOAc 10:1) to 
yield tert-butyl 2-iodo-3-(2-(2,2,2-trifluoroacetamido)ethyl)-1H-indole-1-carboxylate 
49d (0.248 g, 0.515 mmol, 66%) as white solid. 
1
H NMR (201 MHz, CDCl3) δ 8.18 
– 7.99 (m, 1H), 7.48 (ddd, J = 10.3, 6.2, 2.8 Hz, 1H), 7.35 – 7.16 (m, 2H), 6.76 (s 
(br), 1H), 3.62 (q, J = 6.7 Hz, 2H), 3.06 (t, J = 6.9 Hz, 2H), 1.71 (s, 9H). 
13
C NMR 
(50 MHz, CDCl3) δ 158.15 (q, J = 39.9 Hz), 157.03, 149.15, 138.04, 129.33, 
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125.58, 124.69, 122.94, 117.77, 115.69 (q, J = 286.1 Hz), 115.61, 85.37, 39.23, 
28.21, 26.95. 
19
F NMR (189 MHz, CDCl3) δ -75.87. 
 
N-(2-(2-Chloro-1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide (50a) 
1.0 eq. N-(2-(1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 47d (2.00 g, 7.81 mmol) 
was dissolved in CH2Cl2 (Volume: 60 ml) at 21 °C. 
Then, a solution of 1.1 eq. iodine monochloride in 
CH2Cl2 (1N)  (11.71 ml, 11.71 mmol) was added 
dropwise. The reaction mixture was stirred at this 
temperature, and the progress of the reaction was 
followed by TLC. After full conversion, the mixture was 
washed with water and brine and the organic phases 
were dried over MgSO4. After removal of all volatiles, 
the crude product was purified by column chromatography (Rf = 0.75 in 
pentane/EtOAc 8:2, SiO2, pentane/EtOAc 10:1) to yield N-(2-(2-chloro-1H-indol-3-
yl)ethyl)-2,2,2-trifluoroacetamide 50a (1.807 g, 6.22 mmol, 80%) as a light brown 
solid. 
1
H NMR: (201 MHz, CDCl3) δ 8.43 (s (br), 1H), 7.56 – 7.43 (m, 1H), 7.38 – 
7.06 (m, 3H), 6.60 (s (br), 1H), 3.64 (q, J = 6.5 Hz, 2H), 3.03 (t, J = 6.6 Hz, 2H). 
13
C 
NMR: (50 MHz, CDCl3) δ 134.49, 127.08, 122.64, 121.71, 120.46, 117.68, 110.75, 
107.79, 39.77, 23.15. COCF3 peaks not observed. 
19
F NMR: 189 MHz, CDCl3) δ -
76.06. HRMS: (APCI, m/z) calculated for C12H1oF3N2O1 [M-Cl
-




1.0 eq. 2,2,2-trifluoro-N-(2-(1-methyl-1H-indol-3-yl)ethyl)acetamide 48a (1.920 g, 
7.10 mmol) was dissolved in CH2Cl2 (Volume: 50 ml) at 
21 °C. Then, a solution of 1.1 eq. iodine monochloride 
(1M in CH2Cl2) (7.81 ml, 7.81 mmol) was added 
dropwise. The reaction mixture was stirred at this 
temperature, and the progress of the reaction was 
followed by TLC. After full conversion, the mixture was 
washed with water and brine and the organic phases 
were dried over MgSO4. After removal of all volatiles, 
the crude product was purified by column chromatography (Rf = 0.80 in 
pentane/EtOAc 8:2, SiO2, pentane/EtOAc 10:1) to yield N-(2-(2-chloro-1-methyl-
1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 50b (1.688 g, 5.54 mmol, 78%) as a 
yellow solid. 
1
H NMR: (201 MHz, CDCl3) δ 7.52 (d, J = 7.6 Hz, 1H), 7.35 – 7.25 (m, 
2H), 7.24 – 7.08 (m, 1H), 6.48 (s (br), 1H), 3.74 (d, J = 2.5 Hz, 3H), 3.64 (q, J = 6.4 
Hz, 2H), 3.06 (t, J = 6.6 Hz, 2H). 
13
C NMR: (50 MHz, CDCl3) δ 135.82, 126.20, 
124.50, 122.22, 120.19, 117.70, 109.30, 106.86, 39.87, 29.89, 23.58. COCF3 
peaks not observed. 
19
F NMR: (189 MHz, CDCl3) δ -76.06. HRMS: (APCI, m/z) 
calculated for C13H12F3N2O1 [M-Cl
-
]: 269.0902, found: 269.0894. 
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General procedure for the Stille coupling of iodides 37/49 (Synthesis of 40/51) 
1.0 eq. of iodide 49, 1.5 eq. of (E)-3-(tributylstannyl)prop-2-en-1-ol 52, 5.0 mol% 
bis(triphenylphosphine)palladium(II) chloride and 3.0 eq. of lithium chloride were 
dissolved in DMF (Volume: 20 ml / mmol) and the mixture was heated to 75 °C. 
The reaction mixture was stirred at this temp for 16 h. The reaction was quenched 
by addition of water (20 ml / mmol), EtOAc (50 ml / mmol) was added and the 
organic phases were washed with brine (2x 50 mL / mmol). After drying over 
MgSO4 and removal of all volatiles the crude mixture was purified by column 




Following the general procedure, 0.304 g (E)-tert-butyl 3-(2-(1,3-dioxoisoindolin-2-
yl)ethyl)-2-(3-hydroxyprop-1-en-1-yl)-1H-indole-1-
carboxylate 40 (0.681 mmol, 65%) were isolated from 
the reaction of tert-butyl 3-(2-(1,3-dioxoisoindolin-2-
yl)ethyl)-2-iodo-1H-indole-1-carboxylate 37 (0.541 g, 
1.048 mmol) after purification by column 
chromatography using EtOAc/pentane 1:1 as eluent. (Rf 
= 0.85 in pentane/EtOAc). 
1
H NMR (400 MHz, CDCl3) δ 
8.19 – 7.97 (m, 1H), 7.89 – 7.77 (m, 2H), 7.75 – 7.58 (m, 
3H), 7.37 – 7.19 (m, 2H), 6.78 (d, J = 16.1 Hz, 1H), 6.25 
(ddd, J = 16.1, 5.7, 4.1 Hz, 1H), 4.42 (d, J = 5.0 Hz, 2H), 
3.95 – 3.77 (m, 2H), 3.24 – 2.98 (m, 2H), 1.65 (s, 9H). 
13
C NMR (101 MHz, CDCl3) δ 168.13, 150.22, 135.33, 
134.85, 133.89, 132.89, 131.90, 129.58, 124.48, 123.13, 122.80, 122.36, 118.48, 
115.76, 115.44, 83.87, 63.51, 37.71, 28.11, 23.75. HRMS: (ESI
+
) calculated for 
C26H25N2O5 [M+H
+




Following the general procedure, the reaction of 1.0 eq. 2,2,2-trifluoro-N-(2-(2-iodo-
1-methyl-1H-indol-3-yl)ethyl)acetamide 49a (0.300 g, 
0.757 mmol) gave (E)-2,2,2-trifluoro-N-(2-(2-(3-
hydroxyprop-1-en-1-yl)-1-methyl-1H-indol-3- 
yl)ethyl)acetamide 51a (0.167 g, 0.512 mmol, 68%) as 
an orange solid after purification by column 
chromatography (Rf = 0.30 in Pentane / EtOAc 1:1, 
SiO2, pentane/EtOAc 1:1). 
1
H NMR: (201 MHz, CDCl3) 
δ 7.58 (dd, J = 7.8, 0.7 Hz, 1H), 7.44 – 7.22 (m, 3H), 
7.20 – 7.07 (m, 1H), 6.69 (d, J = 16.3 Hz, 1H), 6.29 (dd, J = 13.4, 8.1 Hz, 1H), 4.40 
(d, J = 5.3 Hz, 2H), 3.69 (s, 3H), 3.59 (dd, J = 13.7, 6.8 Hz, 2H), 3.14 (t, J = 7.3 Hz, 
2H). 
13
C NMR: (50 MHz, CDCl3) δ 157.44 (q, J = 37.3 Hz), 137.16, 134.46, 133.84, 
127.26, 122.17, 119.43, 118.92, 118.09, 115.78 (q, J = 287.9 Hz), 109.19, 109.09, 
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63.31, 40.45, 30.42, 23.92. 
19
F NMR: (189 MHz, CDCl3) δ -75.88. HRMS: (APCI, 
m/z) calculated for C16H18F3N2O2 [M+H
+




Following the general procedure, the reaction of 1.0 eq. N-(2-(1-benzyl-2-iodo-1H-
indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 49b (0.285 g, 
0.604 mmol) gave (E)-N-(2-(1-benzyl-2-(3-hydroxyprop-
1-en-1-yl)-1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 
51b (0.172 g, 0.427 mmol, 71%) as a white solid after 
purification by column chromatography (Rf = 0.50 in 
pentane/EtOAc 1:1, SiO2, pentane/EtOAc 1:1). 
1
H 
NMR: (400 MHz, CDCl3) δ 7.59 (d, J = 7.7 Hz, 1H), 
7.33 – 7.10 (m, 6H), 7.00 (d, J = 7.0 Hz, 2H), 6.71 – 
6.54 (m, 2H), 6.18 (dt, J = 16.1, 5.3 Hz, 1H), 5.37 (s, 2H), 4.28 (d, J = 5.2 Hz, 2H), 
3.65 (dd, J = 13.4, 6.8 Hz, 2H), 3.19 (t, J = 7.1 Hz, 2H). 
13
C NMR: (101 MHz, 
CDCl3) δ 137.61, 137.15, 134.73, 134.59, 128.80, 127.56, 127.37, 125.87, 122.68, 
119.98, 118.80, 118.33, 109.88, 109.60, 63.47, 47.31, 40.42, 24.04. COCF3 peaks 
not observed. 
19
F NMR: (376 MHz, CDCl3) δ -76.00. HRMS: (ESI+, m/z) calculated 
for C22H21F3N2O2Na [M+Na
+
]: 425.1447, found: 425.1432. 
 
(E)-N-(2-(1-Benzyl-2-(3-hydroxyprop-1-en-1-yl)-5-methoxy-1H-indol-3-yl)ethyl)-
2,2,2-trifluoroacetamide (51c)  
Following the general procedure, the reaction of N-(2-(1-benzyl-2-iodo-5-methoxy-
1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 49c 
(0.270 g, 0.538 mmol) gave (E)-N-(2-(1-benzyl-
2-(3-hydroxyprop-1-en-1-yl)-5-methoxy-1H-indol-
3-yl)ethyl)-2,2,2-trifluoroacetamide 51c (0.158 g, 
0.366 mmol, 68%) as a white solid after 
purification by column chromatography (Rf = 0.5 
in pentane/EtOAc 1:1, SiO2, pentane/EtOAc 1:1). 
1
H NMR: (400 MHz, CDCl3) δ 7.26 (d, J = 6.7 
Hz, 3H), 7.08 (d, J = 8.6 Hz, 1H), 7.03 (s, 1H), 6.98 (d, J = 6.0 Hz, 2H), 6.91 (s (br), 
1H), 6.83 (d, J = 8.2 Hz, 1H), 6.58 (d, J = 16.2 Hz, 1H), 6.15 (d, J = 15.8 Hz, 1H), 
5.31 (s, 2H), 4.25 (s, 2H), 3.85 (s, 3H), 3.62 (d, J = 5.6 Hz, 2H), 3.14 (s (br), 2H). 
13
C NMR: (101 MHz, CDCl3) δ 157.38 (q, J = 37.6 Hz), 154.40, 137.70, 135.12, 
134.11, 132.39, 128.75, 127.92, 127.30, 125.80, 118.89, 115.83 (q, J = 287.4 Hz), 
112.75, 110.70, 109.22, 100.08, 63.40, 55.83, 47.34, 40.29, 24.06. 
19
F NMR: (376 
MHz, CDCl3) δ -75.94. HRMS: (ESI
+
, m/z) calculated for C23H23F3N2O3Na [M+Na
+
]: 
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(E)-tert-Butyl 2-(3-hydroxyprop-1-enyl)-3-(2-(2,2,2-trifluoroacetamido)ethyl)-
1H-indole-1-carboxylate 51d  
Following the general procedure, the reaction of 1.0 eq. tert-butyl 2-iodo-3-(2-
(2,2,2-trifluoroacetamido)ethyl)-1H-indole-1-carboxylate 
49d (0.240 g, 0.498 mmol) gave (E)-tert-butyl 2-(3-
hydroxyprop-1-en-1-yl)-3-(2-(2,2,2-
trifluoroacetamido)ethyl)-1H-indole-1-carboxylate 51d 
(0.129 g, 0.314 mmol, 63%) as a white solid after 
purification by column chromatography (Rf = 0.5 in 
pentane/EtOAc 1:1, SiO2, pentane/EtOAc 2:1). 
1
H NMR 
(400 MHz, CDCl3) δ 8.79 – 8.54 (m, 1H), 8.14 (dd, J = 
15.1, 7.4 Hz, 2H), 8.01 – 7.70 (m, 2H), 7.51 – 7.24 (m, 
1H), 6.82 – 6.50 (m, 1H), 4.93 (dd, J = 14.8, 8.7 Hz, 2H), 4.11 (d, J = 5.9 Hz, 2H), 
3.66 (dd, J = 23.4, 14.9 Hz, 2H), 2.27 (s, 9H).  
13
C NMR (101 MHz, CDCl3) δ 
157.61 (q, J = 36.0 Hz), 150.40, 135.36, 134.87, 132.45, 129.52, 124.70, 122.96, 
122.90, 118.41, 115.89, 115.83 (q, J = 291.0 Hz), 115.58, 84.25, 63.24, 40.06, 
28.13, 23.87. 
 
General procedure for the synthesis of allylic carbonates 41/53: 
To a solution of allyl alcohol 40 or 51 (1 eq.) and pyridine (3 eq.) in CH2Cl2 (20 mL / 
mmol) methyl chloroformate (1.5 eq.) was added dropwise at 0 °C. After 5 min. The 
solution was warmed to room temperature and stirred for 1 h. Then, it was washed 
with aq. HCl (2N) (3 x 5 mL/mmol) and dried over Na2SO4. The corresponding 




Following the general procedure, 0.428 g (E)-tert-butyl 3-(2-(1,3-dioxoisoindolin-2-
yl)ethyl)-2-(3-((methoxycarbonyl)oxy)prop-1-en-1-
yl)-1H-indole-1-carboxylate 41 (0.848 mmol, 91%) 
were isolated from the reaction of (E)-tert-butyl 3-
(2-(1,3-dioxoisoindolin-2-yl)ethyl)-2-(3-
hydroxyprop-1-en-1-yl)-1H-indole-1-carboxylate 
40 (0.415 g, 0.929 mmol) as a white solid. 
1
H 
NMR (400 MHz, CDCl3) δ 8.09 (t, J = 13.4 Hz, 
1H), 7.82 (dt, J = 6.9, 3.5 Hz, 2H), 7.76 – 7.64 (m, 
3H), 7.37 – 7.21 (m, 2H), 6.87 (t, J = 21.8 Hz, 1H), 
6.33 – 6.07 (m, 1H), 4.89 (dt, J = 24.2, 12.1 Hz, 
2H), 3.97 – 3.86 (m, 2H), 3.82 (s, 3H), 3.07 (dt, J 
= 32.4, 14.9 Hz, 2H), 1.65 (s, 9H). 
13
C NMR (101 
MHz, CDCl3) δ 167.90, 155.52, 150.12, 135.57, 
133.86, 133.78, 132.00, 129.50, 126.26, 125.20, 124.73, 123.06, 122.84, 118.70, 





]: 527.1789, found: 527.1782. 
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Following the general procedure, the reaction 1.0 
eq. (E)-2,2,2-trifluoro-N-(2-(2-(3-hydroxyprop-1-
en-1-yl)-1-methyl-1H-indol-3-yl)ethyl)acetamide 
51a (0.160 g, 0.490 mmol) gave (E)-methyl (3-(1-
methyl-3-(2-(2,2,2-trifluoroacetamido)ethyl)-1H-
indol-2-yl)allyl) carbonate 53a (0.185 g, 0.481 
mmol, 98%) as a yellow foam. 
1
H NMR: (400 
MHz, CDCl3) δ 7.62 – 7.55 (m, 1H), 7.32 – 7.25 
(m, J = 8.3, 7.8, 0.9 Hz, 2H), 7.17 – 7.10 (m, J = 
8.0, 6.6, 1.4 Hz, 1H), 6.84 – 6.72 (m, J = 16.2, 1.3 Hz, 2H), 6.19 (dt, J = 16.2, 6.2 
Hz, 1H), 4.85 (dd, J = 6.2, 1.4 Hz, 2H), 3.83 – 3.82 (s, 2H), 3.73 (s, 3H), 3.60 (q, J 
= 6.8 Hz, 2H), 3.13 (t, J = 7.1 Hz, 2H). 
13
C NMR: (101 MHz, CDCl3) δ 157.14 (q, J 
= 36.5 Hz), 155.47, 137.51, 133.42, 127.18, 126.88, 122.84, 122.70, 119.66, 
118.37, 115.73 (q, J = 288.2 Hz), 110.40, 109.30, 68.29, 54.78, 40.41, 30.70, 
23.96. 
19
F NMR: (376 MHz, CDCl3) δ -75.98. HRMS: (APCI, m/z) calculated for 




Following the general procedure, the reaction 1.0 
eq. (E)-N-(2-(1-benzyl-2-(3-hydroxyprop-1-en-1-
yl)-1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 
51b (0.230 g, 0.572 mmol) gave (E)-3-(1-benzyl-
3-(2-(2,2,2-trifluoroacetamido)ethyl)-1H-indol-2-
yl)allyl methyl carbonate 53b (0.257 g, 0.558 
mmol, 98%) as a yellow foam. 
1
H NMR: (201 
MHz, CDCl3) δ 7.65 (d, J = 6.9 Hz, 1H), 7.41 – 
7.10 (m, 6H), 7.09 – 6.98 (m, 2H), 7.10 – 6.95 (m, 2H), 6.12 (dt, J = 16.2, 6.1 Hz, 
1H), 5.38 (s, 2H), 4.76 (d, J = 6.1 Hz, 2H), 3.79 (s, 3H), 3.66 (dd, J = 13.2, 6.7 Hz, 
2H), 3.19 (t, J = 7.0 Hz, 2H). 
13
C NMR: (50 MHz, CDCl3) δ 155.39, 137.39, 137.36, 
133.54, 128.74, 127.53, 127.47, 127.34, 125.82, 123.01, 122.57, 120.03, 118.55, 
110.79, 109.83, 68.12, 54.76, 47.29, 40.33, 24.10. COCF3 peaks not observed. 
19
F 
NMR: (189 MHz, CDCl3) δ -75.95. HRMS: (APCI, m/z) calculated for C22H20F3N2O1 
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(E)-3-(1-Benzyl-5-methoxy-3-(2-(2,2,2-trifluoroacetamido)ethyl)-1H-indol-2-
yl)allyl methyl carbonate (53c) 
Following the general procedure, the reaction 1.0 eq. (E)-N-(2-(1-benzyl-2-(3-
hydroxyprop-1-en-1-yl)-5-methoxy-1H-
indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 
51c (0.137 g, 0.317 mmol) gave (E)-3-(1-
benzyl-5-methoxy-3-(2-(2,2,2-
trifluoroacetamido)ethyl)-1H-indol-2-yl)allyl 
methyl carbonate 53c (0.142 g, 0.290 
mmol, 91%) as a yellow foam. 
1
H NMR: 
(201 MHz, CDCl3) δ 7.35 – 7.20 (m, 3H), 
7.11 (d, J = 8.9 Hz, 1H), 7.05 (d, J = 2.3 
Hz, 1H), 7.03 – 6.96 (m, 2H), 6.85 (dd, J = 8.9, 2.4 Hz, 1H), 6.79 – 66.0 (m, 2H), 
6.07 (dt, J = 16.2, 6.1 Hz, 1H), 5.33 (s, 2H), 4.74 (dd, J = 6.1, 1.2 Hz, 2H), 3.85 (s, 
3H), 3.77 (s, 3H), 3.65 (dd, J = 13.2, 6.7 Hz, 2H), 3.14 (t, J = 7.0 Hz, 2H). 
13
C NMR: 
(50 MHz, CDCl3) δ 157.15 (q, J = 37.0 Hz), 155.41, 154.49, 137.48, 133.95, 
132.65, 128.75, 127.82, 127.34, 127.08, 125.79, 122.74, 115.76 (q, J = 287.2 Hz), 
113.38, 110.74, 110.39, 100.00, 68.18, 55.70, 54.78, 47.41, 40.24, 24.14. 
19
F 
NMR: (189 MHz, CDCl3) δ -75.93. HRMS: (ESI
+
, m/z) calculated for 
C25H25F3N2O5Na [M+Na
+




Following the general procedure, (E)-tert-butyl 2-(3-((methoxycarbonyl)oxy)prop-1-
en-1-yl)-3-(2-(2,2,2-trifluoroacetamido)ethyl)-1H-
indole-1-carboxylate 53d (0.108 g, 0.230 mmol, 
76%) were isolated from the reaction of (E)-tert-
butyl 2-(3-hydroxyprop-1-en-1-yl)-3-(2-(2,2,2-
trifluoroacetamido)ethyl)-1H-indole-1-carboxylate 
51d (0.125 g, 0.303 mmol) as a white solid. 
1
H 
NMR (201 MHz, CDCl3) δ 8.12 (d, J = 8.2 Hz, 1H), 
7.67 – 7.49 (m, 1H), 7.42 – 7.18 (m, 2H), 6.92 (d, 
J = 16.1 Hz, 1H), 6.81 (s (br), 1H), 5.98 (dt, J = 
16.1, 6.1 Hz, 1H), 4.84 (d, J = 6.1 Hz, 2H), 3.80 (s, 3H), 3.59 (dd, J = 13.9, 6.9 Hz, 
2H), 3.02 (dd, J = 17.3, 10.3 Hz, 2H), 1.66 (s, 9H). 
13
C NMR (50 MHz, CDCl3) δ 
157.28 (q, J = 36.9 Hz), 155.65, 150.13, 135.63, 133.99, 129.34, 126.46, 125.90, 
125.04, 122.98, 118.53, 116.41, 115.78 (q, J = 288.8 Hz), 115.64, 84.32, 67.92, 
54.83, 40.10, 28.13, 23.98. 
19













N-(2-(1-benzyl-1H-indol-3-yl)ethyl)-2,2,2-trifluoroacetamide 48b (1.0 eq., 1.00 g, 
2.89 mmol) was dissolved in Et2O (Volume: 10 ml) and 
cooled to 0 °C. Then, 2.5 eq. BuLi (3.97 ml, 6.35 mmol) 
were added dropwise and the reaction mixture was 
allowed to warm to room temperature. After 2 hours, the 
reaction mixture was cooled to 0 °C again, and 1.5 eq. 
acrylaldehyde (0.212 ml, 3.18 mmol) were added. After 
warming to room temperature, the reaction was 
quenched by addition of 10ml saturated Na2S2O3 
solution, washed with water (3x 20ml) and extracted 
with Et2O (3x 30 ml). After drying over MgSO4, all 
volatiles were removed under reduced pressure to give the crude product, which 
was purified by column chromatography (Rf = 0.90 in pentane/EtOAc 8:2, SiO2, 
pentane/EtOAc 7:3) to yield N-(2-(1-benzyl-2-(1-hydroxyallyl)-1H-indol-3-yl)ethyl)-
2,2,2-trifluoroacetamide 58 (0.523 g, 1.299 mmol, 45%) as a yellow solid. 
1
H NMR: 
(400 MHz, CDCl3) δ 8.14 (s (br), 1H), 7.62 (d, J = 7.6 Hz, 1H), 7.37 – 7.10 (m, 6H), 
6.97 (d, J = 6.6 Hz, 2H), 6.04 (ddd, J = 17.0, 10.4, 5.0 Hz, 1H), 5.56 (d, J = 5.0 Hz, 
1H), 5.44 (d, J = 4.6 Hz, 2H), 5.33 – 5.11 (m, 2H), 3.64 (dd, J = 11.9, 5.0 Hz, 3H), 
3.37 – 3.08 (m, 2H). 
13
C NMR: (101 MHz, CDCl3) δ 157.52 (q, J = 37.6 Hz), 
137.81, 137.69, 136.81, 135.86, 128.63, 127.27, 127.24, 125.66, 122.47, 119.71, 
118.37, 115.84 (q, J = 288.4 Hz), 115.52, 109.84, 109.69, 67.47, 46.83, 40.60, 
22.47. 
19
F NMR: (376 MHz, CDCl3) δ -75.67. HRMS: (ESI
+
, m/z) calculated for 
C22H21F3N2O2Na [M+Na
+
]: 425.1447, found: 425.1456. 
 
General Procedure for the racemic synthesis of β-carbolines 60 from 
carbonates 53 
1.0 eq. allyl carbonate 53 was dissolved in dioxane (5 ml / 0.1 mmol) and 2.0 eq. 
Cs2CO3 was added. The reaction mixture was allowed to stir for 16 hours at 100 
°C. After cooling, water (5 ml / 0.1 mmol) was added and the mixture was extracted 
with Et2O (2x 10 ml / 0.1 mmol) . After drying over MgSO4 and removal of all 
volatiles under reduced pressure, the crude products were purified by column 




Following the general procedure, the reaction of 1.0 eq. (E)-methyl (3-(1-methyl-3-
(2-(2,2,2-trifluoroacetamido)ethyl)-1H-indol-2-yl)allyl) 
carbonate 53a (0.020 g, 0.052 mmol) gave 2,2,2-
trifluoro-1-(9-methyl-1-vinyl-3,4-dihydro-1H-
pyrido[3,4-b]indol-2(9H)-yl)ethanone 60a (0.013 g, 
0.043 mmol, 82%) as a white solid after purification 
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by column chromatography (Rf = 0.95 in pentane/EtOAc 10:1, SiO2, 
pentane/EtOAc 10:1). The product was isolated as a mixture of two rotamers (ratio 
1:7) 
1
H NMR: Only signals of the major isomer are given. (201 MHz, CDCl3) δ 7.57 
– 7.45 (m, 1H), 7.38 – 7.23 (m, 2H), 7.23 – 7.06 (m, 1H), 6.23 (d (br), J = 5.2 Hz, 
1H), 6.17 – 5.95 (m, 1H), 5.48 (d, J = 10.0 Hz, 1H), 5.09 (d, J = 17.0 Hz, 1H), 4.17 
(d (br), J = 14.1 Hz, 1H), 3.71 – 3.47 (m, 4H), 3.12 – 2.74 (m, 2H). 
13
C NMR: (50 
MHz, CDCl3) δ 133.05, 130.56, 129.98, 125.93, 122.02, 121.22, 119.47, 118.26, 
109.07, 107.83, 51.60, 39.91, 29.86, 22.15. COCF3 peaks not observed. 
19
F NMR: 
(189 MHz, CDCl3) δ -68.55 (minor), -68.99 (major). HRMS: (APCI, m/z) calculated 
for C16H16F3N2O1 [M+H
+




Following the general procedure, the reaction of 1.0 eq. (E)-3-(1-benzyl-3-(2-(2,2,2-
trifluoroacetamido)ethyl)-1H-indol-2-yl)allyl methyl 
carbonate 53b (0.037 g, 0.080 mmol) gave 1-(9-
benzyl-1-vinyl-3,4-dihydro-1H-pyrido[3,4-b]indol-2(9H)-
yl)-2,2,2-trifluoroethanone 60b (0.023 g, 0.061 mmol, 
76%) as a white solid after purification by column 
chromatography (Rf = 0.85 in pentane/EtOAc 10:1, 
SiO2, pentane/EtOAc 10:1). The product was isolated 
as a mixture of four isomers ratio 1.5 : 5 : 1.5 : 1. Only 
signals for the major isomer are given. 
1
H NMR: (201 MHz, CDCl3) δ 7.53 – 7.41 
(m, 1H), 7.31 – 7.00 (m, 7H), 6.95 – 6.83 (m, 1H), 6.10 – 1.03 (m, 1H), 6.01 – 5.81 
(m, 1H), 5.45 – 5.25 (m, 2H), 5.18 (d, J = 10.3 Hz, 1H), 5.13 – 4.87 (m, 1H), 4.20 – 
4.00 (m, 1H), 3.63 – 3.42 (m, 1H), 3.08 – 2.72 (m, 2H). 
13
C NMR: (50 MHz, CDCl3) 
δ 137.19, 136.86, 132.94, 128.99, 128.84, 127.54, 126.08, 125.78, 122.34, 121.24, 
120.29, 119.74, 118.34, 109.96, 47.01, 29.70, 22.18. COCF3 peaks not observed. 
19
F NMR: (189 MHz, CDCl3) δ -68.91 (1.5), -68.97 (5), -69.04 (1.5), -70.17 (1). 
HRMS: (ESI
+
, m/z) calculated for C22H20F3N2O1 [M+H
+





Following the general procedure, the reaction of 1.0 eq. (E)-3-(1-benzyl-5-methoxy-
3-(2-(2,2,2-trifluoroacetamido)ethyl)-1H-indol-2-
yl)allyl methyl carbonate 53c (0.025 g, 0.051 
mmol) gave 1-(9-benzyl-6-methoxy-1-vinyl-3,4-
dihydro-1H-pyrido[3,4-b]indol-2(9H)-yl)-2,2,2-
trifluoroethanone 60c (0.017 g, 0.042 mmol, 
82%) as a white solid after purification by 
column chromatography (Rf = 0.65 in 
pentane/EtOAc 10:1, SiO2, pentane/EtOAc 
10:1). The product was isolated as four isomers (ratio 2:6:2:1). 
1
H NMR: Only 
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major resonances are reported. (400 MHz, CDCl3) δ 7.44 – 6.77 (m, 8H), 6.11 (d, J 
= 5.4 Hz, 1H), 6.07 – 5.93 (m, 1H), 5.50 – 4.98 (m, 4H), 4.25 – 4.12 (m, 1H), 3.85 
(s, 3H), 3.67 – 3.54 (m, 1H), 3.11 – 2.94 (m, 1H), 2.93 – 2.78 (m, 1H). 
13
C NMR: 
(101 MHz, CDCl3) δ 155.97 (q, J = 35.2 Hz), 154.29, 136.96, 132.96, 131.19, 
128.98, 128.83, 127.52, 126.06, 125.95, 121.13, 116.52 (q, J = 287.7 Hz), 112.17, 
110.77, 108.02, 100.46, 55.90, 51.76, 47.14, 39.92, 22.23 
19
F NMR: (376 MHz, 
CDCl3) δ -68.91 (2), -68.96 (6), -69.02 (2), -70.18 (1). HRMS: (ESI
+
, m/z) 
calculated for C23H22F3N2O2 [M+H
+
]: 415.1628, found: 415.1631. 
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Chapter 5  
Asymmetric Allylic Alkylation in 
Combination with Ring-Closing 
Metathesis for the Preparation of 
chiral N-Heterocycles  
Asymmetric copper-catalyzed allylic substitution with methylmagnesium bromide is 
employed in combination with ring-closing olefin metathesis or ene-yne metathesis 
to achieve the synthesis of chiral, unsaturated nitrogen heterocycles. The resulting 
six- to eight-membered chiral heterocycles are accessible in high yields and with 
excellent enantioselectivities. Preliminary studies to extend this concept to the 













Parts of this chapter have been published:  
Teichert, J.F.; Zhang, S.; van Zijl, A.W., Slaa, J.W.; Minnaard, A.J.; Feringa, B.L. 
Org. Lett. 2010, 12, 4658 – 4660. 
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Nitrogen-containing heterocycles are ubiquitous in naturally occurring compounds, 
in particular alkaloids, and they are also key structural features in many biologically 
active products.
1-4
 Among these, nitrogen heterocycles with various ring sizes 
bearing stereogenic centers are frequently observed.
5-10
 For example, poison dart 
frogs (Dendrobatidae) produce a wide variety of biologically active alkaloids in their 
secretions and thus on their skin. Many of these compounds are poisonous and 
are part of the frog’s defense mechanism. Among these alkaloids, chiral piperidines 
featuring methyl substituents at the stereogenic centers are often found.
11,12
 As 
examples for this class of structures, bicyclic deoxypumiliotoxin 251H (1)
13
 and 
tricyclic indolizidine 251F (2)
14
 are shown in Figure 1. 
 
Figure 1 Alkaloids from poison dart frogs 
Chiral nitrogen-containing heterocycles represent interesting targets for 
synthesis,
15-18
 imposing particular challenges with regard to the construction of the 
stereogenic centers with high selectivity. One approach that has been frequently 




In the synthesis of marine alkaloid manzamine A (7), which shows some antitumor 
activity,
23
 two ring-closing metathesis reactions with Ru-based catalysts
24
 have 
been used to construct the two large nitrogen-containing heterocycles,
25
 
showcasing the potential of this transformation (Scheme 1).  Starting with 
tetracyclic precursor 3 the 13-membered heterocycle was constructed with catalytic 
amounts of Grubbs 1
st
 generation catalyst to give 4 in 67% yield. At a later stage of 
the synthesis, the eight-membered heterocycle was constructed from 5 using the 
same catalyst. However, in the latter case, very low conversion to the desired 
product 6, which contained the pentacyclic core of manzamine A, was observed 
even with equimolar amounts of the ruthenium catalyst.  
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Scheme 1 Ring-closing metathesis in the synthesis of manzamine A 
The combination of asymmetric allylic substitution reactions with ring-closing 
metathesis is a powerful synthetic pathway to chiral hetero- or carbocycles 
(Scheme 2). The allylic substitution furnishes a chiral compound with a terminal 
double bond 9. Compound 9 is an ideal starting point for further functionalization by 
metathesis. If either the backbone R of allylic compound 8 or the backbone of the 
nucleophile carries an olefin (or an alkyne), then different ring structures 10 or 11 
are available by ring-closing metathesis (or ene-yne metathesis, respectively). This 
approach has been applied in a variety of cases (see also Chapter 2), some of 
which are presented in the following. 
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Scheme 2 Combination of asymmetric allylic substitution and ring-closing metathesis 
The combination of Ir-catalyzed allylic amination and ring-closing metathesis for the 
synthesis of chiral pyrrolines 15 was reported.
26
 When chiral primary allylic amine 
12 (also a product of an Ir-catalyzed allylic amination) was reacted with allylic 
carbonate 13 in the presence of catalytic amounts of an Ir/L1 complex, the 
corresponding diallylamine 14 was obtained in good yields and excellent 
diastereoselectivity (Scheme 3). This compound could, after protection as the HBr 
salt, be transformed to chiral pyrroline 15 with catalytic amounts of Grubbs 2
nd
 
generation catalyst. The choice of salt proved to be crucial for the latter 
transformation, as the corresponding HCl salt of 14 led to partial decomposition of 
14. It is important to note that the other diastereomer of 14 (and hence also of 15) 
is available in high stereoselectivity via this synthetic route as well, simply by 
employing the opposite enantiomer of phosphoramidite ligand L1. 
 
Scheme 3 Ir-catalyzed allylic amination in combination with ring-closing metathesis 
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An example of an asymmetric allylic substitution in combination with ring-closing 
metathesis was developed in our laboratories.
27
 When -unsaturated ester 16 
posessing an allylic bromide moiety was subjected to Cu-catalyzed allylic alkylation 
conditions with ethylmagnesium bromide, the corresponding chiral ester 17 was 
obtained in good yield and excellent enantioselectivity (Scheme 4). Compound 17 
could subsequently be transformed to chiral lactone 18 without loss of ee and in 
good yields employing Hoveyda-Grubbs 2
nd
 generation catalyst. In this case, 
styrene is produced as a by-product. 
 
Scheme 4 Cu-catalyzed allylic alkylation in combination with ring-closing metathesis 
A final example of the abovementioned strategy to synthesise chiral cyclic 
structures is a combination of Cu-catalyzed allylic alkylation with Grignard reagents 
to furnish chiral carbocycles (Scheme 5).
28
 Allylic chlorides (19) bearing terminal 
olefins (19) were transformed to the corresponding chiral compounds 20 with a Cu-
phosphoramidite complex as catalyst. It was shown that these intermediates 20 
could be transformed to chiral carbocycles 21 in a one-pot protocol employing 
catalytic amounts of Grubbs 1
st
 generation catalyst. The products 21 are available 
in very good enantioselectivities. 
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Scheme 5 Cu-catalyzed allylic alkylation in combination with ring-closing metathesis 
 
2. Goal 
The aim of this research was to develop a synthetic route to chiral nitrogen-
containing heterocycles with various ring sizes. The proposed approach is to 
comprise two transition metal-based catalytic transformations: First, the Cu-
catalyzed allylic alkylation with Grignard reagents, and second, a ring-closing 
metathesis employing Ru-based catalysts (Scheme 6).  
Allylic bromides with terminal alkenes or alkynes 22 and 25 at the protected 
nitrogen (PG = protecting group) should undergo transformation to chiral amines 
23 and 26 in a straightforward manner. These chiral building blocks bear two 
terminal olefins (23) or an olefin/alkyne substitution (26) that are suitable for a 
subsequent ring-closing or ene-yne metathesis, respectively. This should give rise 
to the chiral N-heterocycles 24 and 27 with various ring sizes. Furthermore, a 
similar approach can be taken to synthesize chiral lactams 30, when starting off 
from the corresponding ,-unsaturated amides 28.  
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Scheme 6 Envisaged synthetic approaches to chiral N-heterocycles 
The envisaged approach has several advantages; it is short and the substituents 
on the stereogenic center stem from the Grignard reagents, which allow for easy 
variation at this position. Furthermore, different ring sizes should be accessible with 
the same approach, making this synthetic route very versatile. 
 
3. Results and Discussion 
3.1 Synthesis of starting materials 
The tosyl-protected allylic bromides 36 bearing olefin substituents with different 
chain lengths for the allylic alkylation were synthesized as depicted in Scheme 7. 
Tosyl-allylamine 32a (n = 1) was prepared from allylamine 31 directly, whereas the 
longer chains (32b and c, n = 2,3) were introduced via a Mitsunobu reaction
29
 from 
the corresponding commercially available alcohols and N-Boc-tosylamine (34) to 
give double protected amines 35b,c in good yields. The Boc group was 
subsequently removed to give tosylamides 32b and 32c, which were transformed 
to the allyl bromides 36 with dibromobutene in good yields. The double protection 
route to amines 32 (via 35) was chosen because of the higher yields of the 
Mitsunobu reaction, even though two extra synthetic steps (protection of 33 with a 
Boc group, deprotection of the Boc group to give 32) are necessary. These 
transformations, however, run smoothly with high yields. 
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Scheme 7 Synthesis of starting materials for allylic alkylation 
For the preparation of allyl bromides 41 posessing a terminal alkyne substituent a 
similar approach was taken (Scheme 8). The amine (38a) with the shortest chain 
length  could be prepared directly from commercially available propargyl bromide 
37 with tosylamide to give 38a, albeit in low yields due to the formation of the 
double substituted tosylamide 39. For substrates bearing longer chains, the 
Mitsunobu approach from the corresponding alcohols with Tosyl-Boc-amine 34 
(see Scheme 7) was followed. The Mitsunobu reaction to give 40b,c followed by 
subsequent deprotection of the Boc group gave the desired products 38b and 38c 
in good yields. Subsequent substitution with dibromobutene gave the allylic 
bromides with alkyne substituents 41 in good yields. 
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Scheme 8 Synthesis of starting materials for allylic alkylation II 
The synthesis of allyl bromide 44 with an -unsaturated amide substituent was 
carried out in a straightforward manner based on a decarboxylative amidation 
protocol developed in our group (Scheme 9).
30
 Cinnamic acid 42 was reacted with 
tosylisocyanate to give tosylamide 43. Compound 43 was then transformed to the 
corresponding allyl bromide 44 by substitution with dibromobutene in moderate 
yield.  
 
Scheme 9 Synthesis of starting material for allylic alkylation III 
 
3.2 Cu-catalyzed allylic alkylation of allyl bromides bearing terminal olefins 
substituents 
The conditions for the allylic alkylation of allyl bromide 36a had been described in 
earlier studies,
31
 and were similar to those reported earlier.
32-34
 During further 
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were necessary to ensure full regioselectivity. When allyl bromides 36 with terminal 
olefin substituents were subjected to allylic alkylation conditions (3.0 mol% CuBr • 
SMe2, 4.0 mol% L2 (Taniaphos
35-37
), 1.2 eq. MeMgBr in CH2Cl2 at -80 °C), the 
desired chiral products 45 were obtained in good yields and up to excellent 
enantioselectivities (reaching 99% ee, Table 1, entry 1). Furthermore, at this 
temperature, the product distribution of branched (45) to linear (46) was very good, 
exceeding 92:8 favoring the branched products 45. To reach full conversion of 36c 
(n = 3) (Table 1, entry 3), a higher catalyst loading of 6.0 mol% CuBr • SMe2 and 
8.0 mol% L2 was required. One could speculate that with this particular chain 
length the coordination of the substrate or the corresponding product to the catalyst 
is much stronger, due to the possible coordination of 36c or 45c to the Cu catalyst 
through the terminal olefin moiety. Therefore, a higher catalyst loading was 
necessary to overcome catalyst deactivation. It is remarkable that 45a and 45c are 
formed with excellent enantioselectivity, whereas 45b with an intermediate chain 
length is formed with significantly lower ee. This, hints towards a secondary 
coordination or steric effect of 36b to the catalyst, which interferes with the 
stereodiscriminating step of the transformation. 
Table 1 Asymmetric allylic alkylation of allylic bromides 36 
 
Entry  n Branched (45)/linear (46) Isolated yield (for 45) ee 
1 1 (36a) 95:5 62% (45a) 99% 
2 2 (36b) 98:2 84% (45b) 90% 
3 3
a 
(36c) 92:8 72% (45c) 98% 
a
6.0 mol% CuBr • SMe2 and 8.0 mol% L2 were used. 
 
3.3 Cu-catalyzed allylic alkylation of allyl bromides bearing terminal alkyne 
substituents 
For the synthesis of chiral N-heterocycles carrying a diene motif (27), the synthesis 
started from allylic bromides 41 bearing terminal alkyne substituents of various 
chain lengths. Under standard allylic substitution conditions, the desired chiral 
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products 47 were isolated in good yields (Table 2). In all cases, excellent regio- 
and enantioselectivities were achieved (47/48 >95:5, 99% ee). Since the terminal 
alkyne protons of 41 are acidic and have to be deprotonated first, 2.2 equivalents 
of methylmagnesium bromide were necessary for this transformation to achieve full 
conversion of bromides 41. One exception in this particular series of 
transformations is the reaction of the alkyne 41b, which only went to 75% 
conversion. Remarkably, the reaction to the desired chiral homoallylic tosylamides 
47 still proceeds in the presence of the Mg-acetylidene moiety, in spite of the fact 
that Cu-acetylide complexes are known to be very stable.
38,39
 In this case, the 
stability of the Cu-bisphosphine complex seems to be high enough for the reaction 
to proceed with acceptable yields providing excellent enantioselectivities. As in the 
case of the olefinic substrates 36 (Table 1), the longest spacer length (41c, n = 3) 
required a slightly higher catalyst loading to achieve full conversion to 47c (Table 2, 
entry 3). 
Table 2 Asymmetric allylic alkylation of allylic bromides 41 
 
Entry  n Branched (47)/linear (48) Isolated yield for 47  ee 
1 1 (41a) 95:5 77% (47a) 99% 





(41c) 95:5 82% (47c) 99% 
a
Reaction reaches 75% conversion of 41b, no side products were observed.
 b
6.0 mol% CuBr • SMe2 and 
8.0 mol% L2 were used. 
 
3.4 Cu-catalyzed allylic alkylation of cinnamide 44 
The allylic alkylation of cinnamide 44 was investigated next, which required a more 
thorough optimization of the reaction conditions. At first, the transformation of 44 to 
the corresponding addition products 49 and 50 with a catalyst comprising 6.0 mol% 
CuBr • SMe2 and 8.0 mol% bisphosphine ligand at -80 °C was investigated (Table 
3). From earlier studies, it was known that ferrocenyl-based ligands L2 and L4 are 
generally the best-performing in terms of enantioselectivities and yields for allylic 
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 and thus they were tested in a variety of solvents (Table 3). 
Dichloromethane outperforms MTBE and Et2O in terms of regio- and 
enantioselectivities (Table 3, entries 1,4; regioselectivity 49/50: >95:5). The low 
conversion in Et2O could be explained by the fact that cinnamide 44 does not fully 
dissolve in this solvent under the reaction conditions. It is also apparent that the 
Taniaphos ligand L2 outperforms Josiphos L4 with regard to enantioselectivity 
(97% (L2) vs. 67% ee (L4)), however, at the expense of conversion (27% (L2) vs. 
full conversion (L4)). It is important to note that this reaction, just as in the case of 
the conjugate addition to coumarins (see Chapter 6), had to be quenched with a 
HCl solution in Et2O. This was necessary to prevent the desired product 49 from 
decomposing during workup. When the reaction was quenched with MeOH, quick 
and complete esterification to methyl cinnamate was observed. 











1 L2 CH2Cl2 27% >95:5 97% 
2 L2 MTBE 16% 83:17 56% 
3 L2 Et2O 7% 57:43 87% 
4 L4 CH2Cl2 full >95:5 67% 
5 L4 MTBE 85% 71:29 11% 
6 L4 Et2O 80% 76:24 5% 
a
Reaction conditions: MeMgBr (1.5 eq.), 44 (1.0 eq., added slowly (~1h) after all the other reagents), 






Determined by chiral HPLC. 
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To further improve the allylic alkylation of 44 in terms of enantioselectivity and 
conversion, some structurally related ferrocenyl-based ligands were tested under 
the optimized reaction conditions (compare Table 3). As can be seen from Table 4, 
none of the ligands could outperform the two orginally tested ones Taniaphos L2 
and Josiphos L4 in terms of enantioselectivity and conversion (Table 4, entries 
1,3). The structurally related ligands L5 – L7 (Table 4, entries 2,4,5) gave much 
lower conversion, and, with the exception of L6, lower enantioselectivity as well. 
This shows that even small structural and/or electronic changes of the ligands, 
especially of the aryl-substituents on the phosphorus atoms, have a large impact 
on the outcome of the reaction. Other ligand classes, like the Mandyphos (L8) and 
the Walphos (L9) class as well as the CuI/tolBINAP (L10) catalyst
40
 (Table 4, 
entries 6-8) could not compete with the previous chiral ligands, again emphasizing 
the special spatial requirements of the allylic alkylation catalyst for this particular 
transformation. 











1 L2 27% >95:5 95% 
2 L5 52% 34:66 7% 
3 L4 full >95:5 67% 
4 L6 full >95:5 64% 
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5 L7 66% 69:31 30% 
6 L8 30% 70:30 0% 
7 L9 15% 47:53 23% 
8
d
 L10 95% 70:30 21% 
a
Reaction conditions: MeMgBr (1.5 eq.), 44 (1.0 eq., added slowly (~2h) after all the other reagents), 






Determined by chiral HPLC. 
d
 6.0 mol% of CuI was used. 
Summarizing the attempts to develop an efficient allylic alkylation of cinnamide 44, 
it can be said that the results display a dilemma: The desired product 49 is either 
available in very good enantioselectivity, but with low yield, employing L2, or with 
moderate enantioselectivity and high yields, using L4. The regioselectivity in both 
cases is very good, favouring the branched product. Attempts to improve the 
conversion with L2 by employing higher amounts of Grignard reagent or by 
changing the order of addition of substrates and Grignard reagent did not lead to 
better results. Furthermore, it was established that chiral amide 49 is stable under 
the reaction conditions, so that in situ deterioration of the desired product can be 
excluded.  
 
3.5 Ring-closing metathesis of chiral diolefins 
Chiral diolefins 45 could subsequently be transformed to the corresponding N-





 the six- to eight-membered rings were obtained in 
moderate to good yields. The best result was found for the eight-membered 
unsaturated azocane 51c (77%, Table 5, entry 3). It is important to note that the ee 
of the desired products 51 was not compromized during the reaction.  
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Table 5 Ring-closing metathesis of chiral diolefins 
 
Entry n Yield ee 
1 1 (45a) 54% (51a) 99% 
2 2 (45b) 46% (51b) 90% 
3 3 (45c) 77% (51c) 98% 
 
The yield of chiral piperidine 51a (Table 5, entry 1) is comparatively low, even 
though the reaction reaches full conversion. In the crude reaction mixture, one 
unidentified side product is present. It is known from studies of ring-closing 
metathesis of related lactams
41
 that the concentration of the starting materials has 
an influence on the reaction since theoretically, also the homodimer of 45a could 
be obtained. In general, higher concentrations (40 mM) of the starting materials 
yield homodimers, whereas lower concentrations (1 mM) of the starting materials in 
the reaction mixture afford the desired ring-closed products. The ring-closing 
metathesis reactions in Table 5 were run at a concentration of 5 mM and therefore 
the formation of homodimers (and polymers) of 45a could not be excluded, but it 
was unlikely. From the crude 
1
H NMR, no such products were observed, an thus 
the side-products observed must arise from another reaction pathway. 
 
3.6 Ring-closing ene-yne metathesis of chiral terminal alkynes 
For the ene-yne metathesis of compounds 47 to reach full conversion, 5.0 mol% 
Grubbs 1
st
 generation catalyst under an ethene atmosphere was employed.
31
 The 
addition of ethene was found to be essential for the reaction to proceed to 52, as in 
its absence, no conversion was observed (see section 3.7).
42
 The resulting six- and 
seven-membered nitrogen-containing rings with diene motifs 52a,b were isolated in 
good yields (Table 6). Again, no loss of ee was observed in this transformation, 
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making this a viable pathway for the construction of chiral nitrogen-containing 
heterocycles with various ring sizes. 
Table 6 Ene-yne metathesis of chiral terminal alkynes 
 
Entry n Yield ee 
1 1 (47a) 77% (52a) 99% 
2 2 (47b) 65% (52b) 99% 
3 3 (47c) N/A N/A 
 
The reaction of 47c under the given conditions did not produce the desired eight-
membered ring 52c. The ene-yne metathesis proceeded to the linear product 53 in 
moderate yields (Table 7, entries 1,2), where the alkyne moiety of 52c reacted in 
an intermolecular fashion with ethene instead of intramolecularly with the terminal 
olefin. Product 53 did not react any further to the desired ring system under the 
reaction conditions. Furthermore, this reaction could not be improved in terms of 
conversion to 53, as other Ru-based metathesis catalysts under a variety of 
conditions
43
 did not give any conversion to neither 52c nor 53 (Table 7). It is known 
in literature that the synthesis of eight-membered rings via cross-metathesis is 
difficult, due to steric restraints of the products as well as the kinetics of the ring-
closing reactions.
44
 This can lead to unwanted side-reactions such as 






  153 
Chiral N-Heterocycles 
Table 7 Ene-yne metathesis of 47c 
 
Entry Catalyst (mol%) Solvent Atm. Temp. Yield (53) 
1 Grubbs 1
st









































Complex mixture of products. 
 
3.7 Role of the ethene atmosphere for the ene-yne metathesis 
It was found that an ethene atmosphere was crucial for the ene-yne metathesis of 
terminal alkynes 47 to cyclic dienes 52, an observation that had been made in 
earlier studies of ene-yne metathesis reactions.
42
 The necessity for the ethene 
atmosphere can be explained with the various equilibria present in an ene-yne 
metathesis reaction (Scheme 10). The Ru-alkylidene catalyst A reacts, due to the 
higher electron density, first with the terminal alkyne of 47a to yield a 
ruthenacyclobutene 54. This undergoes cycloreversion to yield Ru-alkylidene 55. 
The intramolecular olefin metathesis leads to diene 52a via ruthenacyclobutane 56. 
The driving force of this reaction pathway is the thermodynamic stability of the 
diene 52a. However, the Ru-catalyst A can enter a non-productive olefin cross 
metathesis with the terminal diene of 52a leading to ruthenacycle 57, and finally to 
Ru-alkylidene 58 and ethene. This last equilibrium is affected by an ethene 
atmosphere, as it should lie on the side of 57, and therefore also further on the side 
of the desired product, and free alkylidene A. Through the unproductive pathway, 
the effective amount of active catalyst in the reaction mixture is lowered. If an 
ethene atmosphere is present, any ruthenacycle 57 formed is quickly reacted back 
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to the free Ru-alkylidene catalyst A (and possibly onward to ruthenacycle B) and 
the desired product 52a, and thus removed from the unproductive pathway.  
 
Scheme 10 Ene-yne metathesis in the presence of ethene atmosphere 
 
3.8 Ring-closing metathesis for the synthesis of a chiral lactam 
Enantioenriched amide 49, from the reaction with ligand L4 (vide supra), was 
subjected to ring-closing metathesis conditions to probe whether the anticipated 
pathway to synthesize chiral lactams was viable. When 49 was reacted in the 
presence of catalytic amounts of Hoveyda-Grubbs 2
nd
 generation catalyst, the 
corresponding chiral lactam 59 was isolated in good yields without compromizing 
the ee (Scheme 11). This shows that the general approach to chiral lactams is 
indeed feasible as anticipated. 
 
Scheme 11 Ring-closing metathesis for the synthesis of chiral lactam 
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4. Conclusions and future prospects 
In summary, we have demonstrated that chiral unsaturated heterocycles are 
available in excellent enantiomeric excess and good yields via a combination of 
Cu-catalyzed allylic substitution and Ru-catalyzed ring-closing metathesis. Six- to 
eight-membered chiral nitrogen-containing rings are easily available through this 
short synthetic pathway in high enantioselectivity. By employing terminal olefins, 
singly unsaturated rings are accessible, while terminal alkynes were transformed to 
the corresponding dienes in good yields and 99% ee. The obtained compounds are 
ideal chiral building blocks for further functionalization through the olefinic bonds. It 
should be noted that the synthesis of an eight-membered diene was not achieved 
via this synthetic route, since a side reaction to a linear diene moiety was found. 
It has been demonstrated that the same pathway can be employed for the 
synthesis of chiral lactams, when allylic bromides with amide substituents are used. 
The allylic substitution has yet to be optimized, since either high enantioselectivity 
accompanied by low yields, or high yields accompanied with moderate 
enantioselectivities are obtained with the tested catalysts. However, it has been 
shown that the subsequent ring-closing metathesis proceeds without endangering 
the chiral information. 
 
For further extension of this project, some follow-up studies could be envisaged. To 
improve the results of the allylic alkylation of amides different N-protecting groups 
(like Boc) or no N-protecting group of 60 could be tested in the enantioselective 
reaction to give 61. It is possible that the tosyl group used in this study is interfering 
with the catalyst and therefore reducing the catalytic activity. Further transformation 
to chiral lactam 62 (Scheme 12) has been shown to work well and it is not 
expected to encounter problems with different N-protecting groups. 
 
Scheme 12 Change of protecting group for the synthesis of chiral lactams 
Secondly, the newly developed allylic alkylation-ring-closing metathesis protocol 
could be extended to the use of functionalized Grignard reagents, ideally ones 
bearing terminal olefins (Scheme 13). Through this approach, a multifunctional 
chiral building block 64 would be accessible. Posessing three terminal double 
bonds, a variety of chiral carbo- or heterocycles 65 and 66 would be accessible, 
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and it would be interesting to probe whether the ring-closing metathesis step could 
be rendered selective towards one of the products. 
 
Scheme 13 Allylic alkylation with functionalized Grignard reagents 
One of the most interesting future prospects of this work would be to examine the 
asymmetric alkylation to enamides 68 (Scheme 14). The trifluoroacetamide 67 is 
accessible,
45
 and conversion to the corresponding allyl bromide 68 could be 
envisaged. If the asymmetric allylic alkylation of enamides could be accomplished, 
it would not only be the aza-version of the already reported work with esters,
27
 but 
69 itself is an important multifunctional building block. By deprotection of the 
trifluoroacetamide,
46
 chiral primary allylic amines 70 would be accessible. 
Secondly, 69 could be used to prepare chiral aminoacids 71 and 72 by oxidation of 
the double bond either by a hydroboration-oxidation sequence or by ozonolysis 
with oxidative workup. 
 
Scheme 14 Synthesis of chiral nitrogen-containing building blocks 
As a last possible extension of this project, one could envisage the use of the chiral 
building blocks 73, products of the asymmetric allylic alkylation to substrates 
bearing terminal alkynes, in new transformations such as for example the Pauson-
Khand reaction,
47
 which would furnish chiral bicyclic systems 74 (Scheme 15). 
Reduction of the ,-unsaturated ketone
48
 would furnish bicyclic compound 75 
with three stereocenters. 
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Scheme 15 Possible further reactions of 73 
 
5. Experimental Section 
General remarks: 
1
H NMR and 
13
C NMR spectra were recorded on a Varian AMX400 (400 and 100 
MHz, respectively), a Varian VXR300 (300 and 75 MHz, respectively), or a Varian 
VXR200 NMR spectrometer (200 MHz and 75 MHz, respectively) with CDCl3 as 
solvent. Chemical shifts were determined relative to the residual solvent peaks 
(CHCl3, δ = 7.26 ppm for 
1
H NMR, δ = 77.0 ppm for 
13
C NMR). The following 
abbreviations are used to indicate signal multiplicity: s, singlet; d, doublet; t, triplet; 
q, quartet; qi, quintet; m, multiplet; br, broad, app, apparent. Enantiomeric 
excesses were determined by chiral HPLC using a Shimadzu LC-10ADVP HPLC 
equipped with a Shimadzu SPD-M10AVP diode array detector, in comparison with 
racemic products or, in some cases, mixtures of both enantiomers. Racemic 
products were obtained by the same procedure as the enantioselective allylic 
alkylation only using CuBr·SMe2 (10 mol%), PPh3 (20 mol%) and MeMgBr (1.15 
eq.) at -40 °C in CH2Cl2. The opposite enantiomer of a product is obtained by using 
the enantiomer of L2, following the general procedure D. Regioselectivities were 
determined by 
1
H NMR. Optical rotations were measured on a Schmidt + Haensch 
polarimeter (Polartronic MH8) with a 10 cm cell (c given in g/100 mL) at 20 °C. 
Thin-layer chromatography (TLC) was performed on Merck TLC Silica gel 60 
Kieselguhr F254. Flash chromatography was performed on silica gel Merck Type 
9385 230-400 mesh. Mass spectra were recorded on a AEI-MS-902 mass 
spectrometer (EI
+







p-Toluenesulfonyl chloride (37.9 mmol, 7.23 g, 0.95 eq.) and pyridine (44 mmol, 
3.5 g, 1.1 eq.) were added to a solution of allylamine (40 mmol, 
2.28 g, 1.0 eq.) in dry CH2Cl2 (25 mL). The mixture was stirred at 
room temperature for 16 h and washed with aqueous 0.5 M HCl 
(3 x 5 mL). The combined aqueous phases were extracted with 
CH2Cl2 (10 mL) and the organic layer was dried and concentrated 
under reduced pressure to afford product 32a (75% yield, 6.3 g, Rf (1:5 
EtOAc/heptane) = 0.51) as a white solid. 
1
H NMR (300 MHz, CDCl3) δ 7.75 (d, J = 
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8.1 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 5.76-5.63 (m, 1H), 5.10 (dd, J = 24.9 Hz, 13.7 
Hz, 2H), 4.92 (br, 1H), 3.55 (t, J = 5.9 Hz, 2H), 2.41 (s, 3H). 
13
C NMR (75 MHz, 
CDCl3) δ 145.81, 143.51, 128.66, 127.49, 126.37, 113.35, 43.44, 21.00. HRMS 
calcd. for C10H14NO2S [M+H
+





A mixture of p-toluenesulfonamide (22 mmol, 3.77 g, 1.1 eq.) and K2CO3 (50 mmol, 
6.9 g, 2.5 eq.) in MeCN (500 mL) was stirred at room temperature. 
To this mixture a solution of propargyl bromide (20 mmol, 2.38 g, 
1.0 eq.) in MeCN (20 mL) was added dropwise. The mixture was 
heated to reflux for 16 h, cooled to room temperature and filtered. 
The filtrate was concentrated under reduced pressure and purified 
by flash chromatography (SiO2, 1:7 EtOAc/heptane, Rf (1:5 EtOAc/heptane) = 
0.37) to yield the product (39% yield, 1.64 g) as a colorless oil. The disubstituted 
side product 38a (38%, 1.63 g, Rf (1:5 EtOAc/heptane) = 0.45) was obtained as a 
pale yellow solid. 
1
H NMR (300 MHz, CDCl3) δ 7.77 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 
8.0 Hz, 2H), 4.53 (br, 1H), 3.83 (dd, J = 6.1 Hz, 2.5 Hz, 2H), 2.44 (s, 3H), 2.11 (t, J 
= 2.5 Hz, 1H). 
13
C NMR (75 MHz, CDCl3) δ 143.83, 139.31, 129.93, 126.68, 98.20, 
74.22, 36.39, 21.73. HRMS calcd. for C10H12NO2S [M+H
+






p-Toluenesulfonamide (30 mmol, 5.14 g, 1.0 eq.) was suspended in CH2Cl2 (25 
mL) containing Et3N (33 mmol, 3.34 g, 1.1 eq.) and DMAP (3 mmol, 
0.37 g, 0.1 eq.). A solution of di-(t-butyl) dicarbonate (36 mmol, 7.86 
g, 1.2 eq.) in CH2Cl2 (40 mL) was added dropwise with stirring over 
8 min. After 2 h, the solution was concentrated under reduced 
pressure and the residue treated with EtOAc (100 mL) and 2 M aq. 
HCl (60 mL). The organic phase was washed successively with water and brine, 
dried and concentrated under reduced pressure to afford a solid. Heating in 
pentane (30 mL), cooling to room temperature and filtration provided the product as 
a white solid (87% yield, 7.06 g, Rf (1:5 EtOAc/heptane) = 0.57). 
1
H NMR (400 
MHz, CDCl3) δ 7.90 (d, J = 7.5 Hz, 2H), 7.34 (d, J = 7.6 Hz, 2H), 2.45 (s, 3H), 1.38 
(s, 9H). 
13
C NMR (75 MHz, CDCl3) δ 149.19, 144.97, 136.15, 129.71, 128.46, 
84.28, 28.09, 21.88. HRMS calcd. For C12H18NO4S [M+H
+













E-Cinnamic acid (6.8 mmol, 1.0 g, 1.0 eq.) was dissolved in dry THF (20 mL) under 
nitrogen and tosyl isocyanate (7.4 mmol, 1.46 g, 1.1 eq.) was 
added to the solution. After stirring at room temperature for 
10 min the inert atmosphere was disconnected and 
triethylamine (7.4 mmol, 0.75 g, 1.1 eq.) was added drop-
wise to the open flask, allowing the release of the formed 
CO2. After stirring for 1h at room temperature the solution 
was diluted with 20 mL of EtOAc and washed with 2M aq. HCl and brine. After 
drying and filtration the organic phase was concentrated in vacuo and the product 
was precipitated by addition of pentane to a saturated ether solution followed by 
decantation and washing with pentane. Compound 43 was obtained as a pale 
yellow solid (71% yield, 1.4 g). 
1
H NMR (200 MHz, CDCl3) δ 8.01 (d, J = 8.4 Hz, 
2H), 7.69 (d, J = 15.7 Hz, 2H), 7.49 – 7.32 (m, 7H), 6.44 (d, J = 15.7 Hz, 2H), 2.42 
(d, J = 4.5 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 163.65, 145.94, 145.10, 135.64, 
133.69, 130.82, 129.62, 128.88, 128.40, 128.36, 117.51, 21.61. HRMS calcd. for 
C16H15NO3SNa [M+Na
+
]: 324.0665, found 324.0659. 
 
General procedure A: Preparation of olefinic and propargylic N-Boc 
protected sulfonamides
5
 (35b,c and 40b,c) 
N-Boc p-toluenesulfonamide 34 (7.37 mmol, 2.0 g, 1.5 eq.) was dissolved in dry 
THF (3 mL) and triphenylphosphine (14.7 mmol, 3.87 g, 3.0 eq.) was added. The 
solution was stirred under nitrogen atmosphere and the olefinic or propargylic 
alcohol (4.9 mmol, 1.0 eq.) was added followed by diethyl azodicarboxylate (12.2 
mmol, 2.12 g, 2.5 eq.). The mixture was stirred at room temperature for 3h, 






The title compound was prepared from 3-buten-1-ol (5.5 mmol, 0.40 g) following 
general procedure A. Purification by column chromatography 
(SiO2, 1:8 EtOAc/heptane, Rf (1:5 EtOAc/heptane) = 0.54) 
afforded product 35b as a yellow oil (86% yield, 1.54 g). 
1
H 
NMR (200 MHz, CDCl3) δ 7.79 (d, J = 8.4 Hz, 2H), 7.30 (d, J 
= 8.1 Hz, 2H), 5.91 – 5.71 (m, 1H), 5.20 – 5.02 (m, 2H), 3.92 
– 3.85 (m, 2H), 2.58 – 2.46 (m, 2H), 2.44 (s, 3H), 1.34 (s, 9H). 
13
C NMR (75 MHz, 
CDCl3) δ 151.14, 144.26, 137.74, 134.62, 129.42, 128.08, 117.64, 84.34, 46.60, 
34.80, 28.09, 21.81. HRMS calcd. for C16H23NO4SNa [M+Na
+
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(N-tert-Butoxycarbonyl)(but-3-ynyl)tosylamide (35c):  
The title compound was prepared from 4-penten-1-ol (0.81 mmol, 70 mg) following 
general procedure A. Purification by column 
chromatography (SiO2, 1:8 EtOAc/pentane, Rf (1:6 
EtOAc/pentane) = 0.44) afforded product 35c as a 
colorless oil (97% yield, 266 mg). 
1
H NMR (200 MHz, 
CDCl3) δ 7.74 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 
5.81 (ddt, J = 16.7 Hz, 10.2 Hz, 6.5 Hz, 1H), 5.11 – 4.91 
(m, 2H), 3.85 – 3.73 (m, 2H), 2.40 (s, 3H), 2.16 – 2.05 (m, 2H), 1.91 – 1.80 (m, 
2H), 1.30 (s, 9H). 
13
C NMR (50 MHz, CDCl3) δ 150.91, 144.02, 137.47, 137.41, 
129.19, 127.72, 115.17, 84.04, 46.71, 30.82, 29.18, 27.83, 21.54. HRMS calcd. for 
C17H26NO4S[M+H
+




   
The title compound was prepared from 3-butyn-1-ol (1.4 mmol, 95 mg) following 
general procedure A. Purification by column chromatography 
(SiO2, 5:1 heptane/EtOAc, Rf = 0.24) afforded product 40b as 
an opaque oil (89% yield, 391 mg). 
1
H NMR (300 MHz, 
CDCl3) δ 7.80 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 
4.03 – 3.98 (m, 2H), 2.69 – 2.63 (m, 2H), 2.44 (s, 3H), 2.03 – 
2.01 (m, 1H), 1.35 (s, 9H). 
13
C NMR (75 MHz, CDCl3) δ 150.93, 144.46, 137.45, 
129.47, 128.11, 84.74, 80.65, 70.60, 45.42, 28.06, 21.82, 20.21. HRMS calcd. for 
C16H21NO4SNa [M+Na
+
]: 346.1089, found 346.1084. 
 
(N-tert-Butoxycarbonyl)(pent-4-ynyl)tosylamide (40c) 
The title compound was prepared from 4-pentyn-1-ol (0.64 mmol, 54 mg) following 
general procedure A. Purification by column 
chromatography (SiO2, 5:1 heptane/EtOAc, Rf = 0.27) 
afforded product 40c as an opaque oil (76% yield, 165 mg). 
1
H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.2 Hz, 2H), 7.28 
(d, J = 8.0 Hz, 2H), 3.90 (t, J = 8.0 Hz, 2H), 2.41 (s, 3H), 
2.26 (td, J = 7.1 Hz, 2.4 Hz, 2H), 1.97 (m, 3H), 1.32 (s, 9H). 
13
C NMR (75 MHz, 
CDCl3) δ 151.07, 144.36, 137.53, 129.46, 128.00, 84.42, 83.24, 69.23, 46.48, 









To a solution of the N-Boc olefinic or propargylic tosylamide 35 or 40 (0.62 mmol, 
1.0 eq.) in CH2Cl2 (10 mL) was added trifluoroacetic acid (12.4 mmol, 1.41 g, 20 
eq.) at 0 °C, and the mixture was stirred at rt for 3 h. The mixture was diluted with 
EtOAc, and the organic layer was washed with saturated aq. NaHCO3 solution and 
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The title compound was prepared from 35b (4.74 mmol, 1.54 g) following general 
procedure B (70% yield, 744 mg). 
1
H NMR (300 MHz, CDCl3) δ 
7.74 (d, J = 8.2 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 5.69 – 5.55 
(m, 1H), 5.07 – 4.98 (m, 2H), 4.66 (t, J = 5.7 Hz, 1H), 3.00 (app 
q, J = 6.6 Hz, 2H), 2.42 (s, 3H), 2.19 (app q, J = 6.7 Hz, 2H). 
13
C NMR (75 MHz, CDCl3) δ 143.63, 137.21, 134.39, 129.92, 
127.34, 118.31, 42.31, 33.83, 21.73. HRMS calcd. for C11H16NO2S [M+H
+
]: 





The title compound was prepared from 35c (0.77 mmol, 260 mg) following general 
procedure B (86% yield, 157 mg). 
1
H NMR (400 MHz, CDCl3) δ 7.75 (d, J = 8.3 Hz, 
2H), 7.29 (d, J = 8.1 Hz, 2H), 5.68 (ddt, J = 16.9 Hz, 10.2 
Hz, 6.7 Hz, 1H), 5.01 (t, J = 6.1 Hz, 1H), 4.97 – 4.89 (m, 2H), 
2.91 (dd, J = 13.5 Hz, 6.8 Hz, 2H), 2.41 (s, 3H), 2.02 (app q, 
J = 7.2 Hz, 2H), 1.54 (app qi, J = 7.2 Hz, 2H). 
13
C NMR (100 
MHz, CDCl3) δ 143.29, 137.25, 136.95, 129.66, 127.06, 
115.44, 42.58, 30.60, 28.63, 21.48. HRMS calcd. for C12H17NO2SNa [M+Na
+
]: 





The title compound was prepared from 40b (0.62 mmol, 200 mg) following general 
procedure B (74% yield, 103 mg). 
1
H NMR (300 MHz, CDCl3) δ 
7.75 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 5.13 (t, J = 
6.2 Hz, 1H), 3.08 (app q, J = 6.6 Hz, 2H), 2.41 (s, 3H), 2.32 (td, 
J = 6.7 Hz, 2.6 Hz, 2H), 1.98 (t, J = 2.6 Hz, 1H). 
13
C NMR (75 
MHz, CDCl3) δ 143.81, 137.13, 130.00, 127.29, 80.61, 71.02, 
41.89, 21.74, 20.00. HRMS calcd. for C11H14NO2S[M+H
+






The title compound was prepared from 40c (0.50 mmol, 170 mg) following general 
procedure B (83% yield, 99 mg). 
1
H NMR (300 MHz, CDCl3) 
δ 7.75 (d, J = 8.2 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 4.54 (br, 
1H), 3.08 (app q, J = 6.6 Hz, 2H), 2.43 (s, 3H), 2.22 (td, J = 
6.8 Hz, 2.5 Hz, 2H), 1.95 (s, 1H), 1.69 (qi, J = 6.8 Hz, 2H). 
13
C NMR (100 MHz, CDCl3) δ 143.42, 136.86, 129.71, 
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127.07, 82.89, 69.39, 42.11, 28.12, 21.50, 15.69. HRMS calcd. for C12H16NO2S 
[M+H
+
]: 238.0902, found 238.0896. 
 
General procedure C: Preparation of allylic bromide substrates (36a-c, 41a-c) 
To a suspension of olefinic or propargylic tosylamide 32 or 38 (19.2 mmol, 1.0 eq.) 
and K2CO3 (28.8 mmol, 3.98 g, 1.1 eq.) in 20 mL MeCN was added 1,4-
dibromobut-2-ene (77.0 mmol, 16.5 g, 4.0 eq.) and the mixture was heated to reflux 
for 24 h. The mixture was then concentrated under reduced pressure and water (10 
mL) and Et2O (10 mL) were added. The organic layer was separated and the 
aqueous layer was extracted with Et2O (2 x 5 mL). The combined organic layers 
were dried, filtered and concentrated under reduced pressure. Purification by 






The title compound was prepared from 32a (19.2 mmol, 4.06 g) following general 
procedure C. Purification by column chromatography 
(SiO2, 1:5 EtOAc/Pentane, Rf = 0.38) afforded 36a 
(70% yield, 4.63 g) as an opaque oil. 
1
H NMR (200 
MHz, CDCl 3) δ 7.68 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 
8.0 Hz, 2H), 5.85 – 5.68 (m, 1H), 5.66 – 5.43 (m, 2H), 
5.20 – 5.08 (m, 2H), 3.85 (d, J = 7.3 Hz, 2H), 3.78 (d, J = 6.2 Hz, 4H), 2.41 (s, 3H). 
13
C NMR (75 MHz, CDCl3) δ 143.63, 137.36, 132.73, 130.71, 129.99, 129.84, 
127.38, 119.57, 49.94, 47.94, 31.67, 21.75. HRMS calcd. for C14H19BrNO2S 
[M+H
+




The title compound was prepared from 32b (2.87 mmol, 734 mg) following general 
procedure C. Purification by column chromatography 
(SiO2, 1:5 EtOAc/Pentane, Rf = 0.23) afforded 36b 
(74% yield, 762 mg) as an opaque oil. 
1
H NMR (300 
MHz, CDCl3) δ 7.68 (d, J = 8.2 Hz, 2H), 7.30 (d, J = 
8.1 Hz, 2H), 5.87 – 5.76 (m, 1H), 5.74 – 5.54 (m, 
2H), 5.11 – 4.98 (m, 2H), 3.87 (d, J = 7.4 Hz, 2H), 
3.81 (d, J = 6.3 Hz, 2H), 3.17 (t, J = 6.5 Hz, 2H), 2.42 (s, 3H), 2.27 (app q, J = 6.4 
Hz, 2H). 
13
C NMR (75 MHz, CDCl3) δ 143.56, 137.15, 134.77, 130.42, 130.37, 
129.94, 127.39, 117.41, 49.37, 47.32, 33.22, 31.51, 21.73. HRMS calcd. for 
C15H21BrNO2S [M+H
+









The title compound was prepared from 32c (0.648 mmol, 155 mg) following 
general procedure C. Purification by column 
chromatography (SiO2, 1:7 Et2O/Pentane, Rf (1:6 
Et2O/Pentane) = 0.23) afforded 36c (47% yield, 
116 mg) as an opaque oil. 
1
H NMR (400 MHz, 
CDCl 3) δ 7.67 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 
8.1 Hz, 2H), 5.87 – 5.69 (m, 2H), 5.65 – 5.55 (m, 1H), 5.04 – 4.92 (m, 2H), 3.86 (d, 
J = 7.4 Hz, 2H), 3.78 (d, J = 6.5 Hz, 2H), 3.09 (t, J = 8.0 Hz, 2H), 2.42 (s, 3H), 2.02 
(dd, J = 14.2 Hz, 7.2 Hz, 2H), 1.64 – 1.57 (m, 2H). 
13
C NMR (100 MHz, CDCl3) δ 
143.28, 137.42, 136.83, 130.24, 130.09, 129.70, 127.13, 115.27, 49.10, 47.25, 









The title compound was prepared from 38a (1.20 mmol, 250 mg) following general 
procedure C. Purification by column chromatography 
(SiO2, 1:15 EtOAc/Heptane, Rf (1:9 EtOAc/Heptane) = 
0.25) afforded 41a (73% yield,  299 mg) as a colorless 
oil. 
1
H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 8.3 Hz, 
2H), 7.30 (d, J = 8.4 Hz, 2H), 5.98-5.90 (m, 1H), 5.75 – 
5.64 (m, 1H), 4.09 (d, J = 2.4 Hz, 2H), 3.92 (d, J = 7.5 
Hz, 2H), 3.85 (d, J = 6.5 Hz, 2H), 2.43 (s, 3H), 2.03 (t, J = 2.5 Hz, 1H). 
13
C NMR 
(100 MHz, CDCl3) δ 143.73, 135.75, 131.46, 129.55, 128.71, 127.72, 76.31, 74.01, 







The title compound was prepared from 38b (0.34 mmol, 76 mg) following general 
procedure C. Purification by column chromatography 
(SiO2, 1:7 EtOAc/Heptane, Rf (1:5 EtOAc/Heptane) 
= 0.22) afforded 41b (71% yield, 85 mg) as an 
opaque oil. 
1
H NMR (300 MHz, CDCl3) δ 7.69 (d, J = 
8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 5.84 (dt, J = 
14.8 Hz, 7.4 Hz, 1H), 5.69 – 5.55 (m, 1H), 3.93 – 3.81 (m, 4H), 3.28 (t, J = 7.4 Hz, 
2H), 2.46 (m, 2H), 2.43 (s, 3H), 1.97 (t, J = 2.4 Hz, 1H). 
13
C NMR (75 MHz, CDCl3) 
δ 143.79, 136.93, 130.76, 130.11, 130.03, 127.40, 81.13, 70.51, 49.92, 46.53, 
31.32, 21.74, 19.66. HRMS calcd. for C15H19BrNO2S [M+H
+










The title compound was prepared from 38c (0.12 mmol, 28 mg) following general 
procedure C. Purification by column 
chromatography (SiO2, 1:8 EtOAc/Heptane, Rf 
(1:5 EtOAc/Heptane) = 0.29) afforded 41c (72% 
yield, 78 mg) as an opaque oil. 
1
H NMR (400 
MHz, CDCl 3) δ 7.68 (d, J = 8.3 Hz, 2H), 7.30 (d, 
J = 8.0 Hz, 2H), 5.83 (dt, J = 15.0 Hz, 7.5 Hz, 1H), 5.66 – 5.55 (m, 1H), 3.87 (d, J = 
7.5 Hz, 2H), 3.80 (d, J = 6.5 Hz, 2H), 3.20 (t, J = 7.2 Hz, 2H), 2.42 (s, 3H), 2.20 (dt, 
J = 7.0 Hz, 2.6 Hz, 2H), 1.95 (t, J = 2.6 Hz, 1H), 1.75 (app qi, J = 7.2 Hz, 2H). 
13
C 
NMR (100 MHz, CDCl3) δ 143.41, 136.60, 130.44, 129.96, 129.75, 127.18, 83.13, 
69.11, 49.49, 46.65, 31.25, 27.38, 21.51, 15.73. HRMS calcd. for C16H20BrNO2SNa 
[M+Na
+
]: 392.0296, found 392.0290. 
 
N-((E)-4-Bromobut-2-en-1-yl)-N-tosylcinnamamide (44) 
The title compound was prepared from 43 (6.2 mmol, 1.86 g) following general 
procedure C. Purification by column chromatography 
(SiO2, 1:5 EtOAc/heptane, Rf (1:3 EtOAc/heptane) = 
0.48) afforded 44 (75% yield, 2.02 g) as a pale 
yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 7.82 (d, J = 
8.4 Hz, 2H), 7.66 (d, J = 15.4 Hz, 1H), 7.51 – 7.49 
(m, 2H), 7.43 – 7.37 (m, 3H), 7.34 – 7.28 (m, 3H), 6.05 – 5.96 (m, 1H), 5.93 – 5.84 
(m, 1H), 4.56 (d, J = 5.5 Hz, 2H), 3.95 (d, J = 8.0 Hz, 2H), 2.42 (d, J = 7.8 Hz, 
3H).
13
C NMR (75 MHz, CDCl3) δ 165.62, 146.11, 144.90, 136.70, 134.30, 130.59, 
130.27, 129.78, 128.87, 128.26, 127.65, 126.59, 117.83, 46.94, 31.38, 21.53. 
HRMS calcd. for C20H21BrNO3S [M+H
+
]: 434.0426, found 434.0420. 
 
General procedure D: Enantioselective Cu-catalyzed allylic alkylation with 
methylmagnesium bromide (45a-c, 47a-c) 
In a dry Schlenk tube equipped with septum and stirring bar, CuBr·SMe2 (15 μmol, 
3.1 mg, 1.0 mol%) and L2 (18 μmol, 12.4 mg, 1.2 mol%) were dissolved in CH2Cl2 
(2.0 mL) and stirred under nitrogen atmosphere at room temperature for 10 min. 
The mixture was cooled to -80 °C and a solution of methylmagnesium bromide 
(1.73 mmol, 3M solution in Et2O, 1.15 eq.) in 1.0 mL CH2Cl2 was added dropwise 
over 20 min via syringe pump. Subsequently, a solution of allylic bromide 36 or 41 
(1.5 mmol) in 1.0 mL CH2Cl2 was added dropwise over 30 min via syringe pump. 
Once the addition was complete, the resulting mixture was stirred at -80 °C for 16h. 
The reaction was quenched by addition of MeOH (2.0 mL) and was allowed to 
warm up to rt. Aqueous NH4Cl solution (1M, 10 mL) was added and the organic 
phase separated. The aqueous phase was extracted with Et2O (2 x 10 mL). The 
combined organic phases were dried over MgSO4 and concentrated under reduced 
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The title compound was prepared from 36a (1.50 mmol, 516 mg) following general 
procedure D. Purification by column chromatography (SiO2, 
EtOAc/pentane 1:9, Rf = 0.44) afforded 45a (74% yield, 277 
mg, ratio 45a:46a = 95:5, 99% ee, [α]D = -1.1 (c 17.4, 
CHCl3)) as a yellow oil. Enantiomeric excess determined by 
chiral HPLC analysis, Chiralpak AD (99% n-heptane/1% i-
PrOH, flow rate 0.5 mL/min), 40 °C, retention times (min) 16.1 (major) and 17.4 
(minor). 
1
H NMR (300 MHz, CDCl3) δ 7.65 (d, J = 8.1 Hz, 2H), 7.25 (d, J = 8.0 Hz, 
2H), 5.75 – 5.41 (m, 2H), 5.13– 4.92 (m, 4H), 3.76 (d, J = 6.4 Hz, 2H), 3.10 – 2.86 
(m, 2H), 2.51 – 2.42 (m, 1H), 2.36 (s, 3H), 0.96 (d, J = 6.7 Hz, 3H). 
13
C NMR (75 
MHz, CDCl3) δ 143.38, 141.27, 137.31, 133.25, 129.85, 127.38, 119.11, 115.01, 
52.92, 51.32, 36.71, 21.67, 17.62. HRMS calcd. for C15H22NO2S [M+H
+
]: 280.1371, 




The title compound was prepared from 36b (0.017 mmol, 3.4 mg) following general 
procedure D. Purification by column chromatography 
(SiO2, EtOAc/Pentane 1:7, Rf (EtOAc/pentane 1:5) = 
0.64) afforded 45b (84% yield, 69 mg, ratio 45b:47b = 
98:2, 90% ee, [α]D = +1.2 (c 0.5, CHCl3)) as a yellow oil. 
Enantiomeric excess determined by chiral HPLC 
analysis, Chiralcel OJ (99% n-heptane/1% i-PrOH, flow rate 0.5 mL/min), 40 °C, 
retention times (min) 9.3 (major) and 11.6 (minor). 
1
H NMR (300 MHz, CDCl3) δ 
7.68 (d, J = 8.2 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 5.76 – 5.59 (m, 2H), 5.07 – 4.95 
(m, 4H), 3.15 (m, 2H), 3.09 – 2.93 (m, 2H), 2.54 – 2.44 (m, 1H), 2.41 (s, 3H), 2.32 
– 2.17 (m, 2H), 1.02 (d, J = 6.7 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 143.30, 
141.21, 137.20, 134.94, 129.79, 127.44, 117.14, 115.13, 54.26, 48.47, 37.06, 
33.16, 21.69, 17.70. HRMS calcd. for C16H24NO2S [M+H
+





The title compound was prepared from 36c (0.11 mmol, 42 mg) following general 
procedure D. Purification by column chromatography 
(SiO2, Et2O/pentane 1:8, Rf = 0.39) afforded 45c 
(72% yield, 25 mg, ratio 45c:46c = 92:8, 98% ee, [α]D 
= +0.7 (c 0.8, CHCl3)) as a yellow oil. Enantiomeric 
excess determined by chiral HPLC analysis, 
Chiralpak OD-H (99.5% n-heptane/0.05% i-PrOH, flow rate 0.5 mL/min), 40 °C, 
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retention times (min) 45.4 (minor) and 47.9 (major). 
1
H NMR (400 MHz, CDCl 3) δ 
7.68 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 5.80 – 5.63 (m, 2H), 5.06 – 4.94 
(m, 4H), 3.11 – 3.05 (m, 2H), 3.05 – 2.94 (m, 2H), 2.53 – 2.43 (m, 1H), 2.42 (s, 
3H), 2.00 (dd, J = 14.2 Hz, 7.4 Hz, 2H), 1.67 – 1.57 (m, 2H), 1.02 (d, J = 6.7 Hz, 
3H). 
13
C NMR (75 MHz, CDCl3) δ 143.22, 141.27, 137.67, 137.14, 129.76, 127.45, 
115.47, 115.08, 54.35, 48.71, 37.17, 31.13, 27.75, 21.69, 17.72. HRMS calcd. for 
C17H25NO2SNa [M+Na
+




The title compound was prepared from 41a (22 mmol, 75 mg) following general 
procedure D. Purification by column chromatography (SiO2, 
EtOAc/petroleum ether 40-60 1:9, Rf = 0.59) afforded 47a 
(77% yield, 47 mg, 99% ee, [α]D = -4.9 (c 1.4, CHCl3)) as a 
colorless oil. Enantiomeric excess determined by chiral 
HPLC analysis, Chiralpak AD (99% n-heptane/1% i-PrOH, 
flow rate 0.5 mL/min), 40 °C, retention times (min) 17.6 (major) and 19.1 (minor). 
1
H NMR (300 MHz, CDCl3) δ 7.71 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.1 Hz, 2H), 5.72 
(ddd, J = 17.5 Hz, 10.3 Hz, 7.5 Hz, 1H), 5.11 – 5.01 (m, 2H), 4.20 – 4.06 (m, 2H), 
3.14 – 3.02 (m, 2H), 2.57 – 2.44 (m, 1H), 2.41 (s, 3H), 1.99 (t, J = 2.5 Hz, 1H), 1.04 
(d, J = 6.7 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 143.63, 141.04, 136.21, 129.62, 
127.95, 115.28, 76.68, 73.99, 51.74, 36.92, 36.35, 21.73, 17.71. HRMS calcd. for 
C15H20NO2S [M+H
+




The title compound was prepared from 41b (84 μmol, 30 mg) following general 
procedure D. Purification by column chromatography 
(SiO2, 1:7 Et2O/ petroleum ether 40-60, Rf (1:5 Et2O/ 
petroleum ether 40-60) = 0.43) afforded 47b (53% yield, 
13 mg, 99% ee, [α]D = -1.4 (c 1.0, CHCl3)) as an opaque 
oil. Enantiomeric excess determined by chiral HPLC 
analysis, Chiralpak AD (95% n-heptane/5% i-PrOH, flow rate 0.5 mL/min), 40 °C, 
retention times (min) 8.1 (major) and 9.6 (minor). 
1
H NMR (400 MHz, CDCl3) δ 7.69 
(d, J = 7.9 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 5.74 – 5.59 (m, 1H), 5.08 – 4.93 (m, 
2H), 3.33 – 3.20 (m, 2H), 3.12 – 2.99 (m, 2H), 2.54 – 2.47 (m, 1H), 2.47 – 2.43 (m, 
2H), 2.41 (s, 3H), 1.99 – 1.92 (m, 1H), 1.01 (d, J = 6.7 Hz, 3H). 
13
C NMR (100 
MHz, CDCl3) δ 143.58, 141.03, 136.78, 129.91, 127.45, 115.39, 81.22, 70.44, 
54.82, 47.94, 37.17, 21.73, 19.47, 17.73. HRMS calcd. for C16H22NO2S [M+H
+
]: 








The title compound was prepared from 41c (0.26 mmol, 80 mg) following general 
procedure D. Purification by column chromatography 
(SiO2, 1:7 EtOAc/heptane, Rf (1:6 EtOAc/heptane) = 
0.45) afforded 47c (82% yield, 66 mg, 99% ee, [α]D = 
-3.2 (c 1.1, CHCl3)) as an opaque oil. Enantiomeric 
excess determined by chiral HPLC analysis, 
Chiralcel OJ (97% n-heptane/3% i-PrOH, flow rate 0.5 mL/min), 40 °C, retention 
times (min) 11.7 (major) and 13.7 (minor). 
1
H NMR (200 MHz, CDCl3) δ 7.69 (d, J = 
8.3 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 5.69 (ddd, J = 17.5 Hz, 10.3 Hz, 7.4 Hz, 1H), 
5.10 – 4.95 (m, 2H), 3.25 – 3.13 (m, 2H), 3.12 – 2.91 (m, 2H), 2.61 – 2.45 (m, 1H), 
2.42 (s, 3H), 2.18 (td, J = 6.9 Hz, 2.6 Hz, 2H), 1.96 (t, J = 2.6 Hz, 1H), 1.85 – 1.67 
(m, 2H), 1.02 (d, J = 6.7 Hz, 3H). 
13
C NMR (50 MHz, CDCl3) δ 143.13, 140.97, 
136.60, 129.59, 127.25, 115.00, 69.03, 54.52, 48.02, 44.41, 36.91, 27.35, 21.47, 
17.55, 15.92. HRMS calcd. for C17H23BrNO2SNa [M+Na
+




The title compound was prepared from 44 (0.114 mmol, 50 mg) following general 
procedure D, except that the reaction was quenched 
with 3.0 M HCl solution in Et2O (1 mL). Purification by 
column chromatography (SiO2, Et2O/Pentane 1:9, Rf 
(Et2O/Pentane 1:7) = 0.43) afforded 49 (71% yield, 30 
mg, ratio 49:50 = 95:5, 67% ee, [α]D = +20.5 (c 0.7, 
CHCl3)) as a colorless oil. Enantiomeric excess 
determined by chiral HPLC analysis, Chiralpak OJ-H 
(99% n-heptane/1% i-PrOH, flow rate 0.5 mL/min), 40 °C, retention times (min) 
17.3 (major) and 19.1 (minor).  
1
H NMR (200 MHz, CDCl3) δ 7.80 – 7.24 (m, 11H), 
5.85 – 5.62 (m, 1H), 5.15 – 4.95 (m, 2H), 3.96 – 3.70 (m, 2H), 2.80 – 2.65 (m, 1H), 
2.39 (s, 3H), 1.10 (d, J = 6.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl 3) δ 166.32, 
145.57, 144.68, 140.56, 137.22, 134.53, 130.51, 129.78, 128.91, 128.29, 127.30, 
118.70, 115.53, 51.39, 38.50, 21.58, 17.53. HRMS calcd. for C21H23NO3SNa 
[M+Na
+
]: 392.1291, found 392.1275. 
 
General procedure E: Ru-catalyzed olefin ring-closing metathesis (51a-c) 
Substrate (45a-c) was dissolved in degassed CH2Cl2 (5 mL) and Hoveyda-Grubbs 
2
nd
 generation catalyst (5.0 mol%) was added to the solution under a N2 
atmosphere. The mixture was stirred at rt until full conversion (3h) was achieved, 
as judged by TLC. The mixture was concentrated under reduced pressure and 









The title compound was prepared from 45a (0.80 mmol, 223 mg) following general 
procedure E. Purification by column chromatography (SiO2, 1:9 
EtOAc/heptane, Rf (1:5 EtOAc/heptane) = 0.45) afforded 51a (54% 
yield, 80 mg, 99% ee, [α]D = -0.4 (c 5.2, CHCl3)) as a colorless oil. 
Enantiomeric excess determined by chiral HPLC analysis, Chiralpak 
AS-H (95% n-heptane/5% i-PrOH, flow rate 0.5 mL/min), 40 °C, 
retention times (min) 17.1 (minor) and 17.8 (major). 
1
H NMR (300 
MHz, CDCl3) δ 7.66 (d, J = 7.1 Hz, 2H), 7.31 (d, J = 7.8 Hz, 2H), 5.63 – 
5.54 (m, 2H), 3.68 (d, J = 16.4 Hz, 1H), 3.45 – 3.33 (m, 1H), 2.55 – 2.45 (m, 2H), 
2.42 (s, 3H), 0.99 (d, J = 6.4 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 143.68, 133.56, 
131.63, 129.84, 127.85, 121.84, 49.60, 44.94, 30.49, 21.72, 18.49. HRMS calcd. 
for C13H18NO2S [M+H
+
]: 252.1058, found 252.1053. 
 
(S)-3-Methyl-1-tosyl-2,3,6,7-tetrahydro-1H-azepine (51b) 
The title compound was prepared from 45b (0.14 mmol, 34 mg) following general 
procedure E. Purification by column chromatography (SiO2, 1:9 
EtOAc/heptane, Rf = 0.34) afforded 51b (61% yield, 19 mg, 90% ee, 
[α]D = -1.8 (c 1.0, CHCl3)) as a colorless oil. Enantiomeric excess 
determined by chiral HPLC analysis, Chiralpak OJ-H (99% n-
heptane/1% i-PrOH, flow rate 0.5 mL/min), 40 °C, retention times 
(min) 40.9 (minor) and 42.2 (major). 
1
H NMR (400 MHz, CDCl3) δ 
7.69 – 7.63 (m, 2H), 7.30 – 7.28 (m, 2H), 5.69 – 5.62 (m, 1H), 5.55 – 
5.49 (m, 1H), 3.55 – 3.45 (m, 2H), 2.97 (ddd, J = 13.1 Hz, 7.4 Hz, 4.0 Hz, 1H), 2.76 
(dd, J = 13.0 Hz, 9.1 Hz, 1H), 2.57 (br, 1H), 2.42 (s, 3H), 2.35 – 2.25 (m, 2H), 1.05 
(d, J = 7.2 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 143.24, 137.29, 129.86, 128.40, 
127.23, 77.42, 54.58, 48.63, 35.63, 29.98, 21.69, 19.47. HRMS calcd. for 
C14H20NO2S [M+H
+
]: 266.1215, found 266.1209. 
 
(S)-7-Methyl-1-tosyl-1,2,3,4,7,8-hexahydroazocine (51c) 
The title compound was prepared from 45c (34 μmol, 10.5 mg) following general 
procedure E. Purification by column chromatography (SiO2, 1:8 
Et2O/pentane, Rf (1:7 Et2O/pentane) = 0.37) afforded 51c (77% 
yield, 7.0 mg, 98% ee, [α]D = +5.7 (c 0.7, CHCl3)) as a colorless oil. 
Enantiomeric excess determined by chiral HPLC analysis, Chiralpak 
OD-H (98% n-heptane/2% i-PrOH, flow rate 0.5 mL/min), 40 °C, 
retention times (min) 26.2 (major) and 27.6 (minor). 
1
H NMR (200 
MHz, CDCl 3) δ 7.68 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 9.1 Hz, 2H), 
5.70 – 5.54 (m, 1H), 5.40 – 5.30 (m, 1H), 3.54 – 3.43 (m, 1H), 3.36 
(dt, J = 14.8, 4.1 Hz, 1H), 2.87 (ddd, J = 14.8, 10.7, 4.1 Hz, 1H), 2.75 – 2.63 (m, 
1H), 2.47 – 2.34 (m, 2H), 2.47 – 2.31 (m, 5H), 2.10 – 1.99 (m, 2H), 1.52 – 1.39 (m, 
1H), 1.01 (d, J = 6.9 Hz, 3H). 
13
C NMR (100 MHz, CDCl3) δ 142.85, 135.46, 
129.57, 129.55, 126.84, 57.39, 48.42, 33.21, 29.84, 29.68, 24.09, 21.46, 18.80. 
HRMS calcd. for C15H21NO2SNa [M+Na
+
]: 302.1202, found 302.1181. 
  




The title compound was prepared from 49 (43 mmol, 16 mg) following general 
procedure E. Purification by column chromatography (SiO2, 1:30 
MeOH/toluene, Rf (1:25 MeOH/toluene) = 0.53) afforded 59 (65% 
yield, 7.5 mg, % ee, [α]D = +36.0 (c 1.2, CHCl3)) as a colorless oil. 
Enantiomeric excess could not be determined by chiral HPLC 
analysis or chiral GC analysis. 
1
H NMR (200 MHz, CDCl3) δ 7.93 
(d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 6.65 (dd, J = 9.7, 3.6 
Hz, 1H), 5.77 (dd, J = 9.8, 1.9 Hz, 1H), 4.16 (dd, J = 12.2, 5.1 Hz, 
1H), 3.65 (dd, J = 12.2, 8.2 Hz, 1H), 2.83 – 2.71 (m, 1H), 2.42 (s, 
3H), 1.18 (d, J = 7.1 Hz, 3H). 
13
C NMR (75 MHz, CDCl3) δ 166.98, 150.46, 144.94, 
136.13, 129.57, 128.77, 124.00, 50.39, 30.69, 21.86, 17.08. HRMS calcd. for 
C13H16NO3S [M+H
+
]: 266.0845, found 266.0842. 
 
General procedure F: Ru-catalyzed ene-yne metathesis (52a-b) 
Substrate (47a-b) was dissolved in degassed CH2Cl2 (5 mL) and Grubbs 1
st
 
generation catalyst (1.0 mol% per hour during 5 h) was added to the solution. The 
mixture was refluxed under an ethylene atmosphere (1 atm, balloon) until full 
conversion was reached, as judged by TLC. The mixture was concentrated under 
reduced pressure and purified by column chromatography to yield the desired 
products 52a-b as a colorless oils.  
 
(S)-3-Methyl-1-tosyl-5-vinyl-1,2,3,6-tetrahydropyridine (52a) 
The title compound was prepared from 47a (0.15 mmol, 42 mg) following general 
procedure F. Purification by column chromatography (SiO2, 1:9 
Et2O/petroleum ether 40-60, Rf (5:95 Et2O/ petroleum ether 40-
60) = 0.15) afforded 52a (77% yield, 31 mg, 99% ee, [α]D = +33.6 
(c 0.6, CHCl3)) as a colorless oil. Enantiomeric excess 
determined by chiral HPLC analysis, Chiralpak AS-H (99% n-
heptane/1% i-PrOH, flow rate 0.5 mL/min), 40 °C, retention times 
(min) 29.6 (minor) and 31.3 (major). 
1
H NMR (300 MHz, CDCl3) δ 
7.70 (d, J = 8.2 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 6.24 (dd, J = 17.8 Hz, 11.0 Hz, 
1H), 5.63 (s, 1H), 5.11 – 4.93 (m, 2H), 3.88 (d, J = 15.4 Hz, 1H), 3.51 – 3.46 (m, 
2H), 2.52 – 2.46 (m, 2H), 2.43 (s, 3H), 1.02 (d, J = 6.7 Hz, 3H). 
13
C NMR (75 MHz, 
CDCl3) δ 143.71, 136.57, 132.97, 131.59, 129.89, 127.85, 118.71, 111.91, 49.65, 














The title compound was prepared from 47b (38 μmol, 11 mg) following general 
procedure F. Purification by column chromatography (SiO2, 1:6 
Et2O/ petroleum ether 40-60, Rf (1:4 Et2O/ petroleum ether 40-60) = 
0.38) afforded 52b (65% yield, 7 mg, 99% ee, [α]D = -8.4 (c 1.0, 
CHCl3)) as a colorless oil. Enantiomeric excess determined by 
chiral HPLC analysis, Chiralpak OJ-H (95% n-heptane/5% i-PrOH, 
flow rate 0.5 mL/min), 40 °C, retention times (min) 22.5 (minor) and 
25.4 (major). 
1
H NMR (400 MHz, CDCl3) δ 7.65 (d, J = 8.1 Hz, 2H), 
7.29 (d, J = 8.4 Hz, 2H), 6.24 (dd, J = 17.5, 10.8 Hz, 1H), 5.55 (d, J 
= 3.4 Hz, 1H), 5.07 – 4.93 (m, 2H), 3.67 (ddd, J = 13.1, 8.0, 2.3 Hz, 1H), 3.60 – 
3.53 (m, 1H), 2.89 (ddd, J = 13.0, 8.9, 1.9 Hz, 1H), 2.71 – 2.66 (m, 2H), 2.59 – 2.50 
(m, 1H), 2.41 (s, 3H), 1.08 (d, J = 6.3 Hz, 3H). 
13
C NMR (100 MHz, CDCl3) δ 
143.38, 140.37, 139.20, 138.82, 136.13, 129.90, 127.31, 111.41, 53.80, 47.10, 
34.37, 27.55, 21.73, 19.98. HRMS calcd. for C16H22NO2S [M+H
+





The title compound was prepared from 47c (43 μmol, 13 mg) following general 
procedure F with the following modification: 
Grubbs 1
st
 generation catalyst was added to the 
reaction mixture (2.0 mol%) and the same amount 
again after 8 h and the reaction was heated to 
reflux for 7 days. Purification by column 
chromatography (SiO2, 1:7 Et2O/ petroleum ether 
40-60, Rf = 0.42) afforded 53 (35% yield, 5 mg, [α]D = +4.0 (c 0.3, CHCl3)) as a 
colorless oil. 
1
H NMR (400 MHz, CDCl3) δ 7.68 (d, J = 6.6 Hz, 2H), 7.27 (dd, J = 
9.9, 4.7 Hz, 2H), 6.34 (dd, J = 17.0, 10.1 Hz, 1H), 5.67 (dd, J = 17.2, 7.4 Hz, 1H), 
5.14 (d, J = 17.7 Hz, 1H), 5.09 – 4.88 (m, 5H), 3.10 (t, J = 10.3 Hz, 2H), 3.05 – 2.89 
(m, 2H), 2.53 – 2.43 (m, 1H), 2.41 (s, 3H), 2.14 (t, J = 7.7 Hz, 2H), 1.70 (dd, J = 
14.8, 6.9 Hz, 2H), 1.01 (d, J = 6.7 Hz, 2H). 
13
C NMR (75 MHz, CDCl3) δ 145.09, 
143.00, 141.05, 138.59, 136.98, 129.56, 127.23, 116.00, 114.88, 113.39, 54.00, 
48.63, 36.92, 28.50, 26.45, 21.46, 17.52. HRMS calcd. for C19H28NaNO2S [M+Na
+
]: 
370.1823, found 370.1801. 
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Chapter 6 
Catalytic Asymmetric Conjugate 
Addition of Grignard Reagents to 
Coumarins – Synthesis of Versatile 
Chiral Building Blocks 
 
A new protocol for the Cu-catalysed asymmetric conjugate addition of Grignard 
reagents to coumarins has been developed. The corresponding products are 
formed in high yields and enantioselectivites. Through a sequential protocol 
involving conjugate addtion followed by nucleophilic ring opening of the chiral 
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1.1 Cu-catalyzed conjugate addition of organometallic reagents 
The Cu-catalyzed asymmetric conjugate addition of organometallic reagents, such 
as diorganozinc, triorganoaluminum and organomagnesium compounds, to 
unsaturated carbonyl compounds is a well-established synthetic methodology that 
has been studied extensively and reviewed thoroughly.
1-8
 A wide variety of chiral 
copper catalysts, based on various ligands has been reported. Notable are the 











 ligands.  
As a representative example, the asymmetric Cu-catalyzed conjugate addition of 
Grignard reagents to -unsaturated esters based on a chiral Cu-Josiphos 
complex is depicted in Scheme 1.
21
 This reaction is especially suited for the 
transformation of alkyl Grignard reagents, leading to the corresponding chiral 
conjugate addition products in high yields and with excellent enantiomeric 
excesses. A wide variety of alkyl- as well as aryl-substituted esters 1 are 
transformed to β-chiral esters.  
 
Scheme 1 Cu-catalyzed asymmetric 1,4-addition of Grignard reagents with Josiphos 
 
1.2 Asymmetric Cu-catalyzed conjugate reduction reactions 
A related synthetic methodolgy is the conjugate reduction of -unsaturated 
carbonyl compounds based on copper hydride complexes.
25
 This marks an 
extension of the previously reported asymmetric catalytic reduction of ketones with 
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the same catalysts.
26,27
 If a stoichiometric external reducing agent, for example a 
silane,
28
 is employed, the conjugate reduction of ,-unsaturated carbonyl 
compounds can be conducted with catalytic amounts of Cu-H complexes.
29,30
 
Furthermore, if the ,-unsaturated substrate bears substituents either in the α- or 
the β-position, this transformation can be rendered enantioselective. As an 
example, the Cu-catalyzed asymmetric conjugate reduction of cyclopentenones 
and cyclohexenones 3 is depicted (Scheme 2).
29
 When 3 is subjected to conjugate 
reduction conditions with a catalyst comprising of [(PPh3)CuH]6 (“Stryker’s 
reagent”)
31
 and SEGPHOS ligand L2, the resulting chiral ketones 4 are available in 
excellent yields and enantioselectivities. In this case, polymethylhydrosiloxane 
(PMHS) is employed as a stoichiometric reducing agent. 
 
Scheme 2 Cu-catalyzed asymmetric conjugate reduction 
This methodology has recently been applied to the asymmetric conjugate 
reductions of coumarin derivatives.
32
 A variety of 3-aryl coumarins 5 could be 
reduced with the abovementioned catalyst. However, overreduction to the 
corresponding lactols could not be suppressed, so that an additional oxidation step 
was necessary to obtain the desired chiral lactones 6 reaching excellent yields and 
enantioselectivities (Scheme 3). In this transformation, diethoxymethylsiloxane 
(DEMS) was used as the stoichiometric reducing agent. The products 6 were 
shown to be valuable chiral building blocks for the synthesis of a variety of 
biologically active compounds. In this study, the reactivity of the chiral lactones 6 
and the corresponding lactols was exploited in various ways e.g. ring-opening, 






Scheme 3 Cu-catalyzed conjugate reduction of coumarins 
 
1.3 Rh-catalyzed asymmetric conjugate addition of boronic acids to 
coumarins 
The Rh-catalyzed conjugate addition is a well-established synthetic methodology to 
construct chiral β-aryl carbonyl compounds, which is especially well suited for 
cyclic enones and arylboronic acids as substrates.
33,34
 This transformation has also 
been applied in the asymmetric conjugate addition to coumarins, employing chiral 
Rh complexes with diene and phosphine ligands.
35,36
 The application of this 
methodology for the synthesis of (R)-Tolterodine (9), a drug against incontinence, 
was recently disclosed.
36
 When 6-methyl coumarin 7 was reacted with a large 
excess of phenylboronic acid in the presence of a chiral rhodium catalyst, the 
corresponding lactone 8, a synthetic intermediate for the synthesis of (R)-
Tolterodine, was isolated with excellent enantioselectivities (Scheme 4). 
 
Scheme 4 Rh-catalyzed asymmetric conjugate addition of phenylboronic acid/synthesis of (R)-
tolterodine 
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Other asymmetric approaches to chiral coumarin derivatives include asymmetric 
electrochemical reduction,
37,38
 or asymmetric sparteine-mediated lithiation of 
amides followed by ring-closing
39
 or Cu-catalyzed asymmetric conjugate addition to 
α-nitrocoumarins 10.
40
 The latter reaction is depicted in Scheme 5. When 3-
nitrocoumarins 10 were subjected to conjugate addition with dialkylzinc reagents 
using a Cu/L4 complex, the corresponding addition products 11 were accessible in 
good yields and stereoselectivities (up to 20:1 d.r. and 92% ee). The presence of 
the nitro group is crucial for this reaction to occur, as most likely a conjugate 
addition to the nitroolefin moiety
5
 takes place. When we studied this particular 
catalytic system with the unsubstituted coumarin (see Table 1 below), no reaction 
took place. 
 
Scheme 5 Cu-catalyzed conjugate additions to 3-nitrocoumarins 
 
2 Goal 
The aim of this research project was to develop an asymmetric conjugate addition 
protocol of Grignard reagents to coumarins. It has been shown that the 
corresponding chiral lactones are versatile chiral building blocks in synthesis. By 
employing the asymmetric Cu-catalyzed conjugate addition, it would be possible to 
introduce alkyl chains at the sterogenic center of the coumarin derivatives. These 
products are not accessible via Rh-catalyzed conjugate addtions of boronic acids, 
since this methodology is limited to arylboronic acids. Furthermore, this new 
approach would offer a substantial advantage over the related conjugate reduction, 
since it would be much more modular and thus circumvent the necessity to 







3 Results and Discussion 
3.1 Catalyst screening and optimization 
The low reactivity of coumarin (12) made it necessary to develop a new catalyst 
system. Our investigation started with the conjugate addition of dialkylzinc reagents 
to 12 employing phosphoramidite ligands.
5,17
 This catalytic system did not prove to 
be reactive enough and did not result in any turnover (Table 1, entry 1). When we 
turned our attention to the conjugate addition reaction with the more reactive 
Grignard reagents
2,3
 employing Josiphos ligand L1 (compare Scheme 1), full 
conversion to the desired 1,4-adduct 13a with 82% ee was observed,
41
 when 12 
was reacted with ethylmagnesium bromide (Table 1, entry 3). Ligand L6, which had 
been previously employed in the related 1,6-conjugate addition,
42
 proved to be the 
ligand of choice to reach high levels of enantiocontrol. At -78 °C, the conjugate 
addition product 13a was formed with 96% ee, albeit in a low yield (Table 1, entry 
4). Neither Taniaphos (L7) nor the Cu-tolBINAP (L5) catalyst, which had previously 
been reported for conjugate addition reactions with Grignard reagents,
20
 could 
compete with our findings in terms of conversion or enantioselectivity (Table 1, 
entries 2,8). It appeared that fine-tuning of the electronic properties of the ligand 
was necessary to obtain the conjugate addition product with high enantioselectivity. 
To achieve full conversion with L6, higher amounts of Grignard reagent were 
necessary along with a slightly higher reaction temperature of -72 °C (Table 1, 
entry 7).
43
 Furthermore, the catalyst loading could be lowered to 2.5 mol% of Cu 
without compromising the yield or the enantioselectivity. The absolute configuration 
of the conjugate addition product 13a was established by comparison of the sign of 
the optical rotation values to literature sources.
44,45
 All other absolute configurations 
were assigned in accordance to this compound. 
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Table 1 Ligand Screening / Optimization
a 
 








 L4 toluene -40 °C - - 
2
d
 L5 MTBE -40 °C Full (55%) 21% (R) 
3 L1 MTBE -78 °C Full (57%) 82% (R) 
4 L6 MTBE -78 °C 50% (26%) 96% (R) 
5 L6 CH2Cl2 -78 °C 40% (25%) 81% (R) 
6
e
 L6 MTBE -78 °C 80% (62%) 95% (R) 
7
e
 L6 MTBE -72 °C Full (92%) 95% (R) 
8 L7 MTBE -78 °C Traces (-) - 
a
 Reaction conditions: CuBr • SMe2 (0.01 mmol, 5.0 mol%, 2.1 mg) and 5.5 mol% (0.0105 mmol) of the 
appropriate ligand were dissolved in 5 mL solvent and stirred at RT for 15 min. After cooling to the 
appropriate temperature, 1.2 eq. of EtMgBr solution (c = 3.0M in Et2O, 0.24 mmol, 0.08 mL) were added 





added dropwise over a period of 1 h. Quenching with 2.0 mL of HCl in Et2O (2M). 
b
 Determined by chiral 
HPLC. 
c
11.0 mol% of ligand, and 5.0 mol% of Cu(OTf)2 and 2.0 eq. ZnEt2 were used. 
d
 5.0 mol% CuI 
were used.
 e 
2.5 eq. EtMgBr were used.  
During the catalyst optimization experiments, it was observed that, in contrast to 
the high conversion, the isolated yields of the desired addition product 13a was 
low. It was found that the cause of this problem was the quenching method 
employed, which led to the unwanted transformation of the intermediate 
magnesium enolate to a side product. The standard quenching protocol, by adding 
methanol at low temperatures (usually -78 °C) followed by warming to room 
temperature and washing with saturated aq. NH4Cl solution, led to the formation of 
considerable amounts of side products, one of which was identified to be ester 15 
(Scheme 6). Under those conditions, varying amounts of the ring-opened ester 15 
were isolated next to the desired product 13a. To overcome this problem, a 
different procedure for quenching the reaction had to be devised. When the 
reaction was quenched with methanol and stirred at room temperature longer than 
1 hour before the wash/extraction with NH4Cl was carried out, full conversion to 
ester 15 was found. However, the enantiomeric excess of the product remained the 
same (97% ee). 
 
 
Scheme 6 Nucleophilic ring opening of enolate 14 during quenching 
This reaction can be explained as follows: The intermediate magnesium enolate 14 
and/or the excess of Grignard reagent in solution leads to deprotonation of 
methanol to form methoxide, which acts as a nucleophile to faciliate the ring 
opening of lactone 13a to give ester 15 (Scheme 7). To prevent the subsequent 
ring-opening during workup, the reaction could simply been quenched by addition 
of HCl solution (2M) in Et2O at low temperatures followed by the usual 
extraction/workup protocol. However, it was found that this side reaction could be 
exploited to develop a sequential conjugate addition/nucleophilic ring opening for 
the synthesis of chiral esters and amides (vide infra). 
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Scheme 7 Plausible mechanism for the formation of ester 15 
 
3.2 Scope of Grignard reagents 
With the optimised conditions in hand, we set off to investigate the scope of the 
reaction. A variety of alkyl Grignard reagents are compatible with this 
transformation (Table 2). Similar trends in reactivity to our previously reported 
conditions with ferrocenyl-based ligands were observed,
21-23
 which implied high 
catalyst control of the envisaged  transformation. There is a preference for linear 
unfunctionalized alkyl Grignard reagents, which could be transformed to chiral 
lactones 13 in high yields and enantioselectivites reaching 99% ee (Table 2, 
entries 1,3,5-8). Use of the relatively unreactive methylmagnesium bromide gave 
no conjugate addition product. As previously observed, α-branched reagents such 
as isopropylmagnesium bromide gave low enantioselectivity for 13d, whereas the 
β-branched reagent was smoothly incorporated into the desired chiral products 13e 
with high ee (Table 2, entries 4,5). One key feature of the catalyst is the fact that it 
tolerates functionalized Grignard reagents; an important advantage with foresight 
to possible synthetic applications of this method. However, slightly higher catalyst 
loadings were necessary to achieve acceptable results in terms of yields. Butenyl-
substituted 13f as well as halogenated products 13h were accessible with excellent 
enantioselectivities when a higher catalyst loading was employed (Table 2, entries 
6,8). The attempt to employ aryl Grignard reagents such as phenylmagnesium 

















13a 96% 95% 
2 
 
13b - - 
3 
 
13c 95% 99% 
4 
 
13d 95% 63% 
5 
 















13h 46% 98% 
9 
 
13i traces - 
a
 For reaction conditions, see experimental section. 
b
 Isolated yields. 
c
 Determined by chiral HPLC. 
d 
5.0 
mol% CuBr • SMe2 and 5.5 mol% L6 were used. 
e
 The product was isolated as a mixture with traces of 
the dehalogenated product. 
From Table 2 can be seen that higher catalyst loadings were necessary to achieve 
acceptable yields with functionalized Grignard reagents (Table 2, entries 6-8). To 
probe whether the conversion and thus the isolated yield could be improved by 
raising the temperature, a series of experiments with varying temperatures were 
carried out (Table 3). Coumarin (12) was reacted under optimized catalyst loading 
and amount of Grignard reagent with phenylethylmagnesium bromide. At -78 °C, 
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13g was formed with 94% ee, however turnover was low (Table 3, entry 1). When 
the temperature was raised slightly to -72 °C, a remarkable improvement in 
conversion was observed, and 13g was isolated in 73% yield with the same ee 
(Table 3, entry 2). Raising the temperature even further led to full conversion to 
13g but this improvement in yield was accompanied by a decrease of 
enantioselectivity (Table 3, entry 3), thus all reactions with various Grignard 
reagents were carried out at -72 °C, which seemed to be acceptable in terms of 
enantioselectivity and yield. 
Table 3 Temperature dependence of conjugate addition 
 
Entry Temp Conversion ee 
1 -78 °C ~ 40% (TLC) 94% 
2 -72 °C ~ 90% (TLC)
a
 94% 
3 -60 °C Full 80% 
a 
73% isolated yield. 
 
3.3 Coumarin Scope 
Subsequently, the scope of our new catalytic transformation with regard to 
substituted coumarins 16 was investigated (Table 4). Methyl substituents in 
positions 6 and 7 were readily tolerated as the desired conjugate addition products 
could be isolated with very good yields and enantioselectivities (Table 4, entries 
1,2). Furthermore, halogen substituents are tolerated and give addition products 
17c and 17d with similarly good results (Table 4, entries 3,4). Dimethoxycoumarins 
16e and 16f could also be converted to the corresponding conjugate addition 
products, albeit with lower yield and enantioselectivity (Table 4, entries 5,6). This 
marks a limitation of this transformation. Two electron-donating groups on the 
aromatic ring result in a lower reactivity to conjugate addition reactions compared 





explained by the fact that the methoxy-substituent in the 5-position of 16f interferes 
with the Cu-catalyst. To overcome this problem the conjugate addition was 
attempted with 6,7-dihydroxy coumarin 16h. A higher amount of Grignard reagent 
was employed, but the reaction did not yield the desired product (Table 4, entry 8), 
possibly due to strong coordination of the dioxycoumarin dianion to the Cu catalyst 
through a chelating effect, and subsequent deactivation of the catalyst. This 
problem could be overcome in the future by preparing the corresponding coumarin 
boronate,
46
 followed by the conjugate addition, as the conjugate addition reaction is 
known to tolerate boron-based functional groups.
47
 The strongly electron-
withdrawing nitro-group of 16g (Table 4, entry 7) is not tolerated due to fast 
decomposition of the starting material under the reaction conditions.  
Table 4 Scope of coumarins
a 
 







17a 92% 94% 
2 
 
17b 93% 97% 
3 
 
17c 80% 95% 
4 
 










17f 66% 48% 
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17h - - 
a
 For reaction conditions, see experimental section. 
b
 Isolated yields. 
c
 Determined by chiral HPLC. 
d 
5.0 
mol% CuBr • SMe2 and 5.5 mol% L6 were used. 
e
 5.0 eq. of EtMgBr were used. 
3.4 Synthesis of coumarins 
The two 6-halosubstituted coumarins 16c and 16d were not commercially 
available, and were therefore synthesized. The synthesis was carried out according 
to a modified literature procedure for a tandem phenol ether 
deprotection/lactonization reaction (Scheme 8).
48
 Starting from the commercially 
available salicylaldehydes 18, O-methylation with MeI and a subsequent Witttig 
reaction yielded -unsaturated esters 20 in very good yields. It was reported
48
 
that one equivalent of BBr3 and refluxing CHCl3 was sufficient to facilitate the 
lactone formation, however, in our hands, the reaction proceeded smoothly only 
with 2.0 equivalents of BBr3 in refluxing toluene to give the desired halocoumarins 
21 in good yields. 
 
Scheme 8 Synthesis of 6-halocoumarins  
3.5 Trapping of intermediates / nucleophilic ring opening 
One of the major advantages of the conjugate addition reaction to coumarins was 





enolate 14 is a highly versatile chiral building block and can be converted in situ to 
a variety of important chiral products. The absence of a fully conjugated enone 
results in a higher reactivity of intermediate 14, which can be exploited by reactions 
with nucleophiles to invoke a ring-opening, as well as electrophiles to trap the 
enolate. When 14 was quenched with ethanol at -72 °C and then warmed up to 
room temperature, the resulting chiral ester 22 was isolated in very good yields 
without compromising the stereogenic center (Scheme 9). It is important to note 
that ortho-phenol esters like 22 were previously not accessible via the conjugate 
addition methodology,
2-4,21-23
 rendering this transformation a valuable addition to 
the present conjugate addition protocols. 
 
Scheme 9 Synthesis of chiral ortho-phenolic ester 22 
 
By intercepting the chiral magnesium enolate 14 with an excess of propylamine, 
amide 24 could be obtained in good yield (Scheme 10). This result marks the first 
formal catalytic asymmetric conjugate addition to amides, a reaction pathway that 
was previously elusive, since -unsaturated amides are not known to be 
susceptible to catalytic asymmetric conjugate additions with Cu-catalysts.  
It is known in literature that the enolates of conjugate addition reactions can be 
trapped with a variety of electrophiles.
5,18,49,50
 Along those lines, enolate 14 could 
be trapped with benzaldehyde to give the corresponding aldol product 23 with 
three contiguous stereocenters in good yields. Two diastereomers of 23 could be 
detected, (in a ratio 3:1) which were attributed to an incomplete stereoinduction at 
the exocyclic stereocenter formed, i.e. the benzylic alcohol. For the relative 
configuration of the first two stereocenters formed, it is expected with inference to 
related reactions in literature
17,18,49,51-53
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Scheme 10 Trapping / ring opening reactions of enolate 14 
  
4 Conclusion and Future Prospects  
To conclude, we have developed a new, highly selective Cu-catalyzed conjugate 
addition of Grignard reagents to coumarins. The corresponding chiral products are 
available with up to excellent enantioselectivities. Furthermore, we have 
demonstrated that the corresponding enolate is a highly versatile starting point for 
the synthesis of a variety of chiral products such as esters and amides which were 
previously not readily available. 
The presented findings on the asymmetric conjugate additions to coumarins could 
lead to some further research: first of all, the generality of the sequential conjugate 
addItion/amide formation could be investigated. Since an asymmetric conjugate 
addition protocol to amides is elusive, this could be a viable pathway towards β-
chiral amides (Scheme 11). Esters 25 could be converted to amides 27 in a one-
pot procedure via their corresponding enolates 26. 
 
Scheme 11 Proposed synthesis of chiral amides 
Secondly, the conjugate addition to 2H-pyranone 28 could be studied. This would 
be the extension of the conjugate addition reaction to coumarins, except that the 
aromatic ring of coumarin would be replaced by just a double bond. This could 
open a variety of interesting routes towards chiral products 31 and 32 among 
others, since pyranone adduct 29 could be transformed in various ways to give 
chiral multifunctional building blocks (Scheme 12). Another interesting question 
would arise if both regio- and enantioselective 1,4- and 1,6-conjugate additions are 
possible on pyranone to give 29 or 30. Both the new 1,4 conjugate addition to 
coumarin as well as the known 1,6 addition to enoates
42
 use the same catalytic 
system, namely reverse Josiphos (L6), so it would be interesting to see whether 
there would be a selectivity towards either one of the products. Furthermore, this 
experiment could give important insight to the mechanism of the conjugate addition 
reaction, since 1,6-addition reactions to cyclic systems have not yet been 
investigated and it would be interesting to determine if the catalyst can compete 






Scheme 12 Suggested conjugate addition to pyranone 
Finally, it could be investigated if the ring-opened esters such as 22 could undergo 
oxidative ring closing after conversion to their corresponding ester-enolates 33, a 
reaction that has been developed in our group (Scheme 13).
54
 This would yield 
ketones with an α-cyclopropyl moiety 34. 
 
Scheme 13 Suggested synthesis of α-cyclopropyl ketones 
 
5 Experimental section 
General 
Chromatography: Merck silica gel type 9385 230-400 mesh, TLC: Merck silica gel 
60,0.25 mm. Components were visualized by UV and cerium/molybdenum staining. 
Progress and conversion of the reaction were determined by GC-MS (GC, 
HP6890: MS HP5973) with an HP1 or HP5 column (Agilent Technologies, Palo 
Alto, CA). Mass spectra were recorded on a AEI-MS-902 mass spectrometer (EI
+
) 








C NMR were recorded on a Varian 
AMX400 (400 and 100.59 MHz, respectively), a Varian VXR300 (300 and 75 MHz, 
respectively) or a Varian Gemini 200, using CDCl3 as solvent. Chemical shift 
values are reported in ppm with the solvent resonance as the internal standard 
(CHCl3: δ 7.26 for 
1
H, δ 77.0 for 
13
C). Data are reported as follows: chemical shifts, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = 
multiplet), coupling constants (Hz), and integration. Optical rotations were 
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measured on a Schmidt + Haensch polarimeter (Polartronic MH8) with a 10 cm cell 
(c given in g/100 mL). Enantiomeric excesses (ee values) were determined by 
HPLC analysis using a Shimadzu LC-10ADVP HPLC equipped with a Shimadzu 
SPD-M10AVP diode array detector and chiral columns as indicated. Ees were 
determined by comparison of the racemic mixture with the corresponding chiral 
compounds or the mixtures of both R and S enantiomers. All reactions were carried 
out under a nitrogen atmosphere using oven dried glassware and using standard 
Schlenk techniques. CH2Cl2  was dried and distilled over calcium hydride, THF and 
Et2O were dried and distilled over Na/benzophenone. Toluene was dried and 
distilled over Na. MTBE was dried and distilled over CaH2. CuBr•SMe2 was 
purchased from Sigma-Aldrich, and used without further purification. Grignard 
reagents were purchased from Sigma-Aldrich (MeMgBr, EtMgBr, n-HexMgBr, i-
BuMgBr), all other Grignard reagents were prepared from the corresponding 
bromides with Mg in Et2O. All Grignard reagents were titrated using s-BuOH and 
catalytic amounts of 1,10-phenanthroline before use. L4 was prepared according to 
literature,
55
 L5-L7 were purchased from Sigma-Aldrich.  
 
General procedure for the methylation of salicylic aldehydes  
Salicylic aldehyde (1.0 eq.) was dissolved in DMF (Volume: 100 mL/10 mmol) and 
the solution was cooled to 0 °C. Then, 1.0 eq. sodium hydride (as 60% suspension 
in mineral oil) was added slowly and the reaction was stirred for 15 min at 0 °C (or 
until gas evolution ceased). Then, 2.0 eq. methyl iodide was added dropwise, and 
the reaction mixture was allowed to warm to 21 °C. When TLC showed full 
consumption of the starting material, the reaction was quenched by addition of 
water (100 mL/10 mmol). The mixture was washed with water and brine (50 mL / 
10 mmol each), extracted with EtOAc (2x 50 mL / 10 mmol) and dried over MgSO4. 
Removal of all volatiles under reduced pressure yielded the crude product, which 
was used without further purification. 
 
5-Chloro-2-methoxybenzaldehyde (19a) 
Following the general procedure for methylation of salicylic aldehydes, 2.167 g  5-
chloro-2-methoxybenzaldehyde 19a (12.70 mmol, 99 % yield) was isolated as a 
pale yellow solid from the reaction of 5-chloro-2-
hydroxybenzaldehyde (2.00 g, 12.77 mmol) with methyl 
iodide (1.597 ml, 25.5 mmol). 
1
H NMR: (400 MHz, CDCl3) δ 
10.30 (s, 1H), 7.64 (s, 1H), 7.46 – 7.34 (m, 1H), 6.87 (d, J = 
8.8 Hz, 1H), 3.84 (s, 3H). 
13
C NMR: (101 MHz, CDCl3) δ 
188.12, 160.07, 135.16, 127.53, 126.00, 125.37, 113.18, 
55.79. HRMS: (ESI
+
) calculated for C8H8ClO2 [M+H
+
]: 







Following the general procedure for methylation of salicylic aldehydes, 2.097 g 5-
bromo-2-methoxybenzaldehyde 19b (9,75 mmol, 98 % yield) 
was isolated as a pale yellow solid from the reaction of 5-
bromo-2-hydroxybenzaldehyde (2.00 g, 9.95 mmol) with methyl 
iodide (1.244 ml, 19.90 mmol). 
1
H NMR: (201 MHz, CDCl3) δ 
10.31 (s, 1H), 7.83 (d, J = 2.6 Hz, 1H), 7.56 (dd, J = 8.9, 2.6 
Hz, 1H), 6.84 (d, J = 8.9 Hz, 1H), 3.86 (s, 3H). 
13
C NMR: (50 
MHz, CDCl3) δ 188.13, 160.57, 138.12, 130.70, 125.83, 
113.63, 113.19, 55.82. HRMS: (ESI
+





General procedure for the Wittig reaction of methyl 2-
(triphenylphosphoranylidene)acetate with salicylic aldehydes 
Salicylic aldehyde 19 (1.0 eq.) was dissolved in toluene (Volume: 50 mL/ 10 mmol), 
and 1.2 eq. methyl 2-(triphenylphosphoranylidene)acetate was added to the 
mixture. This was heated to 110 °C until TLC showed full conversion of the starting 
material. After cooling, diethylether (50 mL/10 mmol) was added to precipitate any 
triphenylphosphine oxide, which was subsequently filtered off. All volatiles were 
removed under reduced pressure to give the crude product 20, which was purified 
by column chromatography (SiO2, pentane/EtOAc 8:2) to yield the desired products 
as a mixture of E/Z isomers. 
 
Methyl 3-(5-chloro-2-methoxyphenyl)acrylate (20a) 
Following the general procedure for the Wittig reaction with salicylic aldehydes, 
2.384 g methyl 3-(5-chloro-2-methoxyphenyl)acrylate 
20a (10.52 mmol, 90 % yield) was isolated as a white 
solid from the reaction of 5-chloro-2-
methoxybenzaldehyde 19a (2.00 g, 11.72 mmol) with 
methyl 2-(triphenylphosphoranylidene)acetate (4.70 g, 
14.07 mmol). (Rf = 0.80 in pentane/EtOAc 8:2). 
1
H 
NMR: (400 MHz, CDCl3) δ 7.86 (d, J = 16.2 Hz, 1H), 7.41 (d, J = 2.6 Hz, 1H), 7.23 
(dd, J = 8.9, 2.6 Hz, 1H), 6.79 (d, J = 8.8 Hz, 1H), 6.45 (d, J = 16.2 Hz, 1H), 3.81 
(s, 3H), 3.77 (s, 3H). 
13
C NMR: (101 MHz, CDCl3) δ 167.25, 156.61, 138.50, 
130.70, 129.68, 127.97, 125.57, 124.64, 119.30, 112.28, 55.62, 51.50. HRMS: 
(ESI
+
) calculated for C11H12ClO3 [M+H
+




Methyl 3-(5-bromo-2-methoxyphenyl)acrylate (20b) 
Following the general procedure for the Wittig reaction 
with salicylic aldehydes, 1.977 g methyl 3-(5-bromo-2-
methoxyphenyl)acrylate 20b (7.29 mmol, 78 % yield) 
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was isolated as a white solid from the reaction of 5-bromo-2-methoxybenzaldehyde 
19b (2.00 g, 9.30 mmol) with methyl 2-(triphenylphosphoranylidene)acetate (3.73 
g, 11.16 mmol). (Rf = 0.65 in pentane/EtOAc 8:2). 
1
H NMR: (201 MHz, CDCl3) δ 
7.87 (d, J = 16.2 Hz, 1H), 7.57 (d, J = 2.5 Hz, 1H), 7.39 (dd, J = 8.8, 2.5 Hz, 1H), 
6.76 (d, J = 8.8 Hz, 1H), 6.46 (d, J = 16.2 Hz, 1H), 3.83 (s, 3H), 3.78 (s, 3H). 
13
C 
NMR: (50 MHz, CDCl3) δ 167.32, 157.14, 138.52, 138.49, 133.68, 130.99, 125.20, 
119.39, 112.85, 112.78, 55.66, 51.61. HRMS: (ESI
+
) calculated for C11H12BrO3 
[M+H
+
]: 270.9964, found: 270.9969. 
 
General procedure for the synthesis of coumarin derivatives 21 from methyl 
acrylates 20 
According to a modified literature procedure,
48
 1.0 eq. methyl acrylate 20 was 
dissolved in toluene (Volume: 50 mL/ 5 mmol) and cooled to 0 °C. Then, 2.0 eq. 
boron tribromide was added dropwise. The reaction was heated to 110 °C for 4h. 
After cooling to room temperature, water (50 mL / 5 mmol) was added and the 
aqueous layer was extracted twice with CHCl3 (30 mL / 5 mmol). After drying over 
MgSO4 and removal of all volatiles under reduced pressure, the crude mixture was 




Following the general procedure for the synthesis of coumarin derivatives from 
esters, 0.613 g 6-chloro-2H-chromen-2-one 21a (3.40 mmol, 
77 % yield) was isolated as a pale yellow solid from the 
reaction of methyl 3-(5-chloro-2-methoxyphenyl)acrylate 20a 
(1.00 g, 4.41 mmol) with boron tribromide (0.834 ml, 8.82 
mmol). (Rf = 0.75 in pentane/EtOAc 8:2). 
1
H NMR: (201 
MHz, CDCl3) δ 7.63 (d, J = 9.6 Hz, 1H), 7.44 (dt, J = 4.9, 2.3 
Hz, 2H), 7.30 – 7.18 (m, 1H), 6.44 (d, J = 9.6 Hz, 1H). 
13
C NMR: (50 MHz, CDCl3) δ 
159.94, 152.32, 142.15, 131.65, 129.58, 127.05, 119.72, 118.20, 117.74. HRMS: 
(ESI
+
) calculated for C9H6ClO2 [M+H
+
]: 181.0051, found: 181.0051. 
6-Bromo-2H-chromen-2-one (21b) 
Following the general procedure for the synthesis of coumarin derivatives from 
esters, 0.522 g 6-bromo-2H-chromen-2-one 21b (2.32 
mmol, 63 % yield) was isolated as an orange solid from the 
reaction of methyl 3-(5-bromo-2-methoxyphenyl)acrylate 
20b (1.00 g, 3.69 mmol) with boron tribromide (0.697 ml, 
7.38 mmol). (Rf = 0.90 in pentane/EtOAc 8:2). 
1
H NMR: (201 
MHz, CDCl3) δ 7.68 – 7.55 (m, 3H), 7.29 – 7.15 (m, 1H), 
6.45 (d, J = 9.6 Hz, 1H). 
13
C NMR: (50 MHz, CDCl3) δ 164.90, 159.88, 142.04, 
134.54, 130.13, 120.28, 118.60, 117.83, 116.94. HRMS: (ESI
+
) calculated for 
C9H6BrO2 [M+H
+






General procedure for the asymmetric Cu-catalyzed conjugate addition of 
Grignard reagents to coumarins 
5.0 mol % Copper bromide dimethyl sulfide complex and 5.5 mol % (R,SFe)-reverse 
Josiphos were dissolved in MTBE (Volume: 15 mL / 1 mmol substrate) and the 
mixture was stirred at room temperature for 15 min. The mixture was then cooled 
to -72 °C and subsequently 2.5 eq. of the appropriate Grignard reagent were 
added. The mixture was stirred for an additional 10 min at -72 °C. A solution of 1.0 
eq. of the appropriate coumarin in MTBE (Volume: 5 mL / 1 mmol) was added 
dropwise over a period of 1 h. The reaction mixture was stirred until TLC showed 
full conversion. The reaction was quenched by adding HCl solution in Et2O (2.0 mL 
/ 1 mmol substrate) at -72 °C. Saturated aqueous NH4Cl solution (20 mL / 1 mmol) 
was added at low temperature and the reaction mixture was allowed to warm to 
room temperature. The mixture was diluted with Et2O (30 mL / 1 mmol). After 
washing two times with aqueous saturated NH4Cl solution (2x 50 mL / 1 mmol) and 
reextraction of the aqueous layer with Et2O (20 mL / 1 mmol), the combined 
organic layers were dried over MgSO4. All volatiles were removed under reduced 
pressure to give the crude product, which was purified by column chromatography 
(SiO2, EtOAc/Pentane) to yield the desired compounds. 
 
General procedure for the synthesis of racemic products of the Cu-catalyzed 
conjugate addition to coumarins 
The appropriate coumarin (1.0 eq., 0.485 mmol) and 30.0 mol % Copper bromide 
dimethyl sulfide complex (0.030 g, 0.145 mmol) and 60.0 mol % triphenylphosphine 
(0.076 g, 0.291 mmol) were dissolved in MTBE (Volume: 15 ml), cooled to -40 °C 
and the mixture was stirred for 10 min. The appropriate Grignard reagent (2.5 eq., 
1.212 mmol) was added dropwise. The reaction mixture was stirred overnight at -
40 °C. The reaction was quenched by addition of 2.0 mL HCl in Et2O (2N), before 
20 mL saturated aqueous NH4Cl solution was added at low temperature and the 
reaction mixture was allowed to warm to room temperature. The mixture was 
diluted with Et2O (30 mL). After washing two times with aqueous saturated NH4Cl 
solution (2x 50 mL) and reextraction of the aqueous layer with Et2O (20 mL), the 
combined organic layers were dried over MgSO4. All volatiles were removed under 
reduced pressure to give the crude product, which was purified by column 





Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.135 g (R)-4-ethylchroman-2-one 13a (0.768 mmol, 
96% yield) was isolated as a pale yellow oil from the reaction of 
2H-chromen-2-one 12 (0.117 g, 0.80 mmol) with ethylmagnesium 
bromide solution (3.0 molar in Et2O) (0.67 ml, 2.00 mmol). The 
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product was purified by column chromatography (SiO2, pentane/EtOAc 10:1, Rf = 
0.68 in pentane/EtOAc 10:1, 95% ee). 
1
H NMR: (400 MHz, CDCl3) δ 7.29 – 7.21 
(m, 1H), 7.21 – 7.15 (m, 1H), 7.11 (dd, J = 10.7, 4.2 Hz, 1H), 7.04 (d, J = 8.1 Hz, 
1H), 2.96 – 2.86 (m, 1H), 2.78 (qd, J = 15.8, 4.9 Hz, 2H), 1.64 (tdd, J = 14.0, 11.3, 
6.2 Hz, 3H), 0.95 (t, J = 7.4 Hz, 3H). 
13
C NMR: (101 MHz, CDCl3) δ 168.48, 151.22, 
128.17, 127.84, 126.42, 124.20, 117.00, 36.52, 34.35, 27.50, 11.11. HRMS: (ESI
+
) 
calculated for C11H12O2Na [M+Na
+
]: 199.0730, found: 199.0730. [α]D
20
 = 53.6 (c = 
1.0 in CHCl3), [α]D
20
 = 114.6 (c = 1.0 in PhH). The two [α]D
20
 values have been used 
for determination of the absolute configuration by comparison with literature.
44,45
 ee 
determination by chiral HPLC (Chiralpak AD: n-heptane/2-propanol 95:5, 40 °C 




Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.177 g (R)-4-hexylchroman-2-one 13c (0.760 
mmol, 95 % yield) was isolated as a pale yellow solid 
from the reaction of 2H-chromen-2-one 12 (0.117 g, 0.80 
mmol) with hexylmagnesium bromide solution (2.0 molar 
in Et2O) (1.00 ml, 2.00 mmol). The desired product was 
purified by column chromatography (SiO2, 
pentane/EtOAc 10:1, Rf = 0.78 in pentane/EtOAc 10:1, 
99% ee). 
1
H NMR: (201 MHz, CDCl3) δ 7.30 – 6.95 (m, 
4H), 3.04 – 2.87 (m, 1H), 2.81 – 2.61 (m, 2H), 1.66 – 
1.45 (m, 2H), 1.44 – 1.02 (m, 8H), 0.84 (t, J = 6.4 Hz, 3H). 
13
C NMR: (50 MHz, 
CDCl3) δ 168.26, 151.09, 127.99, 127.65, 126.72, 124.10, 116.85, 34.94, 34.54, 
34.47, 31.47, 28.94, 26.44, 22.41, 13.88. HRMS: (ESI
+
) calculated for C15H20O2Na 
[M+Na
+
]: 255.1356, found: 255.1356. [α]D
20
 = 47.6 (c = 1.0 in CHCl3). ee 
determination by chiral HPLC (Chiralpak OB-H: n-heptane/2-propanol 95:5, 40 °C 
isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 10.5 min (minor), 12.4 
min (major).  
(S)-4-Isopropylchroman-2-one (13d) 
Following the general procedure for the asymmetric Cu-
catalyzed conjugate addition, 0.145 g (S)-4-isopropylchroman-
2-one 13d (0.760 mmol, 95 % yield) was isolated as a pale 
yellow oil from the reaction of 2H-chromen-2-one 12 (0.117 g, 
0.80 mmol) with isopropylmagnesium bromide solution (1.5 
molar in Et2O) (1.33 ml, 2.00 mmol). The desired product was 
purified by column chromatography (SiO2, pentane/EtOAc 10:1, 
Rf = 0.90 in pentane/EtOAc 10:1, 63% ee). 
1
H NMR: (400 MHz, CDCl3) δ 7.27 – 
7.19 (m, 1H), 7.14 (dd, J = 7.5, 1.5 Hz, 1H), 7.11 – 7.04 (m, 1H), 7.01 (d, J = 8.1 
Hz, 1H), 2.85 (dd, J = 10.7, 8.9 Hz, 1H), 2.78 – 2.63 (m, 2H), 1.82 (dd, J = 13.5, 6.7 
Hz, 1H), 0.93 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.8 Hz, 3H). 
13
C NMR: (101 MHz, 
CDCl3) δ 168.65, 151.46, 128.84, 128.09, 125.30, 123.87, 116.81, 41.61, 32.05, 
31.96, 20.00, 19.00. HRMS: (ESI
+









 = 21.6 (c = 1.0 in CHCl3) ee determination by chiral HPLC 
(Chiralpak OB-H: n-heptane/2-propanol 98:2, 40 °C isotherm, 210 nm, flow rate 0.5 
mL/min), retention times: 15.5 min (major), 17.2 min (minor).  
 
(R)-4-Isobutylchroman-2-one (13e) 
Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.118 g (R)-4-isobutylchroman-2-one 13e (0.576 mmol, 72 % yield) was 
isolated as a pale yellow solid from the reaction of 2H-chromen-
2-one 12 (0.117 g, 0.80 mmol) with isobutylmagnesium bromide 
solution (2.0 molar in Et2O) (1.00 ml, 2.00 mmol). The desired 
product was purified by column chromatography (SiO2, 
pentane/EtOAc 10:1, Rf = 0.78 in pentane/EtOAc 10:1, 93% ee). 
1
H NMR: (400 MHz, CDCl3) δ 7.29 – 7.20 (m, 1H), 7.20 – 7.15 
(m, 1H), 7.09 (t, J = 7.4 Hz, 1H), 7.04 (d, J = 8.1 Hz, 1H), 3.07 
(dd, J = 5.3, 3.9 Hz, 1H), 2.76 (ddd, J = 19.5, 15.8, 4.7 Hz, 2H), 
1.63 (dt, J = 13.4, 6.7 Hz, 1H), 1.42 (dtd, J = 21.2, 13.9, 7.5 Hz, 
2H), 0.98 (d, J = 6.5 Hz, 3H), 0.89 (d, J = 6.6 Hz, 3H). 
13
C NMR: (101 MHz, CDCl3) 
δ 168.34, 151.20, 128.12, 127.48, 127.17, 124.25, 117.09, 43.62, 34.69, 32.76, 
24.84, 22.59, 22.22. HRMS: (ESI
+





 = 72.0 (c = 1.0 in CHCl3). ee determination by chiral HPLC 
(Chiralpak OB-H: n-heptane/2-propanol 98:2, 40 °C isotherm, 210 nm, flow rate 0.5 
mL/min), retention times: 13.8 min (major), 15.4 min (minor).  
 
(R)-4-(But-3-enyl)chroman-2-one (13f) 
Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.106 g (R)-4-(but-3-en-1-yl)-3,4-dihydronaphthalen-2(1H)-one 13f (0.528 
mmol, 66 % yield) was isolated as a pale yellow oil from the 
reaction of 2H-chromen-2-one 12 (0.117 g, 0.80 mmol) with 
butenylmagnesium bromide solution (2.4 molar in Et2O) (0.84 
ml, 2.00 mmol). The desired product was purified by column 
chromatography (SiO2, pentane/EtOAc 10:1, Rf = 0.85 in 
pentane/EtOAc 10:1, 93% ee). 
1
H NMR: (201 MHz, CDCl3) δ 
7.38 – 6.93 (m, 4H), 5.93 – 5.62 (m, 1H), 5.24 – 4.83 (m, 2H), 
3.10 – 2.93 (m, 1H), 2.91 – 2.61 (m, 2H), 2.25 – 1.95 (m, 2H), 
1.79 – 1.55 (m, 2H). 
13
C NMR: (50 MHz, CDCl3) δ 168.20, 151.23, 137.18, 128.27, 
127.76, 126.42, 124.26, 117.09, 115.61, 34.57, 34.28, 33.51, 30.54. HRMS: (ESI
+
) 
calculated for C13H14O2Na [M+Na
+
]: 225.0886, found: 225.0884. [α]D
20
 = 72.6 (c = 
1.0 in CHCl3). ee determination by chiral HPLC (Chiralpak OD-H: n-heptane/2-
propanol 99:1, 40 °C isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 20.4 
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Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.126 g (R)-4-phenethylchroman-2-one 13g (0.499 
mmol, 73% yield) was isolated as an orange solid from the 
reaction of 2H-chromen-2-one 12 (0.117 g, 0.80 mmol) with 
phenylethylmagnesium bromide solution (1.50 molar in Et2O) 
(1.14 ml, 2.00 mmol). The desired product was purified by 
column chromatography (SiO2, pentane/EtOAc 10:1, Rf = 0.65 in 
pentane/EtOAc 10:1, 94% ee). 
1
H NMR: (400 MHz, CDCl3) δ 
7.36 – 7.26 (m, 3H), 7.25 – 7.04 (m, 6H), 3.11 – 2.98 (m, 1H), 2.90 – 2.80 (m, 2H), 
2.79 – 2.58 (m, 2H), 2.04 – 1.85 (m, 2H). 
13
C NMR: (101 MHz, CDCl3) δ 168.06, 
151.17, 140.68, 128.39, 128.25, 128.14, 127.68, 126.30, 126.01, 124.23, 117.02, 
35.86, 34.48, 34.35, 32.56. HRMS: (ESI
+
) calculated for C17H16O2Na [M+Na
+
]: 
275.1043, found: 275.1042. [α]D
20
 = 57.0 (c = 1.0 in CHCl3). ee determination by 
chiral HPLC (Chiralpak AD: n-heptane/2-propanol 95:5, 40 °C isotherm, 210 nm, 
flow rate 0.5 mL/min), retention times: 8.3 min (minor), 9.0 min (major).  
 
(R)-4-(4-Chlorobutyl)chroman-2-one (13h) 
Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.075 g (R)-4-(4-chlorobutyl)chroman-2-one 13h (0.315 mmol, 46 % yield) 
was isolated as a yellow oil from the reaction of 2H-chromen-2-
one 12 (0.117 g, 0.80 mmol) with (4-chlorobutyl)magnesium 
bromide solution (2.3 molar in Et2O) (0.744 ml, 2.00 mmol). The 
desired product was purified by column chromatography (SiO2, 
pentane/EtOAc 10:1, Rf = 0.65 in pentane/EtOAc 10:1, 98% ee). 
The product contains traces of dehalogenated product. 
1
H NMR: 
(400 MHz, CDCl3) δ 7.31 – 7.23 (m, 1H), 7.18 (dd, J = 7.5, 1.5 
Hz, 1H), 7.11 (td, J = 7.4, 1.1 Hz, 1H), 7.06 (d, J = 8.1 Hz, 1H), 
3.52 (dt, J = 6.5, 5.1 Hz, 2H), 2.99 (dd, J = 5.8, 3.8 Hz, 1H), 2.80 
(ddd, J = 19.7, 15.9, 4.8 Hz, 2H), 1.77 (ddd, J = 7.7, 6.1, 3.7 Hz, 2H), 1.68 – 1.52 
(m, 4H). 
13
C NMR: (101 MHz, CDCl3) δ 168.20, 151.21, 128.39, 127.79, 126.33, 





]: 239.0833, found: 239.0842. [α]D
20
 = 84.6 (c = 1.0 in CHCl3). 
ee determination by chiral HPLC (Chiralpak OD-H: n-heptane/2-propanol 98:2, 40 
°C isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 26.0 min (major), 27.0 




Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.140 g (R)-4-ethyl-6-methylchroman-2-one 17a (0.736 mmol, 92 % yield) 
was isolated as a pale yellow oil from the reaction of 6-methyl-
2H-chromen-2-one 16a (0.128 g, 0.80 mmol) with 
ethylmagnesium bromide solution (3.0 molar in Et2O) (0.67 ml, 





chromatography (SiO2, pentane/EtOAc 10:1, Rf = 0.85 in pentane/EtOAc 10:1, 
94% ee). 
1
H NMR: (201 MHz, CDCl3) δ 7.09 – 6.85 (m, 3H), 2.90 – 2.78 (m, 1H), 
2.77 – 2.61 (m, 2H), 2.30 (s, 3H), 1.70 – 1.44 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). 
13
C 
NMR: (50 MHz, CDCl3) δ 168.51, 149.05, 133.63, 128.50, 128.15, 126.03, 116.53, 
36.42, 34.26, 27.43, 20.59, 11.00. HRMS: (ESI
+
) calculated for C12H15O2 [M+H
+
]: 
191.1067, found: 191.1067. [α]D
20
 = 19.0 (c = 1.0 in CHCl3). ee determination by 
chiral HPLC (Chiralpak OJ-H: n-heptane/2-propanol 98:2, 40 °C isotherm, 210 nm, 
flow rate 0.5 mL/min), retention times: 15.8 min (major), 17.3 min (minor).  
 
(R)-4-Ethyl-7-methylchroman-2-one (17b) 
Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.141 g (R)-4-ethyl-7-methylchroman-2-one 17b 
(0.741 mmol, 93 % yield) was isolated as a pale yellow oil 
from the reaction of 7-methyl-2H-chromen-2-one 16b (0.128 
g, 0.80 mmol) with ethylmagnesium bromide solution (3.0 
molar in Et2O) (0.67 ml, 2.00 mmol). The desired product was 
purified by column chromatography (SiO2, pentane/EtOAc 
10:1, Rf = 0.70 in pentane/EtOAc 10:1, 97% ee). 
1
H NMR: (400 MHz, CDCl3) δ 
7.04 (d, J = 7.7 Hz, 1H), 6.90 (dd, J = 7.7, 0.8 Hz, 1H), 6.84 (s, 1H), 2.89 – 2.81 (m, 
1H), 2.74 (qd, J = 15.7, 4.9 Hz, 2H), 2.31 (s, 3H), 1.59 (qt, J = 13.9, 7.2 Hz, 2H), 
0.93 (t, J = 7.4 Hz, 3H). 
13
C NMR: (101 MHz, CDCl3) δ 168.54, 151.05, 138.28, 
127.47, 124.84, 123.22, 117.30, 36.09, 34.45, 27.50, 20.89, 11.00. HRMS: (ESI
+
) 
calculated for C12H15O2 [M+H
+
]: 191.1067, found: 191.1062. [α]D
20
 = 37.0 (c = 1.0 in 
CHCl3). ee determination by chiral HPLC (Chiralpak OJ-H: n-heptane/2-propanol 
98:2, 40 °C isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 16.9 min 
(major), 18.2 min (minor).  
 
(R)-6-Chloro-4-ethylchroman-2-one (17c) 
Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.135 g (R)-6-chloro-4-ethylchroman-2-one 17c 
(0.641 mmol, 80 % yield) was isolated as an orange oil from 
the reaction of 6-chloro-2H-chromen-2-one 16c (0.144 g, 
0.80 mmol), which was added as a solution in 7 mL 
MTBE/CH2Cl2 (5:2), with ethylmagnesium bromide solution 
(3.0 molar in Et2O) (0.67 ml, 2.00 mmol). The desired 
product was purified by column chromatography (SiO2, 
pentane/EtOAc 10:1, Rf = 0.55 in pentane/EtOAc 10:1, 95% ee). 
1
H NMR: (300 
MHz, CDCl3) δ 7.24 – 7.11 (m, 2H), 6.95 (d, J = 8.5 Hz, 1H), 2.93 – 2.83 (m, 1H), 
2.82 – 2.66 (m, 2H), 1.73 – 1.47 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H). 
13
C NMR: (75 
MHz, CDCl3) δ 167.55, 149.73, 129.16, 128.09, 127.57, 118.27, 97.86, 36.36, 
33.81, 27.23, 10.91. HRMS: (ESI
+





 = 16.8 (c = 1.0 in CHCl3). ee determination by chiral HPLC 
(Chiralpak OB-H: n-heptane/2-propanol 98:2, 40 °C isotherm, 210 nm, flow rate 0.5 
mL/min), retention times: 27.0 min (major), 33.1 min (minor).  
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(R)-6-Bromo-4-ethylchroman-2-one (17d) 
Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.175 g (R)-6-bromo-4-ethylchroman-2-one 17d 
(0.686 mmol, 86 % yield) was isolated as a yellow oil from 
the reaction of 6-bromo-2H-chromen-2-one 16d (0.180 g, 
0.80 mmol), which was added as a solution in 8 mL 
MTBE/CH2Cl2 (5:3), with ethylmagnesium bromide solution 
(3.0 molar in Et2O) (0.67 ml, 2.00 mmol). The desired 
product was purified by column chromatography (SiO2, 
pentane/EtOAc 10:1, Rf = 0.55 in pentane/EtOAc 10:1, 96% ee). 
1
H NMR: (300 
MHz, CDCl3 ) δ 7.41 – 7.23 (m, 2H), 6.90 (d, J = 8.5 Hz, 1H), 2.94 – 2.81 (m, 1H), 
2.81 – 2.61 (m, 2H), 1.60 (td, J = 14.5, 7.0 Hz, 2H), 0.94 (t, J = 7.4 Hz, 3H). 
13
C 
NMR: (50 MHz, CDCl3) δ 167.44, 150.25, 131.04, 130.48, 128.54, 118.67, 116.68, 
36.31, 33.80, 27.26, 10.93. HRMS: (ESI
+
) calculated for C11H12BrO2 [M+H
+
]: 
255.0015, found: 255.0010. [α]D
20
 = 5.40 (c = 1.0 in CHCl3). ee determination by 
chiral HPLC (Chiralpak OB-H: n-heptane/2-propanol 98:2, 40 °C isotherm, 210 nm, 
flow rate 0.5 mL/min), retention times: 24.1 min (major), 28.4 min (minor).  
 
(R)-4-Ethyl-6,7-dimethoxychroman-2-one (17e) 
Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.063 g (R)-4-ethyl-6,7-dimethoxychroman-2-one 
17e (0.267 mmol, 55 % yield) was isolated as a brown oil 
from the reaction of 6,7-dimethoxy-2H-chromen-2-one 16e 
(0.100 g, 0.485 mmol), which was added as a solution in 
5.0 mL MTBE/CH2Cl2 (1:1), with ethylmagnesium bromide 
solution (3.0 molar in Et2O) (0.404 ml, 2.00 mmol). The 
desired product was purified by column chromatography 
(SiO2, pentane/EtOAc 8:2, Rf = 0.50 in pentane/EtOAc 8:2, 64% ee). 
1
H NMR: (201 
MHz, CDCl3) δ 6.63 (s, 1H), 6.60 (s, 1H), 3.85 (d, J = 3.3 Hz, 6H), 2.88 – 2.63 (m, 
3H), 1.60 (dd, J = 13.2, 6.6 Hz, 2H), 0.95 (t, J = 7.4 Hz, 3H). 
13
C NMR: (50 MHz, 
CDCl3) δ 168.56, 148.72, 145.46, 145.00, 117.27, 110.41, 101.28, 56.41, 56.07, 
36.34, 34.49, 27.80, 11.12. HRMS: (ESI
+
) calculated for C13H17O4 [M+H
+
]: 
237.1121, found: 237.1118. [α]D
20
 = 20.8 (c = 1.0 in CHCl3). ee determination by 
chiral HPLC (Chiralpak AD-H: n-heptane/2-propanol 98:2, 40 °C isotherm, 210 nm, 
flow rate 0.5 mL/min), retention times: 32.0 min (major), 44.1 min (minor).  
 
(R)-4-Ethyl-5,7-dimethoxychroman-2-one (17f) 
Following the general procedure for the asymmetric Cu-catalyzed conjugate 
addition, 0.125 g (R)-4-ethyl-5,7-dimethoxychroman-2-one 17f (0.528 mmol, 66 % 
yield) was isolated as a pale yellow solid from the reaction 
of 5,7-dimethoxy-2H-chromen-2-one 16f (0.165 g, 0.80 





MTBE/CH2Cl2 (1:1), with ethylmagnesium bromide solution (3.0 M in Et2O) (0.667 
ml, 2.00 mmol). The desired product was purified by column chromatography 
(SiO2, pentane/EtOAc 8:2, Rf = 0.75 in pentane/EtOAc 8:2, 48% ee). 
1
H NMR: (201 
MHz, CDCl3) δ 6.22 (dd, J = 7.8, 2.3 Hz, 2H), 3.78 (d, J = 6.2 Hz, 6H), 3.30 – 3.08 
(m, 1H), 2.71 (qd, J = 15.9, 4.1 Hz, 2H), 1.66 – 1.33 (m, 2H), 0.89 (t, J = 7.4 Hz, 
3H). 
13
C NMR: (50 MHz, CDCl3) δ 168.64, 159.96, 157.28, 152.52, 107.63, 94.69, 
93.82, 55.53, 55.42, 33.82, 30.22, 27.30, 11.03. HRMS: (ESI
+
) calculated for 
C13H17O4 [M+H
+
]: 237.1121, found: 237.1121. [α]D
20
 = 10.6 (c = 1.0 in CHCl3). ee 
determination by chiral HPLC (Chiralpak OJ-H: n-heptane/2-propanol 95:5, 40 °C 
isotherm, 210 nm, flow rate 0.5 mL/min), retention times: 24.0 min (major), 27.4 
min (minor).  
 
(R)-Ethyl 3-(2-hydroxyphenyl)pentanoate (22) 
In a flame-dried Schlenk tube, 2.5 mol% copper bromide dimethyl sulfide complex 
(4.11 mg, 0.02 mmol) and 3.0 mol% reverse Josiphos (0.014 g, 0.024 mmol) were 
dissolved in MTBE (Volume: 10.0 ml) and stirred at room 
temperature for 15 min. Then, the mixture was cooled to -
72 °C and 2.5 eq. ethylmagnesium bromide solution (c = 
3.0 M in Et2O, 0.80 ml, 2.4 mmol) were added and the 
mixture stirred for 10 more min. Then, a solution of 1.0 
eq. 2H-chromen-2-one 12 (0.117 g, 0.80 mmol) in MTBE 
(Volume: 5.0 ml) was added dropwise over a period of 1 
h. The reaction was stirred until TLC showed full 
conversion to the 1,4-addition product (~2 h). Then, 5.0 eq. ethanol (0.234 ml, 4.00 
mmol) were added and the reaction mixture was warmed to room temperature and 
stirred at that temperature for 5 h. Then, the reaction was quenched by adding 
saturated aq. NH4Cl solution (50 mL) and the reaction mixture was diluted with 
Et2O (50 mL). After separation of the organic phase it was dried over MgSO4 and 
all volatiles were removed under reduced pressure to give the crude product as a 
yellow oil. This was further purified by column chromatography (SiO2, 
pentane/EtOAc 10:1, Rf = 0.55 in pentane/EtOAc 10:1, 95% ee) to yield (R)-ethyl-
3-(2-hydroxyphenyl)pentanoate 22 (0.154 g, 0.693 mmol, 87 %) as a colourless oil. 
1
H NMR: (201 MHz, CDCl3) δ 7.19 – 6.98 (m, 3H), 6.96 – 6.82 (m, 2H), 4.30 – 3.91 
(m, 2H), 3.36 (dtd, J = 13.1, 7.6, 5.3 Hz, 1H), 2.70 (qd, J = 16.4, 7.3 Hz, 2H), 1.89 – 
1.59 (m, 2H), 1.18 (t, J = 7.22 Hz, 3H), 0.84 (t, J = 7.3 Hz, 3H). 
13
C NMR: (50 MHz, 
CDCl3) δ 174.74, 154.14, 130.49, 127.22, 120.78, 117.03, 60.86, 40.90, 35.98, 
27.77, 13.92, 12.02. HRMS: (ESI
+





 = -2.0 (c = 1.0 in CHCl3). ee determination by chiral HPLC 
(Chiralpak AD-H: n-heptane/2-propanol 99:1, 40 °C isotherm, 210 nm, flow rate 0.5 
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In a flame-dried Schlenk tube, 2.5 mol% copper bromide dimethyl sulfide complex 
(4.11 mg, 0.02 mmol) and 3.0 mol% reverse Josiphos (0.014 
g, 0.024 mmol) were dissolved in MTBE (Volume: 10.0 ml) 
and stirred at room temperature for 15 min. Then, the 
mixture was cooled to -72 °C and 2.5 eq. ethylmagnesium 
bromide solution (c = 3.0 M in Et2O, 0.80 ml, 2.4 mmol) were 
added and the mixture stirred for 10 more min. Then, a 
solution of 1.0 eq. 2H-chromen-2-one 12 (0.117 g, 0.80 
mmol) in MTBE (Volume: 5.0 ml) was added dropwise over a 
period of 1 h. The reaction was stirred until TLC showed full 
conversion to the 1,4-addition product (~2 h). Then, 5.0 eq. 
benzaldehyde (0.405 ml, 4.00 mmol) were added and the reaction mixture was 
warmed to room temperature and stirred at that temperature for 4 h. Next, the 
reaction was quenched by adding saturated aq. NH4Cl solution (50 mL) and the 
reaction mixture was diluted with Et2O (50 mL). After separation of the organic 
phase it was dried over MgSO4 and all volatiles were removed under reduced 
pressure to give the crude product as a yellow oil. This was further purified by 
column chromatography (SiO2, toluene/MeOH 30:1, Rf = 0.45 (major), 0.35 (minor) 
in toluene/MeOH 30:1) to yield (3S,4R)-4-ethyl-3-(hydroxy(phenyl)methyl)chroman-
2-one 23 (0.176 g, 0.624 mmol, 78 %) as a colourless oil. Compound 23 was 
isolated as a mixture of 2 diastereomers (ratio 3:1), signals are assigned where 
resolved. 
1
H NMR: (201 MHz, CDCl3) δ 7.48 – 6.92 (m, 9H, major + minor), 4.59 
(d, J = 9.4 Hz, 1H, major), 4.43 (d, J = 10.0 Hz, 1H, minor), 3.27 – 3.03 (m, 2H, 
major + minor), 2.73 (s (br), 1H, major + minor), 2.24 (t, J = 7.3 Hz, 1H, minor), 
1.49 (qd, J = 14.4, 7.3 Hz, 2H, major + minor), 0.90 (t, J = 7.3 Hz, 3H, major), 0.77 
(t, J = 7.3 Hz, 3H, minor). 
13
C NMR: (50 MHz, CDCl3) δ 168.46 (minor), 167.92 
(major), 150.48 (minor), 150.45 (major), 140.77 (major), 140.47 (minor), 129.22, 
128.87 (minor), 128.83 (major), 128.61 (major), 128.55 (minor), 128.36, 128.31 
(minor), 128.26 (major), 128.09, 127.38, 126.80, 126.34, 125.89, 124.87, 124.32 
(minor), 124.26 (major), 116.64 (minor), 116.34 (major), 72.58 (major), 64.91 
(minor), 53.93 (major), 53.29 (minor), 39.70 (minor), 39.07 (major), 28.59 (major), 
28.18 (minor), 11.07 (major), 10.87 (minor). HRMS: (ESI
+
) calculated for 
C18H18O3Na [M+Na
+
]: 305.1148, found: 305.1149. [α]D
20






In a flame-dried Schlenk tube, 2.5 mol% copper bromide dimethyl sulfide complex 
(4.11 mg, 0.02 mmol) and 3.0 mol% reverse Josiphos 
(0.014 g, 0.024 mmol) were dissolved in MTBE 
(Volume: 10.0 ml) and stirred at room temperature for 
15 min. Then, the mixture was cooled to -72 °C and 





Et2O, 0.80 ml, 2.4 mmol) were added and the mixture stirred for 10 more min. 
Then, a solution of 1.0 eq. 2H-chromen-2-one 12 (0.117 g, 0.80 mmol) in MTBE 
(Volume: 5.0 ml) was added dropwise over a period of 1 h. The reaction was stirred 
until TLC showed full conversion to the 1,4-addition product (~2 h). Then, 5.0 eq. 
propan-1-amine (0.33 ml, 4.00 mmol) were added and the reaction mixture was 
warmed to room temperature and stirred at that temperature for 16 h. Then, the 
reaction was quenched by adding saturated aq. NH4Cl solution (50 mL) and the 
reaction mixture was diluted with Et2O (50 mL). After separation of the organic 
phase it was dried over MgSO4 and all volatiles were removed under reduced 
pressure to give the crude product as a yellow oil. This was further purified by 
column chromatography (SiO2, pentane/EtOAc 1:1, Rf = 0.60 in pentane/EtOAc 
1:1, 96% ee) to yield (R)-3-(2-hydroxyphenyl)-N-propylpentanamide 24 (0.154 g, 
0.656 mmol, 82 %) as a colourless oil. 
1
H NMR: (400 MHz, CDCl3) δ 8.71 (s (br), 
1H), 7.12 – 7.02 (m, 2H), 6.94 – 6.83 (m, 2H), 6.26 (s (br), 1H), 3.34 (dd, J = 11.5, 
7.3 Hz, 1H), 3.07 (dd, J = 13.3, 6.7 Hz, 2H), 2.65 (dd, J = 15.3, 4.3 Hz, 1H), 2.45 
(dd, J = 15.3, 10.2 Hz, 1H), 1.72 (td, J = 14.2, 6.5 Hz, 2H), 1.48 – 1.28 (m, 2H), 
0.81 (t, J = 7.3 Hz, 3H), 0.75 (t, J = 7.4 Hz, 3H). 
13
C NMR: (101 MHz, CDCl3) δ 
173.76, 154.50, 130.74, 127.19, 127.01, 120.50, 117.24, 43.32, 41.32, 36.21, 
27.77, 22.33, 12.15, 11.03. HRMS: (ESI
+
) calculated for C14H22NO2 [M+H
+
]: 
236.1645, found: 236.1644. [α]D
20
 = -38.4 (c = 1.0 in CHCl3). ee determination by 
chiral HPLC (Chiralpak AB-H: n-heptane/2-propanol 95:5, 40 °C isotherm, 210 nm, 
flow rate 0.5 mL/min), retention times: 25.9 min (minor), 32.4 min (major). 
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Chapter 7 
Ni-catalyzed Reductive Coupling 
Reactions – Application of 
Phosphoramidite Ligands bearing 
chiral N-Heterocycles 
A new asymmetric nickel-catalyzed reductive coupling of isoprene and 
benzaldehyde has been developed. The corresponding products bear 1,3-
stereogenic centers and are available with excellent diastereoselectivity, albeit with 
moderate enantioselectivity. An extensive ligand screening has been carried out to 





H NMR experiments give evidence to support the proposed mechanism. 
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Transition metal-catalyzed reductive carbon-carbon bond formations represent an 
emerging field of organic synthesis and catalysis. Next to hydrogenative coupling 







reductive coupling reactions are among the most prominent. One of the most 
important advantages of these reaction is the fact that they do not require an 
organometallic reagent as carbon nucleophile to faciliate the C-C bond formation, 
what considerably reduces the waste generated during those transformations. (It 
should be noted, though, that some of the reactions employ organometallic 
reagents as reducing agents. See below.) The general approach can be 
summarized as follows: a compound bearing an unsaturated C-C bond such as an 
alkene or alkyne 1 is coupled to a suitable electrophile, in this case an aldehyde or 
a ketone 2 (Scheme 1). For this reaction to occur, a reducing agent is necessary to 
deliver an β-H atom to the alkene/alkyne. The obtained products 3 are highly 
functionalized and bear at least one stereogenic center adjacent to the alcohol. 
Furthermore, through judicious choice of the catalyst, different stereoisomers 
(cis/trans and E/Z) are available through this methodology. 
 
Scheme 1 Reductive coupling reactions 
One example of this transformation is depicted in Scheme 2. When internal or 
terminal alkynes 4 were reacted with aldehydes 5 in the presence of catalytic 
amounts of a Ni/phosphine complex employing triethylborane as the reducing 
agent, the corresponding allylic alcohols 6 were obtained reaching very good 
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Scheme 2 Ni-catalyzed reductive coupling of alkynes with aldehydes 
The proposed catalytic cycle for these transformations
6
 is depicted in Scheme 3. 
The alkyne (4) first coordinates to Ni(0) to give intermediate I. Then Ni can add to 
the alkyne in an oxidative fashion, triggering the nucleophilic attack on the 
activated aldehyde (5) to give nickelacycle II. It is important to note that here BEt3 
serves as a Lewis acid to activate the aldehyde, whereas it will serve as the 
reducing agent later on, so the role of BEt3 is twofold. In the following step, one 
alkyl group of the boron reagent is transmetallated to nickel to give intermediate III. 
Then, a β-hydride elimination can occur, yielding a nickel-hydride complex (IV). 
Subsequent reductive elimination furnishes the desired product as the boroxide 
complex V. Ni(0) can be liberated from intermediate V to enter a new catalytic 
cycle. During workup, the boroxide is protonated to yield the desired product 6.  
 
Scheme 3 Proposed catalytic cycle for the formation of allyl alcohol 6 
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A wide variety of related reactions has been developed,
6
 including an 
intramolecular Ni-catalyzed coupling reaction of alkynes with aldehydes leading to 
nitrogen-containing bicyclic compounds 8 (Scheme 4).
12,13
 In this case triethylsilane 
is employed as the reducing agent, which leads to in situ TMS protection of the 
corresponding alcohols 8. When piperidines 7 were reacted in the presence of a Ni 
catalyst, the corresponding bicyclic TMS-protected alcohols 8 were obtained in 
very good yields and diastereoselectivities (Scheme 4). 
 
Scheme 4 Intramolecular Ni-catalyzed coupling reaction 
Some enantioselective variants of the Ni-catalyzed reductive coupling reactions are 
known, employing chiral phosphine
14,15
 or N-heterocyclic carbene
16
 ligands. While 
this research project was in progress, the application of spiro-phosphoramidites L1 
in a nickel-catalyzed reductive coupling of dienes to aldehydes (Scheme 5) was 
reported.
17
 Using diethylzinc as the reducing agent, 1,4-diphenyl-butadiene 9 was 
coupled to aromatic aldehydes 10 to yield the products 11 in excellent yields and 
ee. In all cases, the 1,2-anti-products 11 were obtained.  
 
Scheme 5 Ni-catalyzed reductive coupling reactions 
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This methodology was extended to a 3-component coupling reaction
18
 of 
dimethylzinc, phenylpropyne 12 and aldehydes 13 to yield chiral allylic alcohols 14 
bearing a tetrasubstituted olefin with excellent enantioselectivities (Scheme 6).
19
 In 
this case, ZnMe2 does not furnish a reducing equivalent in the form of a Ni-H 
complex, since no β-hydrogens are available in ZnMe2. Instead, the methyl group 
is incorporated into the corresponding products 14 and thus serves the role of a 
reducing agent (compare Scheme 3). Again, a phosphoramidite ligand (L2) with a 
spirobiindane backbone gave the best results. 
 




The aim of this research project was to develop an asymmetric nickel-catalyzed 
reductive coupling reaction. We became interested in the reductive coupling 
reaction of 1,3-dienes, especially of isoprene, with aldehydes. This reaction had 
been reported in a non-stereoselective fashion earlier.
20,21
 When an excess of 
isoprene (15) was reacted with benzaldehyde 16 in the presence of Ni(acac)2 as 
catalyst (acac = acetylacetonato), the corresponding homoallylic alcohol 17 could 
be isolated with very good diastereoselectivitiy favoring the anti isomer (Scheme 
7). Both BEt3 and ZnEt2 were examined as reducing agents and were shown to 
give the same product, however, BEt3 as the reducing agent was giving 17 in a 
considerably higher yield. The diastereoselectivity appeared to be unaffected by 
the reducing agent. 
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Scheme 7 Ni-catalyzed reductive coupling of isoprene with benzaldehyde 
The proposed mechanism
7
 of this reaction has close analogy to the previously 
described one (compare Scheme 3), and can generally be described as the 
vinylogous variant thereof. In this reaction, BEt3 (or ZnEt2) serves three purposes: 
first it reduces the Ni(II) precursor to Ni(0), second it activates the aldehyde and 
finally it acts as the reducing agent for the whole transformation. Isoprene (15) can 
coordinate to nickel(0) and subsequently can undergo an oxidative 
insertion/cyclization reaction (A in Scheme 8) with the activated aldehyde 16 to 
give oxallylnickel(II) intermediate II. This reaction represents already the key C-C 
bond forming step and should therefore govern the stereoselectivity at the benzylic 
position. It can be represented as an oxidative insertion of Ni(0) to the terminal, 
sterically less demanding, double bond of isoprene, which will subsequently attack 
the electrophile (16) (A in Scheme 8). The resulting alkoxide can then coordinate to 
Ni(II) to form the neutral cyclic intermediate II. In analogy to the mechanism 
discussed earlier, a transmetallation of one of the alkyl substituents of BEt3 to 
nickel can take place, giving intermediate III. β-Hydride elimination furnishes a 
nickel-hydride complex (IV), which can undergo reductive elimination to form 
boroxide adduct V of the desired product 17. Ni(0) can subsequently enter a new 
catalytic cycle. During the reductive elimination step both the regioselectivity of the 
double bond position as well as the stereoselectivity of the second stereogenic 
center formed at the allylic position are determined. Alternatively, intermediate III 
can be the starting point for a reductive elimination reaction to give the three-
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Scheme 8 Proposed catalytic cycle for the formation of 17 
 
Goal 
This Ni-catalyzed reductive coupling reaction is interesting for a variety of reasons. 
First, it uses cheap and readily available starting materials and takes place at 
ambient temperatures. Second, the products like 17 are highly functional building 
blocks posessing a terminal olefin moiety, a secondary alcohol and an aromatic 
ring. Third, this reaction creates two stereocenters in a 1,3-relationship in only one 
synthetic step. No asymmetric variant of this transformation was known in 
literature, therefore we decided to explore this possible extension. We envisaged to 
start off our study with the investigation of Ni/phosphoramidite complexes as chiral 
catalysts for the reductive coupling of isoprene with aldehydes, since 
phosphoramidite ligands are, due to their modular design, ideally suited for fine-
tuning of their electronic and steric parameters.
22,23
 As already mentioned, during 
the course of this research project, it was demonstrated that those complexes were 
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indeed suitable to induce enantioselectivity in related reactions (see Scheme 5 and 
Scheme 6). It was to be investigated in how far different ligands and/or reducing 
agents would affect the diastereo- as well as the enantioselectivity of the reductive 
coupling of isoprene with aldehydes. Ideally, chiral bishomoallylic alcohols 17 
would be available in high enantiomeric excess and accessible selectively as either 
the syn or the anti diastereomer. 
 
3. Results and Discussion 
3.1 Initial screening results 
Preliminary screening experiments of the envisaged reductive coupling of isoprene 
(15) with benzaldehyde (16) in the presence of Ni/phosphoramidite complexes as 
catalysts revealed several important aspects of this transformation (for selected 
experiments, see Table 1). First of all, we were delighted to observe that the 
envisaged coupling reaction took place with catalysts comprising 
Ni/phosphoramidite complexes with chiral BINOL backbones (Table 1, entries 3-6). 
Even though comparable results in terms of diastereoselectivity with the previously 
published work
20,21
 were found, no stereoinduction was observed with simple 
phosphoramidites L3-L5. With bidentate phosphine ligands, such as BINAP or 
ferrocenyl-based ligands (Josiphos, Taniaphos) no reaction was observed. These 
findings indicated that monodentate ligands are required for the Ni-catalyzed 
reductive coupling to occur. 
A second observation made in preliminary experiments was that dialkylzinc 
reagents had to be employed as reducing agents. When trialkylborane compounds 
were used as reducing agents, no conversion to the desired coupling product 17 
was found (Table 1, entry 3). This is a remarkable observation, since in the original 
reports employing Ni(acac)2 as catalyst, BEt3 had been employed as the reducing 
agent for this particular reaction (also compare Table 1, entry 1).
20,21
 This result 
shows that the electronic properties of the nickel/phosphoramidite complexes differ 
significantly from the properties of their precursors, Ni(acac)2 and Ni(COD)2. Also, 
in terms of yields and enantioselectivity for 17, using a nickel(II) precursor (namely 
Ni(acac)2) or a nickel(0) precursor (Ni(COD)2) did not give different results. This 
suggests a reduction of the Ni(II) precatalyst to Ni(0) by the dialkylzinc reagent 
prior to the actual catalytic cycle, which is consistent with the proposed mechanism 
(see also Scheme 8).
7,20,21
 In the following experiments, Ni(acac)2 was employed 
due to its higher air-stability. 
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To achieve enantioselectivity in the formation of the desired product 17, 
phosphoramidites bearing chiral amine moieties had to be used. Therefore we 
chose bisphenylethylamine-derived phosphoramidite L6, which had been 
successfully employed in a variety of reactions
23
 as the benchmark ligand (Table 1, 
entry 7). With L6 and diethylzinc as the reducing agent, 17 was formed in 56% 
yield and 15% ee. It should be noted that in all cases employing ZnEt2 as the 
reducing agent, full conversion of isoprene (15) was observed. Along with the 
desired product 17, a variety of side products were observed (20 – 22, see Table 
2), including 1-phenylpropanol (22) resulting from nucleophilic attack of ZnEt2 on 
benzaldehyde (16). 









1 - BEt3 92% 20:1 / - 
2 - ZnEt2 55% 20:1 / - 
3 L4 BEt3 - - / - 
4 L4 ZnEt2 71% 10:1 / 0% 
5 L3 ZnEt2 45% 18:1 / 0% 
6 L5 ZnEt2 61% 18:1 / 0% 
7 L6 ZnEt2 56% 19:1 / 15% 
a
Reaction conditions: 0.50 mmol isoprene (15), 0.60 mmol benzaldehyde (16), 0.01 mmol Ni(acac)2 and 
0.011 mmol L were dissolved in 2.5 mL THF at rt. Then, 1.0 mmol of ZnEt2 solution (c = 1.0 M in THF) 
was added dropwise and the reaction mixture was stirred until TLC showed full conversion of 15 (~ 2h). 
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The reaction was quenched with sat. aq. NH4Cl solution, and the product obtained by extraction with 
Et2O.
 b
Determined by GC. The syn diastereomer is the major one. 
c
Determined by chiral GC or HPLC. 
We found that the nickel to ligand ratio needs to be close to 1:1 for the coupling 
reaction to proceed smoothly to 17, with compounds 20 to 22 observed as side-
products (Table 2, entry 1). 22 is the product of the direct addition of ZnEt2 to 
benzaldehyde (16), the formation of 21 could be explained by the double reaction 
of isoprene with two equivalents of benzaldehyde. When a Ni/L ratio of 1:2 was 
employed (Table 2, entry 2), the envisaged coupling reaction still took place, but 
the desired coupling product 17 was accompanied by equal amounts of 
sideproducts 20 to 22. Compound 20 results from the three-component coupling 
(compare intermediate III in Scheme 8). Importantly, 20 is also formed with 15% 
ee, suggesting that 17 and 20 are formed from the same catalytic intermediate in 
which the stereoinformation at the benzylic position is already fixed (intermediate II 
in Scheme 8).  
Table 2 Influence of the Ni/L ratio 
 
Entry Ni/L6 Temperature 17/20/21/22
a
 
1 1 : 1 rt 60 : 20 : 5 : 10 
2 1 : 2 rt 20 : 25 : 30 : 20 
3 1 : 1 0 °C 0 : 70 : 0 : 30 
a
Determined by both, 
1
H NMR and GC/MS. Arbitrary units. 
The abovementioned results suggest that several nickel/L6 complexes with 
different catalytic behaviour are present in solution. Most probably there are 
equilibria present between the various species, since even with a 1:2 Ni/L6 ratio, 
compound 17 is still formed. A 1:1 ratio of metal and ligand favours the formation of 
the desired product 17, a 1:2 ratio leads to the conversion of 15 and 16 to several 
by-products in an unselective manner. This behaviour could be supported by the 
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proposed mechanism presented in Scheme 8, in which the three Ni(II) 
intermediates II to IV leave only one further coordination site to be occupied by a 
ligand to give rise to a 16 electron complex. The data presented in Table 2 suggest 
that a Ni/L2 complex could be catalytically inactive and/or enter different catalytic 
pathways (for mechanistic investigations, see also section 3.6). 
An important finding is reported in Table 2, entry 3. When the reaction was carried 
out at 0 °C with a Ni/L6 ration of 1:1, no formation of 17 was observed, however, 
20 was formed as the major product. This gives important insight to the proposed 
mechanism, as the crucial β-hydride elimination seems to be prevented at lower 
temperatures.
24
 This observation can be explained by the fact that eliminations are 
generally favoured at higher temperatures due to the increase in entropy. 
 
3.3 Screening of reducing agents 
Other reducing agents were investigated in the following studies (Table 3). We 
found that in terms of selectivity, similar results as with ZnEt2 could be observed 
with AlEt3 (Table 3, entry 2). Remarkably, ZniPr2 gave a much more selective 
reaction towards 17 accompanied by a slightly higher ee (Table 3, entry 3). These 
two examples hint towards the fact that the enantiodiscriminating step does 
depend on the metal reagent employed, and sterics of the organic substitutents of 
the organometallic reagent. The related iso-propylzinc bromide (Table 3, entry 4), 
showed similar results in terms of product distribution. However, in this case, the 
syn/anti ratio of 17 was found to be 1:1, and the ee dropped to 17%. These two 
results (Table 3, entries 3,4) demonstrate that with secondary organozinc reagents 
much more selective reactions can be carried out. This could stem from the higher 
steric bulk that the iso-propyl substituents create around the Ni(II)-center. As 
expected, the corresponding Grignard reagent led to only 1,2-addition product 
(Table 3, entry 5). The reactions employing aluminum hydrides or lithium 
triethylborohydride (Table 3, entries 6-8) led to reduction of benzaldehyde (16) to 
benzylalcohol 23. The use of borane gave traces of the desired product 17 along 
with its double bond isomer 20 (R = H), but also in this case, benzylalcohol 23 was 
the major product (Table 3, entry 9). The use of sodium borohydride and sodium 
cyanoborohydride did not lead to any conversion (Table 3, entries 10, 11). 
Attempts to use poly(methylhydrosiloxane (PMHS) as reductant,
25
 as well as the 
attempt to carry out a hydrogenative coupling did not lead to conversion to 17 
(Table 3, entries 12, 13). Since the reaction with ZniPr2 led to higher ee along with 
a considerably higher selectivity for 17 (Table 3, entry 3), we continued to optimize 
  
214 
   
Chapter 7 
 
the asymmetric Ni-catalyzed reductive coupling reaction employing this reducing 
agent. 
Table 3 Screening of reducing agents 
 
Entry Reducing agent 17/20/23/24
a
 Comment 
1 ZnEt2 60 : 20 : 0 : 10 - 
2 AlEt3 60 : 20 : 0 : 10 17: 14% ee 
3 ZniPr2 80 : 10 : 0 : 0 17: 23% ee  
4 ZniPrBr 80 : 10 : 0 : 0
b
 17: 17% ee  
5 iPrMgCl 0 : 0 : 0 : 100 - 
6 DIBAL-H 0 : 0 : 100 : 0 - 
7 LiAlH4 0 : 0 : 100 : 0 - 
8 LiHBEt3 0 : 0 : 100 : 0 - 
9 BH3 10 : 10 : 30 23 = 24 
10 NaBH4 - no reaction 
11 NaCNBH3 - no reaction 
12 PMHS
c
 - no reaction 
13 H2
d
 - no reaction 
a
Determined by both, 
1
H NMR and GC/MS. Arbitrary units. 
b
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3.4 Screening of solvents 
With the optimized results for the reducing agents in hand, we went on to 
investigate the influence of the solvent (Table 4). It was found that the envisaged 
transformation is relatively robust with respect to the choice of solvent, as 
conversion to the desired product 17 was found under most conditions tested. The 
majority of the solvents gave the anti diastereomer of 17 as the main product 
(Table 4, entries 1,2 and 4-6), with toluene giving the highest ee for anti-17 (35%). 
Similar results in terms of enantioselectivity were only found with MeCN as solvent 
(Table 4, entry 3), however, in this case accompanied by a reversed 
diastereoselectivity to give the syn diastereomer of 17 as the major one. This could 
be explained by the ability of MeCN to act as a ligand for the Ni catalyst, leading to 
a catalyst with different spatial constraints. It is remarkable, though, that the 
opposite effect is observed employing THF as the solvent, which one could also 
expect to act as a ligand for Ni (Table 4, entry 2). 








 ee of 17 Comment 
1 toluene full 19 : 1 35% 95% yield 
2 THF full 20 : 1 23%  
3 MeCN 65% 1 : 2 37%  
4 CH2Cl2 full 14 : 1 25% 10% 20 
5 TBME full 8 : 1 30% traces 20 
6 EtOAc 80% 10 : 1 26%  
a
Reaction conditions: 0.50 mmol isoprene (15), 0.60 mmol benzaldehyde (16), 0.01 mmol Ni(acac)2 and 
0.011 mmol L6 were dissolved in 2.5 mL THF at rt. Then, 1.0 mmol of a ZniPr2 solution (c = 1.0 M in 
THF) was added dropwise and the reaction mixture was stirred until TLC showed full conversion (~ 2h). 
The reaction was quenched with sat. aq. NH4Cl solution, and the product obtained by extraction with 
Et2O. 
b
Determined by both, 
1
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3.5 Ligand screening 
One of the major advantages of phosphoramidite ligands is because of their 
modularity they can be easily varied and screened for activity and stereoselectivity 
in catalysis.
23,26-28
 With the optimized conditions, we set off to investigate the 
influence of a variety of phosphoramidite ligands, some of which are reported in 
Table 5. Starting off from the benchmark ligand (S,R,R)-L6, we first investigated 
the influence of its diastereomer, (R,R,R)-L6, which gave significantly worse results 
in terms of conversion and stereoselectivity (Table 5, entry 2). This clearly shows a 
matched/mismatched relationship of the two diastereomers of L6 for the envisaged 
reaction. Replacement of one phenylethyl substituent with an isopropyl group led to 
slightly higher enantioselectivity (Table 5, entry 3), the Ph-substituted derivative 
gave the three-component coupling product 20 as the major one (Table 5, entry 4). 
The octahydroBINOL-backbone of L9 as well as 3,3’-substitution as in L10 led to 
lower enantioselectivity (Table 5, entries 5,6). As observed before (see Table 1), 
phosphoramidites with non-chiral amines L11 and L12 gave no enantioselectivity 
(Table 5, entries 7,8). Ligands bearing (S)-prolinate as the amine substituent 
(Table 5, entries 9,14), posessing an ester moiety which could act as a second 
coordination unit, were favouring the three-component coupling product 20. Both 
17 and 20 were formed in a racemic fashion. Higher enantioselectivities were 
observed employing smaller or more flexible diol backbones, as in the case of 
biphenol-derived L14 (43% ee, Table 5, entry 10) and catechol-derived L16 (46% 
ee, Table 5, entry 12). However, structural variatons of these two ligands L15 and 
L17 led to lower enantioselectivities (Table 5, entries 11,13). The same holds for 
TADDOL-derived L19 (Table 5, entry 15). It is remarkable, though, that some of the 
ligands investigated gave exceptional levels of diastereoselectivity, as in the case 
of L15 and azepine-derived ligand L20 (Table 5, entries 11,16). It has been 
reported in the literature that the olefin moiety in L20 can have a remarkable effect 
on catalysis, most probably due to a flexible, or labile coordination to the metal.
29
 A 
similar trend was observed when comparing the two 2,5-dinaphthylpyrrolidine-
derived
30
 ligands L21 and L22 (see also Chapter 2, Table 5, entries 17, 18). 
Whereas both give excellent diastereoselectivities, it can be seen that L22, bearing 
the unsaturated pyrroline moiety gives higher enantioselectivity (40% ee vs 33% 
ee), which could be attributed to an additional hemi-labile coordination of the olefin 
moiety to the Ni.  
In summary, it can be concluded that the screening of phosphoramidite ligands led 
to some insights with respect to preferred and less preferred structural features of 
the ligands, but the ee reached remained rather low (46%, L16, Table 5, entry 12). 
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Further structural elaboration of these ligands did not lead to improvements in 
terms of enantioselectivity. It should be noted though, that some of the reactions 
achieved outstanding diastereoselectivity favouring the anti-product 17. 

















3 : 1 rac. 
3 
 
L7 - 19 : 1 +39% 
4 
 
L8 Mostly 20 n.d. +6% 
5 
 
L9 - 16 : 1 +29% 
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L10 - 14 : 1 -22% 
7 
 
L11 - 15 : 1 rac. 
8 
 
L12 - 15 : 1 rac. 
9 
 
L13 17 / 20 1:2 n.d. rac. 
10 
 
L14 - 18 : 1 +43% 
11 
 
L15 - >99 : 1 +22% 
12 
 
L16 - 19 : 1 +46% 
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L17 - 16 : 1 -24% 
14 
 
L18 17 / 20 1:1 n.d. rac. 
15 
 
L19 - 23 : 1 +18% 
16 
 
L20 - >99 : 1 +17% 
17 
 
L21 - >99 : 1 +33% 
18 
 
L22 - >99 : 1 +40% 
a
Reaction conditions: 0.50 mmol isoprene (15), 0.60 mmol benzaldehyde (16), 0.01 mmol Ni(acac)2  and 
0.011 mmol ligand were dissolved in 2.5 mL THF at rt. Then, 1.0 mmol of ZniPr2 solution (c = 0.5 M in 
toluene) was added dropwise and the reaction mixture was stirred until TLC showed full conversion (~ 
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2h). The reaction was quenched with sat. aq. NH4Cl solution, and the product isolated by extraction with 
Et2O. 
b
Determined by both, 
1
H NMR and GC/MS.  
Besides investigating the influence of various phosphoramidite ligands on the Ni-
catalyzed reductive coupling reaction, we also studied other types of chiral ligands. 
The results are summarized in Table 6. The related BINOL-derived phosphite L23 
gave 20 as the major product (Table 6, entry 1), whereas chiral phosphines L24 
and L25 led to low conversion to 17 and low or no enantioselectivity (Table 6, 
entries 2,3). Remarkably, aminophosphine L26, coined SimplePhos,
31
 led to 17 
with 23% ee and excellent diastereoselectivity favouring the anti isomer of 17 
(Table 6, entry 4). Secondary phosphine oxide L27
32
 gave only compound 20 
(Table 6, entry 5). An interesting result is shown in entry 6, as chiral diene L28
33
 
also led to some stereoinduction, albeit low (15% ee). To the best of our knowledge 
this marks the first example of an catalytic asymmetric transformation with Ni 
catalysts bearing a chiral diene ligand.
34
 Furthermore, this example demonstrates 
that a coordination of olefins can have an important influence on the catalyst, as 
has been seen in the case of some phosphoramidite ligands bearing olefins as 
additional coordination sites (vide supra). Finally, it was shown that N-heterocyclic 
carbene (NHC) ligands can be successfully applied to this kind of transformation, 
as the reaction employing L29
35
 gave 17 in 15% ee and with excellent 
diastereoselectivity (Table 6, entry 7). It has to be noted, though, that in the case of 
NHC ligands, Ni(COD)2 has to be employed. Using Ni(acac)2 as the Ni precursor in 
those cases lead to considerably lower conversion.  











L23 80% 20 n.d. 17: rac. 
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L26 - >99 : 1 +23% 
5 
 
L27 only 20 - - 
6 
 





L29 - >99 : 1 +15% 
a
Reaction conditions: 0.50 mmol isoprene (15), 0.60 mmol benzaldehyde (16), 0.01 mmol Ni(acac)2  and 
0.011 mmol ligand were dissolved in 2.5 mL THF at rt. Then, 1.0 mmol of ZniPr2 solution (c = 0.5 M in 
toluene) was added dropwise and the reaction mixture was stirred until TLC showed full conversion (~ 
2h). The reaction was quenched with sat. aq. NH4Cl solution, and the product isolated by extraction with 
Et2O. 
b
Determined by both, 
1
H NMR and GC/MS. 
c
Ni(COD)2 was used instead of Ni(acac)2. 
Summarizing the results of the ligand screening, we were able to demonstrate that 
a variety of chiral monodentate ligands as well as a chiral diene ligand can be 
successfully employed in the Ni-catalyzed reductive coupling reaction of isoprene 
with benzaldehyde. With some ligands excellent diastereoselectivities have been 
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3.6 Mechanistic studies 
Since we found that generally in the Ni-catalyzed reductive coupling of isoprene 
with benzaldehyde only the use of monodentate ligands led to conversion to the 
desired coupling product, we decided to study the mechanism of this reaction using 
Ni/phosphoramidite complexes as a probe for NMR spectroscopy. We anticipated 
that we could employ 
31
P NMR spectroscopy to study the reaction in more detail, 
which might give some support to the proposed mechanism (see Scheme 8).  
We started off by carrying out a titration experiment, where various equivalents of 
catechol-based phosphoramidite L16 were added to Ni(COD)2 (Figure 1). We 
observed a fast coordination of L16 to Ni(0) which was accompanied by a change 
of colour from bright yellow to orange. We observed that with Ni/L ratios of 1:1 and 
1:2 a signal at 197 ppm in the 
31
P NMR could be observed. When more equivalents 
of L16 were added, a second peak at 179 ppm appeared. With an even larger 
excess of L16, the peak at 197 ppm disappeared and a new one became visible at 
158 ppm. This can be attributed to the free ligand L16. We conclude from these 
results that more than one Ni/L16 complex is formed, most probably with a different 
stoichiometry. The complex with the signal at 197 ppm should have a higher Ni/L 
ratio in comparison to the one having a signal at 179 ppm, since the latter appears 
at higher concentrations of L16 and seems to have a higher number of ligands 
coordinated to Ni, as with higher concentrations of L16 the uncoordinated ligand 
(at 158 ppm) starts to appear. This behaviour is similar to Ni/PPh3 complexes.
36
 It 
is important to note that the complex with a lower Ni/L ratio (at 179 ppm) seems to 
be symmetric with respect to the coordinating ligands, as only a singlet is 
observed. If the ligands would be inequivalent, one would expect a P-P coupling 
between the ligands,
37,38
 which had been observed with other Ni/phosphoramidite 
complexes (vide infra).  
Figure 1 
31
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a
Reaction conditions: 0.02 mmol Ni(COD)2 and n eq. L16 were dissolved in toluene-d8 at rt and the 
solution stirred for 5 min. At every stage, samples were taken and analyzed by 
31
P NMR. 
When the complexation of Ni(COD)2 with different equivalents of BINOL-derived L5 
in CDCl3 was followed by 
31
P NMR, different results were obtained (Figure 2). It 
should be noted that these experiments were carried out in CDCl3 and therefore a 
different chemical shift in the 
31
P NMR is observed. With 1 and 2 equivalents of L5 
with respect to Ni, the corresponding complexes seemed to have a low stability, as 
quick deposition of elementary Ni on the wall of the NMR tube was observed. 
When we went to higher equivalents of L5, the complexes seemed more stable, 
and could be detected by 
31
P NMR. Two doublets with a roof effect (J = 115 Hz) 
were observed at 137 ppm, which can be interpreted as a Ni/Lx complex with x ≥ 2, 
in which the ligands are not equivalent and therefore couple to each other. This is 
an often observed feature with phosphorus-chelating ligands and transition 
metals.
37-41
 Again, when more L5 was added, the signal of the free ligand (146 
ppm) started to increase. When the spectra of Figure 1 and Figure 2 are compared, 
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it can be seen that the structure of the phosphoramidite ligand has a remarkable 
effect on the symmetry of the corresponding complexes. This could be due to the 
fact that the BINOL backbone of L5 is both, sterically more demanding and axially 
chiral, when compared to the catechol backbone of L6. 
Figure 2 
31




Reaction conditions: 0.05 mmol Ni(COD)2 and n eq. 0.05 mmol L5 were dissolved in CDCl3 at rt and  
the solution stirred for 5 min. At every stage, samples were taken and analyzed by 
31
P NMR. 
Next, we turned our attention to following the Ni-catalyzed reductive coupling 
reaction of 15 with 16 under the optimized reaction conditions by 
31
P NMR (Figure 
3). The only change compared to the benchtop reaction that was made was the 
change of solvent to toluene-d8. As expected, when the Ni(II) precursor, Ni(acac)2, 
and L16 were mixed we only observed the signal of the free ligand L16 (158 ppm), 
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and no Ni/L16 coordination took place (A in Figure 3). When the reducing agent 
ZniPr2 was added, two new species could be observed, at 179 and 177 ppm (B in 
Figure 3) with full consumption of uncoordinated L16. When finally the reagents 
were added and the reaction was run in the NMR tube, two resonances, at 179 and 
158 ppm were observed (C in Figure 3). The latter can be attributed to the 
uncoordinated ligand. This result is somewhat surprising, as we have found a 
Ni/L16 complex at 179 ppm with most probably more than one L16 coordinated to 
Ni in previous experiments as well (compare Figure 1). From the optimization of the 
reaction, we know that a Ni/L16 ratio of close to 1:1 is ideal for good selectivity 
towards the desired coupling product. One could speculate on the basis of these 
results that during the reaction a resting state exists in which the Ni is coordinated 
by more than one ligand L16. 
Furthermore, we carried out the same experiment with Ni(COD)2 as the Ni 
precursor (Figure 4), which had been shown to give the same results in terms of 
selectivity towards the coupling product (vide supra). In this case, we found the 
same results, except that already during the mixing of L16 and Ni(COD)2, two 
complexes with signals at 197 and 179 ppm were formed (A in Figure 4), which is 
consistent with our previous findings (see Figure 1). Interestingly, when both the 
reducing agent and the substrates were added (C in Figure 4), the same resting 
state at 179 ppm as in the case of Ni(acac)2 was observed. This leads to the 
conclusion that both reactions have the same catalytic cycle with the same resting 
states, independent of the Ni precursor used. This has also been shown during the 
optimization of the reaction, as the same results in terms of product distribution and 
selectivity were found with both Ni(0) and Ni(II) precursors (see section 3.1). 
Therefore, the ligands of the Ni precursor (acac or COD) seem not to play a role 















Reaction conditions: 0.01 mmol Ni(acac)2 and 0.011 mmol L16 were dissolved in toluene-d8 at rt and 
the solution stirred for 5 min. (= A). Then, 2.0 eq. ZniPr2 (0.40 mmol) was added (= B). 1.0 eq. isoprene 
(0.20 mmol) and 1.2 eq. benzaldehyde (0.24 mmol) were added (= C). At every stage, samples were 
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Figure 4 
31






Reaction conditions: 0.01 mmol Ni(COD)2 and 0.011 mmol L16 were dissolved in toluene-d8 at rt and 
the mixture stirred for 5 min. (= A). Then, 2.0 eq. ZniPr2 (0.40 mmol) was added (= B). Subsequently, 
1.0 eq. isoprene (0.20 mmol) and 1.2 eq. benzaldehyde (0.24 mmol) were added (= C). At every stage, 
samples were taken and analyzed by 
31
P NMR. 
Besides following the reaction with 
31
P NMR, we also used 
1
H NMR for the 
investigation of the Ni-catalyzed reductive coupling. As in the proposed mechanism 
for this reaction (Scheme 8), nickel-hydride intermediates were postulated, we 
were interested in observing those by 
1
H NMR (Figure 5). Indeed, we were able to 
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observe resonances at around -12 ppm, which is typical for Ni-hydrides.
42-44
 
Employing ZniPr2 as the reducing agent, a resonance was observed at -12.0 ppm 
(A in Figure 5), whereas two signals at -11.5 and -13.5 ppm were found employing 
ZniPrBr as the reducing agent (B in Figure 5). In the benchtop experiment, it was 
found that ZniPrBr gave both syn and anti diastereomers of the product in a 1:1 
ratio, whereas ZniPr2 gave the anti coupling product in about 20:1 selectivity 
(compare Table 1). Therefore, we assign the two signals in B to two diastereomeric 
Ni-H complexes leading to syn-17 and anti-17, and the signal in A to an 
intermediate Ni-H complex leading to anti-17. 
Figure 5 
1





Reaction conditions: 0.01 mmol Ni(acac)2 and 0.011 mmol L16 were dissolved in toluene-d8 at rt and 
the mixture stirred for 5 min. Then, 2.0 eq. ZniPr2 (= A) or ZniPrBr (= B) (0.40 mmol) was added. 
Subsequently, 1.0 eq. isoprene (0.20 mmol) and 1.2 eq. benzaldehyde (0.24 mmol) were added.  
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The observation of nickel-hydride complexes as reaction intermediates in the Ni-
catalyzed reductive coupling reaction gives some evidence for the proposed 
mechanism (Scheme 9). To the best of our knowledge, no further study has been 
carried out so far to support this mechanism. Based on our detection of 
intermediate nickel-hydride complexes, we suggest that the mechanism does go 
via a nickel-hydride intermediate (such as IV in Scheme 9). However, since we 
observed two diastereomeric Ni-H complexes with ZniPrBr, and only one with 
ZniPr2 as the reducing agent, we suggest to adapt the scheme providing the 
reaction intermediates: since previously drawn intermediate IV shows a π-Ni-oxallyl 
compound that has no specified stereochemistry at the second stereocenter, IV 
should be replaced by the σ-Ni-oxallyl complex IVa. Complex IVa represents a 
resonance structure of IV, but displays the stereogenic center bearing the methyl 
group. Therefore, the syn and anti diastereomers of IVa should posess different 




Scheme 9 Some intermediates from the proposed mechanism 
To further gain some insight in the catalytic intermediates of the Ni-catalyzed 
reductive coupling of isoprene and benzaldehyde, we carried out high resolution 
mass spectrometry (ESI-TOF) of the reaction mixture. However, no conclusive data 
could be obtained. We attribute this to the fact that the reaction intermediates as 
shown in Scheme 3 and Scheme 9 are not charged particles and therefore need to 
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be ionized first. Most probably the intermediate Ni-complexes fragment during 
ionization and therefore cannot give any further evidence with regards to the 
catalytic cycle. 
 
4. Conclusions and Future Prospects 
In conclusion, we have developed a new asymmetric Ni-catalyzed reductive 
coupling reaction of isoprene and benzaldehyde. We were able to demonstrate that 
a variety of chiral Ni complexes could catalyze this transformation, and that 
monodentate phosphorus-based ligands were beneficial for conversion to the 
desired products. In an extensive screening of phosphoramidite ligands we were 
able to identify some leading ligand structures, however, the maximal 
enantioselectivity in the envisaged reaction remained at 46% ee with L16. It should 
be noted though that unprecedented levels of diastereoselectivity favouring the anti 
product were achieved with some ligands, including N-heterocyclic carbene (NHC) 
ligands. Furthermore, the use of phosphoramidite and NHC ligands allowed for 
lowering the catalyst loading to 2 mol%. 
Furthermore, it was shown that phosphoramidites bearing a second labile 
coordination moiety generally showed good results with regards to 
stereoselectivity. Along the same lines, it was shown that chiral diene ligands lead 
to effective Ni catalysts for the envisaged reductive coupling reaction. These 
findings could serve as a starting point for a more sophisticated ligand design. The 
nature of the reducing agent was also shown to be highly influencial on the 
outcome of the reaction, as the employment of dialkylzinc reagents was found to 
be beneficial in terms of product selectivity and stereoselectivity. 
Based on Ni/phosphoramidite complexes, mechanistic studies showed that the 
reactions with different Ni precursors run via the same reaction intermediates or 
resting states, an observation consistent with our experimental findings. Second, 
1
H NMR analysis of the reactions gave evidence for the presence of Ni-hydride 
species that had previously been postulated. We were able to produce evidence 





A good starting point for future research would be the investigation of chiral NHC 
ligands for the Ni-catalyzed reductive coupling reaction. It was demonstrated that 
these ligands lead to some ee in the coupling product in our case. Many 
  
  231 
Ni-catalyzed Reductive Coupling Reactions 
applications of chiral NHC complexes have been reported in the literature,
45-49
 
leaving much room for further investigation and optimization of the Ni-catalyzed 
reductive coupling reactions with these chiral complexes. 
As for the reaction itself, a further extension could be the study of the reductive 
coupling reaction of isoprene (15) to imines 25 or related structures (Scheme 10). 
Since it is expected that the intermediate amines would coordinate well to the Ni-
catalyst during the reaction, this could lead to higher enantioselectivity. The non-
enantioselective variant has been reported in the literature, demonstrating that in 
principle Ni catalysts are able to catalyze these transformations.
50
 Chiral secondary 
amines 26 with a 1,3-chiral motif could be valuable chiral building blocks for further 
functionalization. 
 
Scheme 10 Suggested reductive coupling of isoprene with imines 
 
5. Experimental Section 



















































. L28 was purchased from Sigma-Aldrich. L24 and L25 were kindly 
donated by DSM. 
 
Ni-catalyzed reductive coupling reaction of isoprene and benzaldehyde  
In a flame-dried Schlenck tube, 2.0 mol% Ni(acac)2 (2.59 mg, 10.0 µmol) and 2.1 
mol% L16 (3.82 mg, 10.5 µmol) were dissolved in 2.5 mL dry toluene. Then, 1.00 
eq. isoprene (15) (0.050 ml, 0.50 mmol) and benzaldehyde (16) (0.061 ml, 0.600 
mmol) were added. Subsequently, 2.00 eq. diisopropylzinc solution (c = 0.5 M in 
toluene) (1.0 ml, 1.0 mmol) was added slowly. The colour changed from pale green 
via yellow to orange/red. The reaction mixture was stirred at room temperature for 
2h (or until TLC and/or GC/MS showed full conversion). The reaction mixture was 
quenched with a sat. aq. solution of NH4Cl (5 mL) and extracted with EtOAc (3x 10 
mL). The combined organic phases were dried over MgSO4 and all volatiles were 
removed in vacuo. The resulting yellow oil was purified by column chromatography 
(SiO2, pentane / EtOAc 40:1, Rf = 0.60 in Pentane / EtOAc 10:1) to yield 17 (0.085 
g, 0.480 mmol, 96%) as a colorless oil. The ligand screening described in Table 5 
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was carried out with half of the amounts given using stock solutions for Ni(acac)2, 




H NMR (201 MHz, CDCl3) δ 7.42 – 7.22 (m, 5H), 5.79 (ddd, J = 17.8, 10.2, 7.8 Hz, 
1H), 5.09 – 4.91 (m, 2H), 4.73 (t, J = 6.8 Hz, 1H), 2.23 (dt, J = 
13.7, 6.8 Hz, 1H), 1.97 (s (br), 1H), 1.95 – 1.77 (m, 1H), 1.67 
(dt, J = 13.4, 4.8 Hz, 2H), 1.04 (d, J = 6.7, 3H). 
13
C NMR (50 
MHz, CDCl3) δ 144.67, 144.54, 128.46, 127.58, 126.01, 
113.24, 73.04, 45.92, 35.18, 20.46. The enantiomeric excess 
was determined by chiral GC or chiral HPLC. GC: CP-Chiralsil-
Dex-CB (25m x 0.25 mm), 95 °C isotherm. Retention times 61.5 min and 62.8 min. 
HPLC: (Chiralpak OD-H: n-heptane/2-propanol 99:1, 40 °C isotherm, 200 nm), 
retention times: 30.8 min, 34.6 min. GC/MS: 158 (17%), 143 (80%), 128 (73%), 
120 (33%), 115 (33%), 107 (100%), 91 (23%), 79 (60%). 
 
Syn-3-methyl-1-phenylpent-4-en-1-ol (17) 
Isolated from the reaction with ZniPrBr as reducing agent (0.031 g, 0.175 mmol, 
35%) as a colorless oil. Purification by column chromatography 
(SiO2, pentane / EtOAc 40:1, Rf = 0.65 in pentane / EtOAc 
10:1) gave 17 as a colorless oil.  
1
H NMR (201 MHz, CDCl3) δ 
7.47 – 7.19 (m, 5H), 5.93 – 5.61 (m, 1H), 5.21 – 4.94 (m, 2H), 
4.72 (dd, J = 9.2, 3.9 Hz, 1H), 2.55 – 2.28 (m, 1H), 1.87 (s (br), 
1H), 1.86 – 1.71 (m, 1H), 1.60 (ddd, J = 13.7, 9.5, 4.0 Hz, 2H), 1.05 (d, J = 6.8 Hz, 
3H). 
13
C NMR (50 MHz, CDCl3) δ 145.11, 143.84, 128.45, 127.42, 125.70, 113.70, 
72.32, 46.03, 34.87, 20.93. The enantiomeric excess was determined by chiral GC: 
CP-Chiralsil-Dex-CB (25m x 0.25 mm), 95 °C isotherm. Retention times 57.6 min 
and 61.6 min. GC/MS: 158 (19%), 143 (80%), 128 (82%), 120 (45%), 115 (41%), 
107 (100%), 91 (24%), 79 (72%). 
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English Summary 
 
Heterocycles are ubiquitous structural features of naturally occurring and/or 
biologically active chemical compounds. Among these, nitrogen- and oxygen-
containing heterocycles with various ring sizes bearing stereogenic centers are 
frequently observed. The selective construction of these stereogenic centers 
imposes a particular challenge for chemists. 
In this work, a variety of synthetic approaches towards nitrogen- and oxygen-
containing heterocycles have been developed. All methods developed rely on 
asymmetric transition metal catalysis. These methodologies bear the advantage 
that both enantiomers of an envisaged product are accessible, since - in most 
cases - both enantiomers of the chiral catalysts are available. Literature-known 
asymmetric transformations have been applied to new targets to open up new 
routes to chiral heterocyclic compounds, but also new methodologies have been 
developed. In general, the approaches investigated during this work fall into three 
different categories: 
 
1)  The installation of the stereocenter of interest on a linear substrate followed 
 by the construction of the ring through a later transformation (e.g. ring-closing 
 metathesis). (see Chapters 2, 5) 
2)  An asymmetric ring-closing reaction is carried out, which furnishes both the 
 stereocenter and the ring structure in the same transformation. (see Chapters 
 3, 4) 
3) A catalytic asymmetric reaction on a prochiral heterocyclic structure is carried 
 out. (see Chapter 6) 
 
In Chapter 2, the application of iridium-catalyzed allylic amination of allylic 
carbonates with ammonia has been used to construct 2,5-arylpyrrolidines. These 
products are used as chiral auxiliaries, organocatalysts and as key structural motifs 
of phosphoramidite ligands. Ammonia as nitrogen source is a cheap, atom-
economic nucleophile. In the course of the reaction, a double allylic amination 
takes place, as the first addition product, a primary amine, is much more reactive 
than ammonia and directly undergoes a subsequent reaction with another allylic 
carbonate molecule. This particular reaction pathway is exploited, as the resulting 
chiral secondary amine - available in excellent yields and stereoselectivities - can 
be further transformed to a pyrroline by ring-closing metathesis. The desired 
products are obtained by a mild and selective organocatalytic reduction with a 
flavin-derived catalyst. During the course of this research, the latter catalytic 
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Chapter 3 marks one of the highlights of the present work. It describes the 
development of the first intramolecular asymmetric Ir-catalyzed allylic amidation. 
This methodology employs chiral Ir/phosphoramidite complexes and exploits the 
use of the trifluoroacetamide group both as a protecting group in the preparation of 
the allylic carbonates as well as nucleophiles for the key asymmetric Ir-catalyzed 
reaction. This transformation furnishes chiral tetrahydroisoquinolines and saturated 
nitrogen heterocyclic compounds in a highly stereoselective fashion. The products 
are useful building blocks, as they can easily be modified through the terminal 
olefin, which has been demonstrated in two attempted syntheses of a naturally 
occurring compound, Crispine A, as well as a biologically active compound, 
Almorexant. 
 
The attempted extension of allylic amidation methodology to the preparation of 
chiral β-carboline compounds is described in chapter 4. Even though ultimately the 
desired transformation could not be rendered feasible, a number of synthetic 
approaches to substituted indole compounds are presented. These investigations 
gave important insights that influenced the development of the asymmetric allylic 
amidation presented in chapter 3. Finally, the desired products could be prepared 
in a racemic fashion via a non-catalyzed pathway. 
 
In Chapter 5, the development of a new entry to nitrogen heterocycles with various 
ring sizes is presented. Here, a similar approach to the one in chapter 2 is followed. 
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An allylic substitution reaction furnishes a stereogenic center and a terminal double 
bond of which the latter is subsequently employed for the construction of a 
heterocycle through a metathesis reaction. By combining copper-catalyzed allylic 
substitution reactions with Grignard reagents with a subsequent olefin or ene-yne 
ring-closing metathesis the corresponding chiral products are available in excellent 
stereoselectivities. One advantage of this variable approach is that six- to eight-
membered heterocycles become available. The products from the ene-yne 
metathesis bear a diene motif, which is perfectly suited for further modifications. It 
has been demonstrated that his methodology can been extended to the 
construction of chiral lactams, however, some more investigations are needed to 
improve yields and enantioselectivities. 
 
In Chapter 6, another approach to chiral heterocycles is taken, as in this case the 
starting materials already possess a heterocycle: the development of an 
asymmetric copper-catalyzed conjugate addition reaction of Grignard reagents to 
coumarins is presented. These substrates had been elusive for this particular 
catalytic transformation, since they are relatively unreactive towards Michael 
addition. However, through judicious choice of ligands, the corresponding chiral 
lactones are accessible in excellent stereoselectivities. One important feature of 
this transformation was discovered in the course of the investigations: the 
intermediate chiral magnesium enolates can be trapped with amines or alcohols to 
give the ring-opened phenol-derived chiral esters and amides. On the one hand, 
these particular chiral esters were previously not accessible, on the other hand, this 
marks the development of a new formal asymmetric conjugate addition to amides.  
 
The research described in chapter 7 was directed towards the development of an 
asymmetric nickel-catalyzed reductive coupling of dienes with aldehydes yielding 
chiral bis-homoallylic alcohols. One of the major advantages of this reaction is that 
it generates two stereocenters in one catalytic transformation. The chiral products 
are highly functional and perfectly suited for further modification through their 
terminal olefin, the alcohol and the aromatic group. It was found that chiral nickel 
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lead to the desired products in unprecedented diastereoselectivity, but with only 
moderate enantioselectivity. 
1
H NMR and 
31
P NMR studies were carried out to 
provide some evidence for the postulated reaction mechanism via nickel-hydride 
complexes. 
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Nederlandse Samenvatting 
 
Heterocyclische substructuren zijn in een groot aantal in de natuur voorkomende 
en/of biologisch actieve chemische stoffen te vinden. In de natuur komt men vaak 
stik- en zuurstof bevattende heterocycli van verschillende ring groottes tegen die 
een stereocentrum in de ring hebben. Vooral het selectief maken van deze 
stereocentra in heterocycli is een grote uitdaging voor chemici. 
In dit proefschrift wordt de ontwikkeling van een verscheidenheid aan synthetische 
methoden beschreven die het mogelijk maken stik- en zuurstof bevattende 
heterocycli te synthetiseren. Asymmetrische katalyse, gebruik makend van 
overgangsmetalen, wordt in de hier beschreven methoden gebruikt voor het 
vormen van het gewenste stereocentrum. Een attractief aspect van de nieuw 
ontwikkelde methoden is dat via deze nieuwe methoden beide enantiomeren van 
het product gesynthetiseerd kunnen worden, aangezien -in de meeste gevallen- 
beide enantiomeren van de chirale katalysatoren beschikbaar zijn. Naast het 
toepassen van in de literatuur bekende asymmetrische transformaties op nieuwe 
uitgangsstoffen, om op deze manier nieuwe routes te ontwikkelen voor de 
synthese van chirale  heterocyclische stoffen, zijn in dit proefschrift ook nieuwe 
methoden ontwikkeld voor het synthetiseren van deze klasse van verbindingen. De 
beschreven methoden kunnen worden onderverdeeld in drie categoriën: 
1)  Eerst wordt een stereocentrum in een lineair substraat geintroduceerd, waarna 
in een opvolgende reactie de ring gevormd wordt (bijvoorbeeld via „ring-
closing metathesis‟). (Zie hoofdstukken 2 en 5) 
2)  Een asymmetrische ring-sluitende reactie wordt uitgevoerd om én het 
stereocentrum én de ring structuur te vormen in een enkele transformatie. (Zie 
hoofdstukken 3 en 4) 
3) Een katalytische asymmetrische reactie wordt uitgevoerd op een prochiraal 
heterocyclisch substraat. (Zie hoofdstuk 6) 
 
In hoofdstuk 2 wordt iridium-gekatalyseerde allylische aminering van allylische 
carbonaten met ammonium als nucleofiel gebruikt om 2,5-arylpyrrolidines te 
synthetiseren. De gevormde producten worden gebruikt als chirale „auxiliaries‟, als 
organokatalysatoren en als de belangrijkste structuureenheid van verscheidene 
fosforamidiet liganden. Het gebruik van ammonium als stikstof nucleofiel is én 
kostenefficiënt én atoom efficiënt. Tijdens de reactie vindt een dubbele aminering 
plaats waarbij als eerste additieproduct een primair amine gevormd wordt. Dit 
primaire amine is veel reactiever dan ammonium en voert direct de volgende 
additie uit aan een ander allylisch carbonaat molecuul. Deze specifieke manier van 
synthese wordt gebruikt omdat het aldus gevormde chirale secondaire amine -dat 
wordt verkregen met excellente opbrengst en selectiviteit- via een „ring-closing 
metathesis‟ kan worden omgezet naar het pyrroline. Het gewenste eindproduct 
wordt vervolgens verkregen door het gebruik van een milde en selectieve 
organocatalytische reductie met een katalysator wiens structuur gebaseerd is op 
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gekatalyseerde transformatie geoptimaliseerd en werd er voor deze omzetting een 
nieuw reactieprotocol ontwikkeld. 
 
Hoofdstuk 3 is een van de hoogtepunten van het hier beschreven werk. In dit 
hoofdstuk wordt de ontwikkeling van de eerste intramoleculaire asymmetrische Ir-
gekatalyseerde allylische amidering beschreven. Voor deze transformatie worden 
chirale Ir/fosforamidiet complexen gebruikt als katalysator. Verder wordt de 
trifluoroacetamide groep gebruikt als beschermgroep én als nucleofiel voor de 
asymmetrische Ir-gekatalyseerde reactie. De ontwikkelde transformatie vormt 
chirale tetrahydroisoquinolines en verzadigde stikstof-bevattende heterocyclische 
verbindingen met uitstekende stereoselectiviteit. De producten zijn bruikbare 
chemische bouwstenen en kunnen bovendien makkelijk verder worden 
gefunctionaliseerd door het omzetten van het eindstandige olefine. De vele 
mogelijkheden voor het gebruik van deze producten wordt geillustreerd door twee, 
ondernomen maar niet voltooide, syntheseroutes van een in de natuur 
voorkomende stof, crispine A, en de synthese van een biologisch actieve stof, 
Almorexant. 
 
Pogingen tot het gebruik van de ontwikkelde allylische amiderings methodologie 
voor de vorming van β-carboline verbindingen worden beschreven in hoofdstuk 4. 
Ondanks dat het uiteindelijke doel, een asymmetrische formatie van de gewenste 
verbindingen, niet haalbaar bleek, worden toch een aantal syntheseroutes voor het 
vormen van indol verbindingen beschreven. De studies naar de asymmetrische 
transformatie hebben ook tot belangrijke inzichten geleid die het mogelijk maakten 
om de asymmetrische allylische amidering te ontwikkelen die is beschreven in 
hoofdstuk 3. Uiteindelijk is het ook gelukt om de gewenste produkten racemisch te 
synthetiseren via een niet-gekatalyseerde route. 
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In hoofdstuk 5 wordt een nieuwe route voor het synthetiseren van stikstof 
heterocycli gepresenteerd. Voor deze nieuwe route wordt een aanpak gebruikt die 
erg lijkt op de aanpak beschreven in hoofdstuk 2. Een allylische substitutie reactie 
geeft een stereogeen centrum én een eindstandige dubbele binding, waarna het 
gevormde olefine wordt gebruikt om een heterocyclisch product te vormen door 
middel van een metathese reactie. Door de koper-gekatalyseerde allylische 
substitutie reactie met Grignard reagentia te combineren met een opeenvolgende 
olefinische of een-yn „ring-closing metathesis‟ worden de overeenkomstige chirale 
producten verkregen met excellente stereoselectiviteit. Een voordeel van de 
modulaire aanpak is dat heterocycli met een grootte van zes tot acht atomen 
gevormd kunnen worden. Verder kunnen de gevormde producten van de een-yn 
metatheses, die een dieen functionele groep bezitten, makkelijk verder worden 
gefunctionaliseerd. Ook wordt gedemonstreerd dat deze methodologie kan worden 
gebruikt om chirale lactamen te vormen, wel moet door verder onderzoek de 
opbrengsten en selectiviteiten van de laatst genoemde reacties worden verbeterd. 
 
In hoofdstuk 6 wordt gebruik gemaakt van een andere aanpak om chirale 
heterocycli te vormen. In dit hoofdstuk wordt beschreven hoe door middel van een 
koper-gekatalyseerde asymmetrische geconjugeerde additie reactie van Grignard 
reagentia aan coumarines, waarbij het substraat dus al een heterocyclus is, chirale 
heterocycli gevormd worden. De gekozen substraten werden nog niet gebruikt voor 
dit soort katalytische transformaties aangezien de coumarines een relatief lage 
reactiviteit als Michael acceptor hebben. Door het kiezen van de juiste katalysator 
kunnen de overeenkomstige chirale lactonen worden verkegen met excellente 
stereoselectiviteit. Een belangrijke eigenschap van deze transformatie werd 
ontdekt tijdens dit onderzoek: het chirale magnesium enolaat, dat gevormd wordt 
als intermediair, kan in-situ verder reageren met alcoholen of amines tot ring 
geopende chirale phenol esters en amides. Voor deze specifieke ring geopende 
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Verder betekend de ring-opening door amines de eerste in literatuur beschreven 
formele asymmetrische geconjugeerde additie aan amides.  
 
Het onderzoek dat beschreven wordt in hoofdstuk 7 was gericht op het ontwikkelen 
van een asymmetrische nikkel-gekatalyseerde reductieve koppeling van diënen 
met aldehyden dat zou moeten leiden tot chirale bis-homoallylische alcoholen. Een 
van de grote voordelen van deze reactie is dat twee stereocentra in één 
gekatalyseerde transformatie gevormd worden. De chirale producten zijn 
verscheidende malen gefunctionaliseerd en uitstekend geschikt voor verdere 
modificatie via het eindstandige olefine, het alcohol en de aromatische groep. Het 
werd ontdekt dat de chirale nikkel complexen met monodentaat fosforamidiet of N-
heterocyclische carbeen liganden leiden tot het gewenste product met een nog 
nooit vertoonde hoge diastereoselectiveit, maar met slechts middelmatige 
enantioselectiveit. 
1
H NMR en 
31
P NMR studies werden uitgevoerd om bewijs voor 
het gepostuleerde mechanisme via nikkel-hydride complexen te verkrijgen. 
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Deutsche Zusammenfassung 
 
Heterozyklische Strukturelemente sind in einer großen Anzahl in natürlich 
vorkommenden und/oder biologisch aktiven Substanzen zu finden. Darunter finden 
sich häufig stickstoff- oder sauerstoffhaltige Ringsysteme variabler Größe mit 
Stereozentren. Der selektive Aufbau letzterer stellt eine Herausforderung für die 
organische Synthese dar. 
In der vorliegenden Arbeit ist die Entwicklung synthetischer Routen zur 
Konstruktion stickstoff- und sauerstoffhaltiger chiraler Heterozyklen beschrieben. 
Alle angewandten Synthesestrategien greifen auf die asymmetrische Katalyse mit 
Übergangsmetallen zurück. Dies ermöglicht den selektiven Aufbau beider 
Enantiomere des gewünschten Stereozentrums, da in den hier diskutierten Fällen 
beide Enantiomere des jeweils verwendeten chiralen Liganden erhältlich sind. Dies 
stellt einen deutlichen Vorteil gegenüber anderen asymmetrischen 
Synthesemethoden, wie z.B. des Rückgriffs auf den “chiral pool” dar. In dieser 
Arbeit wurden sowohl literaturbekannte Synthesemethoden auf neue Substrate 
angewendet als auch neue Methoden für die Synthese von heterozyklischen 
Verbindungen entwickelt. Die Synthesewege lassen sich in drei Kategorien 
klassifizieren: 
 
1) Die Konstruktion des gewünschten Stereozentrums an einem linearen 
Substrat, welches in der Folge durch Ringschlussreaktionen (wie z.B. der 
Ringschlussmetathese) zu einem Heterozyklus umgesetzt wurde (siehe 
Kapitel 2 und 5). 
 
2) Sowohl das Stereozentrum als auch der Heterozyklus werden in einer 
einzigen Reaktion aufgebaut (siehe Kapitel 3 und 4). 
 
3) Eine katalytisch asymmetrische Transformation an einem prochiralen 
Heterozyklus wird durchgeführt (siehe Kapitel 6). 
 
In Kapitel 2 wird die Synthese von 2,5-Diraylpyrrolidinen mittels asymmetrischer 
iridium-katalysierter allylischer Aminierung von Allylcarbonaten mit Ammoniak 
beschrieben. Die so zugänglichen Produkte finden als chirale Auxiliare, 
Organokatalysatoren sowie Schlüsselbestandteile von chiralen 
Phosphoramiditliganden Anwendung in der organischen Chemie. Die Verwendung 
von Ammoniak als Stickstoffnukleophil ist vorteilhaft, da es günstig und 
atomökonomisch ist. Im Verlauf der Reaktion kommt es zu einer zweifachen 
allylischen Aminierung, da das intermediär auftretende primäre Amin ein deutlich 
besseres Nukleophil als Ammoniak ist und sofort mit einem weiteren Äquivalent 
Allylcarbonat abreagiert. In unserem Fall ist dieser Reaktionsweg erwünscht, da 
das resultierende chirale sekundäre Amin – zugänglich in exzellenten 
Stereoselektivitäten und sehr guter Ausbeute – mittels Ringschlussmetathese zu 
einem chiralen Pyrrolidin umgesetzt werden kann. Die Synthese der gewünschten 
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Flavinderivat abgeschlossen. Letztere Reaktion wurde anhand der vorliegenden 
Reaktion optimiert und daraus ein neues Reaktionsprotokoll entwickelt. 
 
Ein Höhepunkt der vorliegenden Arbeit ist in Kapitel 3 beschrieben. Dort wird die 
Entwicklung der ersten asymmetrischen intramolekularen iridiumkatalysierten 
allylischen Amidierung vorgestellt. Diese neue Methode basiert auf der 
Verwendung von chiralen Iridium-phosphoramiditkomplexen sowie der Ausnutzung 
der Reaktivität der Trifluoracetamidgruppe als Schutzgruppe zum einen und als 
Nukleophil in der allylischen Amidierung zum anderen. Die Zielmoleküle dieser 
Umsetzung, chirale Tetrahydroisoquinoline und gesättigte Stickstoffheterozyklen, 
sind mit sehr guter Stereoselektivität zugänglich. Beide Produktklassen stellen 
nützliche Synthesebausteine dar, da sie durch die terminalen Olefine leicht zu 
modifizieren sind. Die Vielseitigkeit dieser Moleküle wurde in zwei versuchten 
Synthesen eines natürlich vorkommenden Alkaloid, Crispine A, sowie eines 
Arzneistoffs, Almorexant, demonstriert. 
Die angestrebte Erweiterung dieser Methode auf die Synthese von chiralen β-
Carbolinverbindungen ist in Kapitel 4 beschrieben. Auch wenn letztendlich die 
gewünschte Umsetzung nicht erreicht wurde, stellt dieses Kapitel einige mögliche 
Ansätze für die Synthese von substituierten Indolverbindungen vor. Diese 
Untersuchungen ergaben wichtige Erkenntnisse, die sich auch für die Entwicklung 
der in Kapitel 3 vorgestellten Tetrahydroisoquinolinsynthese wertvoll erwiesen 
haben. Die angestrebten β-Carbolinverbindungen konnten letztendlich auf einem 
nicht-katalysierten Syntheseweg in racemischer Form hergestellt werden. 
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In Kapitel 5 wird die Entwicklung einer neuen Synthese von chiralen 
Stickstoffheterozyklen variaber Ringgröße diskutiert. Ähnlich der in Kapitel 2 
vorgestellten Syntheseroute wird hier zunächst ein Stereozentrum an einem 
linearen Substrat mittels asymmetrischer allylischer Substitution eingeführt, 
wonach das Ringsystem per Metathese aufgebaut wird. Diese wird durch die 
terminale Doppelbindung, das Produkt der allylischen Substitution, ermöglicht. Die 
Kombination von asymmetrischer kupferkatalysierter allylischer Alkylierung mit 
Ringschlussmetathese liefert die gewünschten sechs- bis achtgliedrigen 
Heterozyklen in exzellenten Stereoselektivitäten. Diese Variabilität der 
Syntheseroute stellt einen großen Vorteil dar. Falls eine Enin-metathese verwendet 
wird, entstehen Heterozyklen mit einem Dienmotiv, welches sich gut für die spätere 
Funktionalisierung, z.B. durch eine Diels-Alder-Reaktion, eignet. Es konnte gezeigt 
werden, dass sich diese Methode auch auf die Synthese von chiralen Laktonen 
erweitern lässt. Allerdings sind weitere Untersuchungen notwendig, um die 
Ausbeuten und Stereoselektivitäten dieser Umsetzung zu verbessern. 
 
Kapitel 6 beschreibt die Entwicklung einer asymmetrischen kupferkatalysierten 
konjugierten Additionsreaktion von Grignardreagenzien an Coumarinderivate. 
Coumarine konnten bisher nicht mit diesem Reaktionstyp umgesetzt werden, da 
sie verhältnismäßig reaktionsträge sind. Durch die richtige Ligandenwahl sind die 
Additionsprodukte jedoch in guten Stereoselektivitäten und Ausbeuten erhältlich.  
Während der Untersuchung dieser Reaktion wurde eine weitere Eigenschaft dieser 
Substratklasse entdeckt: Die intermediären chiralen Magnesiumenolate lassen sich 
mit Aminen oder Alkoholen per Ringöffnungsreaktion zu den entsprechenden 
ortho-Phenolestern oder –amiden umsetzen. Zum einen waren diese Ester mit der 
bisher bekannten Methode nicht herstellbar und zum anderen stellt dies eine neue 
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Im letzten Abschnitt dieser Arbeit (Kapitel 7) werden die Untersuchungen zur 
Entwicklung einer neuen nickelkatalysierten reduktiven Kupplungsreaktion von 
Dienen mit Aldehyden zur Herstellung von chiralen Bishomoallylalkoholen 
vorgestellt. Ein großer Vorteil dieser Reaktion ist die Tatsache, dass in dieser 
katalytischen Umsetzung zwei Stereozentren zugleich aufgebaut werden können. 
Die chiralen Produkte sind durch das terminale Olefin, den sekundären Alkohol 
sowie durch den Aromaten hochfunktional und damit wertvolle chirale 
Synthesebausteine. Chirale Nickelkomplexe mit Phosphoramidit- oder N-
heterozyklischen Carbenliganden konnten als sinnvolle Katalysatoren zur 
Herstellung der gewünschten Produkte identifiziert werden. Diese konnten mit 
exzellenter Diastereoselektivität, jedoch mit nur mäßiger Enantioselektivität isoliert 
werden. 
1
H NMR- und 
31
P NMR-Studien der Reaktion konnten wichtige Messdaten 
zur Unterstützung des vorgeschlagenen Reaktionsmechanismus via 
Nickelhydridkomplexe liefern. 
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